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  ABSTRACT 
Curcuma zedoaria (Christm.) Rosc. (local name: Temu putih) and Curcuma 
purpurascens are two medicinally important plants of the genus Curucma and grow 
abundantly in Asian countries including Malaysia and Indonesia. These two plants are 
extensively used in the traditional medicinal practice of Malaysia and many other 
countries of the world for the treatment of various ailments. Phytochemical 
investigation of the rhizomes of C. zedoaria and C. purpurascens resulted in the 
isolation of 27 compounds. C. zedoaria afforded eighteen sesquiterpenes, including 
eight germacrane type (dehydrocurdione 19, curdione 20, furanodiene 21, 
furanodienone 22, germacrone 23, germacrone 4,5-epoxide 24, germacrone 1,10-
epoxide 25,  and zederone 26), four guaiane type (gweicurculactone 41, curcumenol 42, 
curcumenol second monoclinic 150,  isoprocurcumenol 43, and procurcumenol 44), one 
seco-guaiane (curcuzedoalide 62), one elemane (curzerenone 111), one humulane 
(zerumbone epoxide 151), one cadianene (comosone II 104), one carabrane 
(curcumenone 65), and one spirolactone type (curcumanolide 101). The work also 
resulted in the isolation of three labdane diterpenes (labda-8(17), 12 diene-15, 16 dial 
127, calcaractrin A 128, and zerumin A 129, which are reported for the first time from 
C. zedoaria. Phytochemical investigation of C. purpurascens produced five compounds 
including one bisabolane (ar-turmernone 74) and one guaiane (zedoalactone B 60) 
sesquiterpene while the rest three are curcuminoids curcumin 138, 
bisdemethoxycurcumin 139, demethoxycurcumin 140). A total of 34 compounds were 
identified through the GC and GC-MS spectroscopic analysis of the essential oil 
obtained by hydrodistillation of C. putpurascens. The major compounds were ar-
turmerone 74 (9.4%), germacrone 23 (13.2%), and turmerone 80 (13.5 %). Supercritical 
fluid extraction of C. purpurascens rhizomes showed that the optimum parameters for 
higher yield and selective extraction could be obtained at the temperature of 313 K, with 
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the pressure 10.34 MPa and the flow rate of liquid CO2 at 12 ml/min. Open column 
chromatography on silica gel (CC), thin layer chromatography (TLC), preparative thin 
layer chromatography (PTLC), high performance liquid chromatography (HPLC), and 
size exclusion chromatography by Sephadex
®
 (LH-20) were used for the detection and 
isolation of the compounds. Extensive spectroscopic and chromatographic analysis 




C NMR, DEPT, COSY, HMBC, HSQC, and 
NOESY), IR, UV, GC-MS, LC-MS were used for the structure elucidation of the 
isolated compounds. X-ray crystallographic analysis was performed on the second 
monoclinic crystals of curcumenol (151) which is new dimer crystals isolated from C. 
zedoaria. Isolated compounds were subjected to cytotoxicity, anti-oxidant and 
neuroprotective assays. Curcumenol (42) and dehydrocurdione (19) showed the highest 
protection (100%) against hydrogen peroxide induced oxidative stress in NG108-15 
cells at the concentrations of 4 and 8 µM, respectively. In the oxygen radical antioxidant 
capacity assay, zerumbone epoxide (151) showed the highest level of antioxidant 
activity with a Trolox equivalent (TE) of 35.41 µM per 100 µg of sample. In the MTT 
based cytotoxicity assay against four cancer cell lines (CaSki, MCF-7, PC-3 and HT-29) 
curcumenol (42) and curcumenone (65) displayed strong antiproliferative activity (IC50 
9.3 and 8.3 µg/ml, respectively). A quantum chemical study was performed to 
investigate its relationship with cytotoxic activity and revealed that the dipole moment 
(µ), molecular volume (V), molecular area (A), polarizability (α) and hydrophobicity 
(log P) are the most important descriptors that influence the cytotoxic activity of the 
compounds under investigation. The essential oil obtained the hydrodistillation 
exhibited strong cytotoxicity against HT29 cells but mild cytotoxicity against the non-
cancerous human lung fibroblast cell line (MRC5). The two most active compounds; 
curcumenol (42) and curcumenone (65), were investigated for their binding to human 
serum albumin (HSA), a transportation protein of human blood. The spectroflurometric 
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analysis, in conjunction with molecular docking study suggested that both curcumenol 
(42) and curcumenone (65) could bind to binding sites I and II of HSA with 
intermediate affinity while site I was the preferred binding site for both molecules.  
 iv 
ABSTRAK 
Curcuma zedoaria (Christm.) Rosc. (nama tempatan: Temu putih) dan Curcuma 
purpurascens (nama tempatan: Temu parlimen) merupakan dua tumbuhan ubatan yang 
penting daripada genus Curucma dan banyak didapati di negara-negara Asian 
termasuklah Malaysia dan Indonesia. 
Kedua-dua tumbuhan ini digunakan secara meluas dalam amalan perubatan tradisional 
di Malaysia dan negara-negara lain di dunia untuk merawat pelbagai penyakit. Kajian 
fitokimia terhadap rizom C. zedoaria dan C. purpurascens berjaya mengasingkan 
sebanyak 27 sebatian.  
C. zedoaria menghasilkan lapan belas seskuiterpena, termasuk lapan jenis 
germakrana (dehidrokurdiona 19, kurdiona 20, furanodiena 21, furanodienona 22, 
germakrona 23, germakrona 4,5-eposida 24, germakrona 1,10-epoksida 25, dan 
zederona 26), empat jenis guaiana (gweikurkulaktona 41, kurkumenol 42, kukumenol  
monoklinik kedua 150,  isoprokurkumenol 43, dan prokurkumenol 44), satu seko-
guaiana (kurkuzedoalida 62), satu elemana (kurzerenona 111), satu humulana 
(zerumbona epoksida 151), satu kadianena (komosona II 104), satu karabrana 
(kurkumenona 65), dan satu jenis spirolactona (kurkumanolida 101). 
Kajian ini juga berjaya mengasingkan tiga diterpena labdana (labda-8(17), 12 diena-
15, 16 dial 127, kalkaraktrin A 128, and zerumin A 129, yang mana ini merupakan 
laporan kali pertama bagi C. zedoaria. 
Kajian fitokimia bagi C. purpurascens menghasilkan lima sebatian termasuk satu 
bisabolana (ar-turmernona 74) dan satu guaiana (zedoalaktona B 60) seskuiterpena 
sementara tiga lagi adalah kurkuminoid kurkumin 138, bisdemetoksikurkumin 139, 
demetoksikurkumin 140). 
Sejumlah 34 sebatian telah dikenalpasti melalui analisis spektroskopi GC dan GC-
MS terhadap minyak pati yang diperolehi daripada penyulinganhidro C. putpurascens.  
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Sebatian major adalah ar-turmerona 74 (9.4%), germacrona 23 (13.2%), dan turmerona 
80 (13.5 %). Pengekstrakkan cecair superkritikal daripada rizom C. purpurascens 
menunjukkan parameter optima bagi penghasilan hasil yang lebih banyak dan 
pengekstrakkan terpilih berlaku pada suhu 313 K, dengan tekanan 10.34 MPa dan kadar 
aliran cecair CO2 pada 12 ml/min. 
 Kromatografi turus menggunakan gel silica (CC), kromatografi kepingan nipis 
(TLC), kromatografi kepingan nipis persediaan (PTLC), kromatografi cecair 
berteknologi tinggi (HPLC), dan kromatografi penyisihan saiz menggunakan Sephadex
®
 
(LH-20) untuk penentuan dan pengasingan sebatian . Analisis spektroskopi dan 




C NMR, DEPT, COSY, 
HMBC, HSQC, dan NOESY), IR, UV, GC-MS, LC-MS digunakan untuk penentuan 
struktur sebatian yang telah diasingkan. 
Analisis kristalografi X-ray telah dilakukan pada kristal kurkumenol monoklinik 
kedua (151) yang merupakan dimer baru yang dipencilkan daripada C. zedoaria.  
Sebatian yang diasingkan telah dilakukan essei sitotoksisiti, anti-oksidan dan 
perlindungan neuro.Kurkumenol (42) dan dehidrokurdiona (19) menunjukkan 
perlindungan tertinggi (100%) terhadap hidrogen peroksida tekanan oksidatif yang 
disebabkan oleh sel NG108-15 pada kepekatan 4 dan 8 µM. 
Essei kapasiti antioksidan radikal oksigen, zerumbona epoksida (151) menunjukkan 
tahap tertinggi aktiviti antioksidan dengan menggunakan Trolox setara (TE) pada 35.41 
µM per 100 µg sampel. 
Dalam essei sitotoksisiti MTT terhadap empat jujukan sel kanser (CaSki, MCF-7, 
PC-3 dan HT-29) kurkumenol (42) dan kurkumenona (65) menunjukkan aktiviti 
antiproliferatif yang kuat (IC50 9.3 dan 8.3 µg/ml). 
Kajian kuantum kimia yang dijalankan untuk mengkaji hubungan antara aktiviti 
sitotoksisiti dan menunjukkan bahawa momen dwikutub (µ), isipadu molekul (V), 
 vi 
kawasan molekul (A), kebolehupayaan kekutuban (α) dan hidrofobisiti (log P) adalah 
sangat penting bagi menggambarkan kesan aktiviti sitotoksisiti sebatian terhadap 
kajian.Minyak pati yang terhasil daripada penyulingan hidro menunjukkan kesan 
sitotoksisiti yang kuat terhadap sel HT29 tetapi sitotoksisiti sederhana terhadap jujukan 
sel bukan kanser fibroblast paru-paru (MRC5). 
Dua sebatian teraktif; kurkumenol (42) dan kurkumenona (65), telah dikaji untuk 
perlekatan kepada serum albumin manusia (HSA), iaitu pengangkutan protein di dalam 
darah manusia. Analisis spektroflurometrik, selari dengan kajian doking molekul 
mencadangkan kedua-dua kurkumenol (42) dan kurkumenona (65) boleh melekat pada 
tapak pelekatan HSA I dan II dengan perantaraan afiniti sementara tapak I dicadangkan 
tapak perlekatan bagi kedua-dua molekul. 
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CHAPTER 1: INTRODUCTION 
1.1 Introduction 
 The use of plants in the treatment of diseases is as old as human civilization on 
the earth. Although it is not clear how the primitive people discovered the phenomenon 
that plants could be used to cure disease, but probably through the process of trial and 
error, they mastered the use of proper plants for the treatment of certain disease. 
Thereby, some of the most well-known traditional medicinal practices e.g. Indian 
Ayurveda, Chinese Medicine, Galenical Greek, and Egyptian were developed. Such 
herbal practices still have thrived throughout the centuries to reserve their values to the 
modern medications and their efficacies are now proven to be efficient by scientific 
explorations. The utilization of the plant materials is an active area of research that takes 
advantage of readily available, valuable and renewable resources. Isolation of 
biologically active compound(s) is a field of ever increasing interest that originates from 
the basic ideas to systematic research and high-throughput screening of the plant 
kingdom. Medicinal plants were and are still the reservoir to produce a wide variety of 
chemicals that can impart various important biological activities (P. Lai et al., 2004). 
Surprisingly, the use of medicinal plants remained popular and common in almost all 
communities, while it is the sole source of basic health care needs in the developing 
countries, even if it is not very common in developed countries. Not only is this but 
another fascinating fact about traditional medicines that they represent one of the 
strongest links in the history of the human kind between the man and nature. Despite the 
modern lifestyle and westernization, scientists are increasingly turning their attention to 
natural products with a view to develop important new leads against various diseases, 
and in particular, for the treatment of cancer (Organization, 2013). Hence, natural 
medicines continue to play a key role as a source of contemporary cancer 
chemotherapeutic agents (Balunas et al., 2005). 
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The WHO reported that in some Asian and African countries, up to 80% of the 
population relies on traditional medicine for their primary health care needs. Therefore, 
the updated strategy of the WHO for the period 2014-2023 devotes more attention than 
its predecessor to prioritizing traditional medicine based health services and systems 
(Organization, 2002)  
 (Recent drug discovery techniques based on structure-activity relationships, 
computer aided molecular modelling, combinatorial chemistry, high throughput 
screening, various chromatographic tools and spectroscopic methods (MS, NMR, X-ray, 
and IR) have led to the discovery of many natural products and natural product derived 
drugs. 
Natural products in their simple forms based on the above mentioned 
technological analysis, dominate the current therapeutic practice. While some pure 
compounds have been isolated successfully and used as single therapeutic agent in the 
treatment of a particular disease, i.e. artemisinin (1), paclitaxel (2) and its analogue 
docetaxel (3) as presented in Figure  1.1, preparations containing extract of one plant or 
a number of plants also have been exploited, mainly by traditional healers.  
 
Figure  1.1: Examples of some therapeutic agents from plants 
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Artemisinin (1) for instance is a secondary metabolite of the sesquiterpene 
lactone type with an unusual endoperoxide bridge produced by Artemisia annua, a plant 
used in Traditional Chinese Medicine (TCM). Artemisinin is the drug of choice for the 
treatment of malaria and is effective against quinine-resistant strains of Plasmodium 
falciparum. The peroxide bridge is believed to be essential for the drug’s antimalarial 
property (Chaturvedi et al., 2010). A. annua, of the family Asteraceae, is native to China 
and has been used there for over two thousand years to treat fever. In addition to its use 
in treating malaria, artemisinin has been demonstrated to be effective against a variety 
of other diseases including hepatitis B, schistosomiasis (Romero et al., 2005), and a 
wide range of cancers (Singh et al., 2004).  
The diterpenoid paclitaxel (taxol) 2, first isolated from Taxus brevifolia, is one 
of most widely used anti-cancer drugs for the treatment of breast, ovarian and lung 
cancers (Heinig et al., 2009). Docetaxel (texotere) 3 is a semi-synthetic derivative of 
paclitaxel, and has potent activity against breast cancer (Ravdin et al., 1995).   
Plant derived essential oils also represent an important class of natural products 
that contributes in various domains of human activities. In nature, essential oils play an 
important role in the protection of plants. They also attract some insects which in turn 
disperse pollen and seeds, or repel the undesirable attention of predators (Bakkali et al., 
2008; Nerio et al., 2010). Essential oils can be divided into three major classes: oils used 
for therapeutic purposes; oils used as flavoring agents in foods; used for perfumery, 
soap and cosmetics perfumery, cosmetics, pharmaceuticals, and aromatherapy. Since 
the Middle ages, essential oils have been widely used for their antiparasitic, antiviral, 
bactericidal, fungicidal, insecticidal, and medicinal cosmetic applications broadly 
nowadays in pharmaceutical, sanitary, cosmetic, agricultural and food industries. For 
example, the essential oils extracted from the dried lemongrass (Cymbopogon citratus 
or Andropogon citratus). The main constituents of the lemongrass derived essential oils 
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of the lemongrass are citral, citronellal, geranyl acetate, geraniol limonene, myrcene, 
and nerol. Essential oils also have many beneficial properties e.g. analgestic, 
antidepressant, anti-pyretic, antifungal and antibacterial (Leite et al., 1986; Sessou et al., 
2012; Tzortzakis et al., 2007). The tea tree oil is an essential oil from the leaves of 
Melaleuca alternifolia and has a long history of traditional uses. Australian aboriginals 
use tea tree leaves for healing skin cuts, burns, and infections by crushing the leaves and 
applying them on the affected area. Tea tree oil contains terpenoids, which have 
antiseptic and antifungal properties. Tea tree oil is a complex mixture of approximately 
100 components, whereas terpinen-4-ol is the most abundant and thought to be the 
major contributing factor towards the antimicrobial activity of tea tree oil, while 1,8-
cineole is a skin irritant (Carson et al., 1995) . 
Collectively, natural products shape the modern medical treatment either in the 
form of a cutting edge pharmaceutical drug, a component of cosmetic preparation, or as 
simple as a decoction in rural traditional practice. 
 In view of the importance of natural medicines in the world communities, 
coupled with the advancement of science and technology to discover the underlying 
prospects that could be responsible for the manifestation of their biological and 
pharmacological activities, this work was undertaken to study of two selected Indo-
Malay medicinal herbs from the Curcuma species used in the Malay archipelago.  
1.2 Aims and objectives 
C. zedoaria and C. purpurascens presents some important uses in traditional 
practice. However, no scientific evidence has been reported to justify their use. 
Therefore, it is worth applying modern techniques to support the traditional claims 
phytochemically and pharmacologically. Results obtained, perhaps, can be used for 
development therapeutic agents. 
The specific aims and objectives of this study are as follows: 
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Isolation, purification and identification of the chemical constituents from the n-hex and 
DCM extracts of C. zedoaria and C.  purpurascens. 
 Extraction of volatile components from C. purpurascens using hydrodistillation 
and supercritical fluid extraction techniques, then analysing by combination of 
GC/GC-MS spectroscopy. 
 Investigation of cytotoxic activity of isolated compounds from C.zedoaria: 
o Cytotoxicity test against MCF-7, Ca Ski, HT-29, and PC-3 cell line as 
well as against non-cancer human fibroblast cell line (MRC-5), and 
HUVEC cell line using in vitro MTT cytotoxicity assay.  
o Elucidation of the structure-cytotoxic activity relationship of twenty-one  
compounds isolated from C. zedoaria using the density functional theory 
(DFT) method at B3LYP/6-31+G (d,p) level, with a view to calculate 
electronic and steric molecular descriptors of the compounds under 
investigation. Statistical methods were applied (SLR, MLR, PCA and 
HCA) to determine the main descriptors responsible for the cytotoxic 
activity of the isolated compounds. 
 Investigation of cytotoxic activities of the n-hex, DCM, MeOH extracts, 
hydrodistilled essential oil, supercritical fluid extracts, and the isolated pure 
compounds of C. purpurascens using an in vitro MTT cytotoxicity assay against 
various human cancer cell lines.    
 Test for neuroprotective activity of selected compounds against H2O2-induced 
oxidative stress in NG108-15 cells. 
 Test for antioxidant activity of the compounds tested for neuroprotective 
activity.  
 Investigations on the interaction of human serum albumin (HSA) to the two 
most active compounds (curcumenol 42 and curcumenone 65) based on 
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fluorescence spectroscopic results coupled with molecular docking study. 
 Application of molecular docking to investigate the location of interaction of 
these two compounds at the binding sites (site I and site II) of HSA. 
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CHAPTER 2: LITERATURE REVIEW  
2.1 Introduction 
In the present study, the rhizomes of two plants namely, Curcuma zedoaria and 
Curcuma purpurascens were chosen for the phytochemical and biological 
investigations. Thus literature survey on these plants was carried out using some of the 
most widely accepted abstracting indices including Scifinder Scholar, Pubmed, Web of 
Knowledge and Scopus. In addition, Google scholar was also used to search for 
published research work on these two plants that is not available through the above 
websites. This chapter contains the literature review of the two plants and the topics 
encompass habitat, traditional uses, previous phytochemical investigation, and 
biological investigation. This chapter also deals briefly with the classification, 
biosynthesis of the some of the monoterpenes, sesquiterpenes and diterpenes, found in 
the genus Curcuma and represented as the major class of natural products. 
2.2 Botanical and chemical aspects 
The family Zingiberaceae and one of its major genera Curcuma has drawn the 
attention of the researchers for their wide use in daily diet, folkloric medicine and rich 
secondary metabolite content. The use of such plant species in traditional medicine for 
the treatment of specific disease coupled with their bioactive component holds a good 
promise towards the development of potential drug leads and nutraceuticals. The 
following sections deals with the botanical identity of the family Zingiberaceae and the 
genus Curcuma as well as the chemical diversity seen in this genus.   
2.2.1 The family Zingiberaceae 
The Zingiberaceae is one of the most prolific plant families found in tropical 
rainforests. Species of the Zingiberaceae are famous for their use and also for their 
medicinal properties. The family contains approximately 1400 species distributed in 47 
genera (Pancharoen et al., 2000).  In Peninsular Malaysia, approximately 160 species 
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belonging to 18 genera are found, mostly growing naturally in damp, shaded parts of the 
lowland or hill slopes, as scattered plants, or thickets (Larsen et al., 1999). In Asian 
countries, several species are commonly used as spices, medicines, flavouring agents, as 
well as the source of certain dyes (Burkill, 1966). Many plants of this family are 
extensively used in the traditional herbal remedies for treating and preventing diseases 
particularly in Malaysia, Indian Ayurveda and Chinese medicine (Lakshmi et al., 
2011a). All parts of the plants of all members of this family contain essential oils. 
Leaves, seeds, and rhizomes are usually rich in monoterpenes, sesquiterpenes, aliphatic 
hydrocarbons, aromatic ketones, which are the characteristic components of volatile oils 
(Brouk, 1975).  
2.2.1.1 The genus Curcuma 
The genus Curcuma (Zingiberaceae) contains various rhizomatous herb and is 
known as the turmeric genus. The name “Curcuma” derived from the Arabic word 
“Kurkum” meaning “Saffron”, but now refers to turmeric only. The genus Curcuma has 
over 100 species growing in tropical and subtropical areas in Asia. Some of the most 
famous species of Curcuma used in the traditional medicine for thousands of years 
include C. aromatic, C. longa , C. xanthorriza. and  C. zedoaria. 
   The orange coloration of the Curcuma species is often associated with their 
curcumin content and other curcumin derivatives, collectively known as curcuminoids. 
Terpenoids and curcuminoids are the major bioactive compounds of Curcuma 
(Ravindran et al., 2007).  
2.2.1.1.1 Curcuma zedoaria 
C. zedoaria, also known as the white turmeric, is a perennial herb of the family 
Zingiberaceace and largely found in many Asian tropical countries including Malaysia, 
Indonesia, India, Japan, and Thailand.  In Malaysia, it is locally known as ‘Temu putih’ 
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or ‘Kunyit putih’ and is widely consumed as a spice, a flavouring agent for native 
dishes, and is frequently incorporated in food preparations for women in confinement 
after child birth. It is one of the three most widely used medicinally important plant 
species from the genus Curcuma. Traditionally, the dried rhizomes of C. zedoaria are 
used to make drinks or to be extracted and used as a remedy for various ailments 
(Larsen et al., 1999). 
 
(a) Morphology of C. zedoaria  
The leaf blades are 80 cm long, usually with a purple-brown flush running along 
the midrib on both surfaces of the leaf. In the young plants, the rhizomes of C. zedoaria 
are easily confused with those of C. aeruginosa and C. mangga since both have almost 
similar yellow colouration. However, a cross-section of the rhizomes of the mature 
plants of C. aeruginosa is slightly dark purplish, whilst C. mangga rhizomes have 
brighter yellow colour (Figure  2.1 and  2.2)  (Maciel et al., 2002) . 
 





Figure  2.2: Rhizomes of C. zedoaria 
 
(b) Traditional uses of C. zedoaria 
 C. zedoaria has been widely used for thousands of years as a healing agent for a 
variety of illnesses in traditional medicinal practices in many Asian countries. In 
Malaysia and Indonesia, it is used for the treatment of cancer, dyspepsia, menstrual 
disorders, stomachic, and vomiting (Lobo et al., 2009). The plant is reported to have 
antimicrobial, antifungal (Bugno et al., 2007; Ficker et al., 2003; Uechi et al., 2000), 
antiulcer (P. Gupta et al., 2003), analgesic (Navarro et al., 2002; Pamplona et al., 2006), 
anti-inflammatory (Tohda et al., 2006), antioxidant (Mau et al., 2003a), 
hepatoprotective (Hisashi Matsuda et al., 1998b), cytotoxic (Hong et al., 2002; Seo et 
al., 2005) and antimutagenic (Lee et al., 1988) activities. The rhizomes of this plant 
have been used as a stimulant, stomachic, carminative, diuretic, anti-diarrheal, anti-
inflammatory, anticancer, anti-emetic, antic-pyretic, depurator and also as topical 
ointment for ulcers, wounds, and other skin disorders (Larsen et al., 1999). 
Temu putih is used by the Malaysians and Indonesians in the preparation of 
traditional medicine-consumed either on their own or in mixtures with other plant 
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species. C. zedoaria is one of the ingredients in “Jamu”, a mixture of Indo-Malay 
traditional herbal medicine, a preparation that came into practice from the experiences 
of the past, embedded in the culture of the society. Jamu is believed to maintain good 
health and assists in the prevention and treatment of various diseases. The other major 
herbs used in Jamu preparation are C. aromatica, C. domestica. And C. xanthorrhiza 
.They are also widely consumed as spices, flavours in native dishes and as food 
preparations in postpartum confinement. C. zedoaria commonly referred as Er-chu in 
Chinese is clinically used for the treatment of cervical cancer. In Japan, it is used in the 
treatment of stomach ailments. In the Ayurvedic medicine, it is used for the treatment of 
fever (cooling), as mild expectorant, antiseptic, and deodoriser. In Indonesia, C. 
zedoaria is widely consumed in the form of ‘Jamu’ for the treatment of breast and 
cervical cancers. 
 
2.2.1.1.2 Curcuma purpurascens  
C. purpurascens is another medicinally important plant of the family Zingeberaceae. 
In Malaysia and Indonesia it is locally known as “Temu tis”, and is synonymous to 
Solo’s (East of Yogyakarta),  “Temu gleneyeh” or “Temu belenyeh” with the scientific 
name of Curcuma soloensis (Koller, 2009) Villagers from the Kediri district located at 
the base of the Mount Wilis of East Java is one of the major commercial producers of 
the  plant C. purpurascens or ‘Temu tis’. The rhizomes are dried and ground before 
selling to the wholesalers as an alternative medicine. C. purpurascens is included in the 
Javanese medicinal plants used in rural communities (Koller, 2009).  
(a) Morphology: C. purpurascens 
            C. purpurascens is a herb with the branched rhizomes, outside and inside 
orange-yellow with whitish tips; leaf blades elliptical (55-70 cm × 19-23 cm), green but 
purple along the midrib above; inflorescence terminal on a leafy shoot, bracts pale 
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green, coma bracts white at base and pale green towards the top or almost entirely 
white, outside pale brown spotted at the top;  corolla about 5 cm long, white; labellum 
about 17 mm × 17 mm, pale creamy yellow with a dark yellow median, other 
staminodes pale creamy yellow, another with long spurs. C. purpurascens grows 
spontaneously in teak forest (Figure  2.3)  (Koller, 2009).     
  
 
Figure  2.3: The aerial parts of C. purpurascens with flowers 
 
(b) Traditional uses of C. purpurascens 
The plant is a Javanese medicinal plant which has been used for numerous 
indications in rural Javanese communities. Same as other Curcuma species, the 
rhizomes of C. purpurascens are extensively used as a spice and also as a folk medicine. 
Rural communities in Indonesia use this plant for the treatment of boils, cough, fever, 
itches, scabies, and wounds. Rhizomes are used against tussis, and mixed with Alyxia 
stellate to apply as a poultice after childbirth. The central tuberous root contains 
extractable starch (Koller, 2009). There are eleven Curcuma species used as ingredients 
of Jamu which includes C. aeruginosa, C. aurantiaca, C. coloraya, C. domestica 
(synonym: C. longa), C. euchroma, C. manga, C. petiolata, C. purpurascens, C. 
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soloensis, C. xanthorrhiza, and C. zedoaria. These plants are used traditionally as spices 
and to treat diseases including abdominalgia, anaemia, appendicitis, asthma, diarrhoea, 
dysentery, hypertension, itch, and rheumatism (Hatcher et al., 2008).  
2.3 Chemistry of the Curcuma species 
Reported Curcuma species accounts for over 100. About twenty of these species 
have undergone extensive phytochemical and biological investigations and resulted in 
the isolation of various types of compounds presented in Table  2.1- 2.9. These 
compounds can be classified into three major groups: monoterpenoids, 
sesquiterpenoids, diterpenoids and diarylheptanoids (curcuminoids). The most extensive 
investigated species are C. longa, C. xanthorrhiza, and C. zedoaria. The highest number 
of the compounds which have a similar skeleton previously isolated from the genus 
Curcuma documented was a guaiane type sesquiterpenoids. The essential oils from the 
rhizomes or the leaves of the genus are rich in monoterpenes, but also contain 
sesquiterpenes. While the essential oils from C. zedoaria have been investigated for its 
content, there is no such report on C. purpurascens with respect to its chemical 
constituents or essential oil composition. The following subchapters will discuss briefly 
the chemical aspects and biosynthesis of monoterpenes, sesquiterpenes, diterpenes and 
curcuminoids. 
2.3.1 Monoterpenes 
Biogenetically, monoterpenes derive from the condensation of two isoprene 
units (Banthorpe et al., 1972). They are widely distributed in nature as the major 
components of the plant essential oils. Economically, the important usage of 
monoterpenes is as perfume and flavor. The Curcuma essential oils obtained from 
various Curcuma species are rich in monoterpenes. Among the Curcuma species, C. 
zedoaria rhizomes produce monoterpenes in high amounts, with the major 
monoterpenes found in most of the Curcuma species are 1,8-cineole, α-pinene, β-
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pinene, camphor, and comphene. 
Monoterpenes can be divided into three major categories:  
 Acyclic (linear) structures such as myrcene 4 and linalool 5. 
 
 Monocylic monoterpenes like o-cymene 6, p-cymene 7, -phellandrene 8, and 
terpinolene 9.  
 





2.3.2 Sesquiterpenes  
The sesquiterpenes contain a total of 15 carbon atoms, formed by the assembly 
of three isoprene units. A large number of sesquiterpenoids (more than 140 compounds) 
have been isolated from the Curcuma species and they can be classified into ten 
distinctly different structural types; guaiane, germacrane, bisobolane, seco-guiane, 
carabrane, humulane, spirolactone, cadinane, elemane, and eudesmane (Figure  2.6 ). 
However, most of these compounds fall into one the major categories, guaiane, 
germacrane, and bisabolane types. Sesquiterpenoids are known to be the key 
components of many essential oils.  
 
2.3.2.1 Classification of sesquiterpenes based on skeleton type 
The plants of the genus Curcuma is rich in sesquiterpenoids having a wide range 
of chemical structures. Different types of sesquiterpenes have been isolated from 
Curcuma which include germacrane, guaiane, seco-guaiane, carabrane, bisabolane, 
humulane, spirolactone, and cadinane type. These types are presented in Table  2.1- 2.10 
and Figure  2.4- 2.13. 
 
2.3.2.1.1 Germacrane type sesquiterpenes 
To date, germacrane types sesquiterpenes has been found in ten of the twenty 
chemically investigated Curcuma species. These are C. zedoaria, C. longa, C. 
heyneana, C. comosa, C. aeruginosa, C. malabarica, C. aromatica, C. sichuanensis, C. 
wenyujin and C. amada (Table 2.1).  
The characteristic features of this skeleton are a ten membered ring (C-1 to C-
10) ring having two methyls attached to C-4, and C-10 while some compound has 
isopropyl group attached to C-7. Some of these can undergo cyclisation of the side 
chain at C-7 (i.e, C-12, C-11, C-13) to form furan ring fused to the ten membered ring. 
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As per the reported data, the number of germacrane type sesquiterpenes isolated 
is the second highest after guaiane type sesquiterpenes. So far, C. zedoaria is the most 
prolific producer of gemacrane sesquiterpenes. This species has been widely studied and 
samples from India, Indonesia, Malaysia and China have reported the occurrence of 25 
different germacrane derivatives such as dehydrocurdione 19, curdione 20, furanodiene 
22, furanodienone 22,  germacrone,  23, and neocurdione 32. The structure of zederone 
19 was first time proposed by Hikino group (Hikino et al., 1968) and was the first 
gemacrane sesquiterpene to have its absolute configuration determined through X-ray 
crystallography by Prof. Isao Kitagawa et al., 1987. Dehydrocurdione 19 is the most 
widely distributed germacrane type sesquiterpene in the Curcuma species where it has 
been reported in eight species. Other commonly found germacranes are curdione 20, 
furanodiene 21, furanodienone 22, germacrone 23, zederone germacrone-4, 5-epoxide 
24, germacrone-1, 10 epoxide 25, neocurdione 32 and zederone epoxide 38. Table  2.1 
and Figure  2.4 represent some of the most common sources of germacranes found in 













Table  2.1: Germacrane type sesquiterpenes from the Curcuma (cont) 
Compounds Source 
Dehydrocurdione 19 C. zedoaria (Makabe et al., 2006) 
C. longa  (Ohshiro et al., 1990a)  
C. heyneana (Firman et al., 1988b) 
C. comosa (Qu et al., 2009b) 
C. aeruginosa (Suphrom et al., 2012b) 
C. malabarica (Wilson et al., 2005) 
C. aromatica (Choudhury et al., 1996) 
C. sichuanensis  
Curdione 20 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, et al., 2001b) 
C. wenyujin (Yan et al., 2005) 
C. aromatica (Choudhury et al., 1996) 
C. kwangsiensis (Zeng et al., 2009) 
Furanodiene 21 C. zedoaria (Makabe et al., 2006) 
C. wenyujin (Sun et al., 2009) 
C. aromatica (Giang et al., 2000) 
Furanodienone 22 C. zedoaria (Shibuya et al., 1986) 
C. aromatica (Giang & Son, 2000) 
Germacrone 23 C. zedoaria (Makabe et al., 2006) 
C. wenyujin (Yan et al., 2005) 
C. aeruginosa (Suphrom et al., 2012a) 
C. aromatica (Giang & Son, 2000) 
Germacrone-4,5-epoxide 24 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, et al., 2001a) 
C. longa (Ohshiro et al., 1990a) 
C. aromatica (Choudhury et al., 1996) 
Germacrone-1, 10-epoxide 25 C. wenyujin (X.-y. Liu et al., 2007) 
Zederone  26 C. zedoaria (Makabe et al., 2006) 
C. aeruginosa (Suphrom et al., 2012a) 
C. amada (Faiz Hossain et al.) 
C. aromatica (Pant et al., 2001) 
Germacrone-13-al 27 C. longa (Ohshiro et al., 1990a) 
Curcuzederone 28 C. zedoaria (Eun et al., 2010) 
13-Hydroxygermacrone 29 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, et al., 2001b) 
Isofuranodienone 30 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, et al., 2001a) 
Glechomanolide 31 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, et al., 2001b) 
Neocurdione 32 C. zedoaria (Makabe et al., 2006) 
C. aromatica (Choudhury et al., 1996) 
(4S)-Acetoxydehydrocurdione 33 C. aromatica (Kuroyanagi et al., 1990b) 
4S)-Hydroxydehydrocurdione 34 C. aromatica (Kuroyanagi et al., 1990b) 
(4S, 5S)-13-Hydroxygermacrone 
-4,5-epoxide 35 








C. aromatic (Kuroyanagi et al., 1990b) 
(4S, 5S)-12-Acetoxygermacrone 
-4,5-epoxide 37 
C. aromatica  (Kuroyanagi et al., 1990b) 
Zederone epoxide 38 Curcuma comosa (Qu et al., 2009b) 
Germacrone-1(10), 4 (diepoxide) 39 Curcuma comosa (Qu et al., 2009b) 
(2S)-2-Hydroxycurdione 40  Curcuma aromatica (Bamba et al., 2011) 
 
 





Figure  2.4: Germacrane-type sesquiterpenes from the Curcuma (cont.) 
 
2.3.2.1.2 Guaiane type sesquipterpenes        
Guaiane type sesquiterpenes represents a major class of sesquiterpenes found in 
at least 6 species from the genus Curcuma. Isocurcumenol 47 being the most abundant 
compound identified in more than eight species of the genus Curcuma such as C. 
zedoaria, C. aeruginosa, C. heyneana, C. phaeocaulis, C. sichuanensis, and C. 
wenyujin.  Most of the guaiane type sesquiterpenes have been isolated from C. zedoaria 
such as 4-epi-curcumenol 45, neocurcumenol 46, isocurcumenol 47, alismoxide 49, 
zedoarondiol 51, zedoarolide A 52. The characteristic feature of the main skeleton of 
this type is the presence of a seven membered ring fused onto a five membered ring. 
Some of the guaiane type sesquiterpenes possess a 5,8-cyclic ether, such as cucumenol 
44, 4-epi-curcumenol 45 neocurcumenol 46, isocurcumenol 47, zedoarolide B 53, 
zedoarol 54, and isozedoarondiol 55. Interestingly some guaianes possess a five 
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membered lactone ring e.g. zedoarolide A 52, zedoarolide B 53, and zedoarol 54. 
Shiobara (Shiobara et al., 1986), a Japanese group reported first guaiane type 
sesquiterpene possess a fused furan ring system isolated from C. zedoaria. Table  2.2 
lists the guaiane type sesquiterpenes found in Curcuma species. 
Table  2.2: Guaiane type sesquiterpenes from the Curcuma 
Compounds  Source  
Gweicurculactone  41 C. wenyujin (Yin et al., 2013) 
C. kwangsiensis (Phan et al., 2014) 
Curcumenol 42 C. longa (Ohshiro et al., 1990a) 
C. aeruginosa (Suphrom et al., 2012a) 
Isoprocurcumenol 43 C. longa (Ohshiro et al., 1990a) 
Procurcumenol  44 C. longa (Ohshiro et al., 1990a) 
C. aromatica (Choudhury et al., 1996) 
4-epi-Curcumenol 45 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, Iwao Toguchida, et al., 2001) 
Neocurcumenol 46 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, Iwao Toguchida, et al., 2001) 
Isocurcumenol 47 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, Iwao Toguchida, et al., 2001) 
C. aeruginosa (Suphrom et al., 2012a) 
C. heyneana (Firman et al., 1988a) 
C. phaeocaulis (Chen et al., 2006) 
C. sichuanensis (Zhou et al., 2007a) 
C. wenyujin (J. Cao et al., 2006) 
C. ochrorhiza (Mohd Aspollah Sukari et al., 
2010) 
C. aromatica (Kuroyanagi et al., 1990a) 
Curcumol 48 C. wenyujin (Lou et al., 2010) 
Alismoxide 49 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, Iwao Toguchida, et al., 2001) 
Aerugidol 50 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, Iwao Toguchida, et al., 2001) 
Zedoarondiol 51 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, Iwao Toguchida, et al., 2001) 
C. aromatica (Choudhury et al., 1996) 
C. aeruginosa (Suphrom et al., 2012a) 
Zedoarolide A 52 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, Iwao Toguchida, et al., 2001) 
Zedoarolide B 53 C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, Iwao Toguchida, et al., 2001) 
Zedoarol 54 C. zedoaria (Shiobara et al., 1986) 
Isozedoarondiol 55 C. zedoaria (H. Matsuda et al., 2001) 
9-Oxo-neoprocurcumenol 56 C. aromatica (Etoh et al., 2003) 













guaiaen-8-one  58 
C. zedoaria (Hisashi Matsuda, Toshio 
Morikawa, et al., 2001a) 
Zedoalactone A 59 C. aeruginosa    (Takano et al., 1995a)      
Zedoalactone B 60 C. aeruginosa     (Takano et al., 1995a)        
Methylzedoarondiol 61 C. aromatica (Kuroyanagi et al., 1987) 
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                      Figure  2.5: Guaiane type of sesquiterpenes from the Curcuma  
 
2.3.2.1.3 Seco guaiane type sesquiterpenes 
The major source of these sesquiterpenes is C. zedoaria. The main features of 
this skeleton (different from that of guaiane) are the replacement of  the seven 
membered ring by a six-membered ring containing an ,β-unsaturated lactone. Isolated 
compounds include curcuzedoalide 62, gajutsulactone A 63, and gajutsulactone B 64 
and are presented in Table  2.3 Figure  2.6.. 
Table  2.3: Seco guaiane type sesquiterpenes from the Curcuma  
Compounds  Source  
Curcuzedoalide 62 C. zedoaria (Park et al., 2012b) 
Gajutsulactone A 63 C. zedoaria (Hisashi Matsuda, Toshio Morikawa, et al., 
2001a) 






Figure  2.6: Seco-guaiane type sesquiterpenes from the Curcuma  
 
2.3.2.1.4 Carabrane type sesquiterpenes 
Carabrane type sesquiterpenes have a unique skeleton and can be identified by 
the presence of a cyclohexane ring fused to a cyclopropane ring. The most widespread 
carabrane sesquiterpene in Curcuma species is curcumenone. It is expressed in C. 
zedoaria, C. longa and C. wenyujin. Some of the carabrane also possess lactone from 
their basic carabrane skeleton such as curcumenolactone A 69, curcumenolactone B 70, 
and curcumenolactone C 71 (Table  2.4, Figure  2.7). From the reported published data, 
the major source of these sesquiterpenes was found to be C. zedoaria. 
Table  2.4: Carabrane type sesquiterpenes from the Curcuma  
Compounds Source 
Curcumenone 65 C. zedoaria (Shiobara et al., 1985b) 
C. longa (Ohshiro et al., 1990a) 
C. wenyujin (Sun et al., 2006) 
Curcurabranol A 66 C. zedoaria (Morikawa, 2007) 
Curcurabranol B 67 C. zedoaria (Morikawa, 2007) 
4S-Dihydrorcumenone 68 C. zedoaria (Morikawa, 2007) 
Curcumenolactone A 69 C. zedoaria (Morikawa, 2007) 
Curcumenolactone B 70 C. zedoaria (Morikawa, 2007) 
Curcumenolactone C 71 C. zedoaria (Morikawa, 2007) 
Dimethoxycurcumenone 72 C. comosa (F. Xu et al., 2008) 






Figure  2.7: Carabrane type sesquiterpenes from the Curcuma  
 
 
2.3.2.1.5 Bisabolane type sesquiterpenes from Curcuma species 
Bisabolanes are aromatic ring containing sesquiterpenes. It is among the three 
major classes of sesquiterpenes found in the genus Curcuma. The other two types are 
the guaiane and germacrane sesquiterpenes. The most abundant compound in this genus 
is ar-turmerone 74. It is found in C. longa and C. zedoaria. Sesquiterpenes found in C. 
longa, C. zedoaria, C. xanthorrhiza, C. caesia, and C. aromatica and are presented in 
Table  2.5 and Figure  2.8. Non aromatic bisabolanes like the α, β, γ curcumenes, 









Table  2.5: Bisabolane type sesquiterpenes from the Curcuma 
Compound  Source  
ar-Turmerone 74 C. longa (Tavares et al., 2013) 
C. zedoaria (Chai Hee Hong et al., 2001) 
C. xanthorrhiza (TAKEYA, 1985) 
C. caesia (Pandey et al., 2003) 
C. aromatica (Bordoloi et al., 1999) 
β-Turmerone 75 C. zedoaria (Chai Hee Hong et al., 2001) 
-Turmerone 76 C. xanthorrhiza (S Uehara et al., 1992) 
C. longa (Ohshiro et al., 1990a) 
-Curcumene 77 C. xanthorrhiza (S Uehara et al., 1992) 
β-Curcumene 78 C. xanthorrhiza (S Uehara et al., 1992) 
γ-Curcumene 79 C. longa (G Singh et al., 2010) 
Turmerone  80 C. longa (Chatterjee et al., 2000) 
Bisacumol 81 C. longa (Ohshiro et al., 1990a) 
C. xanthorrhiza (Shinichi Uehara et al., 1989) 
Bisacurone 82 C. longa (Ohshiro et al., 1990a) 
C. xanthorrhiza (Shinichi Uehara et al., 1989) 
4-Hydroxybisabola-2,10-dien-9-one  83 C. longa (Ohshiro et al., 1990a) 
Bisabola 3, 10-diene-2-one 84 C. longa (Ohshiro et al., 1990a) 
4,5-Dihydroxybisabola-2,10-diene        
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C. longa (Ohshiro et al., 1990a) 
Bisacurol B  86 C. domestica (Ishii et al., 2011) 
Bisacurol  87 C. domestica (Ishii et al., 2011) 
E--atlantone 88 C. domestica (Ishii et al., 2011) 
Curlone  89 C. domestica (Ishii et al., 2011) 
Termernol A  90 C. longa (Khan et al., 2010) 
Termernol B  91 C. longa (Khan et al., 2010) 
2,3,5,6-Tetrahydroxyarturmerone   92 C. longa (Khan et al., 2010) 
Bisacurone A  93 C. xanthorrhiza (Shinichi Uehara et al., 1990) 
Bisacurone B  94 C. xanthorrhiza (Shinichi Uehara et al., 
1990) 
Bisacurone C  95 C. xanthorrhiza (Shinichi Uehara et al., 1990) 


















Figure  2.8: Bisabolane-type sesquiterpenoids from the Curcuma 
 
2.3.2.1.6 Humulane-type sesquiterpenes from Curcuma species 
Humulane skeleton consist of only one ten membered ring system with usually 4 
methyl substituents. The major sources of these sesquiterpenes are C. ochrorhiza and 
C.zedoaria. Zerumbone 97 which is predominant in the Zingiber species was also 
isolated from C. ochrorhiza. The compounds -humulene 98, β-humulene 99, and 
humulene-8-hydroperoxide 100 were isolated from C. zedoaria . These sequiterpenes 
are presented in Table  2.6 and Figure  2.9. 
Table  2.6: Humulane type sesquiterpenes from the Curcuma 
Compound Source 
Zerumbone 97 C. ochrorhiza (Mohd Aspollah Sukari 
et al., 2010) 
-Humulene (-Caryophyllene) 98 C. zedoaria (Mau et al., 2003b) 
β-Humulene (β-Caryophyllene) 99 C. zedoaria (Garg et al., 2005) 





Figure  2.9: Humulane type sesquiterpenes from the Curcuma 
 
2.3.2.1.7 Spirolactone-type sesquiterpenes from Curcuma species 
Spirolactones sesquiterpenes are consisting of two five membered fused at C-5. 
Curcumanolide A 101, and curcumanolide B 102 were isolated from C. zedoaria while 
curcumanolactone 103 was reported from C. wenyujin (Table  2.7, Figure  2.10). The 
former two compounds are diastereomers and all the three compounds are also found in 
essential oils of the Curcuma species. 
Table  2.7: Spirolactone type sesquiterpenes from the Curcuma 
Compound  Source 
Curcumanolide A    101 C. zedoaria (Shiobara et al., 1985a) 
Curcumanolide B    102 C. zedoaria (Shiobara et al., 1985a) 




Figure  2.10: Spirolactone types sesquiterpenes from the Curcuma 
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2.3.2.1.8 Cadinane type sesquiterpenes 
The main skeleton of this type contains two fused six membered with a side 
chain attached to C-8. This type is mainly isolated from C. parviforenes and C. comosa 
which includes comosone I 104, comosone II 105, cadalenequinone 106, 8-
hydroxycadalene 107, 4α,3α,4β-acetoxycadina-2, 9-diene-1,8-dione 108, 4α,3α,4β-
acetoxycadina-2, 9-diene-1,8-dione 109 ( Table  2.8, Figure  2.11).  
Table  2.8: Cadinane type sesquiterpenes from the Curcuma 
Compound Source  
Comosone I 104 C. comosa (F. Xu et al., 2008) 
Comosone II 105 C. comosa (F. Xu et al., 2008) 
Cadalenequinone 106 C. parviforenes (Takahashi et al., 2003) 
8-hydroxycadalene 107 C. parviforenes (Takahashi et al., 2003) 
4α, 3α, 4β-Acetoxycadina-2, 9-     
diene-1,8-dione 108 
C. parviforenes (Sadhu et al., 2009) 
1a, 3a, 4b, Trihydroxy 
-cadinen-8-one 109 
C. parviforenes (Sadhu et al., 2009) 




Figure  2.11: Cadinane type sesquiterpenes from the Curcuma 
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2.3.2.1.9 Elemane type sesquiterpenes from Curcuma 
It is well known that germacrone type sesquiterpenes undergo cope 
rearrangement to give elemane type sesquiterpenes. Curzerenone 111 is the most widely 
reported elemane and it occurs in several Curcuma species such as C. caesia, C. 
zedoaria, C. comosa and C. aromatica (Table  2.9, Figure  2.12) 
 
Table  2.9: Elemane type sesquiterpenes from the Curcuma  
Compound  Source  
Curzerenone 111 C. caesia (Vairappan et al., 2013a) 
C. zedoaria (Hisashi Matsuda, 
Toshio Morikawa, et al., 2001a) 
C. comosa (Qu et al., 2009a) 
C. aromatica (Giang & Son, 2000) 
β-Elemene  112 C. zedoaria (Mau et al., 2003b) 
γ-Elemene 113 C. zedoaria (Mau et al., 2003b) 
Curzerene 114 C. zedoaria (Mau et al., 2003b) 
epi-curzerenone 115 C. zedoaria (Mau et al., 2003b) 
Elemol 116 C. zedoaria (Mau et al., 2003b) 
β-Elemenone 117 C. zedoaria (Mau et al., 2003b) 
Elema-1,3,7(11),8-tetraen-8,12-lactam 118 C. wenyujin (Qiu et al., 2013) 
Hydroxyisogermafurenolide 119 C. wenyujin (Qiu et al., 2013) 





Figure  2.12: Elemane type sesquiterpenes from the Curcuma 
 
2.3.2.10 Eudesmane type sesquiterpenes 
The main skeleton of this type consists of two fused membered rings with a side 
chain attached to C-7. C. zedoaria and C. comosa are the major sources of these 
sequiterpenes. Curcolone 123, a furanoeudesmane type sesquiterpene was isolated from 
C. zedoaria and C. comosa. Additionally, zedoarofuran 124, curcolonol 125 also a 




Table  2.10: Eudesmane type sesquiterpenes from Curcuma 
Compound  Source  
β-Eudesmol  121 C. zedoaria  (Hisashi Matsuda, Toshio Morikawa, et al., 
2001a) 
β-Dictyopterol 122 C. zedoaria  (Hisashi Matsuda, Toshio Morikawa, et al., 
2001a) 
Curcolone 123 C. comosa (Qu et al., 2009a) 
C. zedoaria (Morikawa, 2007) 
Zedoarofuran 124 C. zedoaria (Morikawa, 2007) 
Curcolonol 125 C. zedoaria (Syu et al., 1998) 
β-Silenene 126 C. zedoaria (Mau et al., 2003b) 




Figure  2.13: Eudesmane type sesquiterpenes from the Curcuma 
 
2.3.3 Diterpenoids:  
Diterpenoids are a structurally diverse class of C20 natural compounds, widely 
distributed in nature and forms by the condensation of four isoprene units through the 
mevalonate or deoxyxylulose phosphate pathways. Diterpenoids can be classified as 
linear, bicyclic, tricyclic, tetracyclic, and pentacyclic. 
In nature, diterpenoids are commonly found in a polyoxygenated form, 
containing keto and hydroxyl functions. Such groups can be esterified by small-sized 
aliphatic or aromatic acids (Dickschat, 2011). Diterpenes have attracted growing 
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attention because of their interesting biological and pharmacological activities (Lanzotti, 
2013). The presence of diterpenoids in Curcuma species is less common compared with 
sesquiterpenes and diaryl heptanoids. Labdanes are the major type of diterpenes known 
to occur in the Zingiberaceous plants (Abas et al., 2005). The Curcuma species reported 
to contain labdane-type diterpenoid were C. manga, C. heyneana, C. kwangsiensis, and 
C. amada with the most abundant compound was labda-8(17),12 diene-15,16-dial. 
Labdane compounds from the genus Curcuma are presented in Table  2.11 and 
Figure  2.14.  
Table  2.11: Labdane-type diterpenoids from the Curcuma 
Compound Source  
Labda-8(17),12-diene-15,16-dial  127 C. longa (Roth et al., 1998) 
C. managga (Y. Liu et al., 2011) 
C. amada (Alan Sheeja et al., 2012)   
C. heyneana (Firman et al., 1988a) 
Calcaratarin A 128 C. managga (Y. Liu & Nair, 2011) 
Zerumin A 129 C. amada (Alan Sheeja & Nair, 2012) 
(E)-Labda-8(17),13diene-15,16-olide 130 C. amada (Alan Sheeja & Nair, 2012) 
Coronarin B  131 C. amada (Alan Sheeja & Nair, 2012) 
Coronarin D 132 C. kwangsiensis (Schramm et al., 2013) 
C. amada (Alan Sheeja & Nair, 2012) 
Zerumin B  133 C. managga (Abas et al., 2005) 
C. amada (Alan Sheeja & Nair, 2012) 
Copallic acid 134 C. managga (Y. Liu & Nair, 2011) 
(E)-16-Hydroxylabda-8(17),11,13-trien-
15,16-olide 135 
C. kwangsiensis (Schramm et al., 2013) 
(E)-15-Hydroxylabda-8(17),11,13-trien-
15,16-olide 136 
C. kwangsiensis (Schramm et al., 2013) 




Figure  2.14: Labdane type diterpenoids from the Curcuma 
2.3.4 Biosynthesis of monoterpenes, sesquiterpenes and diterpenes 
Terpenoids, including monoterpenes, sesquitepenes and diterpenes are formed 
from the build-up of isoprene units. In the biological system, the isoprene units are 
interconvertible into isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophophate 
(DMAPP). The first step of terpenoid synthesis is the formation of geranyl 
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pyrophosphate (GPP) from one IPP and one DMAPP (Scheme 2.1). Synthesis of 
monoterpenes involves the ionisation of GPP to give the carbocatonic species which 
undergoes various steps of cyclisations, hydride shifts or rearrangement reactions and 
the reaction being terminated through deprotonation or water incorporation. 
Involvement of a wide range of terpene synthases and the ability of one enzyme to 
produce more than one product has led to the wide variety of monoterpenes found in 
abundant in nature (Scheme 2.3) 
For the synthesis of sesquiterpenes, one GPP reacts with one IPP to form 
farnesyl diphosphate (Scheme 2.1). Removal of the phosphate resulted in an allylic 
cation, which is prone to electrophilic attack through double bond leading to cyclisation. 
Depending on whether electrophilic attack occurs on the central or distal double bond, a 
wide range of structures can be produced (Scheme 2.2) (Chern, 2014). These generated 
various cations such as humulane cation that gives humlane type, eudesmenayl cation 
that gives eudesmane type, and germacradienyl cation that gives germacrane type. The 
latter is the precursor of many sesquiterpene skeletons such as cadinane, guaiane and 















































2.3.5 Diarylheptanoids  
Diarylheptanoids are the most abundant group of the compounds in the genus 
Curcuma, commonly known as curcuminoids. Although over 100 curcuminoids have 
been identified from Curcuma species with varying biological activities, many more 
have been synthesized to study the structure activity relationships with the view to 
improve the bioactivities. The main skeleton of curcuminoids have an aryl-C7-aryl 
skeleton. 
Curcumin 138, desmethoxycurcumin 139 and bisdesmethoxycurcumin 140 are 
the most widely found compounds in Curcuma species. Among the Cucuma species, C. 
longa was found to have the highest number of curcuminoids previously isolated. The 
curcuminoids from Curcuma are presented in Table  2.12 and Scheme 2.4 
 
2.3.5.1 Biosynthetic pathway of curcuminoids 
(Tomoko et al) have investigated the biosynthesis of curcuminoids in C. longa 
employing 
13
C-labeled precursors. Analyses of labelled desmethoxycurcumin 140 by 
13
C-NMR revealed one molecule of acetic acid or malonic acid and two molecules of 
phenylalanine or phenylpropanoids where incorporated into desmethoxycurcumin 140. 
Similarly curcumin 138 incorporation efficiencies of the same precursors and both were 
in the order malonic acid > p-coumaric acid 
Based on this study the suggested pathway to curcuminoids utilized two 
cinnamoyl CoAs and one malonyl CoA, and the methoxy and the hydroxyl groups on 














Table  2.12: Curcuminoids isolated from the Curcuma  







C. longa (Inoue et al., 2008) 
C. longa (Kuttan et al., 1985)  
C. zedoaria  (Syu et al., 1998) 
C. domestica (Masuda et al., 1993) 
C.amada (A. Gupta et al., 1999) 
Bisdesmethoxycurcumin 139 C. longa (Inoue et al., 2008) 
C. zedoaria  (Syu et al., 1998) 
C.amada (A. Gupta et al., 1999) 
C. domestica  (Masuda et al., 1993) 
Desmethoxycurcumin 140 C. longa (Inoue et al., 2008) 
C. zedoaria  (Syu et al., 1998) 
C.amada (A. Gupta et al., 1999) 
C. domestica (Masuda et al., 1993) 
Tetrahydrocurcumin 141 C. longa (Sandur et al., 2007) 
1,5-Dihydroxy-1,7-bis(4-
hydroxyphenyl) -4,6-heptadiene-3-one 141 
C. longa (Li et al., 2009) 
1, 5-Dihydroxy-1-(4-hydroxy-3- 
methoxyphenyl)-7-(4-hydroxy) 
-4, 6-heptadiene-3-one 142 




C. longa (Li et al., 2009) 
1,5-Dihydroxy-1,7- bis(4-hydroxy- 
3-mehoxyphenyl)-4, 6-heptadiene-3-one   
144 
C. longa (Li et al., 2009) 
3-Hydroxy-1,7-bis-(4-hydroxyphenyl) 
-6-heptene-1,5-dione 145 
C. longa (Li et al., 2009) 
5-Hydroxy-1, 7-bis(4-hydroxyphenyl)-
4,6-heptadiene-3-one 146 
C. longa (Li et al., 2009) 
(3R', 5S')-3, 5-Dihydroxy-1-(4-hydroxy- 
3-methoxyphenyl)-7-(3,4-
dihydroxyphenyl) heptane 148 
C. kwangsiensis (ZHU et al., 2009) 
2,3,5-Trihydroxy-1-(3-methoxy-4-
hydroxyphenyl)-7-(3,5-dimethoxy-4-
hydroxyphenyl) heptane 149 













2.4 Bioactivity of the compounds previously isolated from the genus Curcuma 
A good number of compounds with important biological activities have been 
reported from this genus. The bioactivities of the compounds include cytotoxicity, 
antibacterial, anti-oxidant, hepatoprotective, analgesic, anti-inflammatory, 
antiandrogenic, and antiplasmodial activity (Table 2.14). The most studied compound 
isolated from the genus Curcuma which showed multi-biological activities is curcumin 
138 (Maheshwari et al., 2006). Curcumin has long history of use as a traditional remedy 
and food in Asia. Many studies have reported that curcumin has various therapeutic 
effects for the treatment of several diseases such as anti-cancer, anti-inflammatory, and 
antioxidant. Extensive research over the last half century has revealed important 
functions of curcumin 138. In addition, terpenoids from the genus Curcuma have been 
used in the prevention, inhibition and therapy of many diseases. Curcumenol 42, a 
guaiane type sesquiterpene has been reported as analgesic and hepatoprotective (Table 
2.14). ar-Turmerone 74, a bisabolane type sesquiterpene is one of the major active 
compounds isolated from C. longa exhibited potent cytotoxic activity against various 












Table  2.13: Bioactive compounds from the Curcuma 
Compounds  Reported biological activity  
Dehydrocurdione 19 Anti-inflammatory (Yoshioka et al., 1998) 
Curdione 20 Anti-platelet aggregation and antithrombotic (Xia 
et al., 2012) 
Prostaglandin E2 inhibitor (Oh et al., 2007) 
Germacrone 23 Antiandrogenic potent activity (Suphrom et al., 
2012a) 
Furanodiene 21 Anti-inflammatory (Makabe et al., 2006) 
Anti-cancer (Sun et al., 2009) 
Zederone 26 Cytotoxic (Mohd Aspollah Sukari et al., 2010) 
Furanodienone 22 Anti-inflammatory (Makabe et al., 2006) 
Curcumenone 65 Hepatoprotective (Vairappan et al., 2013b) 
Curcumenol 42 Analgesic (Pamplona et al., 2006) 
hepatoprotective  (Hisashi Matsuda et al., 1998a) 
Isocurcumenol 47 Antitumor (Lakshmi et al., 2011b) 
Neocurdione 32 Hepatoprotective (Morikawa et al., 2002) 
Curcumin 139 Multi-biological activities (Aggarwal et al., 2003; 
Maheshwari et al., 2006; Noorafshan et al., 2013) 
9-Oxo-neoprocurcumenol 
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Inhibitor against the Blue Mussel (Etoh et al., 
2003) 
ar-Turmerone 74 Cytotoxic (Ji et al., 2004) 
 
 
2.5 Chemical composition of the essential oils from the Curcuma species  
 The major constituents of the essential oils from the Curcuma species are 
monoterpenes and sesquiterpenes, which remain in the form of a complex mixture of 
low molecular weight compounds, and can be separated by steam distillation or by 
extraction with organic solvents. Essential oils are prescribed in the traditional 
medicinal practices and are known to possess various pharmaceutical and biological 
activities such as anti-inflammatory anti-mutagenic, antidiabetic, antiprotozoal, 
antiviral, antifungal, and anticancer activity (Raut et al., 2014). 
 By extensive phytochemical analysis, especially using a combination of GC and 
GC-MS spectroscopic technique, and the calculation of  Kovats indices, major 
components of the essential oils from different Curcuma species were characterized and 
identified. Table 2.15 lists the major components of the essential oils from some 
important species of the genus Curcuma. The presence of unique compounds in variable 
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concentrations from 0.25 to 70% in the essential oil can be the key to distinguish 
Curcuma species of different geographic origin. For curzerene and epicurzerenone in C. 
zedoaria from India while camphor is the chemical marker for the species from 
Indonesia, curdione and xanthorhizol in C. aromatica, α-fenchene in C. sylvatica, 
elemenone in C. rakthakanta, curcumenene in C. malabarica, and β-eudesmol in C. 
aeruginosa and C. longa. The comparison of chemical constituents of C. zedoaria 
essential oils showed that the Indian sources is rich in elemane type sesquiterpenes, e.g., 
epicurcuzerenone and curzerenone, while the Indonesian one has relatively more 
monoterpenes with a high content of camphor (Table  2.15).  
Bisabolane type sesquiterpenes were the major chemical constituents of the 
essential oils of C. longa irrespective of their geographic origin, for example ar-
termenone was found to be the major compound for Indian C. longa sample while 
bisabolene for the  Nigerian one (Table 2.16). 
In case of C. aeruginosa essential oils of Indian origin was found to have 
guaiane type sesquiterpene as the main constituent i.e., curcumenol 42. On the other 
hand, Malaysian sample expressed predominantly elemane type sesquiterpenes and 
curzerenone 111 as the major constituent. The essential oils of C. aromatica from India 
was found to contain monoterpenes (camphor, 19%), while the Japanese one had the 
guaiane sesquiterpene curcumol as the major compound (36%) (Table  2.15).  
 Angel et al. (2014) reported recently that some monoterpenes including 1,8-
cineole, α-pinene, β-pinene, camphor, and camphene were present in most of the 








Table  2.14: The major constituents of the essential oils of the C. zedoaria identified 
by GC/GC-MS analysis 
Plant name  Origin Major constituents  Reference 
C. 
zedoaria  
Indonesia Camphor                  (49.51%)                
Isobornyl alcohol     (12.66%)         
borneol                     (4.23%)                   
Furanodiene              (3.61%)                  
Furanodienone    (3.49%) 
1,8-Cineol                   (3.42%)                  
Camphene                 (2.28%)                
β-Pinene                     (2.93%)              
(Retnowati et 
al., 2014) 
 India Epicurcuzerenone       (19.0%)    
ar-curcumene             (12.1%)          
Zingiberene                (12.0%)          
β-sesquiphellandrene (9.8%)      
Curzerene                   (8.0%)                     
Germacrene B            (6.0 %) 
(Angel et al., 
2014) 
 
 India Curzerenone            (31.6%)                  
Germacrone             (10.8%)                  
(P. Singh et al., 
2013) 
 India Curzerenone              (22.3%)            
1.8-cineole                  (15.9%)                  
germacrone                    (9.0%) 
(Purkayastha et 
al., 2006) 
 China Epicurzerenone              (46%)  
Curdione                      (13.7%) 
1,8-Cineole                  (1.36%)  
Camphor                     (1.46%), 
(E. Y. Lai et al., 
2004). 
 





 Cymene       (18.42%) 
α-Phellandrene          (14.93%) 
Terpinolene                 (4.11%) 
α-Pinene                     (3.28%), 
β-Turmernone              (3.1%), 
β-Pinene                      (2.93%) 











Table  2.15: The major constituents of the essential oils of other Curcuma species 
identified by GC/GC-MS analysis 
Plant name  Origin  Major constituents  Reference  
C. longa Bhutan α-Turmerone          (30-2%)  
ar-Turmerone         (17-6%)  
β-Turmerone          (15-
18%) 
(Sharma et al., 1997). 
 
C. longa India  ar-Turmerone          (51.8%) 
Ar-Turmerol           (11.9%) 
(G. Singh et al., 
2002) 
C. longa Gorakhpur 
 
ar-Turmerone         (24.4%) 
-Turmerone          (20.5%) 
β -Turmerone          (11.1%) 
(G. Singh et al., 
2010) 
C. longa North 
Central Nigeria 
Bisabolene              (13.9%) 
Trans-ocimene        (9.8%) 
Myrecene                (7.6%) 
1,8-cineole              (6.9%) 
Thujene                   (6.7%) 
Thymol                   (6.4%) 
(Usman et al., 2009) 
C. aeruginosa 
 
India  Curcumenol             (38.7%) 
β-Pinene                  (27.5%)  
β-Eudesmol             (3.6%) 
(Angel et al., 2014) 
C. aeruginosa 
 
Malaysia Curzerenone            (24.6%)  
1.8-Cineole              (11.0%) 
Camphor                  (10.6%)  
Zedoarol                  (6.3%) 
 Isocurcumenol       (5.8%) 
Curcumenol            (5.6%)  
Furanogermenone   (5.5%) 
(Sirat et al., 1998). 
 
 
C. brog India  1,8-Cineole             (28.2%) 
β-Elemene             (8.2%)  
Camphor                (6.9%) 
(Angel et al., 2014). 
C. aromatica  India β-Curcumene           (31.41%)  
ar-Curcumene,          (23.35%) 
Germacrone               (6.05%) 
Curzerenone              (5.46%) 
Xanthorrhizol             (5.27%) 
(Catalan et al., 1989) 
C. aromatica  India  Camphor                  (18.8%) 
Camphene                 (10.2%)  
1,8-Cineol             (10.1%) 
Borneol                 (8.2%) 
(Angel et al., 2014) 
C. aromatica (G. 
Singh et al., 2002) 
Japanese Curcumol              (35.77%) 
1,8-Cineole           (12.22%)  
 (Tsai et al., 2011) 
 
C. aromatica  t India Camphor                 (32.3%)  
Curzerenone           (11.0%) 
 α-Turmernone        (6.7%) 
ar-Turmerone         (6.3%)  
1,8-Cineole             (5.5%) 
(Bordoloi et al., 1999) 
C. sichuanensis  
 
China δ-Cadinene             (13.22%) (Tsai et al., 2011) 
C. sichuanensis  China epi-Curzerenone     (26.9%) 
Germacrone            (12.4%) 
Isocurcumenol        (9.7%)  
β-Elemene              (6.4%) 
 Curzerene              (6.2%) 





Table 2.15: The major constituents of the essential oils of other Curcuma species 
identified by GC/GC-MS analysis (Cont.) 
Plant name  Origin  Major constituents  Reference  
C. heyneana Indonesia Curcumanolide    (19.6%) 
Dehydrocurdione    (17.2%)  
Isocurcumenol        (16.5%) 
Curcumenol            (13.7%) 
Curcumenone         (6.4%) 
Germacrone            (5.0%) 
(Sirat et al., 2009) 
C. inodora 
 
Malaysia Curzerenone            (20.8) 
Germacrone             (11.1%) 
Curdione                  (7.5%)  
1,8-Cineole               (5.3%)  
β-Eudesmol              (4.6%) 




C. haritha India Camphor                    (36.0%) 
1,8-Cineol                  (13.9%) 
Isoborneol                  (10.6%) 
Camphene                  (5.7%) 
Linalool                      (4.7%) 
Curdione                     (6.9%) 
Furanogermenone       (3.3%) 
Germacrone                 (2.8%) 








India  1, 8-Cineole                (24.6 %) 
 β-Sesquiphellandrene (1.5%)  
Elemenone                   (13.6%) 
(Angel et al., 2014) 
   C. caesia  
 
India  1,8-Cineole                (40.8%)  
Camphor                     (15.2%)  
ar-Curcumene             (18.7%) 
β-Piene                        (2.5%) 
 
 
C. sylvatica India  α-Fenchene                 (70.0%) (Angel et al., 2014). 
C. malabarica 
 
India  1,8-Cineole                 (40.8%) 
Curcumenene               (18.7%) 
Camphor                      (10.2%) 
β-Pinene                       (2.5%) 
(Angel et al., 2014). 
.  
 
C. amada India  Myrcene                      (80.54%) 
β-Pinene                        (4.64%) 
(G. Singh et al., 2002) 
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CHAPTER 3: RESULTS AND DISCUSSION 
3.1 Phytochemical studies 
The phytochemical investigations on the two medicinally important Asian 
plants; C. zedoaria and C. purpurascens were performed in the search for bioactive 
components which resulted in the isolation of a total of 27 compounds. Among these, 
22 compounds were isolated from C. zedoaria and five compounds were from C. 
purpurascens. The isolation of the pure compounds was accomplished by various 
chromatographic techniques such as open column chromatography (CC), size exclusion 
chromatography (Sephadex
©
 LH-20), high performance liquid chromatography 
(HPLC), high performance thin layer chromatography (HPTLC), and preparative thin 
layer chromatography (PTLC). PTLC was found to be the most efficient technique for 
the isolation of the pure compounds from the plants under investigation. 
Structure elucidation of the pure compounds were established on the basis of 




C-NMR, and DEPT), 2D-
NMR (COSY, HSQC, HMBC, NOESY, J-resolved, and H2BC), IR, GC-MS, LC-MS, 
UV, as well as X-ray crystallography, the latter technique was used for the identication 
of curcumenol as second monoclinic modification. (O. Ahmed Hamdi et al., 2010). 
The structures of the isolated compounds were identified through analysing their 
spectroscopic data and also by the comparison of their spectral data with those reported 
in the literature. 
Sesquiterpenoids are the major constituents isolated from the rhizomes of C. 
zedoaria (eighteen compounds). However three compounds were labdane-type 
diterpenoids, whereas ar-turmerone and curcuminoids were the major compounds 
isolated from C.  purpurascens rhizomes.  
 The essential oil obtained by hydrodistillation of C. purpurascens rhizomes has 
resulted in identification of 34 compounds analysed by combination of GC/GC-MS. In 
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addition, supercritical fluid extraction for the same rhizomes of plant was performed 
using variable temperatures and pressures. 
3.1.1 Compounds isolated from C. zedoaria  
The summary of the compounds isolated from C. zedoaria are listed in Table  3.1 
Table  3.1: Compounds isolated from C. zedoaria 
No Compounds  Skeleton  
2 Dehydrocurdione 19 Germacrane  
1 Curdione 20 Germacrane 
3 Furanodiene 21 Germacrane 
4 Furanodienone 22 Germacrane 
5 Germacrone 23 Germacrane 
6 Germacrone-4, 5-epoxide 24 Germacrane 
7 Germacrone-1, 10-epoxide 25 Germacrane 
8 Zederone 26 Germacrane 
11 Gweicurculactone 41 Guaiane 
9 Curcumenol 42 Guaiane 
10 Curcumenol a second monoclinic    
modification 150 
Guaiane 
12 Isoprocurcumenol 43 Guaiane 
13 Procurcumenol 44 Guaiane 
14 Curcuzedoalide 62 Seco guaiane 
15 Curzerenone 111 Elemane 
16 Zerumbone epoxide 151 Humulane 
17 Comosone II 104 Cadinane 
18 Curcumenone 65 Carabrane 
19 Curcumanolide A 101 Spirolactone 
20 Labda-8(17),12-diene-15,16-dial 127 Labdane-type diterpenoid 
22 Calcaractrin A 129 Labdane-type diterpenoid 















Dehydrocurdione 19 was isolated as pale yellow oil with [𝛼]𝐷
20 + 280° (c 0.3, 





peak at m/z 234 corresponding to the molecular formula of C15H22O2. The base 
peak at m/z 68 was also observed in the EI-MS (Figure 3.7)(Firman et al., 1988a). The 
UV spectrum showed absorption maxima (λmax) at 207 nm. The IR spectrum exhibited 
strong absorptions  at 1680 and 1742 cm
-1
 implying the presence of conjugated and non 
conjugated carbonyl groups, respectively. 
The 
1
H NMR (Figure  3.2, Table  3.2) spectrum displayed proton signals typical 
of germacrane-type sesquiterpenes. These include four methyl signals at δH 1.01, 1.63, 
1.73, and 1.76 which were assigned as H3-14, H3-15, H3-13, and H3-12, respectively. 
Furthermore, four sets of methylene protons were observed at δH 2.09 (H2-2), 2.08, 1.64 
(H2-3), 3.29, 3.32 (H2-6) and 3.06, 3.23 (H2-9). In addition, there were signals for two o 
methine protons, one was an olefinic proton resonated at δH 5.13 (H-1) while the other 
at δH 2.38 (H-4).  
The 
13
C NMR, DEPT-135 and HSQC spectra (Figure  3.3, 3.5, Table  3.2)  
revealed a total of 15 carbon consisting of four sp
3
 methyls at δC 16.3 (C-15), 18.4 (C-
14), 22.1 (C-13), and 21.0 (C-12), four sp
3 
methylenes at δC 26.4 (C-2), 34.2 (C-3), 43.4 
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(C-6) and δC 57.0 (C-9), two methines, one of which is sp
2 olefinic carbon at δC  133.0 
(C-1), while the other is an sp
3
 carbon atom at δC 46.4 (C-4),  five quaternary carbons 
three of which are sp
2 olefinic carbons resonated at δC 129.9 (C-10), 133.0 (C-1) and 
137.0 (C-11), and the other two signals are for the carbonyl carbons C-8 (δC  207.2), and 





H COSY correlations observed were H-4/H3-14, H-3/H-4, H-2/H-3, H-
1/H-2, H-9/H-9’, H-6/H-6’ coupled with HMBC cross peaks of  H-4/ C-5, H-6/C-5, H-
1/CH3-15 H-9/CH3-15, H-9/C-8, H-6/C-7 confirmed the sequence of C1–C2–C3–C4–
C5–C6–C7–C8–C9–C10, or the presence of a ten membered cyclic system of 
germacrane type sesquiterpene. In addition, the HMBC cross peaks of   H3-12, H3-13 to 
C-11 and C-7 confirmed the existence of a dimethyl ethylene group attached to the ring 
at C-7. COSY and HMBC spectra were able to establish the germacrane skeletal of 
dehydrocurdione. 
From the above spectral data analysis, the identity of the compound was 
confirmed as dehydrocurdione and were in agreement with the spectral data described in 
the literature (Makabe et al., 2006). 
 





Table  3.2: 1H NMR (400 MHz) and  13C NMR (100 MHz) spectral data of  
dehydrocurdione 19 in CDCl3 
Position H (ppm) J in Hz C (ppm) 
1 5.13, t (8.24)  133.0 
2 2.09, m 26.4 
3 2.08,1.64,  m 34.2 
4 2.38, m 46.4 
5 - 211.1 
6 1H-6a,  3.29, d (16.48) 
1H-6b 3.32, d(16.48) 
43.4 
7 - 129.3 
8 - 207.2 
9 1H-9a 3.23,d (11.4) 
1H-9b,  3.06, d, (11.44) 
57.0 
10 - 129.9 
11 - 137.0 
12 1.76, s 21.0 
13 1.73, s 22.1 
14 1.01, d (6.88) 18.4 





























Figure  3.5: HSQC spectrum of dehydrocurdione 19 
 
 












Curdione 20 was afforded as a white amorphous powder with an optical rotation 
of [α]D
20
 + 26° (c=1 in MeOH). The EI-MS analysis showed the base peak observed  at 
m/z 69 while the molecular ion (M
+
) peak at m/z 236 thus corresponding to the 
molecular formula C15H24O2. The IR spectrum presented strong absorption bands for 
two carbonyls at 1735 and 1702 cm
-1
. The UV spectrum displayed one distinct 





C  NMR spectra (Figure  3.8,Figure  3.9) of compound 20  
followed same pattern as that of dehydrocurdione 19, except for the presence of two 
additional proton signals at δH 2.81 and 1.84 (H-7, and H-11, respectively). The methyl 
signals appeared to be shielded as compared to that of dehydrocurdione 19, further 
suggesting the saturation of the double bond at ∆7(11) of dehydrocurdione 19. The 13C-
NMR spectra showed similar chemical shifts for carbons C1 to C-6, while abviously the 
number of signals in the double  bond  region  reduce from 4 to 2 due to the change of 
the hybridization of C-7 and C-11 from sp
2
 in 19 to sp
3
 in 20. 
The 
1
H NMR spectrum (Figure  3.8, Table   3.3) of compound 20 showed similar 
evidence for the existence of signals common to a germacrane-skeleton. The proton 
signals were due to four methyls, one appeared as singlet at δH 1.67 (H3-15), whereas 
the remainder appeared as doublets at  0.96 (d, J=6.8 Hz, Me-14), 0.88 (d, J= 6.4 Hz, 
Me-13), and δH 0.93 (d, J=6.4 Hz, Me-12). Furthermore, four sets of  methylene protons 
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could be assigned to the signals at δH 2.08 (H2-2), 1.63, 2.08 (H2-3), 2.4 (H2-6), and  δH 
2.91, 3.04 (H2-9). The proton spectrum also displayed one olefinic proton triplet at δH 
5.10 belonging to H-1 with a coupling constant of 8.24 Hz. 
The 
13
C-NMR and DEPT-135 spectra (Figure  3.9, Table   3.3) revealed the 
presence of a total of 15 carbons implying the sesquiterpenic nature of compound 20. 
Among them, there were four sp
3 methyls signals resonated at δC 16.6 (C-15), 18.6 (C-
14), 21.2 (C-13), and δC 19.9 (C-12). Furthermore,  four sp
2
 methylenes at δC 26.5 (C-
2),  34.1 (C-3), 44.3 (C-6), and δC 55.9 (C-9), four methines at δC 131.5 (C-1), 46.8 (C-
4), 53.7 (C-7), and 30.1 (C-11) were observed.  In addition, three quaternary carbons 
were apparent including two carbonyls at δC 211.0 (C-5), and 214.2 (C-8) and one sp
2
 





H-COSY correlations observed for compound 20 were reminiscent of 
the profile of compound 19 but with an additional correlation of the cross peaks 
between H-7 and H-11. HMBC profile of compound 20 was similar spectral to that of 
compound 19 but with extra cross peaks presented for the correalations between H-7/C-
8, C-6, C-5 and H-11/C-12, C-13,C- 9. 
The in depth analysis of 2D spectra icluding COSY, HMQC, and HMBC 
identified the compound 20 and confirmed its identity as curdione 20 and the spectral 
data were in agreement with the reported literature data  (Hisashi Matsuda, Toshio 




Figure  3.7: Selected HMBC Correlations H C of curdione 20 
  
Table   3.3:  1 H (400 MHz)  NMR and 1 3 C (100 MHz)  NMR spect ra l  da ta of  curdione  20  in  CDCl 3 
Position δH in ppm, J (Hz) δC in ppm 
1 5.13, d (8.24) 131.5 
2 2.08, m 26.5 
3 1.63, 2.08, m 34.1 
4 2.36, m 46.8 
5 - 211.0 
6 2.4, m 44.3 
7 2.81, m 53.7 
8 - 214.2 
9 2.91, 3.04, d (11) 55.9 
10 - 129.9 
11 1.84, m 30.1 
12 0.93, d (6.4) 19.9 
13 0.88, d (6.8) 21.2 
14 0.96, d (6.8) 18.6 
15 1.67, s 16.6 
 
 





Figure  3.8: 1H NMR spectrum of curdione 20 












Furanodiene 21 was isolated as white amorphous powder. The GC-MS analysis 
exhibited the molecular ion peak (M
+
) at m/z 216 corresponding to the molecular 
formula of C15H20O. The UV spectrum (MeOH) of 21 showed absorption maximum at 
λmax nm (log ε): 217 (1.385). The IR spectrum (CHCl3) showed absoportions at νmax cm
-
1
: 3429, 2928, 1740, 1448. 
The 
1
H NMR spectrum (Figure  3.10, Table  3.4) of 21 displayed similar proton 
signals common to the germacrane sketeton due to the presence of three methyl singlets 
at δH 1.26 (H3-15), δH 1.59 (H3-14), and δH 1.92 (H3-13), four set of methylenes protons  
at δH  2.11 (H2-2), 2.13 (H2-3), 2.2, 1.59  (d, J=7 Hz, H2-6) and δH 3.51, 3.72 (d, J=16 
Hz, H2-9). In addition, three olefinic methines appeared at δH 4.91 (H-1), 4.73 (t, J=7 
Hz, H-5), and one proton signal was evident for the presence of furan ring resonated in 
the downfield region of  δH 7.07 (1H, s, H-12).  
The 
13
C and DEPT-135 spectra (Figure  3.11, Table  3.4) revealed the presence 
of a total of  15 carbon signals corresponding to three sp
3
 methyls at δC 16.7 (C-15), 
16.3 (C-14), and δC 9.0 (C-13), four sp
3
 methylenes at δC 26.8 (C-2), 39.5 (C-3), 24.4 
(C-6), 40.9 (C-9), three sp
2 
methines at δC 129.0 (C-1), 127.6 (C-5), and δC 136.0 (C-
12), and five sp
2
 quaternary carbons at δC 128.9 (C-4), 118.9 (C-7), 149.8 (C-8), 134.4 
(C-10), and 121.9 (C-11).  
 65 
Further, analysis of 2D spectra including COSY, HSQC, HMBC confirned the 
identity compound 21 as furanodiene and the structural assignment was supported by 
the published literature (Makabe et al., 2006). 
Table  3.4: 1H NMR (400 MHz), and 13C NMR (100 MHz) spectral data of 
furanodiene 21  
Position δH, J (Hz) δC 
1 4.91, m 129.0 
2 2.13, m 26.8 
3 1.78, 2.25, m 39.5 
4 - 128.9 
5 4.73, t,  (7.32)  127.6 
6 3.06, d (7.32) 24.4 
7 - 118.9 
8 - 149.8 
9 3.40, 3.55 (16) 40.9 
10 - 134.4 
11 - 121.9 
12 7.06, brs 136.0 
13 1.92, s 9.0 
14 1.59, s 16.3 






















Furanodienone 22 was obtained as a colourless crystal (m.p 86-88 
o
C). The EI-
MS displayed the molecular ion peak (M
+
) at m/z 230 corresponding to the molecular 
formula of C15H18O2. The UV spectrum showed absorption band at 217 nm (log ε 1.38). 
The IR spectrum showed strong absorption band at 1653 and 1376 cm
-1
 representing 
carboyl group and olefinic carbons, respectively. 
  The 
1
H NMR spectrum (Figure  3.12, Table  3.5) showed the presence of an 
olefinic proton characteristic of the furan ring appearing as a singlet at δ 7.06 (H-12). 
The proton spectrum also displayed two methyl singlets at δ 1.29 (H3-15), and δ 1.98 
(H3-14), and one methyl appeared as a doublet (J=1.36 Hz) at δ 2.12. Three methylenes 
protons were observed, one appeared as a singlet at δ 3.73 (H2-9) while the two other 
methylenes observed as two doublet of triplet at δ 2.17 (H2-2) and 1.90 (H2-3). 
Furthermore, the value of the chemical shift of the olefinic proton (H-5) was shifted to 
the lower field at δ 5.80 compared to the value normal double is due to the deshielding 




C NMR and DEPT 135 spectra (Figure  3.13, Table  3.5) exhibited the 
presence of a total of 15 carbons including  three sp
3 
methyls at δC  9.6 (C-13), 19.0 (C-
14), 15.8 (C-15), three sp
3
 methylenes at  δC  26.5 ( C-2), 41.7 ( C-3), and δC 40.7 (C-9), 
and three sp
2
 methines at δC 130.6 (C-1), 132.5 (C-5), and δC  138.1 (C-12), and six sp
2 
quaternary cabons at δ 145.9 (C-4), 135.5(C-10), 123.7 (C-11), 122.2 (C-7), 156.6 (C-
8),  and a carbonyl at δ 189.9 (C-6). 
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The compound was identified as furanodienone based on the similarity of above 
spectral data and with those spectral data previously reported (Dekebo et al., 2000).    
Table  3.5:  1H NMR (400 MHz) and 13C NMR (100 MHz) spectral data of 
furanodienone 22 
 
Position δH, J (Hz) δC 
1 5.15, dd (5.04, 11.8) 130.6 
2  (1H) 2.17, dt (5.04, 11.8)  
 (1H) 2.31, m 
26.5 
3 (1H) 1.90 dt (4.12, 11.4) 
 (1H)  2.46, td, (3.64, 11.4) 
41.7 
4 - 145.9 
5 5.80, br s 132.5 
6 - 189.9 
7 - 122.2 
8 - 156.6 
9 3.73, br s 40.7 
10 - 135.5 
11 - 123.7 
12 7.06, brs 138.1 
13 2.12, d (1.36) 9.6 
14 1.98, s 19.0 








































Germacrone 23 was isolated as white amorphous powder. The EI-MS of 
germacrone obtained by GC-MS, showed a molecular ion peak (M
+
) at m/z 218 
corresponding to the molecular formula of C15H22O, and also revealed the base peak at 
m/z 107. The UV spectrum absorption band at 206 nm (log ε 1.47), while the IR 
spectrum revealed the absorption at 1677 cm
-1 




H NMR spectral pattern (Figure  3.14, Table  3.6) was similar to that of 
germacrane skeleton with four methyl singlets at δH 1.62 (H3-15), 1.43 (H3-14),  1.76 
(H3-13), and 1.73 (H3-12). Four pair of methylene protons were observed at δH 2.08, 
2.35 (m, H2-2), 2.15 (m, H2-3),  2.86 (m, H2-6), 3.42, 2.95 (dd, J=11, 3.68, H2-9). 
Moreover, the proton spectrum showed also two olefinic methine protons at δH 4.94 
(1H, d,  J=11.8, H-1) and δH 4.71 (1H, d, J=11 Hz, H-5)  
The 
13
C NMR  and DEPT-135 spectra (Figure  3.15, Table  3.6) indicated the 
presence of a total of 15 carbons; four sp
3 methyls at δC 16.8 (C-15), 15.6 (C-14), 22.4 
(C-13), and 20.0 (C-12), four sp
3
 mehylenes at δC 24.0 ( C-2), 38.1 ( C-3), 29.3 (C-6), 
and 56.0 (C-9), two sp
2
 methines at δC 132.8 (C-1), 125.4 (C-5), five sp
2 
 quaternary 
carbons at δC 126.0 (C-4), 129.0 (C-7), 135.1 (C-10), and 137.0 (C-11),  and a carbonyl 
at δC 208.0 (C-8).    
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Detailed analysis of spectral data including COSY, HSQC, and HMBC 
confirmed the identity of the compound 23 as germacrone and it is in agreement with 
those spectral data previously described in the literature (Makabe et al., 2006). 
Table  3.6: 1H NMR (400 MHz), and 13C NMR (100 MHz) spectral data (in CDCl3) of 
germacrone  23 
Position δH, J (Hz) δC 
1 4.94,d , (11.8) 132.8 
2 2.08, 2.35, m 24.0 
3 2.15, m 38.1 
4 - 126.0 
5 - 125.4 
6 2.8, m 29.3 
7 - 129.0 
8  208.0 
9 2.91, 3.04, d (11) 56.0 
10 - 135.1 
11 3.42, 2.95, dd,  (11, 
3.68) 
137.0 
12 1.73, s 20.0 
13 1.76, s 22.4 
14 1.43, s 15.6 














 .  
Figure  3.15: 13C NMR and DEPT 135 spectra of germacrone 23 
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Germacrone 4,5-epoxide  24 
 
Germacrone 4,5-epoxide 24 was obtained as a white amrphous solid. The EI-MS 
analysis showed a molecular ion peak (M
+
) at m/z 234 corresponding to the molecular 
formula of C15H22O2. The UV spectrum showed an absorpotion maximum at 205 nm 






H NMR spectrum (Figure  3.16, Table  3.7) revealed the presence of four 
methyl singlets at  δH 1.71 (H3-15), 1.02 (H3-14 ), 1.80 (H3-13), and δH 1.81 (H3-12), 
four set of methylene protons at δH 2.24 (H2-2 ), 2.13, 2.43 (d, J=1.84 Hz, H2-3), 2.88, 
2.03 (d, 15.12 Hz, H2-6),  and δH 3.43 (br.s, H2-9). In addition to two methines at 5.28 
(d, J=9.15, H-1), and δH 2.40, 2.44  (dd, 1.84, 2.28 Hz). 
The 
13
C NMR and DEPT 135 spectra (Figure  3.17, Table  3.7) displayed a total 
of 15 cabons suggesting a possible sesquiterpene structure,  four sp
3
 methyls at δC 17.0 
(C-15), 15.9 (C-14 22.8 (C-13), ), and δC 20.5 (C-12), four sp
2 
methylenes at δC  24.7 ( 
C-2), 37.7 ( C-3), 29.7 (C-6), and δC 55.6 (C-9), one sp
2 
methine at  129.8 (C-1), one sp
3
 
methine at δC 64.3 (C-5), three sp
2
 quaternary carbons at δC 126.7 (C-7), 133.7 (C-10), 
and δC 133.9 (C-11), one sp
3
 quaternary carbon at 60.9 (C-4), and one carbonyl at δC 
204.8 (C-8).  
From the spectroscopic data obtained and in comparison with the literature 
values. The structure of compound 24 was established as germacrone 4, 5-epoxide  
(Ohshiro et al., 1990a) 
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Table  3.7:  1H NMR (400 MHz), and 13C NMR (100 MHz) spectral of germacrone 
4,5-epoxide 24 data in CDCl3 
Position δH, J (Hz) δC 
1 5.18, d (8.24) 129.8 
2 2.24, m 24.7 
3 2.12, m 37.7 
4 - 60.9 
5 2.40, 2.44, dd 
(1.84, 2.28) 
64.3 
6 2.87 m, 2.03, d 
(13.8) 
29.7 
7 - 126.7 
8 - 204.8 
9 2.99, 3.43, brs 55.6 
10 - 133.7 
11 - 133.9 
12 1.81, s 20.5 
13 1.80, s 22.8 
14 1.02, s 15.9 




















Germacrone 1, 10-epoxide 25 
 
Germacrone 1,10-epoxide 25 was obtained as a white solid, the molecuar 
formula was calculated C15H22O2 on the basis on the GS-MS analysis (M
+ 
, m/z 234). 
The UV spectrum showed an absorption maximum at 218 nm. The IR absorption at 
1710 cm
-1
 presented for carbonyl group. 
The 
1
H NMR spectrum ( Figure  3.18, Table  3.8) revealed four methyl singlets 
at  δH 1.51 (H3-15), 1.24 (H3-14), 1.75 (H3-13), and 1.64 (H3-12), four methylenes at δH 
2.85, 3.05 (d t, J=12.36 Hz, H-2), 1.40, 2.00 (H-3),  2.17 (d, J=4.12 Hz, H-6),  and δH 






C NMR  and DEPT -135 spectra (Figure  3.19, Table  3.8) revealed a total 
of 15 carbons, including four sp
3
 methyls at δC 15.5 (C-15), 17.4 (C-14), 20.0 (C-13), 
and δC 22.3 (C-12),  four sp
3
 methylenes at δC  29.7 ( C-2), 23.3 ( C-3), 36.1 (C-6), and 
δC 55.3 (C-9), one sp
2
 methine at δC 123.7 (C-5), one sp
3
 methine at δC 64.6 (C-1), four 
quaternary carbons, three among them sp
2
 appearing at δC 134.0 (C-4), 130.7 (C-7), and 
δC 138.1 (C-11), whereas one was sp
3
carbon resonating at δC 57.8 (C-10). Additionally 







C-NMR assignements (Table  3.8) were established by 
thorough analysis of COSY, HSQC and HMBC. From the analysis of the spectroscopic 
data observed and comparsion with the literature values, the identity of germacrone-1, 
10 epoxide 25  was ensured (Sakui et al., 1992). 
Table  3.8: : 1H NMR (400 MHz), and 13C NMR (100 MHz) spectral data of 
germacrone-1, 10-epoxide 25 in CDCl3   
 
Position δH, J (Hz) δC 
1 2.70, d, 11 64.6 
2 2.85, 3.05, dt (12.36) 29.7 
3 1.40, 2.00, m 23.3 
4 - 134.0 
5 5.01, m 123.7 
6 2.17, d (4.12) 36.1 
7 - 130.7 
8 - 209.5 
9 2.46, 2.95, d (11) 55.3 
10 - 57.8 
11 - 138.1 
12 1.64, s 22.3 
13 1.75, s 20.0 
14 1.24, s 17.4 








   






   





Zederone 26 was obtained as a colourless crystal (m.p.152-154
o
C) with an optical 
rotation of [α]D
20
 + 260° (c 0.5, MeOH). The GC-MS analysis showed the base peak (M
+
) at 
m/z 175 and the molecular ion peak M
+ 
at m/z 246 analysed for C15H18O3. The IR absorptions 
at 1654, 1404, 1266 cm
-1
 indicated the presence of carbonyl group and double bonds.  
The 
1
H NMR spectrum (Figure  3.21, Table  3.9) showed the proton signals 
characteristic for the germacrane-type of sesquiterpene. Three methyl singlets were observed 
at δH 2.07, 1.30, and 1.56 for the protons H3-13, H3-14, and H3-15, respectively, and also 
three pair of methylenes protons  at δH 2.24, 2.46 (H2-2), 1.24, 2.27 (H2-3), and δH 3.68 (H2-
9). The proton spectrum also suggested the presence of a furan ring due to the downfield 
olefinic proton singlet at δH 7.06 (H-12). Additionally, one olefinic proton signal at δH 5.46 
(H-1) appeared as a doublet. 
The 
13
C NMR, DEPT 135 and HSQC (Figure  3.22,  3.24, Table  3.9) spectra revealed 
a total of 15 carbons corresponding to three sp
3
methyls at δC 15.8 (C-15), 15.2 (C-14), and δC 
10.3 (C-13), three methylenes at δC 24.7 (C-2), 38.0 (C-3), and δC 41.9 (C-9), three methines 
comprising two olefinic sp
2
carbons at δC 131.2 (C-1), 138.1 (C-12), and one sp
3
 at  δC 66.6  
(C-5). The downfield carbonyl signal was observed at δC 192.2.  
 
In the COSY spectrum (Figure  3.23) cross peaks were observed between  H-1/H-2 
and H-2/H-3, thus indicating that they are vicinal to each other. The HMBC correlations; H3-
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15/C-10, H3-13/C-11 and H3-14/C-4 established that the methyl groups are attached to C-10, 
C-11, and C-4, respectively. The nature of the 10 membered ring fused to a furan ring system 
was deduced from the analysis of COSY, HSQC, and HMBC spectra (Figure  3.23-‎3.25).  
 Thorough spectral data analysis of the above compound and by using 2D-NMR 
spectra the structure of compound 26 was elucidated as zederone also by comparsion with 
spectral data reported in literature (Makabe et al., 2006). 
 
Figure  3.20: Selected HMBC Correlations H C of zederone 26 
 
Table  3.9:  1H (400 MHz) NMR and  13C (100 MHz) NMR spectral data of zederone 26 
 
Position δH, J (Hz) δC 
1 5.46, d (11.8) 131.2 
2 2.24, 2.46, m 24.7 
3 1.24, 2.27, m 38.0 
4 - 64.0 
5 3.77, s 66.6 
6 - 192.2 
7 - 123.2 
8 - 157.2 
9 3.68, m 41.9 
10 - 131.1 
11 - 122.2 
12 7.04, brs 138.1 
13 2.07, s 10.3 
14 1.30, s 15.2 

































HMBC  spectrum of  zederone 26 
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at m/z 228 which was consistent with the molecular formula of C15H16O2. The UV 
spectrum showed maximum absorption at λmax 218 nm indicating the presence of an , 
β-unsaturated γ-lactone of conjugated double bonds. The IR absorption at 1726 cm-1 
indicated the presence of a , β-unsaturated γ-lactone. 
The 
1
H NMR spectrum (Figure  3.27, Table  3.10) had proton signals similar to 
those obseved for guaiane-type sesquiterpenes. The spectrum showed signals 
corresponding to two methyl singlets which appeared at δH 2.24 (H3-15), and 1.98 (H3-
13).  Furthermore, one methyl signal was observed as a doublet at δH 1.30 (3H, d, 
J=6.84 Hz , H-14). In addition, two sets of methylene protons multiplets were observed 
at δH 1.53 (H2-2) and δH 2.81, 2.67 (H2-3).  Moreover, three methine protons signals 
were observed, two of these protons signals were olefinic proton singlets at δ 6.88  (H-6 
), and δH 6.73 (H-9) while the other resonated as quarted (J=14.2 Hz) at δH 3.08 (H-4) 
The 
13
C NMR and DEPT-135 spectra (Figure  3.28, Table Table  3.10) of 41 
revealed a total of 15 carbons suggested its sequiterpenic nature. Three sp
3
 methyls were 
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observed at δC 24.8 (C-15), 20.1 (C-14), and 7.7 (C-13). Furthermore, two sp
2
 
methylenes at 31.9 (C-2), and 33.3 (C-3). In addition,  two sp
2 
methines at δC 117.9  (C-
6),  and 116.4 (C-9) were observed, while one sp
3
 methine signal was at δC 43.9 (C-4). 
The 
13
C NMR spectrum also showed six sp
2
 quaternary carbons  at δC 144.2 (C-1), 
156.6 (C-5), 146.2 (C-7), 154.8 (C-8), 136.5 (C-10), and 103 (C-11) with an  additional 





H COSY correlations between H-2/H-3, H-3/H-4, H-4/H3-14, together 
with HMBC correlations observed between H-2/C-1, H-2/C-5, H-4/C-5, H3-15/C-1, H-
6/C-1, and H-6/C-5 suggested a five membered ring fused to a seven membered ring 
system indicating a guaiane type sesquiterpene skeleton with unsaturations at ∆1(10), ∆5, 
and ∆8. Further investigation of the HMBC correlations of H3-13 to C-7, C-12 and C-11 
suggested an ,β-unsaturated lactone ring attached to the 7-membered ring system 
through C-7 and C-8. The spectral data of 41 ascertained the identity of the compound 
as gweicurculactone and were in agreement with the published literature(Phan et al., 
2014). 
 




Table  3.10:  1H (400 MHz) NMR and 13C (100 MHz) spectral data of  
gweicurculactone 41 in CDCl3 
 
Position δH, J (Hz) δC 
1 2.12, m 144.2 
2 1.53, m 31.9 
3  2.81, 2.67, m 33.3 
4 3.08, q (14.2) 43.9 
5 - 156.6 
6 6.88, s 117.9 
7 - 146.2 
8 - 154.8 
9 6.73, s 116.4 
10 - 136.5 
11 - 103 
12 - 170.7 
13 1.98, s 7.7 
14 1.30, d (6.84) 20.1 
15 2.24, s 24.8 
 
 































Figure  3.31:  HMBC spectrum of  gweicurculactone 41 




Curcumenol 42 was obtained as a colourless oil. The GC-MS analysis revealed 
the  molecular formula of C15H22O2 (m/z 234). The IR spectrum showed absorptions at 
3432, 2934, and 1457 cm
-1
, indicating the presence of hydroxy and olefinic carbons, and 
C-O bond, respectively. The UV spectrum (MeOH) showed an  absorption band at 224 
nm (log ε 3.047). 
The 
1
H NMR spectrum (Figure  3.32, Table Table  3.11) showed the presence of 
three methyl singlets at δH 1.79 (H3-15), 1.61 (H3-13), and 1.54 (H3-12). One methyl 
proton appeared as a doublet at δH 1.01 ( J=6.4 Hz, H-14). three methylenes at δH 1.9 ( 
H-2, 3), and δH  2.11, 2.66 (2H, d, J=15.4 Hz, H-6 ), and three methine at δH 2.07 ( 1H. 
d. J=15.6 Hz, H-1), 1.9 (H-4), and δH 5.74 (H-9). 
The 
13
C NMR and DEPT-135 spectra (Figure  3.33, Table  3.11) exhibited 15 
carbons, including  five quarternary carbons at  δC 85.8 (C-5), 139.2 (C-7), 101.6 (C-8), 
137.2 (C-10), δC 122.3 (C-11), three methylenes at δC 27.6 ( C-2), 31.2( C-3), and δC 
37.2  (C-6), three methines at δC 51.3(C-1), 40.4 (C-4), and δC 125.7 (C-9), four methyls 
at δC 21.0 (C-15), 11.9 (C-14), 18.9 (C-13), and δC 22.4 (C-12). This compound is 
different from procurcumenol by the lack of the carbonyl group and the presence of an 
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ether linkge between C-5 and C-8. This is evidenced by the presence of two deishielded 
signals of two oxygenated methines.  
In depth inspection of all spectral data and comparision with the literature values 
established the identity of this compound as curcumenol (Ohshiro et al., 1990b). 
Table  3.11:  1H NMR (400 MHz) and 13C NMR (100 MHz) spectral data of 
curcumenol 42 
 
Position δH, J (Hz) δC 
1 2.07, d, (15.6) 51.3 
2 1.9, m 27.6 
3  1.9, m 31.2 
4 1.9, m 40.4 
5 - 85.8 
6 2.11, 2.66, d 
(15.4) 
37.2 
7 - 139.2 
8 - 101.6 
9 5.74, br.s 125.7 
10 - 137.2 
11 - 122.3 
12 1.54, s 22.4 
13 1.61, s 18.9 
14 1.01, d, (6.4) 11.9 



























Figure  3.34:  ORTEP (Oak Ridge Thermal Ellipsoid Plot) representation of the crystal 
structure of curcumenol second monoclinic (molecule I and molecule II) 
 
The structure of the title compound was established by a single crystal X-ray 
crystallographic analysis, also known as curcumenol a second monoclinic modification 
(C15H22O2) was obtained as colorless prisms crystals from fraction 10 of hexane extract 
by using silica gel column chromagraphy (CC) followed by HPTLC. The compound 
was crystallized with two molecules of similar conformation in an asymmetric unit, 
featuring three fused rings, two of which are five membered and the rest is a six 
membered ring. Of the two five-membered rings, the one with an oxygen atom has a 
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distinct envelop shape (with the O atom representing the flap). The six-membered ring 
is also envelop-shaped as it shares a common O atom with the five-membered ring. In 
the crystal, the two independent molecules are linked by a pair of O-H...O hydrogen 
bonds, generating a dimer crystal; O1-H1---O4, and O3-H3---O2. The ORTEP structures 
are presented in Figure  3.34.  
The crystals of this compound belong to the monoclinic space group P2, with a 
= 9.3495 (7) 
o
A, b = 12.535 (1) 
o
A, c = 11.7727 (9) 
o





, Z=4. The data were collected at Bruker SMART APEX diffractometer, 
13257 measured reflections.   
The 
I
H-NMR spectrum (Figure 3.35) of the isolated crystal “curcumenol second 
monoclinic” showed similar pattern to the curcumenol previously discussed. All the 
proton signals of the dimer were overlapped, except for the methyls CH3-14 at  δH 1.09 
(d, 4.12 Hz) and CH3-14’ at δH 1.01(d, 6.4 Hz). CH3-14 refers to the molecule with 
ethereal oxygen in the endo position while CH3-14’ possess an exo ethereal oxygen 
linkage. The close proximity of the oxygen to CH3-14’ in the exo-isomer could explain 
its downfield shift, while their opposite orientation in the endo-isomer shifted H3-14 
methyl upfield.   ( Hamdi et al., 2010).  
 






Figure  3.35:  1H NMR   spectrum of curcumenol second monoclinic 
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Isoprocurcumenol 43 
 
Isoprocurcumenol 43 was obtained as colourless oil, the compound revealed the 
molecular formula of C15H22O2 as analysed by GC-MS spectrum (m/z 234). The UV 
spectrum showed maximum band at 205 (log ε , 1.83). IR absorptions at 3450 and 1674  
cm
-1 
were ascribed to hydroxyl and ketone  functional groups, respectively. The ketonic 
function is the difference of this compound compared to gweicurculactone 41  
The 
1
H NMR spectrum  (Figure  3.36, Table  3.12)  revealed the presence of 
three methyl singlets at δH 1.24 (H3-14), 1.82 (H3-13), 1.92 (H3-12), five methylenes at 
δH 1.21 (H2-2), 1.39 (H2-3), 2.81 (2H, d, J=14.2 Hz, H-6), 2.16 (H2-9), 4.90 (2H, d, 




C NMR and DEPT-135 spectra (Figure  3.37, Table  3.12) disclosed the 
presence of  15 carbons with three sp
3
 methyls at δC 24.4 (C-14), 22.8 (C-13), and 21.9 
(C-12), five methylenes, four of the five are sp
3
 resonaced at δC 24.7 (C-2), 28.2 (C-3), 
39.8  (C-6), and 53.8 (C-9), while one is sp
2 
exomethylene at δC 111.6 (C-15). 
Furthermore, three sp
2 
quaternary carbon atoms at δC 134.5 (C-7), 141.3(C-10), and 
143.9 (C-11), in addition one is sp
3
 quaternary carbon atom at  δC 77.4 (C-4), and two 
sp
3
 methine carbon atoms at  δC 51.2(C-1) and δC 58.9 (C-5). Additionally, a carbonyl 
group resonated at  δC t 203 (C-8) indicating a ketone functionality (Ohshiro et al., 
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1990b). Thorough analysis of the spectral data of the above compound indicated that it 
is very similar in structure with gweicurculactone 41 except that the former has the 
ketone function as a part of the seven membered ring skeleton, whereas the latter has a 
lactone function attached to the main skeleton. Indeed after comparison of spectral data 
with literature values (Kuroyanagi et al., 1990a), the identity of this compound 
confirmed as the known isoprocurcumenol 43. 
Table  3.12:  1H (400 MHz) NMR, and 13C (100 MHz) NMR spectral data of  
isoprocurcumenol 43 in CDCl3 
 
Position δH, J (Hz) δC 
1 3.22, q (14.68) 51.2 
2 1.21, m 24.7 
3 1.39, m 28.2 
4 - 77.4 
5 1.40, m 58.9 
6 2.81, d (14.2) 39.8 
7 - 134.5 
8 - 203(Kuroyan
agi et al., 1990a) 
9 2.16, s 53.8 
10 - 141.3 
11 1.90, brs 143.9 
12 1.92, s 21.9 
13 1.82, s 22.8 
14 1.24, s 24.4 

















Figure  3.37:  13C-NMR   and DEPT -135 spectra of  Isoprocurcumenol 43 
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Procurcumenol 44 
 
 Procurcumenol 44 was isolated as a colourless oil. The UV spectrum 
showed the absorption maximum at 204 nm (log ε 1.16). The IR spectrum showed 
absorption peaks of hydroxyl (3409 cm
-1
) and carbonyl group (1712 cm
-1
). By the 
analysis of GC-MS, the molecular formula of procurcumenol was determined to be 
C15H22O2 (m/z 234).  
The 
1
H NMR spectrum  (Figure  3.38, Table  3.13) revealed the presence of four 
methyl singlets at δH 1.22 (H-15), 1.86 (H-14), 1.76 (H-13), and 1.73 (H-12), three 
methylene protons at δH 1.66, 1.94 (H-2), 1.88 (H-3), and 2.16 δH (1H, dd, J=13.2, 15.6 
Hz, Ha-6), 2.57(1H, d, J=15.6 Hz, Hb-6), three methine protons at δH 2.34 (dd, J=8.7, 
9.6 Hz, H-1), δH 1.91(H-5), and δH 5.85 (1H, d , J=1.4,  H-9). This compound 42 has 
similar  spectral  pattern  to  the compound  44  except the presence of methyl protons at 
H3-15 compared to an exomethylene protons at H2-15 in 44.  
The 
13
C NMR and DEPT 135 spectra (Figure  3.39, Table  3.13) revealed the 
existence of a total of 15 carbons, four sp
3
 methyls at δC 24.3 (C-15), 23.4 (C-14), 22.4 
(C-13), 21.3 (C-12), three sp
2
 methylenes at δC 26.9( C-2), 39.9 ( C-3), and 28.6  (C-6), 
three methines, two of which were sp
2
 resonanced at δC 50.5(C-1), and  δC 53.9 (C-5), 
whereas one was sp
2
 methine carbon at δC 129.2 (C-9), four quaternary carbons, three 
were sp
2 
at δC  136.9 (C-7), 155.1 (C-10), and δC 136.3(C-11), and one carbon was sp
3
 at 
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δC 80.3 (C-4). Similarly C-15 is a methyl group compared to the compound 43 was an 
exomethylene resonated at δC 112 (C-15). 
 Extensive spectral data analysis of the above compounds confirmed the identity 
of compound 44 as procurcumenol 44  and in agreement with the literature values. 
(Ohshiro et al., 1990b). 
Table  3.13:  1H (400 MHz) NMR, and 13C (100 MHz) NMR spectral data of 
procurcumenol 44 
 
Position δH, J (Hz) δC 
1 2.34, dd (8.7, 9.6) 50.5 
2 1.66, 1.94, m 26.9 
3 1.88, m 39.9 
4 - 80.3 
5 1.91, m 53.9 
6 2.16, dd (13.2, 15.6) 
 2.57, d (15.6) 
28.6 
7 - 136.9 
8 - 199.2 
9 5.85, d (1.4)  129.2 
10 - 155.1 
11 - 136.3 
12 1.73, s 21.3 
13 1.76, s 22.4 
14 1.86, s 23.4 
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3.1.1.3 Seco-guaiane type sesquiterpenes 
 
 Curcuzedoalide 62 
 
Curcuzedoalide 62 was obtained as a white amorphous powder, GC-MS anlaysis 
exhibited the molecular formula of C15H20O3 determined from the molecular ion peak at 
m/z 248 (M
+
) in EI MS,  whereas the IR absorption at 1717 cm
-1
 corresponding α,β 




H NMR spectrum (Figure  3.41, Table  3.14) displayed  the signals of three 
methyls, two of which were singlets at δ 1.91 (H3-14) and 1.81 (H3-15). While the other 
proton signals appeared as doublet δ 1.09 with  J= 6.6 .Furthermore,  four methylenes 
were observed at δ  2.17 ( H2-2), 1.25, 1.91 (H2-3), ), δ 3.26 (1H, d, J=14.0, H-6a) and  
δ 2.83 (1H, d, J=14.0 , H-6b).  In addition to  exomethylene was resonated at  δ 6.03 
(1H, s, H-12a) and δ 5.88 (1H, d, J=1.2, H-12b). Additionally  three methines appeared 




C NMR and DEPT-135 spectra ( Figure  3.42, Table 3.14) revealed a total 
of 15 carbons including  three sp
3 
methyls at δC: 11.8 (C-15), 22.7 (C-14), and 17.4 (C-
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13), in addition to three sp
3
 methylenes at δC 30.0 (C-2), 31.0 (C-3), and 41.3 (C-6).  
Furthermore,  one sp
2
 methylene at δC 127.1, and  two quaternary sp
2
 were observed at  
δC 161.0 (C-10), δC 144.9 (C-11), Additionally, one sp
3
 quaternary at δC 90.9 (C-5), and 





H COSY correlations observed for 62 were H-1/H-2, H-2/H-3, H-3/H-4 
and H-4/H-15 while in the HBMC spectrum, H-2 and H-4 showed correlations to C-1, 
C-5; H3-14 showed correlations to C-1, C-8, C-9 and C-10 indicating a five membered 
ring fused to a six membered α,β-unsaturated lactone ring system. In addition,  
correlations between H2-6 to C-5, C-7, and C-11 indicated that the 3-isopentenone 
moiety is attached to the main skeleton at the ring junction C-5. Thus the spectral 
analysis of 62 established it to be a Seco-guaiane type sesquiterpenoid, namely 
curcuzedoalide and the data were similar to those published (Park et al., 2012a). 
 
 
Figure  3.40:  Selected HMBC Correlations H C of curcuzedoalide 62 
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Table  3.14:  1H (400 MHz) NMR, and 13C (100 MHz) NMR spectral data of 
curcuzedoalide 62 in CDCl3 
 
Position δH, J (Hz) δC 
1 2.87, dd (7.2, 10.0) 44.6 
2 1.79, 2.17, m 30.0 
3 1.25, 1.91, m 31.0 
4 2.11, m 44.1 
5 - 90.9 
6 Ha-6, 3.26, d (14.0) 
Hb-6, 2.83, d (14.0) 
41.3 
7 - 199.6 
8 - 164.4 
9 5.62, d (1.2) 113.7 
10 - 161.0 
11 - 144.9 
12 Ha-12, 6.03, s 
Hb-12, 5.88, d 
127.1 
13 1.81, s 17.4 
14 1.91, s 22.7 







































Figure  3.45:  HMBC  spectrum of  curcuzedoalide  62 
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3.1.1.4 Elemane type sesquiterpene 
 
  Curzerenone 111 
 
 
Curzerenone 111 was afforded as a colourless oil.  the IR spectrum showed an 
absorption peak at 1712 cm
-1
.  The GC-MS analysis revealed  a base peak m/z at 122 while 
the molecular ion peak (M
+
) at m/z 230 implying the molecular formula of C15H18O2. 
The 
1
H NMR spectrum (Figure  3.47, Table  3.15) showed the presence of proton 
signals due to three methyl groups as singlets at  δH 1.18 (H3-15), 1.76 (H3-14), and 2.20 (H3-
13). In addition, three methylenes, two of which were exomethylenes at δH 4.93 (H2-2), and 
4.84 (H2-3) and the other protons as doublets with J=17.2 Hz at 2.94, 2.74 (H2-9). 
Furthermore, the proton spectrum also showed three methines, two of which were olefinic 
protons at δH 5.77 ( dd, J=10.8, 17 Hz, H-1),  and  δ 7.01 (H-12). and the other resonated at 
2.94 (H-5).  
  The 
13
C NMR and DEPT-135 spectra (Figure  3.48., Table  3.15)  revealed the signals 
of a total of 15 carbons. Three methyls at δC 24.8 (C-15), 24.9 (C-14), and 8.9 (C-13).  Two 
sp
2
 methylenes were observed at δC 112.9 (C-2), and δ 115.6 (C-3). In addition, one 
sp
3
methylene appeared at δC 33.6 (C-9). Furthermore, two sp
2
 methines at δC 145.5 (C-1), 
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and 139.5 (C-12), while sp
3
 methine at δC 64.1 (C-5).  Additionally a carbonyl signal was 




H COSY correlation between H-1/H-2 together to HMBC correlations of cross 
peaks of H-15 to C-5, C-8, C-9, C-10, in addition to H-9 to C-1, C-5, C-8, and C-10, and also 
H-14 to C-3 and C-5 confirmed the presence of elemane type sesquitertene with additional 
furan ring showed by the correlation of H-12 to C-7, C-8, and C-12 indicated that the furan 
ring fused with a six membered ring at C-8 and C-7.  
The spectral data for 111 showed good agreement with the literature. The identity of the 
compound was thus confirmed as curzerenone (Yang et al., 2011). 
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Table  3.15:  1H (400 MHz) NMR and 13C (100 MHz)  NMR spectral data of curzerenone 
111 in CDCl3 
 
Position δH, J (Hz) δC 
1 5.77, dd (10.8, 17) 145.5 
2 4.93,  dd (17, 4.2) 112.9 
3 4.84, s 115.6 
4 - 141.0 
5 2.94, s 64.1 
6 - 194.8 
7 - 120.1 
8 - 165.4 
9 2.94, 2.74, d (17.2) 33.6 
10 - 42.8 
11  119.2 
12 7.01, s  139.5 
13 2.20, s 8.9 
14 1.76,s 24.9 









































Figure  3.51:  HMBC  spectrum  of  curzerenone 111 
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3.1.1.5 Humulane type sesquiterpenes 
 
Zerumbone epoxide 151 
 
 
Zerumbone epoxide 151 was isolated as a pale yellow. The MS of 151 exhibited 
a molecular ion (M
+
) signal at m/z 234 associated with the molecular formula of 
C15H22O2. The IR absorption at 1712 cm
-1 
indicated the presence of a carbonyl group. 
The UV spectrum (MeOH) showed a   λmax nm (log ε) at 216 (2.6). 
The 
1
H NMR spectrum (Figure  3.53, Table Table  3.16) displayed the presence 
of four methyl singlets at  δH 1.07 (H-15), 1.28 (H-14 ), 1.84 (H-13), and 1.20 (H-12). 
Three methylene signals were observed at δH 1.44 (2H, dd, J=2.7, 11.4 Hz), 1.34, 2.22 
(2H, m, H-4), 1.94 (1H, d, J=13Hz, H-5). Furthermore, four methines at δH 2.74 (1H, d, 
J=11, H-2), 6.1 (1H, d, J=12.3Hz, H-6), 6.10 (2H, d, J=1.36 Hz, H-9), 6.09 (1H, d, 
J=1.36 Hz, H-10).  
The 
13
C NMR and DEPT-135 spectra (Figure  3.54, Table  3.16) indicated the 
presence of 15 carbons. Four methyls at δC 29.8 (C-15), 24.0 (C-14), 12.1 (C-13), and 
15.7 (C-12). Three sp
3
 methylenes carbons were observed at 42.7(C-1), 38.2 (C-4), and 
24.7 (C-5). In addition, three  sp
2 
methines at δC 147.8 (C-6),  128.3 (C-9), and 159.5 
(C-10). Furthermore, one sp
3
 methine appeared at δC 24.0 (C-14). Additionally, three 
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quaternary carbons,  two of which are sp
3










H COSY correlation observed were H-4/H-5, H-5/H-6, H-1/H-2 
together with HMBC correlations of H-1 to C-2,  3, 11. In addition H-15 correlated to  
C-11, 10, while H-10 correlated to C-9 and H-9 correlated to C-8. Moreover H-13 
correlated to C-8, H-4 correlated to C-3, C-6, and H-2 correlated to C-3. These HMBC 
correlations observations indicated the humulane skeleton. 
In view of spectral data analysis observed for the above compound and 
comparsion with literature led to the conclusion that compound 151 was  zerumbone 
epoxide(Matthes et al., 1980, 1982).  
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Table  3.16:  1H (400 MHz) NMR and 13C (100 MHz) NMR spectral data of 
zerumbone epoxide 151 in CDCl3   
 
Position δH, J (Hz) δC 
1 1.44, d (11.8) 42.7 
2 2.74, d (11) 62.5 
3 - 61.9 
4 1.34, 2.22, m 38.2 
5 1.94, d (13.7)  24.7 
6 6.1, d (12.3) 147.8 
7 - 139.5 
8 - 203.0 
9 6.10, d (1.36) 128.3 
10 6.09, d (1.36) 159.5 
11 - 36.0 
12 1.20, s 15.7 
13 1.84, s 12.1 
14 1.28, s 24.0 






































Figure  3.57:  HMBC   spectrum  of  zerumbone epoxide  151 
   138 
3.1.1.6  . Cadinane type sesquiterpenes 
 









MeOH). The EI-MS revealed a molecular ion (M
+
) peak m/z 216 indicating the 
molecular formula of C15H20O. The IR spectrum showed strong absorption band at 1653 
cm
-1
 implying the presence of an α,β-unsaturated carbonyl group which was futher 
supported by the UV spectrum (MeOH) in which it showed absorption band maximum 
at 220 nm.  
The 
1
H NMR spectrum (Figure  3.59, Table  3.17) showed the presence of four 
vinyl methyl singlets at δH 1.56 (H3-15), 1.91 (H3-14), 1.85 (H3-13), 2.04 (H3-12),  two 
methylenes at δH 1.82, 2.17( H2-2) and δH 1.81 (H2-15),  four methines at δH 2.73 (H-1), 
3.74 (H-6), 4.90 (H-5), and 5.88 (H-9),  
The 
13
C NMR, DEPT-135, HSQC spectra (Figure  3.60, 3.62, Table  3.17) 
displayed one carbonyl (δC 191.9), and six olefinic carbons at δC 135.1 (C-4), 122.0 (C-
5), 133.6 (C-7), 141.7 (C-11), 130.8 (C-9), and 158.5 (C-10). In addition, four methyl 
groups resonanted at δC 23.5 (C-15), 20.9 (C-14), 21.9 (C-13), and 23.1(C-12), two 
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methylenes at δC 25.3 (C-2), 26.0 (C-3), and four methines at δC 38.3 (C-1), 39.8 (C-6), 





H-COSY correlations observed were H-1/H-2, H-1/H-6, H-2/H-3, and 
H-5/H-6 coupled with the HMBC correlations: H-14/C-1, C-9, H-1/C-14, H-2/C-1, H-
15/C-3, C-4, C-5, H-9/C-7, H-1/C-7 established the presence of two six membered rings  
fused together, while other HMBC correlations observed between H-12, H-13 to C-7 
and C-7 indicated the dimethylethylene group attached the ring system through C-7. 
Thus, COSY and HMBC spectra were able to establish the cadinane skeletal of 
comosone II.   
Analysis of the above information in combination with other 2D spectra, 
including HMBC, HSQC, NOESY confirmed the structure as comosone II and was in 












Table  3.17:  : 1H NMR (400 MHz) and  13C NMR (100 MHz) spectral data in CDCl3 
of comosone II 104 
 
Position δH, J (Hz) δC 
1 2.73, s 38.3 
2 1.82, m 2.17, m 25.3 
3 1.81, m 26.0 
4 - 135.1 
5 4.90, s 122.0 
6 3.74, s 39.8 
7 - 133.6 
8 - 191.9 
9 5.90, s 130.8 
10 - 158.5 
11 - 141.7 
12 2.04, s 23.1 
13 1.85, s 21.9 
14 1.91, s 20.9 
15 1.56, s 23.5 
 




































Figure  3.63:  HMBC  spectrum  of  comosone II 104 
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Curcumenone 65 was isolated as a colourless oil ([𝛼]D
20 -12.7°, c 1.0, CHCl3). 
The GC-MS analysis revealed a molecular ion (M
+
) peak at m/z 234 analysed for 
C15H22O2. The The UV (MeOH) spectrum displayed absorptoion maximum band at  








H NMR spectrum (Figure  3.65, Table  3.18) revealed the presnce of four 
methyl singlets protons signals at two protons δH 2.07 (H3-12), 1.77 (H3-13), 2.12 (H-
14), and 1.10 (H-15). Furthermore, four sets of methylene protons at  δH 1.64 (H2-2), 
2.47 (H2-3), 2.8 (H2-6), and 2.52 (H2-9). In addition,  two methine protons at δH 0.43 
(H-1) and 0.67 (H-5) were  characteristic for a cyclopropane ring.  
The 
13
C NMR, DEPT-135, and HSQC spectra (Figure  3.66, 3.68, Table  3.18)   





 methines, two sp
2
 quaternary carbon and two carbonyls. The four methyls 
signals were observed at δC 23.53 (C-12), 23.58 (C-13), 30.17 (C-14), and 19.13 (C-15). 
Further, four methylenes resonated at δC 23.4 (C-2), 44.0 (C-3), 28.2 (C-6), and 49.0 (C-
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9), while  two methines appeared at δ 24.1 (C-1), 24.2 (C-5). In addition, two sp2 
quaternary carbons at δ 128.2 (C-7), 147.4 (C-11), while one quaternary carbon sp3 at δ 





H COSY spectrum showed the correlations H-1/H-2, H-1/H-5, H-2/H-
3, H-6/H-5.  
In the HMBC the correlations H-1 to C-1, and C-5 indicated the presence of 
cyclopropane ring. Also the correlation betwwen H-9/C-8, C-10, H-5/C-6, C-10, and H-
6/C-7, C-8 confirmed the cyclohexane ring. 
The 2D spectral data including COSY, HSQC and HMBC showed the skeleton 
having a cyclohexane ring fused to a cyclopropane ring, which is the characteristic of 
caraborane type sesquiterpenes. Based on the above spectral data, the structure of the 
above compound was confirmed as curcumenone. The results were compared with the 
reported data for curcumenone and it was in agreement (Shiobara et al., 1985a). 
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Table  3.18:  1H NMR (400 MHz) and13C NMR (100 MHz)  spectral data in CDCl3 of 




δH, J (Hz) δC 
1 0.43, dt (4.56, 7.32) 24.1 
2 1.64, q (7.32) 23.4 
3 2.47, t (7.36) 44.0 
4 - 209 
5 0.67, q (4.56) 24.2 
6 2.8, m 28.2 
7 - 128.1 
8 - 201.9 
9 2.52, d (15.6) 49.0 
10 - 20.2 
11 - 147.6 
12 2.07, s 23.5 
13 1.77, s 23.5 
14 2.12, s 30.1 















































Figure  3.69: HMBC spectrum of   curcumenone 
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Curcumanolide A 101 was obtained as a colourless oil ([α]D
20
 -23°, c 1.0, 
CHCl3).  The GC-MS analysis revealed the molecular formula of C15H22O2 worked out 
from molecular ion peak (M
+
) at  m/z 234. The IR absorption at 1717 cm
-1
 indicated the 
presence of a carbonyl group. The UV spectrum showed absorption at 218 nm 
suggested for a conjugated system. 
The 
1
H NMR spectrum (Figure  3.71, Table  3.19) displayed four methyl proton 
singlets at δH 1.82 (H3-15), 0.86 (H3-14), 1.83 (H3-13), and 2.22 (H-12) Four  
methylenes were observed at δH 1.65, 1.82 (H2-2), 1.83, 2.22 (H2-3), 2.44 (H2-6), and 




C NMR,  DEPT-135, and HSQC spectra (Figure  3.72, 3.74, Table  3.19) 
revealed a total of 15 carbons corresponding to  four sp
3
 methyls at δC: 19.9 (C-15), 13.1 
(C-14), 23.9 (C-13), and  24.4 (C-12), three sp
3
 methylenes at  δC 26.5( C-2), 23.22( C-
3), 27.6 (C-6). In addition to one sp
2
 exo-methylene signal appeared  at δC 112 (C-9) 
and  two sp
3 
methine carbons observed at δC 52.3 (C-1) and 42.8 (C-4). 
  





H COSY correlations observed H-1/H-2, H-2/H-3, H-3/H-4, H-4/H-14 
coupled with HMBC correlations of the cross peaks of H-14 to C-4, H-4/C-5, H-1/C-5 
indicated that the five memebered ring linked to the other ring through the connection 
C-5. In addition, H-12 and H-13 were correlated to C-11 and C-7. These observations 
indicated that dimethyl ethylene connected to C-7 to the other ring, further H-6 showed 
correlation to C-9 and 8. Therefore, all these evidence supported the presence of 
spirolactone skeleton. From the analysis of the spectral data observed of compound 101 
together with the literature data values, the identity of 101 was established as 
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Table  3.19:  1H NMR (400 MHz), and 13C NMR (100 MHz) spectral data of 
curcumanolide  A 101 
 
Position δH, J (Hz) δC 
1 2.83,dd (11.5, 8.7)  52.3 
2 1.65, 1.82, m 26.5 
3 1.83, 2.22, m 23.2 
4 2.32, m 42.8 
5 - 89.7 
6 2.44, brs 27.6 
7 - 120.8 
8 - 169.9 
9 4.74, 4.93, s 112.7 
10 - 149.4 
11 - 143.8 
12 2.22, brs 24.4 
13 1.83, s 23.9 
14 0.86, s 13.1 











































Figure  3.75:  HMBC spectrum of curcumenolide A 101 
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3.1.1.9 Labdane type diterpenoids isolated from C. zedoaria rhizomes 
Three labdane type diterpenoids were isolated for the first time from C. 
zedoaria. Two of them were obtained from the hexane extract, namely labda-8(17),12-
diene-15,16-dial 127, labda-8(17),12-diene-15,15-dimethoxy-16-al, also known as 
calcaratarin A 128,  and zerumin A 129. 
Labda-8(17), 12 diene-15, 16 dial   127 
 
Labda-8(17),12 diene-15,16 dial 127 was obtained as  colourless oil. The GC-
MS analysis showed a molecular ion peak at m/z 302 (M
+
) corresponding to a molecular 
formula of C20H30O2. The UV spectrum (MeOH) showed absorption bands at λmax 226 
and 208 nm (log ε 1.969 and 2.77, respectively). The IR absportions at 1683 cm-1 





H NMR spectrum (Figure  3.77, Table  3.20) showed some proton signals 
common to labdane type diterpenoids with three methyl singlets at δH 0.71, 0.80 and 
0.87 assignable for H3-20, H3-19, and H3-18, respectively. In addition, a pair of broad 
singlets assignable to the exomethylene protons  were observed at δH 4.37 (H-17a) and 
4.84 (H-17b) which is another characteristic feature of bicyclic labdane diterpenoids. 
The proton signals at δH 9.62 (s), 9.38 (s) indicated the presence of two aldehyde 
protons and were assigned for H-16 and H-15, respectively. Six sets of methylene 
protons resonated as multiplets at δH 1.07, 1.72 (H2-1), 1.52, 1.58 (H2-2), 1.22, 1.42 (H2-
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3), 1.34, 1.76 (H2-6),2.03, 2.42 (H2-7), 2.34, 2.50 (H2-11), while the methylene protons 
H2-14 appeared as a pair of doublets dd at δH 3.39  with J=16.  The methine signal at  
δH  6.75resonated as a triplet with  J=6.4 Hz was assigned to H-12.  In addition, a 
doublet with  J=11.4 Hz at δH 1.92 can be attributed to  H-9 and while the other methine 
proton H-5, resonated as dd (J=2.8, 12.8) at δH 1.3. 
The 
13
C NMR, DEPT-135 and HSQC spectra (Figure  3.78, 3.80, Table  3.20) 
displayed a total of 20 carbons; three sp
3
 methyls at δC 14.4 (C-20), 21.8 (C-19), and 
33.6 (C-18),  seven sp
2
 methylenes at δC 39.3 (C-1), 19.3 (C-2), 42.0 (C-3), 24.1 (C-6), 
37.9 ( C-7), 24.7 (C-11), and δC 39.4 (C-14), one sp
2 
methylene at δC 107.9 (C-17), two 
sp
3 
methine at δC 55.4 (C-5), and 56.5 (C-9), one sp
2
 methine at δC 160.1 (C-12). The 
value of C-12 was shifted downfield due to the influence of the nearby carbonyl group. 
Two sp
3
 quaternary carbons were observed at δC 33.6 (C-4), and 39.6 (C-10), two sp
2
 
quaternary carbons at δC 148.1 ( C-8), and 134.9 (C-13), and two carbonyls at δC 193.6 
(C-16),  and 197.4 (C-15). The presence of the three methyls C-18, C-19, C-20, a 
methylene C-17, and an sp
2
 quaternary carbon C-8 further evidenced the nature of a 





H COSY correlations observed; H-11/H-12, H2-14/H-15 (aldehydic 
proton) coupled with HMBC correlations observed cross peaks between H-12 to C-14, 
and C-16, aldehydic proton H-16 to C-13, and H2-14 to C-13, C-15, C-16 established 
the substructure of the side chain; –CH2-CH=C(CHO)-CH2-CHO. The HMBC 
correlation of C-9  and H-12  together with the 1H-1H COSY crosspeak H-9/H-11, 
indicated that the side chain is connected to the main labdane skeleton through C-9. 
Extensive inspection of the spectral data (HMBC, HSQC, COSY) concluded the 
structure of the compound as labda-8(17),12 diene-15,16 dial 127. The spectral data 
complied with the published literature data (Roth et al., 1998). 
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Figure  3.76:  Selected HMBC Correlations H C of labda-8(17),12  diene-15,16  dial 127 
 
Table  3.20:  1H NMR (400 MHz) and 13C NMR (100 MHz) spectral data in CDCl3 of 
labda-8(17),12 diene-15,16 dial 127 
 
Position δH, J (Hz) δC 
1 1.07, 1.72,  m 39.3 
2 1.52, 1.58, m 19.3 
3 1.22, 1.42, m 42.0 
4 - 33.6 
5 1.3, dd (2.8, 12.8) 55.4 
6 1.34, 1.76, m 24.1 
7 2.0.3, m, 2.42, 37.9 
8 - 148.1 
9 1.92, d (11) 56.5 
10 - 39.6 
11 2.34, 250, m 24.7 
12 6.75, t (6.4) 159.5 
13 - 160.1 
14 3.39, d (16.4) 39.4 
15 9.62, s 197.4 
16 9.38, s 193.6 
17 4.35, 4.85, br.s 107.9 
18 0.87, s 33.6 
19 0.80, s 21.8 





































Figure  3.81:  HMBC spectrum  of labda-8(17), 12-diene-15, 16-dial 127 
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 Calcaractrin A 128 
 
Calcaractrin A 128 was obtained as a colourless oil. The UV spectrum showed 
absorption maximum at 200 nm. The IR spectrum showed absorption bands at 2929, 1708, 
1688 cm
-1
. The GC-MS displayed the M
+
 at m/z 318 corresponding to the molecular formula 
of C22H44O3.  
The 
1
H NMR spectrum (Figure  3.82, Table  3.21:  1H NMR (400 MHz), and 13C 
NMR (100 MHz) spectral data (in CDCl3) of calcaractrin A 128) showed similiar evidence 
for the presence of labdane type diterpenoid due to the presence of three distinct methyl 
singlets at δH 0.87, 0.81, and 0.73 for H-18, H-19, and H-20, respectively. In addition,  two 
exomethylene protons at δH 4.41, 4.82 ( 2H, dd, J=1.4, 0.48 Hz, H-17 was further proof for 
the characteristic of a bicyclic labdane type diterpenoid. Two clear methoxy groups obviously 
observed at δH 3.33,  while  eight set of methylene protons  at δH 1.74 (H2-1), 1.47, 1.56 (H2-
2), 1.03(1H, brs, H-3), 1.2 (1H, d, J=1.36 Hz, H-3), 1.32, 1.72 (m, H2-6), 2..0, 2.38 (m, H2-7),  
2.42, 2.62 (m, H2-11),  2.56 ( m, H2-14),). The proton spectrum showed also four methines 
protons signals observesable at δH 1.12 (dd, J=2.7, 12.8 Hz, H-5), 1.92 (d, J=11 Hz , H-9 ), 
6.53 ( t, J=5.9 Hz, H-12), and 4.41 ( t, J=5.4, H-15).  
The 
13
C NMR and DEPT-135 spectra (Figure  3.83, Table  3.21) displayed the 
presence of a total of 22 carbons comprising of three methyls, eight methylenes, four 
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methines, four quaternary carbons, two methoxy group, one carbonyl.Two observed signals 
were obviously assigned to the two methoxy groups at δC 54.4 (C-21, 22), three methyls at 
14.5 (C-20),  21.8 (C-19), 33.7 (C-18), eight signals observed indicated the presence of eight 
methylenes at 39.2 (C-1), 19.4 (C-2), 42.1 (C-3), 24.2 (C-6), 37.9 ( C-7), 24.6 (C-11), 29.1 
(C-14), and 107.9 (C-17). Four methines signlas were detected at  55.5 (C-5), 56.6 (C-9), 
160.1 (C-12), and 103.9 (C-15). Four quaternary carbons were also observed at δC 33.6 (C-4), 
148.3 (C-8), 39.6 (C-10), and 138.2 (C-13) while one carbonyl at 195.1 (C-16).  
From the the of spectroscopic data obtained (Table  3.21) and comparison with the 
literature values, the identity of the compound was established as  calcaractrin A 128 (Abas et 
al., 2005). 
Table  3.21:  1H NMR (400 MHz), and 13C NMR (100 MHz) spectral data (in CDCl3) of 
calcaractrin A 128 
 
Position δH, J (Hz) δC 
1 1.07, 1.71,  m 39.2 
2 1.47, 1.56, m 19.4 
3 1.17, 1.42, m 42.1 
4 - 33.6 
5 1.11, dd (2.7, 12.8) 55.5 
6 1.32, 1.72, m 24.2 
7 2.01, 2.38, m 37.9 
8 - 148.3 
9 1.92, d (11) 56.6 
10 - 39.6 
11 2.42, 2.62, m 24.6 
12 6.53, t (5.9)  160.1 
13 - 138.2 
14 2.56, dd (5.4, 9.6) 29.1 
15 4.41, t (5.4)  103.9 
16 9.32, s 195.1 
17 4.41, 4.82, dd (1.4, 
0.48) 
107.9 
18 0.87, s 33.7 
19 0.81, s 21.8 
20 0.73, s 14.5 
21 3.33 (OMe) 54.4 















Figure  3.83:  13C NMR  and DEPT-135 spectra of calcaratarin A 128 
 
   175 




Zerumin A 129 was obtained as pale yellow oil. The UV spectrum showed 
maxmium absorption band at 210 nm. The compound was assigned with the molecular 





H NMR spectrum (Figure  3.84, Table  3.22) showed common signals 
similiarily to those signals observed in the labdane type diterpenoids due to the presence 
of two exomethylene protons singlets at δH 4.37, 4.84 and the existence of three three 
methyl singlets at δH 0.73, 0.81, and 0.87 which were assigned to the three methyl 
protons for  H-20, H-19, and H-18, respectively.  
The 
13
C NMR and DEPT-135 spectra (Figure  3.85, Table  3.22) displayed a 
totol of 20 carbon signals due to three methyls, eight methylenes, three methines, four 
quaternary carbons, two carbonyls. Further evidence that 129  was a labdane type 
diterpenoid was the existence of three signals for three methyls a at δC 14.1 (C-20), 21.8 
(C-19), and 33.6 (C-18). In addition to an exomethylene carbon at 107.9 (C-17), and a 
quaternary carbon atδC 148.1 (C-8). The presence of two carbonyls clearly observed at 
δC 193.8 (C-16), and 174.3 (C-15).Seven sp
2
 methylenes were resonated at 39.2 (C-1), 
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19.3 ( C-2), 42.0 (C-3), 24.1 (C-6), 37.9 ( C-7), 24.6 (C-11), and 29.7 (C-14).  Two sp
3 
methines were observed at 55.4 (C-5), and 56.4 (C-9). In addition to one sp
2
 methine at 
159.5 (C-12). Four quaternary carbons, including two sp
2
, and 135.7 (C-13), and 
148.1(C-8),  two sp
3




Based on the spectral data obtained (Table 3.21) and comparison with literature 
values, the structure of 129 was established as zerumin A ( Xu et al., 1996). 
Table  3.22:  : 1H NMR (400 MHz), and 13C NMR (100 MHz) spectral data recorded 
in CDCl3 of zerumin A 129 
 
Position δH, J (Hz) δC 
1 1.07, 1.72,  m 39.2 
2 1.52, 1.59, m 19.3 
3 1.21, 1.42, m 42.0 
4 - 33.6 
5 1.13, dd (2.7, 12.8) 55.4 
6 1.36, 1.75, m 24.1 
7 2.41, m,  
2.02, dd (5.0,13.2)  
37.9 
8 - 148.1 
9 1.92, d (11) 56.4 
10 - 39.6 
11 2.55, ddd (2.7, 3.2, 6.3) 24.6 
12 6.68, (6.4) 159.5 
13 - 135.7 
14 3.36, d (16.4) 29.7 
15 - 174.3 
16 9.37, s 193.8 
17 4.37, 4.84, brs 107.9 
18 0.87, s 33.6 
19 0.81, s 21.8 
20 0.73, s 14.1 
 
 














Figure  3.85:  13C NMR  and  DEPT spectra of zerumin A 129 
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3.1.2 Phytochemical investigation of C. purpurascens rhizomes 
No phytochemical work has been reported so far on the rhizomes of C. purpurascens 
(Temu tis). Therefore, an attempt was done towards the phytochemical investigation of it on 
its essential oil, SFE extracts, and crude extracts obtained by cold maceration with n-hex, 
DCM and MeOH. 
The investigation resulted in the isolation of two major types of compounds: 
(i) Bisabolane sesquiterpenoids were isolated from the n-hex extract. 
(ii)  Curcuminioids and one guaiane sesquiterpene were isolated from DCM extract.  
Table  3.23:  Compounds isolated from C. purpurascens 
 
No. Compound  Skelelton  
23 ar-Turmernone 74 Bisabolane  
24 Curcumin 138 Diaryhepatanoid 
26 Bisdemthoxymethycurcumin 139 Diaryhepatanoid 
25 Demethoxycurcumin 140 Diaryhepatanoid 
27 Zedoalactone B 60 Quaiane 
   
 
3.1.2.1 Bisabolane type sesquiterpenoids 




ar-Turmerone 74 was obtained as a pale yellow oil with [α]D
25
 + 60 (c 0.5, MeOH). 
The EI-MS spectrum showed a molecular ion peak (M
+
) at m/z 216 corresponding to the 
molecular formula of C15H20O. The UV(MeOH) absorption λmax at 240 nm indicating the 
presence of the benzene ring, the carbonyl, and the double bonds. The IR spectrum exhibited 
absorptions at 1700 cm
-1
 (carbonyl) and aromatic (1516 and 1618 cm
-1
) groups. 
  The 
1
H NMR spectrum (Figure  3.87, Table  3.24) showed obvious separation of 
proton signals into aliphatic and aromatic parts of the molecule. The spectrum displayed three 
methyl singlets, two of which were typical of allylic protons at δ 2.09 (H3-12), and 1.84( H3-
13 ), where the methyl protons attached to the benzene ring resonated  further in the 
downfield region compared to  a regular aliphatic methyl group due to the effect of aromatic 
deshielded to the methyl protons and resonated at 2.29 (H3-15). In addition to one methyl 
protons appeared as doublet (J=7.36 Hz) at δ 1.22 (H3-14). The proton spectrum also showed 
symmetrical four protons aromatic at δ 7.09 which can be easily assigned for the protons 3, 5, 
2, and 6.    
The 
13
C NMR and DEPT-135 spectra (Figure  3.88, Table  3.24) are also nicely 
divided with aromatic and an alphatic part. The spectrum revealed a total of 15 carbon signals 
carbons due to one carbonyl, three sp
2 







methylene, and four methyls, among them six carbons were for the symmetrical 
aromatic ring,  both C-2, and C-6 resonated at 126.7, similarly C-3, and C5 at δ 129.2, in 
addition C-1 and C-4 appeared at δ 143.7, and 135.6, respectively.  
Therefore, the structure was deduced as turmernone by the spectral data analysis and 





Figure  3.86:  Selected HMBC Correlations H C of ar-turmerone A 101 
 
 
Table  3.24:  1H NMR (400 MHz) and 13C NMR (100 MHz) spectral data in CDCl3, of ar-
turmerone 74 
 
Position 1H δH 13C δC 
1 - 143.7 
2 7.09 , s 126.7 
3 7.09,  s 129.2 
4 - 135.6 
5 7.09,  s 129.1 
6 7.09,  s 126.7 
7 3.27,  m 35.3 
8 2.63, m 52.7 
9 - 200 
10 6.01, s 124.1 
11 - 155.2 
12 2.09, s 20.8 
13 1.84, s 27.7 
14 1.22,  d (7.36 ) 22.1 





































Figure  3.91:  : HMBC  spectrum of  ar-turmerone 74 
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3.1.2.2 Diarylheptanoids (curcuminoids) 
Three diarylheptanoids were isolated from the DCM extract of C. purpurascens 
including curcumin 138, bisdemethoxycucumin 139 and demethoxycurcumin 
140.However, the presence of curcumin and its structural analogues, predominantly 
found in the plant studied in a high amount arise the attention of the plant as a new 





Curcumin 138 was obtained as an orange crysal (m.p. 184-186
o
C). The HRESI-
MS showed a pseudo molecular ion peak [M+H]
+
 at m/z 369 consistent with the 
molecular formula of C21H20O6. The UV absorption at 430 nm indicating the presence a 
typical conjuageted systems. The IR spectrum presented absorption bands for phenolic 
hydroxyl group (OH stretching) at 1625 cm
1
 and 1600 cm
-1
.  
Judging from the 
1
H NMR spectrum (Figure  3.93, Table  3.25), the compound 
was truly aromatic due to the resonances of the ring protons betwwen 9 and 7 pm. The 
poton spectrum revealed obviously the presence of  the pair of methoxy group signals at 
δ 3.89. The singlet appeared at δ 5.95 was assigned to H-1 indicating the symmetric 
structure as shown in the enol form. The proton spectrum also showed an AX spin 
system at δ 6.69 and δ7.58 with a spin coupling of 16 Hz which were assigned to the 
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protons H-3. 3’ and H-4, 4’, respectively of the trans olefinic bond. The protons H-6, 6’ 
( δ 7.31) showed small meta coupling (J=1.84 Hz) with 7.16 (H-10, 10’). The proton H-
10, 10’ showed ortho coupling with H-9, 9’( 6.86) with  coupling constant  J =8.24 Hz.  
The 
13
C-NMR, DEPT, and HSQC spectra (Figure 3.94, 3.96, Table  3.25) 
presented a total number of 11 signals carbons for the half the symmetrical system of 
the the compound. Also the two obviously assignable signals are from the two methoxy 
groups at δ 55.8 and the carbonyl atom in the enol form at δ 183 (C-2, 2’). Three 
quaternary carbon signals at δ 149.2, 147.9, and 127.3 which were assigned for C-8, 8’, 
C-7, 7’, and C-5, 5’, respectively. In addition, three signals sp2 at the benzene ring were 
observed at δ 110.7 (C-6, 6’), 115.4 (C-9, 9’), and δ 123.0 (C-10, 10’). The two sp2 
olefinic signals at δ 121.1 (C-3,3’), and δ 140.5. The most shielded carbon signals 





H-COSY spectrum (Figure  3.95) showed clear spin couplings between 
H-3/H-4, H-3’/H-4’, H-9/H-10, and H-9’/H-10’ 
In the HMBC spectrum (Figure  3.97),  the assignment of the centred of the 
compound CI (δ 100.8)  was clarified due to the correlations of cross peaks of H-3,3’ (δ 
6.69)and H-4, 4’( δ 7.58) to C-2, 2’. Furthermore, HMBC spectrum also showed the 
cross peaks of H-6’(δ 7.31) and H-OMe (δ 3.89) to C-7, 7 (δ 110.7). 
Based on the above extensive 2D-spectral analysis, the identity of the compound 
was confirmed as curcumin 138 and in agreement of the literature reported values 







Figure  3.92:  Selected HMBC Correlations H C  of  curcumin 138 
 
 
Table  3.25:  1H NMR (400 MHz) and 13C NMR (100 MHz) spectral data of curcumin 
138 in acetone-D 
 
Position δH, J (Hz) δC 
1 5.95, s, 1H 100.8 
2, 2’ - 183.7 
3, 3’ 6.69, d (16) , 2H 121.1 
4, 4’ 7.58, d (16),  2H 140.5 
5, 5’ - 127.3 
6,6’ 7.31, d (1.84) 2H 110.7 
7,7’ - 147.9 
8,8’ - 149.2 
9,9’ 6.86, d (8.24), 2H 115.4 
10, 10’ 7.16, , dd (8.24, 1.84) 2H 123.0 











































Bisdemethoxycurcumin 139  was afforded as a yellow powder (m.p. 312-314
o
C). 
The EI-MS of this compound showed a molecular ion at m/z 309  corresponding to the 
molecular formula C19H16O3 . The UV absorption maximum at 415 nm. The IR 
spectrum showed absorption peaks at 3440 (OH) and 1625 (C=O) cm
-1
 indicating the 
presence of the hydroxyl and carbonyl groups, respectively. 
The 
1
H NMR spectrum (Figure  3.98, Table  3.26) displayed  similar  evidence 
for the presence of some signals common to diarylheptanid. the proton spectrum also 
showed some signals close to curcumin. Like the presence of aromatic pair of protons 
for H-6,  H-6’ at δ 7.57, H-7, and H-7’ at  δ 6.87. In addition,  two sets of signals were 
observed at  δ 6.87 and δ 7.55 attributed for the pairs H-9, H-9’ , and  H-10, H-10’.The 
proton spectrum also exhibited the presence of two protons ( trans, J=16 Hz) for the 
protons H-4, 4’ at δ 7.60 and H-3, 3’ at δ 6.64. 
The 
13
C NMR and DEPT-135 spectra (Figure  3.99, Table  3.26) exhibited the 
presence of eight signals due to two quaternary carbons; one carbonyl at δ 183.7 (C-2, 
2’) and sp2 carbon at 126.8 (C-5, 5’). Four symmetrical aromatic sp2 carbons at (C-7, 7’) 
and similarly C-9, 9’ at δ 115.9. In addition to C- 6, 6’ and C-10, 10’ resonated similarly 
at at δ 130.1. C-The enolic carbon appeared at 100.9 (C-1).Furthermore, two methines 
sp
2
 appeared at δ 121.1 (C-3, 3’), and δ 140.2 (C-4, 4’). 
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From the above spectral data and compared with the spectral data previously 
reported the structure of the compound was elucidated as bisdemethoxycurcumin 140 
(Péret-Almeida, et al., 2005). 
 
Table  3.26:  1H NMR (400 MHz), and 13C NMR (400 MHz) spectral data in  acetone-
d6 of bisdemethoxycurcumin 139 
 
Position δH, J (Hz) δC 
1 5.96, s 100.9 
2, 2’ - 183.7 
3, 3’ 6.64, d (16) 121.1 
4, 4’ 7.60, d (16)  140.2 
5, 5’ - 126.8 
6, 6’ 7.57, d (8.7)  130.1 
7, 7’ 6.87 , d (8.7)  115.9 
8, 8’ - 159.7 
9, 9’ 6.87, d (8.7) 115.9 



























), and 1624 cm
-1 
(C=O). The UV spectrum showed absorption maximum at 
416 nm.  The compound has a molecular formula of C20H18O3 (MW 338). 
The 
I
H NMR and 
13
C-NMR spectra (Figure  3.100, 101,  Table  3.27)  exhibited 
similar features as curcumin and were in evident that compound 140 was belong to 
curcuminds. Spectral analysis data for compound 140  is  very close structural relationship to 
curcumin 138 except the presence of one methoxy  group at δ 3.82 compared to two methoxy 
groups in curcumin. The carbons  signals observed were observed in pairs in 140 with very 
close chemical shift values. Similarly as curcumin the the central carbon (C-1) had an  enolic 
proton signal appeared as a singlet at δ 6.02 (H-1). Two sets of doublets with coupling 
constant 15.8 Hz resonated at 6.67 and 7.53 indicated the presence of two olefinic protons; 
2H (3, 3’) and 2H (4, 4’), respectively.  Similarly two signals appeared as doublet with  J=8.3 
Hz at δ 6.81 and 7.13 assigned for H-9 and H-10, respectively. 
The 
13
C-NMR and DEPT-135 spectra (Figure  3.101, Table  3.27) showed a total of 
16 carbon signals comprising of one methoxy, two carbonyls, one centered carbon, and 9 
pairs of carbons signals were observed almost each pair appeared at close chemical shifts. 
The chemicals shift values of these carbon observed are presented in Table 3.26.  Extensive 
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analysis of all spectroscopic data and with comparison to the literature values confirmed the 
identity of compound 140 as demethoxycurcumin (Péret-Almeida, Cherubino, Alves, 
Dufossé, et al., 2005).   
Table  3.27:  1H NMR (400 MHz) and 13C NMR (400 MHz) spectral data of 
demethoxycurcumin 140 in acetone-d6 
 
Position δH, J (Hz) δC 
1 6.02, s 100.9 
2, 2’ - 183.2/183.1 
3, 3’ 6.67, d (15.8)  121.1/120.8 
4, 4’ 7.53, d (15.8) 140.7/140.4 
5, 5’ - 126.4/125.8 
6, 6’ 7.31 , d (1.6)  111.2/130.4 
7, 7’ - 148.0/115.7 
8, 8’ - 149.8/159.8 
9, 9’ 6.81, d (8.3)  115.9/115.7 
10, 10’ 7.13. dd (8.3, 1.6)  123.2/123.1 



















Figure  3.101:  13C NMR  and  DEPT -135 spectra of  demethoxycurcumin  140 
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Guaiane type sesquiterpenoid  
Zedoalactone B 60 
 
  Zedoalactone B 60 was isolated as a colourless oil. The HRESI-MS showed a 
quasi molecular ion peak at m/z 281 (M+H)
+
 corresponding to the molecular formula of  





hydroxyl group  α, β-unsaturated carbonyl, respectively.  The UV spectrum displayed 
absorption band maximaum at 262 nm implying the presence of a double bond 
conjugated with the lactone ring.  
The 
1
H NMR spectrum (Figure  3.102, Table  3.28) showed some proton signals 
similar to those observed for  guaiane-lactone type sesquiterpene.  Three methyl singlets 
were detected at δ1.84,1.44, and 1.26 attributed for H3-15 and H3-14 H3-13, 
respectively.  Further, one proton signal observed at δ 6.48 assigned for H-9. Muliple 
proton signals observed at δ 2.03, 2.53, 2.72 assignable for H-2, H-3, H-6, respectively.  
The proton spectrum also showed protons signal resonated at δ 3.40 appeared as dd with 
J=2.8,11.9 Hz presented for H-5. 
The 
13
C NMR and DEPT-135 (Figure  3.103, Table  3.28) exhibited a total of 15 
carbon signals due to the presence of three sp
3 methyls at δ 24.8 (C-15), 22.5 (C-14), 
and δ 7.8 (C-13). One sp2 olefinic carbon was observed at δ 117.1(C-9). Furthermore, 
three methylenes were detected at δ 34.6 (C-2), 40.4 (C-3), and 21.0 (C-6). In addition 
to six quaternary carbons, three of the six were sp
2
 carbons at δ 150.3 (C-7), 148.1 (C-
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8), and 125.4 (C-11) while two were sp
3
 at δ 74.4 (C-1), and 79.0 (C-4). In addition,  
one carbonyl at δ 169.5 (C-12).  
From the analysis of the above spectral evidence in combination with other 2D 
spectra, including HMBC, HSQC, NOESY confirmed the structure as zedoalactone B 
60 and was in agreement with those published previously (Takano et al., 1995b). 
Table  3.28:  1H NMR (400 MHz), and 13C NMR (100 MHz) spectral data in acetone-
d6 of zedoalactone 60 
 
Position δH, J (Hz) δC 
1 - 74.4 
2 2.03, m 34.6 
3 2.53, m 40.4 
4 - 79.0 
5 3.40, dd (2.8,11.9) 49.3 
6 2.72, m 21.0 
7 - 150.3 
8 - 148.1 
9 6.48, s 117.1 
10 - 82.2 
11 - 125.4 
12 - 169.5 
13 1.26, s 7.8 
14 1.44, s 22.5 
















Figure  3.103:  13C NMR  and DEPT-135 spectra of  zedoalactone B  60 
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3.1.2.3 Analysis of C. purpurascens essential oil  
Two different techniques were introducted for oil extraction, with the aim of 
identifying the chemical constituents obtained by hydrodistillation with a view to 
determine the optimum parameters (temperature and pressure) for supercritical fluid 
extraction (SFE) for C. purpurascens. Thus attempts were made employing liquid CO2 
as a solvent with varying temperature and pressure to achieve higher yield and 
selectivity of the components in the extract.  
(a) Chemical composition of hydrodistilled essential oil from C. purpurascens  
The yield was 2.2 g from 300 g of sample. Therefore the percentage yield of the 
Essential oil extracted from C. purpurascens was 0.7% (w/w). The oil extracted by 
hydrodistillation was analysed by a combination of GC and GC-MS. 
A total of 34 compounds accounting for 88.1% of the total oil were identified 
( Figure  3.104). Among these, eight were monoterpenoids, fifteen sesquiterpenes, and 
eleven sesquiterpenoids. The oil was especially rich in sesquiterpenoids (51.2%), of 
which the major components were found to be turmerone, followed by germacrone, ar-
turmerone, germacrene-B, and curlone (Table  3.29). The identification of the 
compounds was performed by matching their mass spectra and arithmetic indices with 













identification Calculated Literature 
1 1,8-Cineole 1031 1026 16.87 3.3 MS, AI 
2 Camphor 1144 1141 23.29 4.0 MS, AI 
3 Borneol 1166 1165 24.45 0.3 MS, AI 
4 Terpinen-4-ol 1178 1174 25.06 0.3 MS, AI 
5 p-Cymen-8-ol 1184 1179 25.38 0.2 MS, AI 
6 α-Terpinenol 1191 1186 25.75 0.8 MS, AI 
7 Thymol 1293 1289 30.68 0.1 MS, AI 
8 δ-Elemene 1339 1335 32.70 0.2 MS, AI 
9 Piperitenone 1342 1340 32.87 0.7 MS, AI 
10 β-Elemene 1393 1389 35.08 1.2 MS, AI 
11 
cis-α-
Bergamotene 1416 1411 36.06 0.1 MS, AI 
12 
trans-
Caryophyllene 1421 1417 36.24 1.8 MS, AI 
13 -Elemene 1435 1434 36.82 1.6 MS, AI 
14 Aromadendrene 1441 1439 37.05 0.1 MS, AI 
15 α-Humulene 1455 1452 37.64 0.1 MS, AI 
16 trans-β-Farnesene 1458 1454 37.75 0.2 MS, AI 
17 -Muurolene 1478 1478 38.56 0.5 MS, AI 
18 ar-Curcumene 1484 1479 38.82 2.6 MS, AI 
19 α-Selinene 1488 - 39.98 1.3 MS3 
20 Curzerene 1500 1499 39.44 5.8 MS, AI 
21 β-Bisabolene 1510 1505 39.85 0.4 MS, AI 
22 
β-
Sesquiphellandrene 1526 1521 40.45 2.7 MS, AI 
23 
Selina-3,7(11)-
diene 1544 1545 41.78 0.6 MS, AI 
24 Germacrene-B 1561 1559 41.78 8.8 MS, AI 
25 ar-Turmerol 1580 1580 42.50 3.3 MS
3
, AI 





Elemenone 1607 1602 43.54 2.5 MS, AI 
28 -Eudesmol 1633 1630 44.46 0.7 MS, AI 
29 β-Eudesmol 1637 - 44.62 0.7 MS3 
30 Atractylone 1654 1657 45.21 0.6 MS
3
, AI 
31 ar-Turmerone 1671 1668 45.83 9.4 MS, AI 
32 Turmerone 1675 - 45.98 13.5 MS 
33 Germacrone 1702 - 46.94 13.2 MS 
34 Curlone 1705 - 47.07 6.2 MS 
 




 Remarks: MS = Mass Spectroscopy; AI = Arithmetic Indices; MS = Mass 








Figure  3.104:  The GC-FID profile of the essential oil of C.purpurascens rhizomes 
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3.1.2.4 Supercritical carbon dioxide extraction of C. purpurascens 
(a) General introduction 
Supercritical fluid extraction (SFE) is an attractive alternative extraction 
technique to conventional solvent extraction due to the use of environmentally 
compatible fluids. It also offers the added advantage of oxygen free extraction 
evriroment, reduced solvent consumption, and shorter extraction time.  
Use of liquid carbon dioxide (CO2) as a solvent in SFE has the superiority over 
organic solvents since it is non flammable, nontoxic, and leaves no residue. It also has a 
low critical temperature compared to other solvents. Currently, SFE has been 
implemented in various applications on industrial scales. 
(b) Supercritical carbon dioxide extraction of C. purpurascens 
Supercritical carbon dioxide (SC-CO2) was employed to extract oils from C. 
purpurascens rhizomes at temperatures of 313, 333, and 353 K and at pressures of 
10.34 MPa (1500 Psi), 20.68 MPa (3000 Psi), and 34.47 MPa (5000 psi) at a constant 
flow rate of CO2 liquid 12 ml/min. The process of variable pressure, temperature was 
studied for optimization of total oil yield. 
The extraction rate was measured as a function of pressure and temperature. The 
extraction rate increased with an increase of pressure and decrease of temperature. The 
chemical components of SFE extracted oils were analysed by a combination of gas 
chromatography (GC) and gas chromatography-mass spectrometry (GC-MS) and the 
major components were identified as ar-turmerone, turmerone, germacrone, and 
curlone. The composition C. purpurascens extract obtained by SFE was not different 
from the extract obtained by hydrodistillation. However, the components obtained in the 
extract were dependent on the pressure and temperature applied. Therefore, SFE is 
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much more specific in terms of selectivity as compared to conventional extraction 
methods. In all cases, the yield was more when extracted by SFE. 
Table  3.30:  The yields of the extracts obtained from C. purpurascens by SFE using 
variable temparatures and pressures 
 
Exp. no. Temperature (K) Pressure ( MPa) Yield ( g) 
1 313 10.34 2.3024 
2 313 20.68 0.1248 
3 313 34.47 0.0434 
4 333 10.34 2.2278 
5 333 20.68 0.2421 
6 333 34.47 0.4924 
7 353 10.34 1.9486 
8 353 20.68 0.5856 
9 353 34.47 0.0498 
            K: Kelevin, MPa: mega Pascal  
The extractions were performed in successive steps at increasing pressures to 
obtain the fractional extraction of the soluble compounds contained in the organic 
matrix. 
The extraction rate increased with a decrease in temperature. The effect of 
pressure and temperature on the extracted oil suggested the optimum pressure 10.34 
MPa (1500 Psi) and temperature of 313 K (40
o
C) for higher yield. 
Initially, temperature was set to 313 K and maintained constant while varying 
the pressure, i.e., 10.34, 20.68 and 34.47 MPa for the same sample. The process was 
repeated for the same plant extract but at two different temperature levels (333 and 353 
K). 
The main goal of the present study was to investigate the effects of three 
different pressures starting from 10.34 MPa, increased to 20.68 MPa, followed by 34.47 
MPa, in comparison to one step successive extraction using hex, DCM, and MeOH.   
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i SFE at 313 K and pressures of 10.34, 20.68, and 34.47 MPa 
Interestingly, only ar-turmernone, turmernone, germacrone and curlone (rt: 45.7-
47.0 min) can be extracted as the major soluble constituents at the pressure 10.34 MPa. 
It is therefore, saturated with these aforementioned constituents, and unable to extract 
other components of the plant material having similar polarity. A second extraction at a 
higher pressure allowed the extraction β-sesquiphellandrene (rt: 40.9 min) as the major 
component (peak range 99.9%). A further increase in the pressure to 34.47 MPa resulted 
in the extraction of 1H-3a, 7-methanoazulene as the major component (99.9%) along 
with other four minor componnents.  Thus the pressure played the key role in the 
solubitiy of CO2 offering a selective extraction of compound(s) from the plant material 
under investigation.  
 
Figure  3.105:  Gas chromatogram of SFE extract at 313K and 10.34 MPa 
 
Table  3.31:  Major components of SFE oil extracted at 313 K and 10.34 MPa 
 
No Retention time Peak area % Compound 
1 45.70 20.96 Ar-turmernone 
2 45.85 30.61 Turmernone 
3 46.83 23.67 Germacrone  









Retention time  
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Figure  3.106:  Gas chromagram of SFE extracted oil at 313 K and 20.68 MPa 
 
Table  3.32:  Major component of SFE oil extracted at 313 K and 20.68 MPa 
 
No Retention time  Peak area % Compound 
1 40.99 93.9 β-sesquiphellandrene 
 
 
Figure  3.107:  Gas chromatography profile of SFE extracted oil at 313 K and 34.47  
 
Table  3.33:  Major components of SFE oil extracted at 313 K and 34.47 MPa 
 
no Retention time  Peak area % Compound 
1 45.71 0.018 ar-Turmernone 
2 50.54 0.038 Humulene 
4 56.39 92.66 1H-3a, 7-Methanoazulene 
 
Retention time  
















ii SFE at 333 K and pressures of 10.34, 20.68, and 34.47 MPa  
At 333 K, the four compounds observed in 40C, 1500psi also appeared as the 
major components of the extract but with a relatively lesser yield. It also resulted in the 
extraction of GC-MS detectable components in the same polarity region.  
An increase in the pressure (3000psi) at the same temperature extracted more of 
the four major components, indicating that the extraction of these four compounds were 
not complete at the combination of 60C and 1500 psi in contrast to 40C 1500 psi where 
a complete extraction of these four compounds were observed. Further increase in the 
pressure to 5000 psi failed to render any GC-MS detectable component.  
 




Figure  3.109:  Gas Chromatogram of SFE extracted oil at 333 K and 20.68 MPa 
 
Retention time 
















Table  3.34:  Major components of SFE extracted oil at 333 K and 10.34 MPa 
 
no Retention time  Peak area % Compound 
1 23.30 0.62 Camplor 
2 32.87 0.29 Piperitenone 
3 35.07 0.34 β-elemene 
4 36.22 0.56 cis-α-Bergamotene 
5 36.80 0.61 -elemene 
1 45.70 19.20 ar-turmernone 
2 45.85 10.90 Turmernone 
3 46.83 20.08 Germacrone  
4 47.00 12.90 Curlone 
  
 
Figure  3.110:  Gas chromagraphy profile of SFE extracted oil at 333 K and 34.47 MPa 
 
iii SFE at 353 K and pressures of 10.34, 20.68, and 34.47 MPa 
The extraction at 353 K with 10.34 psi followed a same pattern as that of 60C 
1500psi, but with an additional major component which was identified as bisabolene 
Increase in the pressure (3000 psi) was similar to extraction commenced at 1500 psi 
but with a greater variety of compounds (  no of peaks, RT range ) and the extraction 
was complete for these compounds as they were not observed for an increase in the 
pressure to 500psi. 
The major indicated that the solvent CO2 was fully saturated with the four 
compounds and unable to extract more compounds, it also confirming the powerful 









(2.3024 g, 6.97%) higher compared to 333 K (0.1248 g, 0.37%) and 353 K (0.0434, 
0.13%) successive extraction for the same sample.  
At pressure 20.68 MPa, ar-turmernone appeared with less quantity in 
comparision with 10.34 MPa. 
At pressure 34.47 MPa, non-volatile constituents were observed at temperature 
333 K and 353 k except one major compound obseved at 40
o
C and it was identified as 
β-sesquiphellandrene. 
 
Figure  3.111:  Gas Chromatogram of SFE extracted oil of at 353 K and 10.34 MPa   
 
Table  3.35: Major components of SFE extracted oil of at 353 K and 10.34 MPa   
 
No Retention time Peak area % Compound 
1 45.70 18.84 ar-Turmernone 
2 45.85 13.42 Turmernone 
3 46.83 19.14 Germacrone  
4 47.00 12.22 Curlone 
 

















Figure  3.112:  Gas Chromatography profile SFE extracted oil at 353 K and 20.68 MPa 
 
Table  3.36:  Major components of SFE extracted oil of at 353 K and 20.68 MPa   
 
No Retention time Peak area % Compound 
1 45.70 13.56 Ar-turmernone 
2 45.85 27.36 Turmernone 
3 46.83 18.56 Germacrone  
4 47.00 14.82 Curlone 
 
 
Figure  3.113:  Gas chromagraphy profile of SFE extracted oil at 353 K and 34.47 MPa 
 
Retention time (mins) 









Collectively, based on the above results, the optimum parameters to obtain 
higher yield and selective components were at temperature 313 K, pressure at 10.34 
MPa and flow rate of liquid CO2 at 12 ml/ min. 
Further more, the yields decreased with the increase of temperature (313, 333, 
and 353 K) considering using the same pressure at 10.34 MPa. In addition,, the results 
also implied the powerful SFE technique as high selectively and high yields extractions 
method, it can be an effient way to extract ar- turmernone in a good quantity. Indeed, 
SFE showed immediate advantage over traditional extraction techniques. 
3.2 Cytotoxicity  
The cytotoxic effects of the crude extracts and the pure compounds isolated from 
the rhizomes of C. zedoaria and C. purpurascens were assessed against a range of 
cancer cell lines and non-cancerous cell lines. 
3.2.1 Cytotoxic activity of the crude extracts and the pure compounds from the 
rhizomes of C. zedoaria 
Initially, two human cancer cell lines (MCF-7 and Ca Ski), and non-cancerous 
cell lines (MRC-5 and HUVEC) were used in the MTT assay to test the cytotoxic 
activity of C. zedoaria extracts. The experiments were conducted in triplicate and 
presented as the mean (Table  3.37). The hexane (hex) extract showed strong inhibition 
against the two human cancer cell lines MCF-7 and CaSki with the IC50 values of 18.4 
and 19.0 µg/ml respectively whilst the dichloromethane extract (DCM) showed 
moderate cytotoxicity against MCF-7 (IC50: 40.6 µg/ml) and weak cytotoxicity against 
Ca Ski (IC50: 83.5 µg/ml). The extracts were non-toxic towards the non-cancer cell lines 
HUVEC and MRC-5 even at the highest concentration tested (100 µg/ml). 
Table  3.37:  Cytotoxic activity of C. zedoaria extracts against human cancer cells and 
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non-cancer cell lines (MRC-5 and HUVEC) 
 
Extract IC50 (µg/ml)* 
 Cancer cells Non-cancer cells 
 MCF-7 Ca Ski HUVEC      MRC-5 
Hexane (Hex) 18.4 ± 1.6 19.0 ± 1.5 >100.0 >100.0 
Dichloromethane (DCM) 40.6±2.3 83.5±2.7 >100.0 >100.0 
Ethyl acetate (EA) >100.0 >100.0 >100.0 >100.0 
Methanol (MeOH) >100.0 >100.0 >100.0 >100.0 
Methanol(Soxhlet 
extraction) (MeOH S) 
>100.0 >100.0 >100.0  
Doxorubicin 0.1±0.0 0.2±1.0 1.4±0.0 na 
*Experiments were done in triplicate and presented as mean ± SD.  
The pure compounds isolated from the active extracts (hex and DCM) of C. 
zedoaria were further evaluated on eight selected cancer cell lines (MCF-7, Ca Ski, HT-
29, PC-3, WEHI-3, HL60, A549, and AS-SK-LU1) and non-cancerous cell HUVEC 
(human umbilical vein endothelial cell). The cytotoxic activity of the compounds is 
presented in Table 3.38. Collectively the compounds showed moderate cytotoxic effect 
against the human carcinoma cells. Interestingly two sesquiterpenoids, namely 
curcumenol 42 and curcumenone 65 demonstrated strong cytotoxic activity against 
MCF-7. Nevertheless, there is no report found on the cytotoxicity of compounds 42, 65 
and zerumbone epoxide 150 against human MCF-7, Ca Ski and PC-3 cell lines. Hence, 
it is the first time to document the selective activity of compounds 42 and 65 isolated 
from C. zedoaria against MCF-7 cell line. The results were also in agreement with 
previous study on procurcumenol 44 and zerumbone epoxide 151 where the compounds 
exhibited good cytotoxic effect against PC-3 and HT-29 cell lines. In another study, 
curcumenone 65 isolated from the rhizomes of C. zedoaria showed protective effect on 
alcohol-treated mice, accelerated the liver alcohol dehydrogenase activity, and 
suppressed D-galactosamine/lipopolysaccharide-induced acute liver injury (Hisashi 
Matsuda et al., 1998b). Among the compounds tested, 19, 21, 23, 43, 44, 65, 104, 127, 
150 and 151 displayed appreciable cytotoxic activity against Ca Ski (IC50 values 
ranging from 14.5 to 100.0 µg/ml). The rest of the compounds (19, 23, 44, 101, 127 and 
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128) also exhibited moderate inhibitory effect against PC-3 and HT-29 cell lines. 
Although the pure compounds were not as effective as doxorubicin in inhibiting the 
proliferation of the cancer cells, they inflicted less damage to the non-cancerous cells. In 
this study, zerumin A 128, isolated from the hexane extract displayed moderate 
cytotoxic effect on MCF-7, Ca Ski and PC-3 cell lines. This is in agreement with 
previous report where zerumin A 128 isolated from C. mangga exhibited anti-
proliferative effect on Ca Ski and MCF-7 cells with IC50 values of 8.7 and 14.2 µg/ml, 
respectively (S. N. A. Malek et al., 2011). The cytotoxicity test reported in the present 
study provided important preliminary data to help select from these compounds with 
potential anticancer properties for advanced studies. 
An attempt to search for new anticancer agents that are safe as well as being 
effective, five isolated sesquiterpenoids were subjected to the MTT based cytotoxicity 
test using mouse myelomonocytic leukemia cells (WEHI-3), and promyelocytic human 
leukemia cells (HL-60). Procurcumenol 44 showed the strongest effect on WEHI-3 and 
HL-60 cells with IC50 values of 6 and 25 µg, respectively. The results are presented in 
the Table.3.37. 
In addition, nine sesquiterpenoids and two labdane diterpenoids were evaluated 
against two lungs cancer cell lines; human alveolar adenocarcinomic cells A549, and  
human lung adenocarcinomic SK-LU, and an  immortal human keratinocyte line 
HaCaT. Three of these compounds demonstrated mild cytotoxic activity which includes 







 Table  3.38:  Cytotoxic activity of pure compounds isolated from C. zedoaria against various cell lines 
 
Compounds IC50 (µg/ml) 





Labda-8(17), 12 diene-15, 16 dial 127 16.3±0.2 14.5±0.1 26.3±2.4 21.5±3.1 - - -  45.3±1.9 
Dehydrocurdione 19 33.0±1.1 21.7±1.1 19.1±2.8 22.7±2.4 - - 17.4±2.3 20.96±1.61 24.0±2.1 
Curcumenone 65 8.3±1.0 >100.0 39.8±4.2 43.3±6.2 35 99 na na 50.0±8.6 
Comosone II 104 >100.0 76.0±1.2 na na - - - - na 
Curcumenol 42 9.3±0.3 18.5±1.0 17.3±1.2 24.8±2.7 66 39 na na  25.9±1.4 
Procurcumenol 44 16.1±2.2 62.4±0.3 13.3±1.7 15.5±2.3 6 25 na na 16.3±1.0 
Germacrone 23 59.1±2.9 39.3±1.2 55.2±4.9 42.9±4.1 - - na na 73.7±0.3 
Zerumbone epoxide 151 24.1±0.1 34.5±0.6 10.8±1.9 13.7±2.7 - - 14.0±0.78 20.0±1.09 14.2±1.1 
Zederone 26 >100.0 >100.0 27.0±1.9 19.1±2.5 > 100 > 100 na na 42.1±2.7 
Second monoclinic curcumenol 151 >100.0 >100.0 na na - - - - 71.7±6.1 
Furanodiene 21 36.5±2.6 na 39.5±4.5 47.2±4.4 - - na na 40.9±2.6 
Germacrone-4, 5-epoxide 24 37.2±4.0 na 43.9±7.2 39.6±4.6 - - - - 48.4±4.7 
Calcaratarin A 129 62.5±4.8 na 41.7±3.4 48.3±5.1 - - 31.6±1.55 24.16±2.20 47.3±4.2 
Isoprocurcumenol 43 58.8±4.2 na 37.4±4.5 51.6±3.9 81  - - 45.1±3.0 
Germacrone-1, 10- epoxide 25 61.2±5.8 na 53.2±4.9 72.8±8.3 - - - - 55.5±1.6 
Zerumin A 128 22.3±1.1 na 21.9±1.6 17.4±2.0 - - na na 25.8±1.9 
Curcumanolide A 101 29.8±3.1 na 18.8±2.4 21.3±3.2 - - - - 21.7±7.0 
Curcuzedoalide 62 49.8±3.6 na 62.1±8.1 58.2±3.5 - - - - 45.3±7.8 
Gweicurculactone 41 31.2±3.2 na 38.3±2.2 35.7±5.8 - - - - 71.7±6.1 
Furanodionone 22 32 32.5 na na - - - - - 
Curdione 20 >100.0 >100.0 na na - - - - - 
Curzerenone 111 56.5 60 na na - - ]- - - 
Doxorubicin 0.1±0.0 0.2±1.0 na na na na na na 1.4±0.0 
*Experiments were done in triplicate and presented as mean ± SD.  
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3.2.2 Cytotoxic activity of crude extracts, essential oil, supercritical fluid extracts, 
and pure compounds from C. purpurascens rhizomes   
Initially, the cytotoxicity activity of the C. purpurascens extracts (Hex, DCM, 
and MeOH) were examined against various human cancer cell lines (CEMSS, COAV, 
HEPG-2, SKOV3, MDA-MB-231 and MCF-7). DCM and MeOH extracts showed 
potent inhibitory effect against SKOV3 with the IC50 values of 4.7 and 5.12 µg/ml ( 
Table  3.39). The hexane extract showed activity ranging from weak to moderate levels 
against various cancer cell lines ( Table  3.39).  
In addition, the hydrodistilled oil of dried ground rhizomes was investigated 
against selected carcinoma cell lines (MCF-7, Ca Ski, A549, HT29, and HCT116) and 
normal human lung fibroblast cell line (MRC-5). Results from the MTT assay revealed 
strong cytotoxicity against HT29 cells (IC50 value of 4.9 g/ml), weak cytotoxicity 
against A549, Ca Ski, and HCT116 cells with IC50 values of 46.3, 32.5, and 35.0 g/ml, 
respectively ( Table  3.39). 
Furthermore, nine extracts obtained by SFE were evaluated for cytotoxicity by 
the MTT assay on SKOV and CAOV3 cells. The extracts obtained at 313 K, 34.46 MPa 
demonstrated stronger cytotoxic activity compared to the other extracts (IC50:15 µg/ml). 
The other extracts obtained at 313 K, 10.34 MPa and 313 K, 34.46 MPa exhibited 
moderate cytotoxic activity against the CAOV3 with IC50 values of 34 and 36 µg/ml, 








 Table  3.39:  Cytotoxic activity of crude extracts, hydrodistillation oil, and SFE extracts of the rhizomes of C .purpurascens 
 
Extracts IC50 (µg/ml) 
 CEMSS COAV HEPG-2 SKOV3 HT29 MDA-
MB-231 
MCF-7 WRL-68 WEH3 HL60 Ca Ski A549 HT116 MRC-5 
Hex. 200 147.78 80.1 138.7 68.1 56.24 121.9 100 79 24 - - - - 
DCM 22.13 22.42 31.11 4.7 32.58 21.91 21.03 21.63 32 11 - - - - 
MeOH 25 21.85 83.37 5.12 55.67 50 41.09 23.9 48 20 - - - - 
Hydrodistillation oil - - - - 4.9 - >100 - - - 32.5 46.3 35.0 25.2 
SFE, 313 K,10.34 
MPa 
- 34 - 44 - - - - - - - - - - 
SFE, 313 K, 
20.68MPa 
- 50 - 33 - - - - - - - - - - 
SFE, 313 K, 
34.47MPa 
- 36 - 57 - - - - - - - - - - 
SFE, 333 K, 
10.34MPa 
- 67 - 79 - - - - - - - - - - 
SFE, 333 K, 
20.68MPa 
- >100 - 76 - - - - - - - - - - 
SFE, 333 K, 
34.47MPa 
- >100 - 15 - - - - - - - - - - 
SFE, 353 K,10.34 
MPa 
- >100 - >100 - - - - - - - - - - 
SFE, 353 K, 
20.68MPa 
- >100 - >100 - - - - - - - - - - 
SFE, 353 K 
34.47MPa 
 
- - - >100 - - - - - - - - - - 
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The pure compounds isolated from C. purpurascens were subjected to the MTT 
based cytotoxicity assay using mouse myelomonocytic leukemia cells (WEHI-3), 
promyelocytic human leukemia cells (HL-60), ovarian cancer cell SKOV3, and ovarian 
carcinoma cells CAOV3. Curcumin 139 showed the strongest effect on WEHI-3 and 
HL-60 cells with IC50 values of 25 and 23 µg/ml, respectively. Whereas, 
demethoxycurcumin 140 displayed cytotoxic activity against WEHI-3 and HL-60 with 
IC50 values of 50 and 36 µg/ml, respectively. The results were presented in the 
Table  3.40 
Table  3.40:  Cytotoxic activity of compounds isolated from C. purpurascens 
 
Compound IC50 (µg/ml) 
WRL) WEH3 HL60 SKOV3    CAOV 
Curcumin 139 23 25 23 > 100 > 100 
Demethoxycurcumin 140 > 100 50 36 > 100 >100 
Bisdemethoxycurcumin 141 > 100 > 100 80 > 100 >100 
ar-Turmerone 74 - > 100 > 
100 
  










3.3 QSAR studies 
Quantum chemical methods can be successfully applied to express molecular 
interactions between substrate and receptor in terms of molecular electronic properties 
of the substrates. In recent years, quantitative structure-activity relationships studies 
(QSAR) have been proven a powerful tool in the determination of the relationships 
between the observed biological activities of natural and synthesized compounds and 
their structural, electronic properties (descriptors). Various qualitative and quantitative 
analyses relationship studies can be found in the literature using quantum chemical and 
statistical methods to achieve correlations between calculated and biological activities 
of natural and synthetic substrates.  
This study aimed at elucidating the structure-cytotoxic activity relationships of a 
series of 21 compounds isolated from C. zedoaria  against four human cancer cells 
namely, breast carcinoma cells (MCF-7), cervical carcinoma cells (Ca Ski), human 
prostate cancer cells (PC-3), human colon adenocarcinoma cells (HT-29), and a normal 
cell line, human umbilical vein endothelial cells (HUVEC). Density functional theory 
(DFT) was adopted at the level of B3LYP/6-31+G (d, p) in order to calculate electronic 
and steric molecular descriptors of the isolated compounds, followed by the application 
of statistical methods including simple and multiple linear regressions (SLR, MLR), 
principal component analysis (PCA) and hierarchical cluster analysis (HCA) to 
determine the main descriptors responsible for the cytotoxic activity of the compounds 
under investigation. 
In a view from the studies previously have done, Ishihara et al. employed 
semiempirical PM5 method to delineate the relationship between the cytotoxic activity 
and eleven chemical descriptors of a series of tropolone compounds and were able to 
show that the observed cytotoxic activity correlated well with compounds of structural 
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similarities and governed mainly by dipole moment (µ), hydrophobicity (logP), 
hardness (), electrophilicity () and electronegativity () (Ishihara et al., 2010). In 
another study, Stanchev et al. showed that the cytotoxic activity of a series of 4-
hydroxycoumarins was well correlated with logP, µ, volume (V) and molecular orbital 
energies (EHOMO and ELUMO) (Stanchev et al., 2008). In addition, Yang et al. used 
semiempirical method AM1 to determine the molecular descriptors of a series of 
ganoderic acids with cytotoxicity against tumour cells; they showed that EHOMO, 
electronegativity, electronic energy, logP and molecular area (A) are the variables that 
best discriminate between highly and less active ganoderic acids (Yang et al., 2005). 
 In an effort to find lead compounds at lower cost and greater speed, techniques 
in computational chemistry offers fast and highly efficient ways for virtual screening. In 
recent years progress has been made in developing algorithms that predict molecular 
geometry and its effect at the binding site. Computational techniques are used to search 
databases of small molecules to find suitable compounds that can serve as drug leads. 
Such predictions are not meant to replace experimental affinity determination, but 
virtual screening methods can complement the experimental methods by producing an 
enriched subset of a large chemical database. On the other hand, these methods help to 
evaluate the strength of bonds between the compounds and their cellular interface. 
Possible enzymatic, physical and chemical degradation of the compound cores as the 
compounds will gain access to circulation through blood and lymphatic channels. Such 
efforts could give meaningful guidance to choose the potential compounds, combined 
with the experimental data, and could be involved in analysing the compound’s 
metabolism in vitro and in vivo. Scoring function the calculation of pair-wise atomic 
terms includes evaluations for different secondary interactions, dispersion/repulsion, 
hydrogen bonding, electrostatics, and desolvation. Structure-based virtual screening 
typically employs quantum technique that is designed to explore the possible molecule 
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physical properties within a compound of interest. Thus, compounds from the subset 
that pass the initial virtual screening are found to be pharmaceutically interesting and to 
meet the criteria such as to (i) be reproducible, (ii) maintain the size of the compounds 
complex to a minimum, (iii) maintain the biological properties, (iv) provide chemical 
stability of the complex, and (v) be reliable.  
Quantum chemistry has been applied recently to selectively recognize 
molecules, proteins, and cells of interest. It has revolutionalized the processes of 
introducing molecules within research settings and improves their identification. As the 
unique physical and chemical properties of these molecules are being unravelled, new 
potential methods of therapeutic management are emerging. Additionally, quantum 
chemistry has shown the capability of specifically and effectively label molecular 
targets and been used as a diagnostic tool for cancer at cellular level. Through this 
technique, covalent conjugation of functional groups with a variety of biological 
molecules can be achieved. Once a biological interface has been provided, compounds 
can effectively and specifically target different cellular, tissue, and organ levels. The 
sampling and evaluating methods will be discussed in more detail in the next 
paragraphs.  
To determine the structure-cytotoxicity activity relationship of a series of 21 
compounds isolated from C. zedoaria a large number of electronic, steric and 
hydrophobicity descriptors were calculated using quantum calculations methods 
(density functional theory DFT). The following steps were followed:  
(i) Conformational analysis: For each compound, the stable conformer was obtained 
using molecular mechanics force field as implemented in Spartan Software.  
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(ii) The stable conformers of different compounds were optimized using B3LYP 
hybrid function. The absolute minima were confirmed by the absence of imaginary 
frequencies (i.e, all frequencies are positive).  
(iii) The electronic descriptors were calculated from the HOMO and LUMO energies 
(IP= -EHOMO and EA= -ELUMO).  
(iv) SLR, MLR, PCA and HCA statistical techniques were used to determine the 
main descriptors that influence the cytotoxic activity of the isolated compounds. 











Scheme  3.1: QSAR studies framework 
(i) Conformational analysis of each compound isolated from C. zedoaria 
(ii) Optimization and frequency calculations of the absolute 
minima (i.e., stable conformers) 
(iii) Calculation of quantum chemical descriptors 
(iv) Statistical analysis: SLR, MLR, PCA and HCA techniques 




Figure  3.114:  Structures of compounds isolated from C. zedoaria. 
 
In the present study, QSAR study has been carried out on 21 terpenoids (Figure 
3.114), for which the cytotoxic activity has been investigated. QSAR study was carried 
out using simple and multiple linear regressions (SLR and MLR), principal component 
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analysis (PCA) and hierarchical cluster analysis (HCA) analyses. Quantum-chemical 
calculations have been performed using density functional theory at the B3LYP/6-31+G 
(d, p) level of theory. The optimized structures were confirmed by the absence of 
imaginary frequencies. This methodology employed to calculate a set of molecular 
descriptors for the 21 compounds.  
3.3.1  Simple linear regression (SLR) analysis  
The values of the electronic, steric and hydrophobic descriptors of the studied 
compounds (19-26, 41-44, 62, 65, 104, 111, 127-129 and 151), as well as their cytotoxic 
activities (IC50
 
in µM) against MCF-7, Ca Ski, PC3, HT-29 and HUVEC cell lines are 
presented in Table  3.41. As can be observed from Table  3.41, the cytotoxic activity of 
the isolated compounds varied with the cell type. Thus a simple linear regression 
analysis was performed to determine the effect of each of the descriptors separately on 
the cytotoxicity of the isolated compounds. Figure  3.115 displays simple linear 
regression curves obtained with each descriptor for the cytotoxicity of the test 
compounds against MCF-7 cells, while the statistical parameters (correlation coefficient 
(R
2
), adjusted correlation coefficient (R
2
adj) and standard deviation (SD)) for SLR 
curves between each descriptor and each tested cell line is presented in Table  







Table  3.41:  Cytotoxicity IC50 (µM) and molecular descriptors obtained at B3P86/6-311+G (d, p) and B3P86/6-311+G (d, p) level for the compounds 
under investigation 





MCF-7 Ca Ski PC3 HT-29 HUVEC 
127 6.87 2.15 4.51 4.71 2.16 324 6.13 400 470 3.45 302.46 53.9 ± 0.7 47.9 ± 0.3 87.0 ± 7.9 71.1 ± 10.2 149.8 ± 6.3 
129 6.86 2.09 4.48 4.77 2.10 328 5.62 408 481 3.86 318.46 70.0 ± 3.3 NA 68.8 ± 5.0 54.6 ± 6.3 81.0 ± 6.0 
128 6.85 2.00 4.43 4.85 2.02 363 5.63 457 541 4.20 348.53 14.3 ± 0.6 NA 119.6 ± 9.8 138.6 ± 14.6 135.7 ± 12.1 
19 6.56 1.69 4.12 4.87 1.74 244 2.99 323 368 3.63 234.34 140.8 ± 4.7 92.6 ± 4.7 81.5 ± 11.9 96.9 ± 10.2 102.4 ± 9.0 
20 6.52 1.26 3.89 5.26 1.44 238 1.40 331 377 4.01 236.35 NA - - - - 
23 6.40 1.39 3.89 5.01 1.51 248 4.06 321 355 3.81 218.34 NA 180.0 ± 5.5 252.8 ± 22.4 196.5 ± 18.8 337.5 ± 1.4 
21 5.96 0.29 3.12 5.67 0.86 238 1.88 304 341 1.84 216.32 271.9 ± 12.0 NA 182.6 ± 20.8 218.2 ± 20.3 189.1 ± 12.0 
26 6.58 1.80 4.19 4.78 1.84 241 6.35 313 353 0.84 246.31 NA NA 109.6 ± 7.7 77.5 ± 10.1 170.9 ± 11.0 
24 6.54 1.39 3.96 5.14 1.53 241 5.59 318 364 2.71 234.34 218.8 ± 17.1 NA 187.3 ± 30.7 169.0 ± 19.6 206.5 ± 20.1 
25 6.49 1.66 4.08 4.83 1.72 243 3.67 320 364 2.85 243.34 251.7 ± 23.9 NA 218.6 ± 20.1 299.2 ± 34.1 228.1 ± 6.6 
22 6.07 1.46 3.76 4.61 1.54 240 4.37 320 356 2.60 232.32 137.7 ± 6.5 - - - - 
43 6.50 0.37 3.43 6.13 0.96 254 2.61 342 389 3.80 236.4 154.5 ± 17.8 NA 158.2 ± 19.0 218.3 ± 16.5 190.8 ± 12.7 
44 6.54 1.77 4.16 4.78 1.81 252 7.48 327 362 2.71 234.34 127.2±9.4 266.3 ± 1.3 56.8 ± 7.3 66.1 ± 9.8 69.6 ± 4.3 
42 6.21 0.57 3.39 5.64 1.02 260 3.86 333 376 3.58 248.37 37.4 ± 37.4 74.5 ± 4.0 69.7 ± 4.8 99.9 ± 10.9 104.3 ± 5.6 
41 5.71 2.26 3.99 3.45 2.30 290 11.67 305 330 3.46 228.29 136.8 ± 14.1 NA 167.8 ± 9.6 156.4 ± 25.4 314.1 ± 26.7 
111 6.47 1.55 4.01 4.92 1.63 245 3.76 350 371 2.23 232.32 243.2 ± 13.8 - - - - 
151 7.09 2.12 4.61 4.97 2.14 227 4.90 298 339 3.43 220.31 109.4 ± 0.5 156.6 ± 2.7 49.0 ± 8.6 62.2 ± 12.3 64.5 ± 5.0 
104 6.51 1.80 4.15 4.71 1.83 247 6.66 310 340 3.51 216.32 NA 351.3 ± 5.5 NA NA NA 
65 6.77 1.64 4.21 5.13 1.72 256 0.71 362 394 3.5 248.37 32.2 ± 4.0 NA 160.2 ± 16.9 174.3 ± 25.0 201.3 ± 34.6 
101 6.94 1.48 4.21 5.47 1.62 243 6.39 330 365 2.98 234.34 212.4 ± 13.2 80.2 ± 10.2 90.9 ± 13.7 92.6 ± 29.9 - 
62 7.24 2.03 4.63 5.21 2.06 259 4.88 332 386 3.86 262.35 238.0 ± 13.8 236.7 ± 30.9 221.8 ± 13.3 172.7 ± 29.7 - 
 
IP, EA, , are in eV; in Bohr3; µ in Debye; A in Å2; V in Å3 and M in g.mol-1. 
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Figure  3.115:  Simple linear regression correlation (SLR) curves between the cytotoxic 




log(IC50) = -0.1994IP + 3.3628 



















log(IC50 ) = -0.1494AE + 2.2654 



















log(IC50 ) = -0.1968 + 2.8413 



















log(IC50 ) = 0.1687 + 1.1765 



















log(IC50) = -9.6271S + 2.9858 



















log(IC50) = -0.2407+ 2.4398 



















log(IC50) = -0.007 + 3.8853 



















log(IC50) = 0.00132 + 2.0967 



















log(IC50) = -0.0066A + 4.3375 



















log(IC50) = -0.0049V + 3.9747 



















log(IC50) = -0.3686LogP +  3.2337 



















log(IC50) = -0.0071x + 3.8468 
























 Table  3.42:  Correlation coefficients (R2), adjusted correlation coefficients (R2adj) and standard deviations (SD) of simple linear regression curves 








PC-3  HT-29  HUVEC 





































IP 4 -4 0.40 
 
0 -14 0.31 
 
8 2 0.22 
 






EA 6 -2 0.39 
 
6 -8 0.30 
 
5 -2 0.23 
 






 5 -2 0.39 
 
2 -11 0.31 
 
8 2 0.22  23 18 0.20  13 7 0.21 
 3 -4 0.40 
 
11 -2 0.30 
 
0 -6 0.23 
 






S 4 -4 0.40 
 
10 -3 0.30 
 
0 -7 0.23 
 






 7 0 0.39 
 
4 -10 0.31 
 
5 -1 0.23 
 






 52 48 0.28 
 
28 18 0.27 
 
2 -5 0.23 
 






DM 0 -7 0.40 
 
9 -4 0.30 
 
4 -3 0.23 
 






A 55 51 0.27 
 
42 33 0.24 
 
2 -4 0.23 
 






V 53 49 0.28 
 
43 34 0.24 
 
3 -4 0.23 
 






Log P 40 36 0.31 
 
0 -14 0.31 
 
-7 0 0.23 
 






M 49 45 0.29 
 
36 26 0.25 
 
4 -3 0.23  8 2 0.22  -1 6 0.22 
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3.3.1.1 Cytotoxicity against MCF-7 cells and SLR analysis 
Based on the IC50 values (Table  3.41), the compounds were sorted into two 
groups: inactive group (IC50 > 400 µM) and active group (IC50 < 400 µM). To avoid the 
large discrepancies in the IC50 values, active group was further subdivided into three 
subgroups: group A (200 < IC50 <300 µM); group B (100 < IC50<200 µM) and group C 
(IC50<100 µM). The SLR analysis shows that the influence of a given descriptor on 
cytotoxic activity is dependent on the nature of the descriptor itself. For instance, the 
electronic descriptors IP, AE, , , S,  and  have no significant influence (R2 ≈ 0-
7%), while modest correlations were observed for descriptors α, A, V, LogP and M (R2 
≈ 40-55%) (Figure 3.129). These results are consistent with those obtained by Ishihara 
et al., who showed that cytotoxic activity of twenty synthesized tropolones was poorly 
correlated with the eleven chosen descriptors (Ishihara et al., 2010; Ishihara et al., 
2006). The ionization potentials (IP) and electronic affinities (AE) of the isolated 
compounds were obtained from the highest occupied molecular orbital (HOMO) and the 
lowest occupied molecular orbital (LUMO) energies (IP=-EHOMO and AE=-ELUMO). 
The low correlation obtained for IP and AE may be related to the weak electronic 
delocalization in HOMO and LUMO orbitals. For instance, HOMO and LUMO orbitals 
for 127 (labdane), 19 (germacrane) and 104 (cadinane) compounds showed weak charge 
distribution (Figure 3.130). As can be seen from HOMO and LUMO orbitals, electronic 
transition from HOMO to LUMO orbital induce a charge transfer from one side to 
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3.3.2 Cytotoxicity against PC-3 cells and SLR analysis  
The compounds were classified into groups on the basis of their activity against 
PC-3 cells in the same fashion as discussed earlier. All chosen descriptors showed 
negligible effect on cytotoxic activity (R
2
 ≈ 0-8%) ( Table  3.42) 
3.3.2.1 Cytotoxicity against HT-29 cells and SLR analysis 
In case of cytotoxicity of the isolated compounds against HT-29 cells, moderate 
effects were obtained with the electronic descriptors namely IP, EA, χ, ω and µ with 14, 
19, 23, 14 and 13% correlation coefficients, respectively. In contrast to the results 
obtained for MCF-7 and Ca Ski cells, the steric descriptors did not show significant 
effects (R
2
 ≤ 8%) ( Table  3.42). 
3.3.2.2 Cytotoxicity against HUVEC cells and SLR analysis 
For HUVEC cells, all descriptors showed no significant effect on the cytotoxic 
activity (R
2
 ≤ 5%), except IP and χ, which showed moderate effects (30 and 13% 
correlation coefficients, respectively) ( Table  3.42).  
From the above assays, it was obvious that the cytotoxic activity of the isolated 
compounds depended both on molecular descriptor and type of the cancer cell line. The 
differences in the observed and the calculated results might be more related to different 
types of interactions between the isolated compounds and cell line enzymes. 
3.3.3  Multiple linear regression (MLR) analysis 
 In an attempt to further investigate the correlations between the calculated 
descriptors and the cytotoxic activity of the isolated compounds against each cell line, 
the MLR analysis was performed, the MLR analysis was conducted only for the 
compounds of the active group. 
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3.3.3.1  Cytotoxicity against MCF-7 cells and MLR analysis 
 Among the 17 compounds, for which the IC50 were observed against MCF-7 cell 
line were subjected to the MLR analysis. Gweicurculactone 41 was used as the model 
compound, and therefore excluded from MLR analysis. The MLR model as given in 
equation 1 was obtained from the correlation observed between log(IC50) and the 
descriptors. The corresponding curve is presented in Figure 3.116. 
 
log(IC50)Pred.= -(60.85 ± 73.65) + (2.91 ± 3.91)IP - (0.70 ± 2.22)EA + (1.10 ± 
2.62)χ + (3.62 ± 3.60)η + (314.17 ± 359.28)S - (3.38 ± 9.43)ω - (0.01 ± 0.06)α 






Figure  3.117:  The predicted log(IC50)Pred. and residuals to experimental log(IC50)Obs. 
for the active compounds are given in Table 3.43. 
 
log(IC50)Obs. = log(IC50)Pred.+ 5.10
-06 




























 Table  3.43:  Experimental and predicted log(IC50) for the active compounds.  
Compound 














127 1.79 0.06  1.73 1.69  1.68 0.00  1.86 -0.08  2.02 2.18 
129 1.69 -0.17  1.86 1.82  - -  1.96 0.12  2.06 1.91 
128 1.26 0.11  1.15 1.20  - -  2.03 -0.05  2.13 2.13 
19 1.85 0.30  2.15 2.13  - -  2.39 -0.02  - - 
20 - -  - -  - -  2.26 0.00  - - 
23 - -  - -  2.26 0.00  2.06 0.02  2.48 2.53 
21 2.43 0.00  2.43 2.41  - -  2.28 0.00  2.28 2.28 
26 - -  - -  - -  2.34 0.00  2.27 2.23 
24 2.37 0.03  2.34 2.39  - -  - -  2.30 2.32 
25 2.44 0.04  2.40 2.43  - -  - -  2.38 2.36 
22 2.31 0.17  - -  - -  - -  - - 
44 2.14 -0.05  - -  - -  - -  - - 
43 - -  - -  2.43 -0.01  - -  - - 
42 1.62 0.05  - -  1.87 -0.01  - -  - - 
41 - -  - -  - -  - -  - - 
111 2.13 -0.26  - -  - -  - -  - - 
151 2.22 0.18  - -  2.19 0.00  - -  - - 
104 - -  - -  2.55 0.01  - -  - - 
65 1.74 0.22  - -  - -  - -  - - 
101 2.38 0.05  - -  1.90 0.01  - -  - - 
62 2.25 -0.13  - -  2.37 0.00  - -  - - 
 
 
   239 
The correlation between all descriptors and cytotoxicity was relatively weak, with a 
standard deviation of SD=0.41 and R
2
=84%. The predicted log(IC50)Pred. for the model 
compound tested (41) is relatively high with a residual value of 2.34. While the 
predicted IC50 value suggested compound 41 to be categorised in the inactive group, 
observed IC50 indicates it as an active compound. Consequently, this model (eq. 1) was 
considered not suitable for cytotoxicity prediction. To obtain a better model, first eleven 
compounds (127, 129, 128, 19, 20, 23, 21, 26, 24, 25, and 22) with similar skeleton 
were chosen for MLR analysis. For better consistency in the analysis, they were further 
subdivided into labdane diterpenes (Compounds 127, 129, 128) and germacrane 
sesquiterpenes (19, 20, 23, 21, 26, 24, 25, and 22). Only the active compounds were 
subjected to MLR as shown in the equation 2 (eq.2). While compound 22 was selected 
as a test model in this study. 
log(IC50)Pred.= (7.77 ± 4.74) - (0.18 ± 0.52)IP - (0.06 ± 0.05)A + (0.03 ± 
0.04)V - (0.07 ± 0.15)LogP + (0.02 ± 0.01)M (2) 
 The model of equation. 2 was found to be superior to the previous model (eq. 1) 
with a correlation coefficient of 99.37% and a SD of 0.09. For the purpose of validation, 
this model (eq. 2) was applied for compound 22. The predicted log(IC50)Pred. was 2.10, 
with a difference of only 0.04 from the experimental value. The difference between the 
predicted and observed cytotoxicity was 13 µM. The MLR model of equation. 2 
demonstrated the importance of IP, steric parameters (area and volume), hydrophobicity 
(logP) and molecular weight (M) on the cytotoxic activity of the test compounds. These 
results were in good agreement where steric parameters and hydrophobicity were found 
to be  the most important descriptors to classify compounds into high and low activities 
(Ishihara et al., 2010; H.-l. Yang et al., 2005). Thus the MLR of eq. 2 subdivided the 
test compounds into high and low cytotoxicity (Figure  3.118). 
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Figure  3.118:  Multiple linear regression (MLR) correlation for cytotoxicity against 
MCF-7 of the active compounds with similar skeleton (127-129, 21, 24-25) and the 
most potent descriptors (see eq. 2). 
 
3.3.3.2 Cytotoxicity Ca Ski cells and the MLR analysis 
Nine compounds showing cytotoxic activity against Ca Ski cells were selected 
for this study. Compound 19 (dehydrocurdione) was chosen as model compound and 
thus excluded from the MLR analysis. The MLR model obtained between log(IC50) and 
six best descriptors is given in equation 3 and it corresponding regression curve is 
shown in Figure  3.119.  
log(IC50)Pred.= (122.80 ± 7.42) - (11.88 ± 0.73)η - (608.30 ± 38.85)S + 0.03α 
+ 0.02A - 0.06V + 0.03M (3) 
 
 
log(IC50)Obs. = log(IC50)Pred. + 10
-05 
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Figure  3.119:  Multiple linear regression (MLR) correlation for cytotoxicity against Ca 
Ski of the active compounds and the most potent descriptors (see eq. 3). 
 
The predicted log(IC50) and residuals with respect to experimental values of 
active isolated compounds are presented in  Table  3.43. The model was found to 
correlate the descriptors to the observed log(IC50) with good accuracy ( R
2
 99.94% and 
SD 0.02). For the model compound (19) the predicted log(IC50)pred. is 1.93, with a 
difference of 0.04 from the experimental value. The difference between the predicted 
and observed cytotoxicity was 8 µM. Eqation. 3 shows the function of steric parameters 
(area and volume), molecular weight (M), hardness, softness and the polarizability of 
the isolated compounds towards the cytotoxicity against Ca Ski cells. 
 Cytotoxicity against PC3 cells and MLR analysis 
Seventeen compounds showing cytotoxicity against PC3 cells were included in 
the MLR analysis while compound 19 (dehydrocurdione) was excluded as the model 
compound. The MLR model (equation. 4) obtained between log(IC50) and all 
descriptors gives a correlation of 88% (SD 0.17). 
log(IC50)Pred. = -(42.62 ± 12.74) + (3.48 ± 0.94)IP + (217.76 ± 58.86)EA - 
(4) 
log(IC50)Obs. = log(IC50)Pred. - 10
-05 
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(11.07 ± 2.96)χ - (0.20 ± 0.05)η + (2.98 ± 0.82)S - (0.23 ± 0.11)ω - (0.04 ± 
0.01)α + (0.04 ± 0.02)µ + (0.02 ± 0.01)A - (0.01 ± 0.01)V + (0.98 ± 0.48)LogP 
+ (2.49 ± 0.75)M 
 
The predicted IC50 (> 400 µM) of the compound (19) suggested it as an inactive 
compound which is contradictory to the observed IC50 (81.5 µM) against PC3 cells. In 
attempt to derive a better model, the number of descriptors was reduced and the analysis 
was confined to compounds (19-26) with a similar basic skeleton. Compound 19 was 
excluded from MLR analysis. The best correlation was obtained with the electronic 
descriptors IP, EA, ω and µ (eq. 5 and Figure  3.120). The predicted log(IC50) and 
residuals to experimental results are presented in  Table  3.43.  
Log(IC50)Pred.= (2.52 ± 3.16) + (0.36 ± 0.61)IP + (2.09 ± 0.54)EA + - (3.30 
± 0.92)ω - (0.08 ± 0.05)µ  (5) 
 
 
Figure  3.120:  Multiple linear regression (MLR) correlation for cytotoxicity against 
PC3 cells of the active compounds with similar skeleton (127-129, 21, 24-25) and the 
most potent descriptors (see eq. 5). 
 
log(IC50)Obs. = log(IC50)Pred. - 
8.10-06 
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The predicted log(IC50)Pred. for the test compound 19 was 1.91, with a difference 
of 0.48 from the experimental value. Although the difference between predicted (160 
µM) and experimental IC50 values, the predicted value (82 µM) was relatively high. The 
MLR analysis categorised it in the active group which was consistent with the observed 
result against PC-3 cells. 
3.3.3.3 Cytotoxicity against HT-29 cells and MLR analysis 
Seventeen compounds showing cytotoxicity against HT-29 cells ( Table  3.43) 
were chosen for this study while compound 19 (dehydrocurdione) was excluded from 
MLR analysis. The MLR model obtained between log(IC50) and all descriptors derived 
a correlation of 81% (SD 0.22). The predicted value for the test compound 19 (IC50 = 
283 µM) suggested it as an active compound (experimental IC50 = 97 µM). In terms of 
activity, compound 19 falls in group A as per predicted IC50, which is quite different 
from its group (C) determined from the experimental IC50. In an attempt to obtain a 
better model, the number of descriptors were reduced and the analysis was performed 
for first eleven compounds (19-26) with similar basic skeleton and compound 19 was 
excluded from MLR analysis as a model compound. However, in every case, the 
difference between experimental and predicted IC50 was more than 100 µM, and 
therefore not presented here. 
(a) Cytotoxicity against HUVEC cells and MLR analysis 
Fifteen compounds that showed activity against HUVEC were included in this 
study and compound 19 (dehydrocurdione) was excluded from MLR analysis. The 
correlation between log(IC50) and all descriptors gave an R
2
 of 96% (SD 0.16). The 
predicted IC50 for compound 19 from this model was 142 µM, which is higher than the 
experimental. The best correlation was obtained with IP, χ, S and V descriptors (eq. 6) 
and Figure  3.120 
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Log(IC50)Pred.= (72.92 ± 37.80) - (14.02 ± 7.48)IP + (13.07 ± 7.14)χ + - 
(13.07 ± 7.14)S - (0.0004 ± 0.0016)V (6) 
 
A SD of 0.13 and R
2
 of 77% were obtained using equation 6. The predicted log(IC50) 
and residuals to experimental values are reported in  Table  3.43 The predicted IC50 of 
tested compound showed that it is an active compound with a difference of 48 µM to 




Figure 3.120 Multiple linear regression (MLR) correlation for cytotoxicity against 
HUVEC cells of the active compounds and the most potent descriptors (see eq. 6).  
 
3.3.4  Principal component analysis (PCA) 
 Principal component analysis (PCA) allows the reduction of the number of 
variables used in a statistical analysis and to create a new set of variables (PCs) 
expressed in a linear combination of the original data set (Johnson et al., 2002). The first 
new variable (PC1) contains the largest variance; while the second contains the second 
largest variance, and so on. Before applying the PCA method, each variable was 
standardized for ease of comparison between each other on the same scale. PCA 
log(IC50)Obs. = log(IC50)Pred. - 4.10
-
05 
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analysis was performed only for MCF-7 assay. After several attempts to obtain a good 
classification of the isolated compounds, the best result was achieved with five 
variables, namely IP, A, V, logP and M. The first three components of PCA 
(PC1=90.50%, PC2=7.12, and PC3=2.27%) conceded 99.89% of the overall variance of 
the data set (Table  3.44), while the sole combination of PC1 and PC2 described 97.62% 
of that variance. The loading vectors for PC1, PC2, and PC3 are given in Table  3.44. 
The plot of the score vectors of the two principal components (PC1 × PC2) is shown in 
Figure  3.121  
As can be seen in Figure  3.121, the compounds under investigation are divided into 
two groups based on PCA analysis: compounds with high activity (127, 129, and 128) 
and low activity (19, 20, 23, 21, 26, 24, and 25).  
Table  3.44:  Variances (eigenvalues) obtained for the first three principal components 
 
Component Eigenvalue Variance (%) 
Cumulated variance 
(%) 
PC1 4.525 90.50 90.50 
PC2 0.3560 7.12 97.62 
PC3 0.1134 2.27 99.89 
 
Table  3.45:  Loading vectors for the first three principal components 
 
Variable PC1 PC2 PC3 
IP 0.43 0.61 0.66 
A 0.46 -0.38 -0.04 
V 0.46 -0.34 0.04 
logP 0.43 0.51 -0.74 
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Figure  3.121:  Plot of the score vectors of first principal components for cytotoxicity of 
compounds from C. zedoaria against MCF-7 cells. 
 
The principal component PC1 presented in Table  3.45 can be expressed through the 
following equation: 
PC1 .= 0.34IP + 0.46EA + 0.46V + 0.43logP + 0.46M  (7) 
 Thus, a compound can be considered active if its IP, A, V, log P, and M values 
are similar to those described in equation 7. When compared with published literature, 
the results obtained from the present investigation found to follow same trend of some 
agreement and disagreement in the involvement of descriptors for the activity of a series 
of compounds for example, Yang et al. showed that cytotoxic ganoderic acids can be 
obtained when higher values for the variables EHOMO, V, Eel, and logP is coupled with a 
smaller values for M (H.-l. Yang et al., 2005).  Sauza et al. found that for a given 
flavone to be active (anti-HIV activity), it must have smaller values for log P and V 
while EA must have a larger values (Souza Jr et al., 2003). In the present study, the 
results obtained from MLR or PCA methods are in coordination to show that the 
cytotoxicity of the compounds under investigation is dependent on the same descriptors 
(IP, A, V, logP and M) and afforded same classification of the isolated compounds 
Considering the interactions between active isolated compounds and the biological 
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receptors, we can say that the more active isolated compounds present five main 
descriptors (IP, A, V, logP and M).  
3.3.4.1  Hierarchical cluster analysis (HCA) 
 In case of preliminary data analysis, HCA is a powerful tool for examining data 
sets for expected or unexpected clusters, including the presence of outliers. It examines 
the distances between the samples in a data set and represents them in a dendrogram 
which provides similar information as that of PCA results (Kowalski et al., 1972). In 
HCA, each point forms only one cluster and then the similarity matrix is analysed. The 
most similar points are assembled forming one cluster and the process is repeated until 
all the points belong to only one group (Kowalski & Bender, 1972). The results 
obtained for MCF-7 assay are presented in the dendrogram Figure  3.122 
 
Figure  3.122:  Dendrogram obtained with HCA for compounds with cytotoxic activity 
of compounds from C. zedoaria. 
 
Vertical lines in the dendrogram represent the compounds while the horizontal lines 
represent the distances between compounds within the same group or of compounds 
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between groups. According to the distances, the compounds are subdivided into highly 
and weakly active groups and this classification is similar to those obtained from PCA, 
MLR analysis.  
In summary, QSAR study showed that the influence of each descriptor 
separately on the cytotoxic activity of the isolated compounds is not significant with an 
R
2
 less than 50% and a standard deviation higher than 0.20. The results showed that the 
cytotoxic activity of the isolated compounds depend both on the descriptors and cell 
types. MLR, PCA and HCA allowed us to classify the active isolated compounds into 
high, moderate, low active compounds. For instance, in the MCF-7 assay and based on 
specific chosen descriptors (ionization potential, steric parameters, hydrophobicity and 
molecular weight), the active compounds are classified into high (labdane diterpenes) 
and low active compounds (sesquiterpenes). 
3.4 Neuroprotective and antioxidant activity 
Parkinson’s disease (PD) and Alzheimer’s disease (AD) are two most common 
neurodegenerative diseases greatly affecting the health care system both in developing 
and underdeveloped countries. Present therapy only deals with the symptomatic relief of 
the above two diseases. Recent research shows that natural products represent a 
potential source for the development of drugs for the treatment of neurodegenerative 
disorders including Parkinson’s disease and Alzheimer’s disease. Thus selected 
compounds isolated through the phytochemical investigation of C. zedoaria were 
subjected to neuroprotenctive activity investigation. The compounds were also tested 
for antioxidant activity test to find their role in oxidative stress, which is a major cause 
of neurodegeneration. 
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3.4.1  Effect of test compounds on H2O2-induced cell death in NG108-15 cells 
As summarized in Table  3.47, all the ten compounds tested, protected the 
NG108-15 cells from H2O2 induced oxidative stress at various degrees. Exposure to 
H2O2 (400 μM) reduced the viability of NG108-15 cells to 67.6% after a period of 24 
h. Pretreatment of the cells with curcumenol 42 showed the maximum protection 
(103%) at the concentration of 4 µM. This effect varied from compound to compound 
as well as the concentration. For instance, effect of curcumenol 42 reduced to 97.7% as 
the concentration increased to 30 µM. Dehydrocurdione 19 also showed strong activity 
(100% protection) at the concentration of 10 µM, and the activity showed a decrease in 
the activity both for an increase or a decrease in the concentration. Germacrone 23, 
zerumin A 128, isoprocurcumenol 43, procurcumenol 44, and zerumbone epoxide 151 
showed moderate activity (80-90% viability) as compared to the control. 
 
Table  3.46:  Neuroprotective evaluation of compounds against H2O2-induced cell 
death in NG108-15 cells. 
 
Compound Cell viability (%) 
 1 µM 4 µM 8 µM 10 µM 15 µM 30 µM 
Control 100 
H2O2 67.63±0.86 
Germacrone (23) 79.29±1.05* 77.80±1.15* 81.25±1.72* 79.61±2.38* 89.99±2.01* 78.68±1.39* 
Dehydrocurdione 
(19) 
82.90±1.77* 90.76±1.45* 98.05±2.33* 100.60±1.72* 99.98±2.60* 88.59±1.75* 
Curcumenol (42) 78.03±1.23* 103.04±2.17* 100.73±2.63* 100.60±1.72* 99.98±2.60* 97.79±2.41* 
ZeruminA (129) 77.89±1.95* 77.98±1.09* 82.69±1.12* 86.84±1.76* 91.14±1.42* 74.41±1.45 
Isoprocurcumenol 
(43) 
76.72±0.88* 79.51±0.91* 76.42±1.61* 77.08±1.07* 80.96±0.91* 75.94±1.01* 
Curcumenone (65) 66.25±1.50 59.74±1.86 66.93±1.66 73.86±1.18 70.58±1.13 79.18±1.43* 
Procurcumenol (44) 77.75±0.95* 79.08±1.289* 77.00±1.25* 75.73±2.22* 80.00±0.71* 72.87±0.71 
Zerumbone epoxide 
(151) 
75.66±0.68* 71.29±1.24 78.15±0.98* 73.66±1.70 74.63±1.27 84.32±1.09* 















All experiments done in triplicate and results expressed as mean ± S.E. 
*P<0.05 vs H2O2 treated cells, One way ANOVA followed by Dunnett’s test 
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Figure  3.123:  Neuroprotective effect of curcumenol 42 on the viability of NG108-15 
cells 
 
Figure  3.124:  Neuroprotective effect of dehydrocurdione 19 on the 
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3.4.2 ORAC assay 
In the ORAC assay, zerumbone epoxide 151 showed the highest antioxidant 
activity with a Trolox equivalent (TE) of 35.41 µM per 100 µg of sample. 
Isoprocurcumenol 43, zederone 26, dehydrocurdione 19, germacrone 23 showed higher 
antioxidant capacity (26.43, 27.78, 26.18, and 24.86 TE/100 µg sample, respectively) 
than that of quercetin (21.73 TE/100 µg sample), used as standard in this assay. While 
the antioxidant activity of zerumin A 128, gweicurculactone 41, curcumenone 65, 
procurcumenol 44 were close to that of quercetin, curcumenol 42 showed a lesser extent 
of activity (Table  3.47). 
Table  3.47:  Antioxidant capacity of the compounds by ORAC method. 
 
Compound µM of Trolox per 100μg/ml 
Curcumenol 12.62 ± 2.67 
Zerumin A 19.86 ± 3.92 
Isoprocurcumenol 26.43 ± 1.88 
Zerumbone epoxide 35.41 ± 2.25 
Gweicurculactone 18.26 ± 1.66 
Zederone 27.78 ± 2.53 
Curcuzedoalide 23.38 ± 1.50 
Furanodiene 19.17 ± 2.90 
Curcumenone 21.16 ± 2.12 
Germacrone-4,5-epoxide 23.99 ± 2.14 
Germacrone-1, 10-epoxide 11.86 ± 2.53 
Curcumanolide A 12.87 ± 2.29 
Dehydrocurdione 26.18 ± 2.59 
Labd-8(17), 12-diene-15, 16-dial 30.19 ± 1.77 
Germacrone 24.86 ± 2.33 
Calcaratarin A 22.23 ± 2.82 
Procurcumenol 20.46 ± 1.88 
Quercetin 21.73 ± 2.87 
 
3.4.3 Activity correlations  
In normal physiologic condition, small amount of H2O2 is produced during 
aerobic metabolism in the cell and is neutralised by redox systems of our body. This 
does not pose significant threat at young age due to the presence of strong antioxidant 
defence mechanism. However, in aged person, an increased production of ROS and 
functional decline of neutralising systems creates an imbalance, leading to detectable 
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level of oxidative damages. As a result of cumulative deposition of the pathogenesis, the 
effects get more noticeable which includes lack of coordination, imbalance, cognitive 
dysfunction and reduced muscle tone (Giacalone et al., 2011). 
Use of external H2O2 to create oxidative stress in NG108-15 cell is a popular method 
of studying neuroprotective effect of natural products (Ahlemeyer et al., 2001, 
Weecharangsan et al., 2006). Due to the neuronal glial properties, NG108-15, a mouse 
neuroblastoma-rat glioma hybridoma cell line is used extensively as a neuronal model in 
electrophysiological and pharmacological research (Wong et al., 2012). Application of 
H2O2 to NG108-15 cells mimics the condition that takes place during the oxidative 
stress in the body.  
 Superoxide dismutase (SD), is an important enzyme of the antioxidant system to 
convert superoxide into H2O2 in the human body which further scavenged by catalase or 
glutathione redox pathway (Yanpallewar et al., 2004). When there is an increased level 
of H2O2, the neutralization by catalase or tissue thiols fail, giving rise to various reactive 
oxygen species. Application of exogenous H2O2 creates oxidative stress that is beyond 
the manageable level of the endogenous antioxidant system (Wong et al., 2012). Cell 
death may happen through two major mechanisms, apoptosis and necrosis. Apoptosis is 
the most noticeable programmed cell death mechanism and is associated with distinct 
morphological changes, such as membrane blebbing, cell shrinkage and DNA 
fragmentation. On the other hand, necrosis is the premature death of cells associated 
with the loss in cell membrane integrity followed by uncontrolled release of cell 
products into the extracellular space (Kanduc et al., 2002). 
In the present investigation, nine sesquiterpenes and one labdane diterpene were 
isolated from the rhizomes of C. zedoaria and further tested for their possible 
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neuroprotective role in H2O2-induced oxidative stress of NG108-15 cells. Among these, 
the guaiane type sesquiterpene, curcumenol 42 showed 100% protection of the cells at 4 
µM concentration. The compound showed very little change in its activity even at the 
concentration of 30 µM, indicating that the compound might not be toxic to the cell 
within a wide concentration range. Dehydrocurdione 19, a germacrane type 
sesquiterpene showed maximum protection at concentrations of 10 and 15 µM, reduced 
by 10% at 30 µM concentration. Curcumenol 42 and dehydrocurdione 19 are the two 
major phytoconstituents of C. zedoaria and their content in the rhizomes is more than 
that of any other part of the plant. However, seasonal variation can change the ratio of 
these two constituents in the plant (Pamplona et al., 2005). In the above study by 
Pamplona et al. (2005), curcumenol 42 was found to be more potent than 
dehydrocurdione 19 in the inhibition of pain in experimental mice. Biogenetically, these 
two compounds are closely related compounds which is justified by the biomimetic 
transformation to convert dehydrocurdione 19 into curcumenol 42 in a highly selective 
manner (Shiobara et al., 1985). 
Curcumenol 42 is one of the well-studied compounds and contributed to hepatic 
cells protection from D-GalN-induced cytotoxicity and inhibition of the LPS 
(lipopolysaccharide)-induced nitric oxide (NO) production in mouse macrophage 
(Matsuda et al., 1998). Although inducible NO synthase (iNOS) is not expressed in 
normal brain, it is expressed in microglia and astrocytes in the presence of cytokines 
and LPS. Cytokines release and neuroinflammation can trigger the infiltration of T cells 
and macrophage at the inflammatory site. These cells release immunomodulatory 
molecules including NO, promoting the immunresponse and leading to a more 
widespread CNS-injury (Akiyama et al., 2000, Deleidi and Gasser, 2013, Jackson-
Lewis et al., 2002). A low level of NO is present in brain for cellular signalling, but a 
   254 
high level of NO can be observed in neurodegenerative disorders causing neuronal cell 
death by inhibiting mitochondrial cytochrome oxidase (Brown and Cooper, 1994). 
Thus, the inhibition of NO production by curcumenol 42 can also contribute towards the 
neuroprotective activity of this compound. 
In another study, curcumenol 42 was isolated as the major anti-inflammatory 
agent from Curcuma phaeocaulis using COX-2 inhibitory assay (Tanaka et al., 2008). 
There is a strong evidence that COX-2 level increases significantly in 
neurodegenerative disease conditions. In AD, a direct correlation has been found with 
the COX-2 level with that of amyloid plaque and neuronal atrophy (Akiyama et al., 
2000). While in PD, injection of LPS in brain resulted in the increased level of 
inflammatory factors including COX-2 and iNOS prior to the death of dopaminergic 
neurons (Khandelwal et al., 2011).Therefore, the neuroprotective effect of the 
curcumenol 42 may be due to its anti-inflammatory action stemming through the 
inhibition of COX-2 enzyme (Chung et al., 2009). 
To correlate the antioxidant activity of the compounds under investigation 
toward their neuroprotective activity, ORAC assay was performed. ORAC assay is 
considered as a complementary antioxidant test for neuroprotective assay (Giacalone et 
al., 2011). It is a reliable method of testing antioxidant activity of biological samples 
including natural products due to its sensitivity towards broader class of compounds 
(Cao and Prior, 1998). Moreover, it is the only assay which involves the use of peroxyl 
radical and quantifies the antioxidant capacity via area under curve (AUC) technique 
(Cao et al., 1993, Cao et al., 1995). The results obtained from this assay is from the 
direct quenching of free radicals, which is related to the antioxidant capacity of the 
molecule itself (Cao et al., 1995). In the present experiment, quercetin was used as the 
standard for the comparison of antioxidant activity. All the compounds (1-10) tested 
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showed strong to moderate antioxidant activity, while zerumbone epoxide 151, a 
humulane type sesquiterpene, showed the highest antioxidant capacity (35.41 TE/100 
µg sample), and the activity was stronger than that of quercetin (21.16 TE/100 µg 
sample). In the neuroprotective assay, this compound showed a maximum of 84.32% 
protection of the cells at the highest concentration tested (30 µM). Interestingly, 
curcumenol 42, which showed the strongest neuroprotective activity (100%) among all 
the compounds tested, exhibited a moderate antioxidant activity (12.62 TE/100 µg 
sample) in ORAC assay. This suggests that the neuroprotective activity of this 
compound in not a sole contribution from its antioxidant activity, rather a combined 
effect of its anti-inflammatory, antioxidant and NO-production inhibitory activity. 
Dehydrocurdione 19, the other compound with strong neuroprotective activity (100%), 
showed an antioxidant capacity of 26.18 TE/100 µg sample. 
Curcumenol 42 has been under use for the treatment of various diseases 
including tumor, inflammation and viral diseases. Sometimes it is given in combination 
with commonly available drugs. To investigate possible chance of drug interaction for 
its use with other drugs, curcumenol 42 was tested against seven isoforms of human 
liver microsome. Curcumenol 42 was found to competitively inhibit CYP3A4 while the 
effect on others were negligible, indicating that it can be used safely without affecting 
the metabolism of most of the drugs (Sun et al., 2010). 
3.5 Spectrofluorometric and molecular docking studies on the binding of 
curcumenol 42 and curcumenone 65 to Human Serum Albumin (HSA) 
Curcumenol 42 and curcumenone 65 are two major constituents of the plants of the 
genus Curcuma, and often govern the pharmacological effect of these plant extracts. 
Curcumenol 42 and curcumenone 65 are two of the most important sesquiterpenes 
possessing a number of beneficial biological activities. Curcumenol 42, a guaiane type 
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sesquiterpene is known to exhibit analgesic (De Fátima Navarro et al., 2002), cytotoxic 
(O. A. Ahmed Hamdi et al., 2014; M. Aspollah Sukari et al., 2010), hepatoprotective 
(Matsuda et al., 1998) and antimicrobial (Sukari et al., 2007) properties, while 
curcumenone 65, a carabrane type sesquiterpene has been reported to be a vasorelaxant 
(Hisashi Matsuda, Toshio Morikawa, et al., 2001a), hepatoprotective (Matsuda et al., 
1998) and an effective inhibitor of intoxication (Kimura et al., 2013). These two 
compounds isolated from C. zedoaria rhizomes, were studied for their binding to human 
serum albumin (HSA) using the fluorescence quench titration method. Molecular 
docking was also performed to get a more detailed insight into their interaction with 
HSA at the binding site. 
Human serum albumin (HSA) serves as the primary transport protein in the human 
circulation capable of binding reversibly both endogenous and exogenous ligands such 
as fatty acids, hormones and drugs. It consists of 585 amino acids in a single 
polypeptide chain (Peters Jr, 1995). Crystallographic data have shown the presence of 
three homologous domains (I, II, and III), each comprised subdomains A and B. The 
two high affinity ligand binding sites on HSA, known as Sudlow’s site I and II, are 
located in subdomains IIA and IIIA, respectively (Carter et al., 1994). 
The interaction of a compound with serum albumin is known to influence its 
bioavailability, distribution, metabolism and elimination from the body. In particular, 
the affinity between a protein and a ligand affects the concentrations of the free and 
bound forms of the ligand as well as the duration of its half-life, which consequently 
determine its efficacy (Peters Jr, 1995). Therefore, investigations on the interaction of 
serum albumin with bioactive ligands may provide valuable information concerning 
their therapeutic efficacies ( Yang et al., 2014). 
Being the major and active constituents of C. zedoaria, curcumenol 42 and 
curcumenone 65 play important roles in exerting pharmacological activities after 
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consumption of the herb. As the key components of a widely used natural product, 
curcumenol 42 and curcumenone 65 require the determination of pharmacokinetic 
parameters to establish their safety and efficacy. Furthermore, binding studies to HSA 
provide valuable parameters toward the establishment of the pharmacokinetic profile of 
such agents. In light of the above, the present study describes the binding properties of 
curcumenol 42 and curcumenone 65 to HSA based on fluorescence spectroscopic and 
molecular docking results. 
3.5.1 Analysis of the binding data 
In order to reveal the quenching mechanism of HSA fluorescence, the binding data 
were analyzed according to the Stern-Volmer equation (Lackowicz, 1983): 
𝐹0 𝐹⁄ =  𝐾𝑆𝑉[𝑄] + 1 =  𝑘𝑞𝜏0[𝑄] + 1 (8)  
 
where F0 and F are the fluorescence intensities of HSA in the absence and the 
presence of the quencher, respectively, KSV is the Stern-Volmer constant, [Q] is the 
quencher concentration, kq is the bimolecular quenching constant and τ0 is the 
fluorescence lifetime of free HSA. A value of 6.38 × 10
−9
 s was used for τ0 (Abou-Zied 
et al., 2008).  
The binding constant, Kb and the number of binding sites, n for ligand–HSA 
interactions were determined by treating the fluorescence data according to the 
following equation (Ahmad et al., 2011): 
log (𝐹0 − 𝐹) 𝐹⁄ = 𝑛 log[𝑄] + log 𝐾𝑏 (9)  
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3.5.2  Molecular modelling 
The structures of curcumenol 42 and curcumenone 65 were drawn using 
ACD/ChemSketch Freeware (Advanced Chemistry Development Inc. Ontario, Canada), 
3-D optimized and exported as a mol file. The geometric optimization of the structures 
was refined with the VegaZZ 2.08 (Pedretti et al., 2002) batch processing MOPAC 
script (mopac.r; keywords: MMOK, PRECISE, GEO-OK) using AM1 semiempirical 
theory (Dewar et al., 1985) and converted and stored as a mol2 file.  Molecular docking, 
visualization and rendering simulation were performed using AutoDock 4.2 (Goodsell 
et al., 1996) and AutoDockTools 1.5.4 (Sanner, 1999) at the Academic Grid Malaysia 
Infrastructure. For the docking study, the non-polar hydrogens in the structures were 
merged and the rotatable bonds were defined. The crystal structure of HSA (PDB code 
1BM0, res. 2.5 Å) was downloaded from the Protein Data Bank (PDB) (Berman et al., 
2000). Its water molecules were removed and the atomic coordinates of chain A were 
stored in a separate file and used as input for AutoDockTools, where polar hydrogens, 
Kollman charges and solvation parameters were added. The two binding sites (site I and 
site II) were defined using two grids of 70×70×70 points each with a grid space of 0.375 
Å centered at coordinates x=35.26 y=32.41 z=36.46 for site I and x=14.42 y=23.55 
z=23.31 for site II.  Lamarckian genetic algorithm with local search (GA-LS) was used 
as the search engine, with a total of 100 runs for each binding site. In each run, a 
population of 150 individuals with 27000 generations and 250000 energy evaluations 
were employed. Operator weights for crossover, mutation and elitism were set to 0.8, 
0.02 and 1, respectively. For local search default parameters were used. Cluster analysis 
was performed on docked results using RMS tolerance of 2.0 Å. The protein-ligand 
complexes were visualized and analyzed using AutoDockTools. 
   259 
3.5.3 Results of spectrofluorometric analysis 
Interactions between small ligands and macromolecules such as proteins have 
been widely investigated using fluorescence spectroscopy. Quenching of the protein 
fluorescence as well as shift in the emission maximum in the presence of a ligand can 
indicate a number of phenomena including complex formation, random collisions, 
energy transfer and excited state reactions (Ahmad et al., 2011; Belatik et al., 2012; 
Varlan et al., 2010). Figure  3.125 shows intrinsic fluorescence spectra of HSA in the 
wavelength range, 300–400 nm upon excitation at 280 nm, obtained in the absence and 
the presence of increasing curcumenol 42 and curcumenone 65 concentrations. Addition 
of increasing concentrations of these ligands to HSA produced progressive decrease in 
the fluorescence intensity and significant blue shift in the emission maximum, 
suggesting interactions between these compounds and HSA. About 40% decrease in the 
fluorescence intensity at 338 nm and 2 nm blue shift were observed at the highest 
curcumenol 42 concentration (60 μM), used in this study. On the other hand, 
curcumenone 65 produced ~50% quenching in HSA fluorescence intensity, which was 
accompanied by a 6 nm blue shift in the emission maximum at the same ligand 
concentration. The shift in the emission maximum of HSA towards shorter wavelength 
suggested increased hydrophobicity in the microenvironment of the protein 
fluorophores upon interaction with these compounds (Lackowicz, 1983). The increased 
hydrophobicity can be ascribed to the burial of water-accessible surface area of the 
protein around the fluorophore(s). Since the major contributor of HSA fluorescence, 
Trp-214 is located in the vicinity of Sudlow’s site I, the observed blue shifts suggested 
the involvement of Sudlow’s site I in the binding of both curcumenol 42 and 
curcumenone 65 to HSA.   
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Figure  3.125:  Emission spectra of HSA in the absence and the presence of increasing 
curcumenol (A) and curcumenone (B) concentrations, obtained in 20 mM sodium 
phosphate buffer, pH 7.4 upon excitation at 280 nm. [HSA] = 3 μM, [Ligand] = (1-13): 
0, 3, 6, 9, 12, 15, 18, 24, 30, 37.5, 45, 52.5 and 60 μM. T = 25 °C. 
 
 Although quenching of protein fluorescence can be regarded as an indication of 
binding between a compound and the protein, it is equally probable that the quenching 
phenomenon was due to collisions between the quencher molecule and the protein 
(Lackowicz, 1983). These two mechanisms of fluorescence quenching are known as 
static and collisional quenching, respectively, and can be differentiated by the 
bimolecular quenching constant, kq value, associated with the quenching process 
(Lackowicz, 1983). As a general rule, the kq value for a diffusion-controlled 






, while higher kq value indicates 
a binding reaction (Lackowicz, 1983). Figure  3.126 displays Stern-Volmer plots of the 
ligand–HSA systems, obtained after analyzing the quenching data using Eq. 8. The 
resulting KSV and kq values for the interaction of both curcumenol 42 and curcumenone 
65 with HSA are listed in Table  3.48. As can be seen, the kq values obtained were two 
orders of magnitude higher than the value expected for a process following the 
collisional quenching mechanism. This suggested that the quenching of HSA by 
curcumenol 42 and curcumenone 65 were governed by the static quenching mechanism, 
which involved the formation of a ground state complex between the ligands and HSA. 
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Figure  3.126:  Stern-Volmer plots for the quenching of HSA fluorescence by 
curcumenol 42 and curcumenone 65. 
 
 
Table  3.48:  Quenching and binding parameters for curcumenol-/ curcumenone-HSA 
interactions, as obtained in 20 mM sodium phosphate buffer, pH 7.4 at 
25°C. 
 
Parameter Curcumenol 42 Curcumenone 65 
KSV, M
−1
 1.07 × 10
4







 1.67 × 10
12





 1.97 × 10
4
 2.46 × 10
5
 
n 1.07 1.26 
 
The binding constant (Kb) for the ligand–HSA interaction and the number of binding 
sites (n) on the protein for these ligands were determined from the double logarithmic 
plots of log (F0−F)/F versus  log [Q] (Figure  3.127). The values of n and Kb were 











[Q] × 10−6, M 
Curcumenol
Curcumenone
   262 
Table  3.48. The values of Kb, obtained for the interaction of curcumenol and 
curcumenone with HSA revealed intermediate affinity between these ligands and the 
protein. This was comparable to other ligand binding studies involving HSA (Feroz et 
al., 2012; Freitas et al., 2012; H. Matsuda et al., 1998; Varlan & Hillebrand, 2010). It is 
worth noting that higher extent of quenching of HSA fluorescence by curcumenone 65 




) value in comparison to that obtained 
for the curcumenol–HSA system (1.97 × 104 M−1). Interestingly, the value of n for the 
interaction of curcumenone 65 with HSA was noticeably larger compared to that of 
curcumenol 42. This may suggest the binding of curcumenone 65 to other site(s) on the 
protein molecule in addition to its primary binding site. On the other hand, the smaller n 
value observed for curcumenol 42 indicated the less likelihood of the compound binding 
to more than one site on HSA. 
 
Figure  3.127:  Double logarithmic plots for the interaction of HSA with 
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3.5.4 Results of molecular docking studies 
In order to predict the binding modes of curcumenol 42 and curcumenone 65 to 
the two main ligand binding sites of HSA (site I and site II), docking simulations of the 
interaction between these ligands and HSA were carried out. For each binding site, 100 
docking simulations and clustering analysis at a root-mean-square deviation tolerance of 
2.0 Å were performed. The docking analysis of 1BM0-curcumenol complex at the 
binding site I revealed a total of eight (8) multimember conformation clusters 
(Figure  3.128) with the mean binding energy of −6.40 kcal mol-1. The highest 
populated cluster had 29 out of 100 conformations. However, the configuration with the 
lowest binding energy (−6.77 kcal mol-1) was not a member of the highest populated 
cluster. At the binding site II (Figure  3.129), six (6) multimember conformation 
clusters, possessing mean binding energy of −5.53 kcal mol-1 were identified, with the 
highest populated cluster having 72 members out of 100 conformations. Although the 
lowest binding energy configuration (−5.72 kcal mol-1) was a member of the highest 
populated cluster, its binding energy was higher compared to the lowest binding energy 
configuration at site I (−6.77 kcal mol-1). Thus, it was predicted that site I of HSA 
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Figure  3.128:  Cluster analyses of the AutoDock docking runs of curcumenol 42 in the 
drug binding site I (A) and site II (B) of HSA (1BM0). 
Cluster analysis of the 1BM0-curcumenone complex (Figure  3.129) revealed 
similar clustering pattern for both binding sites, as observed with the 1BM0-curcumenol 
system. The lowest binding energy conformation for site I of 1BM0-curcumenone was 
−6.77 kcal mol-1, while that for site II was −5.74 kcal mol-1. These observations also 
suggested the preference of site I for curcumenone binding to HSA. 
 
Figure  3.129:  Cluster analyses of the AutoDock docking runs of curcumenone 65 in 
the drug binding site I (A) and site II (B) of HSA (1BM0). 
The predicted binding models of curcumenol 42 and curcumenone 65 with the lowest 
docking energy (−6.77 kcal mol-1) at site I of HSA were used for binding orientation 
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analysis (Figure  3.130). Since the cluster analysis also supported the binding of 
curcumenol and curcumenone at site II of HSA, the lowest docking energy complex for 
curcumenol (−5.72 kcal mol-1) and curcumenone (−5.74 kcal mol-1) at site II of HSA 
were also analysed (Figure  3.131). The ligand binding sites were defined as amino acid 
residues within 5 Å distance of the ligand. In the 1BM0-curcumenol complex at site I, 
the binding site was found to be located deep within the protein structure in a 
hydrophobic cleft walled by 18 amino acids: Tyr-150, Lys-195, Gln-196, Lys-199, Leu-
219, Arg-222, Asp-237, Leu-238, Val-241, His-242, Arg-257, Leu-260, Ala-261, Lys-
286, Ser-287, His-288, Ile-290 and Ala-291. However, in the 1BM0-curcumenone 
complex at the same site, the binding site was surrounded by 16 amino acids: Tyr-150, 
Lys-195, Gln-196, Lys-199, Leu-219, Arg-222, Phe-223, Leu-234, Leu-238, His-242, 
Arg-257, Leu-260 Ile-264, Ser-287, Ile-290 and Ala-291. The 1BM0-curcumenol 
complex formation at site II involved 14 amino acid residues, namely Leu-394, Leu-
398, Lys-402, Phe-403, Asn-405, Ala-406, Val-409, Arg-410, Lys-413, Thr-540, Lys-
541, Glu-542, Leu-544 and Lys-545. On the other hand, 1BM0-curcumenone complex 
at site II was associated with 13 amino acid residues: Leu-398, Lys-402, Phe-403, Asn-
405, Ala-406, Leu-407, Val-409, Arg-410, Lys-413, Thr-540, Lys-541, Glu-542, and 
Lys-545. 
Presence of hydrophobic amino acid residues at the binding sites of HSA might have 
contributed towards the stability of the ligand-HSA complex through hydrophobic 
interactions. However, the presence of several polar amino acid residues within the 
proximity of the bound ligands indicated that the interactions between these ligands and 
HSA at both site I and site II cannot be presumed to be exclusively hydrophobic. 
Furthermore, in the 1BM0-curcumenol complex docking conformation, one hydrogen 
bond was predicted involving the hydrogen atom of Arg-257 and the ethereal oxygen 
atom of curcumenol (Table  3.49). For the 1BM0-curcumenone complex docking 
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conformation, 4 hydrogen bonds were predicted involving hydrogen atoms from 3 
different amino acid residues of HSA (Tyr-150, Arg-222 and Arg-257) and the oxygen 
atoms of the acetyl and ketone groups of curcumenone. On the contrary, there was only 
one hydrogen bond in the 1BM0-curcumenone complex at site II, formed by the oxygen 
atom of curcumenone and the hydrogen atom of Lys-413 (Table  3.49) ). Both ligands 
showed one hydrogen bonding at the binding site. For 1BM0-curcumenol complex at 
site II, the hydrogen bond formed between the hydrogen atom of Lys-545 and the 
oxygen atom of hydroxyl group while for 1BM0-curcumenone complex, the hydrogen 
bond was associated with the hydrogen atom of Lys-413 and oxygen of the ketone 
group (Table  3.49). 
 
Figure  3.130:  Predicted orientations of the lowest docking energy conformations of 
1BM0-ligand complexes. The binding sites were enlarged to show hydrogen bonding 
(green lines) between amino acid residues and the ligands. Amino acid residues that 
form hydrogen bonds with the ligands are rendered in ball and stick and coloured 
yellow. (A) Curcumenol in the binding site I of HSA (1BM0). (B) Curcumenone in the 
binding site I of HSA (1BM0). 
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Figure  3.131:  Predicted orientations of the lowest docking energy conformations of 
1BM0-ligand complexes. The binding sites were enlarged to show hydrogen bonding 
(green lines) between amino acid residues and the ligands. Amino acid residues that 
form hydrogen bonds with the ligands are rendered in ball and stick and coloured 
yellow. (A) Curcumenol in the binding site II of HSA (1BM0). (B) Curcumenone in the 
binding site II of HSA (1BM0). 
 
Table  3.49:  Predicted hydrogen bonds between interacting atoms of the amino acid 
residues of HSA (1BM0) and the ligands at site I and site II. 
 
Compound HSA binding site Protein atom Ligand atom Distance (Å) 
Curcumenol Site I Arg257:HH22 O (ethereal) 1.907 
 Site II Lys545:HZ3 O (hydroxyl) 1.684 
     
Curcumenone Site I Tyr150:HH O (ketone) 1.907 
 Arg222:HH11 O (acetyl) 1.930 
 Arg257:HE O (ketone) 1.969 
 Arg257:HH22 O (ketone) 2.236 
 Site II Lys413:HZ3 O (ketone) 2.025 
These results suggested that although curcumenol 42 and curcumenone 65 can bind 
to both sites I and II of HSA, the binding is more preferable at site I, facilitated by 
hydrophobic forces and hydrogen bonds.  Although, the lowest binding energies for 
both ligands at site I were the same (−6.77 kcal mol-1) in molecular docking study, the 
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than that of 1BM0-curcumenol complex (one). This is reflected in the fluorescence 
quenching assay where curcumenone showed a higher extent of fluorescence quenching 
compared to curcumenol. Thus it can be inferred that both curcumenol and 
curcumenone showed similar HSA binding properties, with curcumenone having a 
slightly higher affinity towards HSA. 
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CHAPTER 4: MATERIALS AND METHODS  
4.1 Phytochemical analysis  
4.1.1 Plant Samples 
4.1.1.1 C. zedoaria rhizomes 
The rhizomes of C. zedoaria were collected from Tawamangu, Indonesia and a 
voucher specimen (KL 5764) was deposited at the herbarium of the Department of 
Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia. 
4.1.1.2 C. purpurascens rhizomes 
The rhizomes of C. purpurascens were collected from Yogjakarta, Indonesia, 
and a voucher specimen (KL 5793) was deposited at the herbarium of the Department of 
Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia. 
4.1.2 Solvents 
  The industrial grade solvents (hexane, dichloromethane, ethyl acetate, 
and methanol) were used for bulk extractions, these solvents were distilled twice before 
use.  The HPLC and analytical grade solvents (hexane, dichloromethane, ethyl acetate, 
acetone, petroleum ether, and methanol) were used for the final chromatographic 
separation of the pure compounds. 
4.1.3 Instrumentation 
 1H NMR spectra were obtained using JEOL LA 400 FT-NMR. Spectra were 
recorded in deuterated solvents including chloroform, methanol, and acetone. 
Chemical shifts were expressed in ppm and coupling constants were in Hertz 
(Hz). 
 Mass spectra were carried out for the non-volatile compounds on Agilent 
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Technologies 6530 Accurate-Mass QTOF LC/MS, coupled with ZORBAX 
Eclipse XDB-C18 Rapid Resolution HT (4.6 mm i.d. × 50 mm × 1.8 µm) 
column. 
 The EI MS spectra were obtained for the volatile constituents on Shimadzu   
GC-MS QP2000A spectrometer, high-resolution ESI MS were measured on a 
LTQ Orbitrap XL (Thermo Scientific).  
 UV spectra were recorded on a Shimadzu UV-Visible spectrophotometer using 
HPLC grade ethanol as solvent with mirror UV cell. 
 The infrared (IR) spectra were obtained through Perkin Elmer FT-IR 
spectrometer Spectrum RX1 using chloroform as solvent. 
 Melting points were taken on hot stage Gallen Kamp melting point apparatus 
and were uncorrected. 
 Optical rotations were determined on JASCO (Japan) P1000 automatic digital 
polarimeter. 
4.1.4 Chromatography 
4.1.4.1 Thin Layer Chromatography (TLC) 
 Aluminium supported silica gel 60 F254 plates were  used to check the spots of 
the isolated compounds. UV Light Model UVGL-58 Mineralight Lamp 230V, 50/60 Hz 
was used to examine spots or bands on the TLC after spraying with the required 
reagents. 
4.1.4.2 Column chromatography (CC) 
 Distilled industrial grade of the solvents (hex., DCM, EtOAc, and MeOH) were 
used to run column chromatography. Silica gel F60, 230-400 mesh ASTM (Merck 9385) 
was used for column chromatography. A slurry of silica gel 60 (approximately 30:1 
silica gel to sample ratio) in hex solvent system was poured into a glass column of 
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appropriate size with gentle tapping to remove trapped air bubbles. The crude extract 
was initially dissolved in minimum amount of solvent and loaded on top the packed 
column. The extract was eluted with an appropriate solvent system at a certain flow rate. 
Fractions were collected in conical flasks and evaporated for the next step. Fractions 
with similar spots were then combined by TLC monitoring. 
4.1.4.3 Preparative Thin Layer Chromatography (PTLC) 
 PTLC silica gel 60 F254 glass plates of size 20 cm × 20 cm (Merck 
1.05715.0001) were used for the separation of compounds. UV Light Model UVGL-58 
Mineralight Lamp 230V-50/60 Hz was used to examine bands on the PTLC. 
4.1.4.4 High Performance Liquid Chromatography (HPLC) 
 Waters HPLC System was used for HPLC separation, equipped with Binary 
Gradient Module, System Fluidics Organizer and UV detector set at the range from 200-
400 nm. Chromatographic analysis and separations were performed on a ZORBAX 
Eclipse Plus C18 (9.6 mm i.d. × 250 mm × 3.5 µm) HPLC columns. HPLC grade 
methanol, HPLC grade acetonitrile and deionized water were used as mobile phase 
solvents with HPLC grade formic acid as buffer. All solvents and samples were filtered 
with 0.45 μm nylon membrane filter (Waters) prior to HPLC analysis. The data were 
collected and analysed by using MassLynx software.  
4.1.5 Visualisation  
4.1.5.1 Vanillin-sulphuric acid vapour 
Vanillin (1.0g)  in 10 ml of concentrated H2SO4 was added upon cooling to 90 
ml of ethanol before spraying onto the TLC plate. The TLC plate was then 
heated at 50°C until full development of colours had been observed. The 
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occurrence of blue, purple, dark green, grey or brown indicated the presence of 
terpenes and steroids. 
4.1.5.2 Anisaldehyde-sulphuric acid 
 An aliquot of 0.5 ml of anisaldehyde was mixed with 10 ml glacial acetic acid 
followed by 85 ml methanol and 5 ml of concentrated sulphuric acid. 
4.1.6 Isolation of the pure compounds from C. zedoaria  
The air dried, powdered rhizomes (1.0 kg) of C.zedoaria were successively extracted 
by maceration with n-hexane, dichloromethane (DCM), ethyl acetate (EtOAc) and 
methanol (MeOH). The n-hexane extract (20.2 g, yield 2.4%) was chromatographed on 
a silica gel column (0.063-0.200 mm) with a gradient elution system using n-hexane and 
ethyl acetate (100:0-0:100). Based on the TLC pattern, fractions were pooled together to 
get a total of 21 fractions. F5 by through further CC and preparative thin layer 
chromatography (PTLC), yielded four compounds, namely germacrone-4,5-epoxide 
(24, 12.4mg), germacrone-1,10-epoxide (25, 8.0 mg), curcuzerenone (111, 3.1 mg), and 
furanodienone (22, 8.0 mg). Fraction 6 was chromatographed on a silica gel coloumn 
(0.043-0.063 mm) using a gradient elution system (n-hexane:EtOAc 100:0-0:100), 
followed by purification on preparative thin layer chromatography (n-hex:EtOAc 90:10, 
3 times run) to get germacrone (23, 21.6 and furanodiene (21, 8.8 mg). Fraction 7 was 
subjected to size exclusion chromatography using MeOH and DCM in a 1:1 ratio, 
followed by PTLC (Hex:EtOAc 90:10) and HPTLC (Hex:EtOAc:MeOH 96:3:1) to 
afford dehydrocurdione (19, 34.5), two labdanes, namely labda-8(17),12-diene-15,16-
dial (127, 16.2 mg) and labda-8(17),12-diene-15, 15-dimethoxy-16-al, also named 
calcaratarin A (128, 22.6 mg), and curcumanolide A (101, 4.9 mg). Fraction 8 was 
chromatographed by PTLC using petroleum ether (40-60°C) (PE) and EtOAc in a ratio 
of 85:15 for the first run and 82:18 for the second run to get curcumenol (42, 15.5 mg), 
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and zerumin A (129, 9.8 mg). Fraction 10 was chromatographed by CC followed by 
further purification by HPTLC to afford a second monoclinic modification of 
curcumenol as a crystallized dimer elucidated by single crystal X-ray diffraction 
analysis  or known as 9-isopropylidene-2, 6-dimethyl-11-oxatricyclo [6.2.1.0
1, 5
] undec-
6-en-8-ol (150, 5.4 mg) Isoprocurcumenol (43, 10.2 mg) was isolated from fraction 9 by 
successive development on PTLC using PE:EtOAc in the ratio of 90:10 and 85:15, 
respectively. Curcumenone (65, 16.4 mg) was purified from fraction 12 by PTLC using 
three times run with PE:EtOAc:MeOH in a ratio of 85:14:1.Curdione (20, 13.1mg) was 
obtained using CC, followed by PTLC using solvent system in first run (PE: EA: 
MeOH+formic acid 85%:14%:1%), second run using (PE:EA 80%:20%).  
Procurcumenol (44, 8.9 mg) was isolated from fraction 15 as a colourless oil by PTLC 
(PE:EtOAc:formic acid 85:14.5:0.5). Zerumbone epoxide (151, 11.9 mg) was isolated 
from silica gel (0.043-0.063 mm) coloumn of fraction 16 using a gradient elution 
system of n-hexane and EtOAc (100:0-0:100), followed by three times run on HPTLC 
(Hex:EtOAc:1,4-dioxane(85:14:1). The DCM extract (10 g) was fractionated on a silica 
gel column (Hex:EtOAc 95:5-0:100) to give 23 fractions.  Fraction 2 was subjected to 
micro silica gel column (0.043-0.063 mm) with a gradient elution system of Hex and 
EtOAc (100:0-0:100) followed by RP-HPLC (H2O:MeOH 40:60, run time 80 min, flow 
rate 2.5 ml/min) which afforded zederone (23, 24.4 mg) and gweicurculactone (41, 3.6 
mg) at the retention time of 15.26 and 20.16 min, respectively. Fraction 2 was also 
subjected to micro CC followed by two times run on PTLC (Hex:EtOAc 80:20)  
afforded comosone II (104, 6.6 mg). 
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Scheme  4.1:  Isolation and purification of the compounds from hexane and 
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4.1.7 Isolation of the pure compounds from C. purpurascens 
One kg of the powdered C. purpurascens rhizomes was successively extracted by 
maceration with n-hexane, DCM, and MeOH. The hexane extract (51.1 g) was 
chromatographed on a silica gel column (0.063-0.200 mm) with a gradient elution 
system using n-hexane and ethyl acetate (100:0-0:100). Based on TLC pattern, fractions 
were combined together to get a total of 16 fractions. Fraction 3 was subjected to CC 
and preparative thin layer chromatography (PTLC) using a combination of a solvent 
system, run twice: (petroleum ether PE: EA-95%: 5%) which afforded ar-turmerone 
(74, 20.2 mg). The DCM extract (10 g) was fractionated on a silica gel column (0.043-
0.063 mm) with an isocratic elution system of DCM and MeOH in the ration of DCM 
99%:MeOM 1%) to give 17 fractions.  Fraction 3 was subjected to PTLC using a 
solvent system (DCM: MeOH-99%:1%), to get curcumin (138, 15.2 mg) and 
demethoxycurcumin (140, 12.5 mg). Bisdemethoxycurcumin (139, 11.2 mg) was 
isolated from fraction 4 by using DCM: MeOH in the ratio of 99:1. Zedoalactone B (60, 











Scheme  4.2: Isolation and purification of the compounds from hexane and 
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4.1.8 Isolation of the essential oils from C. purpurascens 
The dried rhizomes (300 g) were cut into small pieces, ground and immediately 
soaked in distilled (1.00 L) in a round-bottomed flask. The soaked sample was distilled 
in a Cleveger-type apparatus for 5 hours. The yield of the oil (2.16 g, 0.72%) was 
calculated based on the weight of the dried plant material.  
The GC analysis of the oil was done on an Agilent Technologies 7890A GC system 
equipped with a FID detector using fused capillary column HP-5 (5% diphenyl and 95% 
dimethyl-polysiloxane, 30.00 M × 0.32 mm ID, 0.25 µm film thickness) with helium as 
a carrier gas at a flow rate of 1 ml per min. The column temperature was initially 
programmed from 60
o
C and kept isothermally for 10.0 minutes, then increased at 3.0
o
C 
per minute to 230
o
C, and held for 1.0 min. The temperature of the injector port and 




C respectively, with a split ratio 1:20. 
GC-MS analysis was performed on an Agilent Technologies 6890N GC System 
equipped with 5975 inert mass selective detector ( 70 eV direct inlet) on HP-5 ms 
capillary column ( 30.0 m × 0.25 mm 1D, 0.25 µm film thickness). The column 
temperature was programmed from 60
o
C for 10 minutes, then increased to 230
o
C at 3 
o
C per minute and was held for 1 minute at 230
o
C. The helium was used as the carrier 
gas at a flow rate of 1 ml per minutes with split ratio 1:20. The injector port temperature 
was set at 230
o
C and detector at 250
o
C. The total ion chromatogram obtained was auto 
integrated by ChemStation and the components were identified by comparison with an 
accompanying mass spectral database. Arithmetic index ( A1) was experimentally 
measured from the programmed temperature GC-FID by arithmetic interpolation 
between bracketing alkane using a homologous series of n-alkanes as standard (Adams, 
2012; Van den Dool et al., 1963). 
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4.1.9 Supercritical fluid extraction of C. purpurascens 
 In the present study, about 33 grams of the dried of C. purpurascens rhizomes 
was placed in 100 ml extraction vessel of an analytical-scale SFT 100 XW SFE system 
supported with a cylinder of liquid CO2 (purity 99.8%, SFE grade). The system 
conditions studied were at 313 K and 10.34 MPa. One-step extractions were performed 
by feeding CO2 into the system until the pressure 10.34 MPa was attained and the 
system temperature was set to 313 K. After 30 min of static extraction (no liquid flow), 
the sample material was subjected to dynamic extraction by flowing liquid CO2 at a rate 
of 12 ml/min. During the extraction, 2 to 5 crude fractions were collected in the vials. 
Each fraction was collected after every 5-10 min from the previous collection. The 
extraction of the crude was terminated when no extract was visually observed in the 
collection vial, then continued by increasing the pressure to 20.68 MPa. Similarly the 
extraction was collected in the collection vials until the extraction was visually observed 
to be finished. Above steps were followed for extraction by setting the pressure to 30.34 
MPa. Similar steps followed for temperatures set at 323 K and 333 K in separate run 
with pressures 20.68 and 30.34 MPa for each cases.  The extracts obtained were 






   279 
4.2 Cytotoxicity assessment 
4.2.1 Cell Culture 
The cancer cell lines MCF-7 (breast cancer), Ca Ski (cervical cancer) and HT-29 
(colon cancer) were cultured as monolayer in RPMI 1640 growth media. HUVEC 
(human umbilical vein endothelial cells) and PC-3 (prostate cancer) cells were cultured 
in DMEM. All cells were purchased from the American Type Culture Collection 
(ATCC, USA) except for human umbilical vein endothelial cells (HUVEC) cells was 
obtained from ScienCell Research Laboratories (Carlsbad, CA). All the media were 
supplemented with 10% v/v foetal bovine serum (FBS), 100 μg/ml 
penicillin/streptomycin and 50 μg/ml amphotericin B. The cells were cultured in a 5% 
CO2 
 
incubator at 37°C.  
4.2.2 MTT based cytotoxicity assay 
Cell viability was investigated using 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay. Cells were detached from the 25cm
3
 tissue 
culture flask when it achieved 80% confluency. The detached cells were pelleted by 
centrifugation (1,000 rpm; 5 minutes). Cells (3.0 x 10
4 
cells / ml) were seeded onto a 96-
well microtiter plate (Nunc). The cells were incubated at 37°C, and 5% CO2 incubator 
for 24 h to give adherent cells. The test compounds (1-100 µg/ml) were added onto the 
96-well microtiter plate containing adherent cells.  The untreated cells were incubated in 
10% media containing 0.5% DMSO (without addition of any test compounds/extracts). 
This mixture was regarded as the negative control whereas doxorubicin as the positive 
control. The plates were incubated for 72 h at 37°C in a 5% CO2 
 
incubator. After 72 h, 
the media was removed and 100 μl of fresh medium and 20 μl of MTT (Sigma, filter 
sterile, 5 mg/ml) was added to each well and further incubated for 4 hours (37°C) after 
which the media was substituted with 150 μl DMSO. The 96-well microtiter plates were 
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then agitated at room temperature onto an incubator shaker to dissolve the formazan 
crystals. The absorbance (A) of the content of the plates was measured at 540 nm using 
a micro plate reader. The percentage of inhibition of each test sample was calculated 
according to the following formula: Percentage of inhibition (%) = (Acontrol – 
Asample)/ Acontrol x 100%. The average of three replicates was then obtained. The 
IC50 for each extract was extrapolated from the graphs of the percentage inhibition 
versus concentration of test agents. Cytotoxicity of each test agent is expressed as IC50 
value. The IC50 value is the concentration of test agents that cause 50% inhibition or cell 
death, averaged from the three experiments. 
4.3 QSAR studies of cytotoxic compounds 
The geometry optimizations to final minimum energy structures of the 21 isolated 
compounds were performed by using the popular Becke three parameter Lee-Yang-Parr 
(B3LYP) exchange-correlation hybrid functional combined with a double-ξ Pople-type 
basis set 6-31+G (d,p), in which polarized and diffuse functions are taken into 
consideration (Becke, 1993). B3LYP hybdrid functional includes a mixture of Hartree-
Fock exchange (20% of HF) with DFT exchange-correlation functional. The frequency 
analyses were carried out at the same level of theory. The absence of imaginary 
frequencies confirmed that the structures are true minima on the potential energy 
surface. The choice of the hybrid functional B3LYP is based on previous QSAR studies 
(Mendes et al., 2012; Sarkar et al., 2012). The chemical descriptors that were chosen to 
be correlated with cytotoxicity activity are: (i) electronic descriptors: frontier molecular 
orbital energies (EHOMO, ELUMO, which are well accepted as molecular descriptors in 
medicinal chemistry, since they are related to the capacity of a molecule to form a 
charge transfer complex with its biological receptor), ionization potential (IP), electron 
affinity (EA), electronegativity (), hardness (), softness (S), electrophilicity index 
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(), dipole moment (), molecular polarizability (α), (ii) steric descriptors: surface area 
of molecule (A), volume (V) and its molecular weights (M); and (iii) hydrophobicity 
descriptor: logP, where P stands for the octanol-water partition coefficient. The 
calculations of logP were carried out using Hyperchem Molecular package 
(HyperChem, 2002) by means of the atomic parameters derived by Ghose, Pritchett and 
Crippen and later extended by Ghose and co-workers (Ghose et al., 1988; Viswanadhan 
et al., 1989). The other descriptors were calculated using the DFT method and obtained 
in two different ways: (i) Orbital consideration, which is based on Koopman’s theorem 
where IP=-EHOMO and EA=-ELUMO (Koopmans, 1934); and (ii) energy consideration, 
which is based on the use of the classical finite difference approximation, where the 
change of one electron is usually involved ΔN=±1 (Parr et al., 1989). In this method, IP 
= E+1-E0 and EA=E0 –E-1 where E0, E-1 and E+1 are the electronic energies of neutral 
molecule, when adding and removing an electron to the neutral molecule, respectively. . 
In addition to the (i) and (ii) methods, the electronic descriptors (e.g. hardness) can be 
calculated using internally resolved hardness tensor (IRHT) approach (Grigorov et al., 
1997; Mineva et al., 1998; Neshev et al., 1996), and it dealing with fractional 
occupation numbers based on the Janak’s extension of DFT (Janak, 1978). This 
approach is also based on orbital energies and it dealing with fractional occupation 
numbers based on the Janak’s extension of DFT (Janak, 1978). De Luca et al. (2002) 
used the above approaches to investigate the solvent effects on the hardness values of a 
series of neutral and charged molecules, and they found that the three methods gave 
similar results in the presence of solvent. 
The solvent effects were taken into account implicitly by using the polarizable 
continuum model (PCM) as implemented in the Gaussian 09 package (M. J. Frisch et 
al., 2009). In PCM, the solute is embedded into a cavity surrounded by solvent 
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described by its dielectric constant ε (e.g., for methanol ε = 32.6) (Tomasi et al., 2005). 
The use of an explicit solvent has been investigated notably by Guerra et al., who 
concluded to a better description of the electronic properties using PCM compared to 
the explicit solvent (Guerra et al., 2004). A hybrid model was tested by Trouillas et al. 
(Kozlowski et al., 2007). The authors showed that only slight differences were obtained 
compared to PCM. All theoretical calculations including ground state geometry 
optimization and frequency analysis calculations were performed with Gaussian 09 
package (M. J. Frisch et al., 2009).  
Simple and multiple linear regression (SLR and MLR, respectively) analyses were 





standard deviations (SD). PCA and HCA were employed to reduce dimensionality and 
investigate the subset of descriptors that could be more effective for classifying the 
isolated compounds according to their degree of cytotoxicity against tumour cells.  
The regression models and statistical analyses of obtained results were carried out by 
using DataLab package (http://www.lohninger.com/datalab/en_home.html).   
4.4 Neuroprotective and antioxidant activity investigation 
NG108-15 hybridoma cell line was obtained from American Type Culture Collection 
(ATCC). Dulbecco’s Modified Eagle’s Medium (DMEM), phosphate buffered saline 
(PBS), sodium bicarbonate, HEPES sodium salt and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) were purchased from Sigma-Aldrich; foetal bovine 
serum (FBS), penicillin/streptomycin and amphotericin B were purchased from PAA 
Laboratories, Austria; accutase was purchased from Innovative Cell Technologies, Inc.; 
hydrogen peroxide (H2O2) was purchased from Systerm
®
. 
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4.4.1 Assessment of neuroprotective activity 
The neuroprotective effects of the test compounds against H2O2-induced cell death in 
NG108-15 cells were evaluated by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] assay. Cells were plated at a total density of 5 × 10
3
 
cells/well in a 96-well plate. The cells were left to adhere for 48 h and treated with LA 
(2 h) prior to H2O2 (400 µM) exposure for 24 h. 20 µL MTT solution (Sigma Aldrich) 
was added into each well and incubated at 37°C for another 4 h. The absorbance was 
measured by using a microplate reader (ASYS UVM340) at 570 nm (reference 
wavelength: 650 nm). 
% Cell viability =
Absorbance of treated cells
Absorbance of control cells
× 100% 
NG108-15 cells were rinsed with PBS, harvested with accutase and plated on 96-well 
microtitre plate such that each well contains 5 x 10
3
 cells. It was kept for 48 h for the 
cells to adhere. Cells preincubated for 2 h with various compounds at different 
concentration (1-30 µM) were exposed to H2O2 (400 μM) for subsequent 24 h. After the 
incubation period is over, 20 µl of MTT solution (5 mg/ml) was added to each well and 
incubated at 37°C for another 4 h. The medium was removed subsequently and DMSO 
was added to dissolve the formazan crystals. The eluted samples were measured directly 
in a microplate reader (ASYS UVM340) at 570 nm (with a reference wavelength of 650 
nm) (Wong et al., 2012). Cell viability was calculated using the following formula: 
% Cell viability =
Absorbance of treated cells (As)
Absorbance of control cells (Ac)
× 100% 
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4.4.2 Antioxidant activity test by ORAC assay 
Oxygen radical antioxidant capacity (ORAC) assay was done as described by G. Cao 
et al. (1997) with slight modification. The assay was performed in a 96-well black 
microtitre plate, with 25µl of sample, standard (Trolox), blank (solvent/PBS) or positive 
control (quercetin) in each well. Subsequently, 150 µl of working fluorescein solution 
was added to each well of the assay plate. The plate was incubated at 37°C for 5 min. 
Aliquot of (25 µl) AAPH working solution was then added to each well, making up a 
total volume of 200 µl. Fluorescence was recorded at an excitation wavelength of 485 
nm and emission wavelength of 538 nm. Data were collected every 2 min during an 
observation period of 2 h, and were analysed by calculating the differences of area 
under fluorescence decay curve (AUC) of samples, standard or positive control against 
blank. The antioxidant capacity was expressed as Trolox equivalent (TE).  
4.5 Binding and docking studies 
4.5.1 Binding studies 
Essentially fatty acid free human serum albumin (HSA) was obtained from Sigma-
Aldrich Inc., USA. All other chemicals were of analytical grade purity. 
The stock solution of HSA was prepared in 20 mM sodium phosphate buffer, pH 7.4 
and its concentration was determined spectrophotometrically using a specific extinction 
coefficient value of 5.3 at 280 nm. Stock solutions of curcumenol 44 and curcumenone 
65 were prepared by dissolving the desired quantity in 5 ml of ethanol and diluting it to 
the desired volume with 20 ml of sodium phosphate buffer, pH 7.4. 
The interaction of curcumenol 44 and curcumenone 65 to HSA were studied by 
fluorescence quench titration method. A constant amount of protein was titrated with 
increasing concentrations of the ligands. The concentration of HSA was maintained at 3 
   285 
μM, while the ligand concentrations ranged from 0–60 μM. The final volume of the 
reaction mixture was made up to 3 ml with the above sodium phosphate buffer. The 
samples were allowed to equilibrate for 30 min prior to fluorescence measurements. The 
fluorescence spectra of these samples were recorded on a Jasco FP-6500 
spectrofluorometer with a 1 cm path length quartz cuvette. Both excitation and emission 
slits were set at 10 nm, while the scan speed was maintained at 500 nm/min. The 
samples were excited at 280 nm, and the emission spectra were recorded in the 
wavelength range, 300–400 nm. 
4.5.2 Molecular docking 
The structure of curcumenol 44 and curcumenone 65 were drawn using 
ACD/ChemSketch Freeware (Advanced Chemistry Development Inc. Ontario, Canada), 
3-D optimized and exported as a mol file. The geometry optimization of these structures 
was refined with the VegaZZ 2.08 (Pedretti et al., 2002) batch processing MOPAC 
script (mopac.r; keywords: MMOK, PRECISE, GEO-OK) using AM1 semiempirical 
theory (Dewar et al., 1985) and converted and stored as a mol2 file.  Molecular docking, 
visualization and rendering simulation were performed using AutoDock 4.2(Goodsell et 
al., 1996) and AutoDockTools 1.5.4 (Sanner, 1999) at the Academic Grid Malaysia 
Infrastructure. For the docking study, the curcumenol and curcumenone non-polar 
hydrogens were merged and the rotatable bonds were defined. The crystal structure of 
HSA (PDB code 1BM0, res. 2.5 Å) was downloaded from the Protein Data Bank 
(PDB)(Berman et al., 2000). Its water molecules were removed and the atomic 
coordinates of chain A were stored in a separate file and used as input for 
AutoDockTools, where polar hydrogens, Kollman charges and solvation parameters 
were added. The two binding sites (site I and site II) were defined using two grids of 
70x70x70 points each with a grid space of 0.375 Å centered at coordinates x=35.26 
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y=32.41 z=36.46 for site I and x=14.42 y=23.55 z=23.31 for site II.  Lamarckian genetic 
algorithm with local search (GA-LS) was used as the search engine, with a total of 100 
runs for each binding site. In each run, a population of 150 individuals with 27000 
generations and 250000 energy evaluations were employed. Operator weights for 
crossover, mutation and elitism were set to 0.8, 0.02 and 1, respectively. For local 
search default parameters were used. Cluster analysis was performed on docked results 
using RMS tolerance of 2.0 Å. The protein-ligand complexes were visualized and 
analyzed using AutoDockTools. 
4.6 Physical and spectral data of isolated compounds from C. zedoaria  
4.6.1 Germacrane type sesquiterpenes 
 Dehydrocurdione 19 : Pale yellow oil 
Molecular formula : C15H22O2 
[𝛼]𝐷
20 : + 280° (c 0.3, MeOH) 
IR (CHCl3) νmax cm
-1
 : 1680, 1742  
UV MeOH) λmax nm (logε)  : 207 (1.16) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.2 
13
C NMR (CDCl3) δ ppm 
 
: Refer Table 3.2 
GC-MS
 
: RT 27.86 min, 234 (M
+
, 10), 178(27), 164(53), 
152(49),121(37),96(53),  68(100), 41(59). 
 
Curdione 20 : White amorphous powder 
Molecular formula : C15H24O2 
              [𝛼]𝐷
20 : + 26° (c=1 in MeOH) 
IR (CHCl3) νmax cm
-1
 : 3584, 2961, 2927, 2873, 1702 
UV(MeOH) λmax nm (log ε) : 204 (0.97) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.3 
13
C NMR (CDCl3 δ ppm : Refer Table 3.3 
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GC-MS
 
: RT= 15.42 min, 180 (82), 167 (75), 69 (100), 55 
(53), 41(57) 
 
Furanodiene 21 : white amorphous powder 
Molecular formula : C15H20O 
IR (CHCl3) νmax cm
-1
 : 3429, 2928, 1740, 1448. 
UV(MeOH) λmax nm (log ε) : 217 (1.385) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.5 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.5 
GC-MS
 
: 216, RT: 21.28 min., 216(M
+
, 48), 201(12), 
159(23), 148(8), 145(2), 108(100), 91(28), 
77(26), 65(12), 53(16), 41(31). 
Furanodienone 22 : Colourless crystal 
Molecular formula C15H18O2 
IR (CHCl3) νmax cm
-1
 : 2926, 1653, 1376 
UV( MeOH) λmax nm (log ε) : 217 (1.38) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.9 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.9 
GC-MS
 
: GC-MS: 230 (32), 215 (15), 122 (100), 94(51), 77 
(15), 66 (26), 65 (25), 41(13). 
                                        
Germacrone 23 : White amorphous solid 
Molecular formula : C15H22O 
IR (CHCl3) νmax cm
-1
 : 1677 
UV(MeOH) λmax nm (log ε) : 206 (1.47)  
1
H NMR (CDCl3) δ ppm : Refer Table 3.4 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.4 
GC-MS
 
: RT: 25.90 min, 218(M
+
, 13), 175(27), 136(61), 
135(85), 121(30), 107(100), 105(20), 91(31), 
67(42). 
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Germacrone-4, 5-epoxide 24 : White solid 
Molecular formula : C15H22O2 
IR (CHCl3) νmax cm
-1
 : 1702  
UV( MeOH) λmax nm (log ε) : 205 (1.17) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.7 
13
C NMR (CDCl3) δ ppm
 




: 31.8 min., 234 (100), 163 (33), 136 
(47), 121 (68), 107 (40), 41 (31). 
Germacrone 1, 10-epoxide 25 : white solid 
Molecular formula : C15H22O2 
IR (CHCl3) νmax cm
-1
 : 1710 
UV( MeOH) λmax nm (log ε) : 218 (1.11) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.8 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.8 
GC-MS
 
: 30.0 min., 97.15 (17.0), 84.1 (12.2), 
81.10 (17.3), 44.05 (7.07), 43.05 
(100), 41 (34.1). 
 
Zederone 26 : Colourless crystal 
Molecular formula C15H18O3 
[𝛼]𝐷
20 : + 260° (c 0.5, MeOH) 
IR (CHCl3) νmax cm
-1
 : 2929, 1664, 1527, 1404 
UV (MeOH) λmax nm (log ε) : 239 (2.08) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.6 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.6 
GC-MS
 
: 32.09 min, 246 (33), 188(35), 176(35), 175(100), 
161 (55), 119 (90), 91 (55), 43 (55). 
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4.6.2 Guaiane type sesquiterpenes 
Gweicurculactone 41 : Reddish crystal 
Molecular formula C15H16O2 
[𝛼]𝐷
20 : + 15.2 (c 0.1, MeOH) 
IR (CHCl3) νmax cm
-1
 : 1726 cm
-1
 
UV( MeOH) λmax nm (log ε) : 2.18 (1.02) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.10 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.10 
GC-MS
 
: 228 (100), 199.1 (89.24), 157.1 
(22.34), 142.1 (16.96), 115.10 (16), 
51 (5.6). 
 
Curcumenol 42 : Colourless oil 
Molecular formula C15H22O2 
IR (CHCl3) νmax cm
-1
 : 3432 (OH), 2934 (C=C), 1457 (C-O) 
UV( MeOH) λmax nm (log ε) : 224.0(3.047) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.13 
13
C NMR (CDCl3) δ ppm
 




: 26.70 min, 234 [M
+
, 26], 189(53), 
147(52), 145(30), 133 (53), 121(39), 
119(35), 105(100), 91(37), 55(18), 
41(25). 
Isoprocucumenol 43 : Colourless oil 
Molecular formula C15H22O2 
IR (CHCl3) νmax cm
-1
 : 3450, 1674, 1610. 
UV( MeOH) λmax nm (log ε) : 205 (1.83) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.11 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.11 
GC-MS
 
: 234, RT: 29.36 min, 158 (35), 121 
(84), 105 (100), 93 (60), 43 (79) 
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 Curcumenol second monoclinic 150 : Colourless crystal 
Crystal data: : C15H22O2 
Mr : 234.33, Monoclinic 
P2 : a=9.3495 A
o
















Mo Kα radiation, µ : 0.07 mm-1 
T : 100 K, 0.4×0.05× 0.05mm 
 
Procucumenol 44 : Colourless oil 
Molecular formula C15H22O2 
IR (CHCl3) νmax cm
-1
 : 3409, 1712  
UV( MeOH) λmax nm (log ε) : 204.0 (1.16) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.12 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.12 
GC-MS
 
: 216 (79), 123 (75), 105 (55), 91 (41), 
43 (100), 41 (40). 
4.6.3 Seco-guaiane type sesquiterpene 
Curcuzedoalide 62 : White amorphous powder 
Molecular formula : C15H20O3 
IR (CHCl3) νmax cm
-1
 : 1717  
UV( MeOH) λmax nm (log ε) : 224.0 ( 3.047) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.14 
13
C NMR (CDCl3) δ ppm
 





), 164 (57), 136 (49), 109 
(35), 69 (100), 41 (95) 
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4.6.4 Elemane type sesquiterpene 
Curzerenone 111 : Colourless oil 
Molecular formula : C15H18O 
IR (CHCl3) νmax cm
-1
 : 1717  
UV( MeOH) λmax nm (log ε) : 224.0 (3.047) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.15 
13
C NMR (CDCl3) δ ppm
 





), 122 (100) 
 
4.6.5 Humulane type sesquiterpene 
Zerumbone epoxide 151 : Pale yellow 
Molecular formula : C15H22O2 
IR (CHCl3) νmax cm
-1
 : 1717  
UV( MeOH) λmax nm (log ε) : 216 ( 2.6) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.16 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.16 
GC-MS
 
: 234, RT: 16.88., 135 ( 89), 121 (44), 
107 (99), 43 (100) 
 
4.6.6 Cadinane type sesquiterpene 
Comosone II 104 : Colourless oil 






 (c, MeOH) 
IR (CHCl3) νmax cm
-1
 : 1717  
UV( MeOH) λmax nm (log ε) : 220 (1.24). 
1
H NMR (CDCl3) δ ppm : Refer Table 3.17 
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13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.17 
GC-MS
 
: 216 ,RT: 18.8 min, 201 ( 90), 159 (95)   
77 (100), 41 (100). 
4.6.7 Carabrane-type sesquiterpene 
Curcumenone  65 Colourless oil 
Molecular formula C15H22O2 
[𝛼]𝐷
20 -12.7°, c 1.0, CHCl3). 
IR (CHCl3) νmax cm
-1
 1679, 1715   
UV( MeOH) λmax nm (log ε) 205 (1.28) 
1
H NMR (CDCl3) δ ppm Refer Table 3.18 
13
C NMR (CDCl3) δ ppm
 
Refer Table 3.18 
GC-MS
 
234, RT: 28.9, 176(78), 163(29), 
161(48), 149 (43), 133(37), 107(32), 
91(29), 68(91), 67(75), 43(100). 
 
4.6.8 Spirolactone type sesquiterpene 
Curcumanolide A 101 : colourless oil 
Molecular formula C15H22O2 
[𝛼]𝐷
20 : -23°, c 1.0, CHCl3) 
IR (CHCl3) νmax cm
-1
 : 1717  
UV( MeOH) λmax nm (log ε) : 218 (1.019) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.19 
13
C NMR (CDCl3) δ ppm
 





, 7], 219(7), 191(20), 178(56), 
165(78), 164(100), 152(72), 121(28), 
109(26), 96(30), 69(45), 68(44), 67(45). 
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4.6.9 Labdane type diterpenoids 
labda-8(17),12 diene-15,16 dial 127 :  Colourless oil 
Molecular formula : C20H30O2 
IR (CHCl3) νmax cm
-1
 : 889, 1643, 1683  
UV( MeOH) λmax nm (log ε) : 226 (1.969), 208 (2.77) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.20 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.20 
GC-MS
 
: 302, RT: 38.48 min, 137 (79), 123 
(55), 109 (39), 95 (88), 81 (100), 69 
(73). 
 
Calcaratarin A  128 : Colourless oil 
Molecular formula : C22H44O3 
IR (CHCl3) νmax cm
-1
 : 2929, 1708, 1688 
UV( MeOH) λmax nm (log ε) : 200 (2.237) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.21 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.21 
GC-MS
 
: 328, RT: 28.20 min, 300 (38), 137 
(73), 123 ( 68), 109 (87), 81 (100), 41 
(89). 
 
Zerumin A 129 : Pale yellow oil 
Molecular formula : C20H30O2 
IR (CHCl3) νmax cm
-1
 : 3080, 1646, 890, 1686  
UV( MeOH) λmax nm (log ε) : 210 (1.37) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.22 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.22 
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GC-MS
 
: 318, RT= 24.32 min, 164 (100), 137 
(81), 95 (60), 81 (70), 41 (55). 
 
4.7 Physical and spectral data of isolated compounds from C. purpurascens 
4.7.1 Bisabolane type sesquiterpene 
ar-Turmerone 74 : Pale yellow oil 
Molecular formula  C15H20O 
[𝛼]𝐷
20 : + 60 (c 0.5,  MeOH) 
IR (CHCl3) νmax cm
-1
 : 1516, 1618, 1700 
UV( MeOH) λmax nm (log ε) : 240 (2.42) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.24 
13
C NMR (CDCl3) δ ppm
 





), 119 (100) 
 
4.7.2 Diarylhepatoids 
Curcumin 138 : Orange crystal 
Molecular formula : C21H20O6 
IR (CHCl3) νmax cm
-1
 : 1600, 1625 
UV( MeOH) λmax nm (log ε) : 430 (3.5) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.25 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.25 
HRESI-MS  : [M+H]
+
 at m/z 369 
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Bisdemethoxycurcumin 139 : Yellow powder 
Molecular formula : C19H16O3 
IR (CHCl3) νmax cm
-1
 : 1625, 3440 
UV( MeOH) λmax nm (log ε) : 415 (2.5) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.26 
13
C NMR (CDCl3) δ ppm
 





 at m/z 309 
 
Demethoxycurcumin 140 : Orange powder  
Molecular formula : C20H18O3 
IR (CHCl3) νmax cm
-1
 : 1624, 3400 
UV( MeOH) λmax nm (log ε) : 416 (2.8) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.25 
13
C NMR (CDCl3) δ ppm
 





 at m/z 338 
4.7.3 Quaiane type sesquiterpene 
Zedoalactone B 60 : Colourless oil 
Molecular formula : C15H20O5 
IR (CHCl3) νmax cm
-1
 : 1732, 3441 
UV( MeOH) λmax nm (log ε) : 262 (3.9) 
1
H NMR (CDCl3) δ ppm : Refer Table 3.27 
13
C NMR (CDCl3) δ ppm
 
: Refer Table 3.27 
HRESI-MS 
 
: m/z 281 (M+H)
+
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CHAPTER 5: CONCLUSIONS 
The phytochemical investigation of C. zedoaria and C. purpurascens led to the 
isolation of 27 compounds, majority of them were sesquiterpenes, while the rest were 
diterpenoids and curcuminoids. The proposed biosynthetic relationships of three 
sesquiterpenes types isolated from C. zedoaria in the present study is given in scheme 
5.1. 
 The GC and GC-MS analysis of the essential oil isolated from C. putpurascens 
by hydrodistillation indicated the presence of 34 compounds, with turmerone, a 
bisabolane type sesquiterpene as the major component. The oil exhibited strong 
cytotoxicity against HT29 cells, but mild cytotoxicity against the non-cancerous human 
lung fibroblast cell line (MRC5). 
Supercritical fluid extraction was performed with a view to find an optimum 
extraction parameter using a green technology that avoids the use of organic solvents. 
The investigation revealed that an increase in the pressure and decrease in the 
temperature could offer higher yield. A comparison of extract obtained from maceration 
as well as supercritical fluid extraction showed that both extracts had turmerone and ar-
turmerone as the major constituents. However, the latter extract contained higher 
percentage of the above compounds suggesting it a more efficient extraction method for 
the isolation of these two compounds from C. purpurascens. 
The isolated pure compounds were subjected to a number of bioactivity 
investigations to find potential lead towards the development of chemotherapeutic agent 
against some of the most problematic diseases including cancer and neurodegeneration. 
Complementary investigations were also carried out to support the observed biological 
activity. These include structure activity relationship study of the cytotoxic compounds, 
antioxidant activity study of neuroprotective compounds. Two compounds were also 
subjected to pharmacodynamic studies to investigate their binding modes with HSA. 
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In the biological studies, the n-hexane extract of C. zedoaria exhibited good 
anti-proliferative effect against MCF-7 and Ca Ski cells, supporting the ethnomedical 
application of C. zedoaria in the treatment of breast cancer. Several of the isolated 
compounds showed antiproliferative effect against four cancer cell lines (MCF-7, Ca 
Ski, PC-3 and HT-29). Among the compounds tested, curcumenol 42 and curcumenone 
65 showed potent in vitro cytotoxicity towards the MCF-7 cells. 
From the present investigation, as well as previous pharmacological reports, it 
could be proposed that curcumenol 42 could be considered as a promising candidate for 
advanced studies of anticancer drug development. However, further studies are 
necessary to determine its mode of action. It is noteworthy that the n-hexane extract of 
C. zedoaria and the two of its active compounds, curcumenol 42 and curcumenone 65 
did not show toxicity towards the non-cancer cell line (HUVEC). Although C. zedoaria 
enjoys extensive use in traditional medicine, it is used cautiously since it shows toxicity 
at higher doses. As our investigation revealed, some of the sesquiterpenes of this plant 
had strong cytotoxic activity and might be responsible for its unwanted effects. 
Quantum chemical analysis of the 21 cytotoxic compounds established the 
correlation between a set of electronic, steric and hydrophobicity descriptors that 
governs their cytotoxic activity against MCF7, Ca Ski, PC3 and HT-29 cancer cell lines, 
and HUVEC normal cell line. MLR, PCA and HCA allowed us to further categorize the 
active compounds according to their activity level into high, moderate, and low 
potential. 
Among the nine sesquiterpenes and one labdane diterpene, tested for 
neuroprotective activity, dehydrocurdione 19 and curcumenol 42 were found to be the 
most promising providing 100% protection against hydrogen peroxide induced 
oxidative stress in NG108-15 cells. In the oxygen radical antioxidant capacity (ORAC) 
assay, zerumbone epoxide 151 showed the highest antioxidant activity. To date, no true 
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neuroprotective drug has been discovered, and curcumenol 42 holds a promising result 
to be considered as a template for the development of new drug for the treatment of 
neurodegenerative disorders. 
The two most active compounds, curcumenol 42 and curcumenone 65 were 
further investigated for their binding properties to HSA which revealed that both 
compounds can bind to site I and site II, while site I is the preferred binding site.  
The humulane type sesquiterpene zerumbone epoxide 151, and three labdane 
diterpenes, namely labda-8(17),12 diene-15,16 dial 127, calcaractrin A 128, and 
zerumin A 129 are the first report from C. zedoaria. 
The findings of the present study support the common practice of 
enthnopharmacological uses of the rhizomes of C. zedoaria in the treatment of breast 
cancer and this plant has the potential to be developed further as a nutraceutical for the 
treatment of cancer. 
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Scheme  5.1: The proposed biosynthetic relationships of three sesquiterpenes 
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Abstract:  This study investigates the effect of phytochemical constituents from medicinally important plant 
Curcuma zedoaria (Christm.) Rosc., on hydrogen peroxide induced oxidative stress in mouse neuroblastoma-rat 
glioma hybridoma cells NG108-15. Phytochemical investigation of C. zedoaria rhizomes resulted in the 
isolation of nine sesquiterpenes (germacrone 1, dehydrocurdione 2, curcumenol 3, isoprocurcumenol 5, 
curcumenone 6, procurcumenol 7, zerumbone epoxide 8, zederone 9 and gweicurculactone 10) and one labdane 
diterpene (zerumin A 4). Curcumenol (3) and dehydrocurdione (2) showed 100% protection of the NG108-15 
cells at the concentrations of 4 and 10 µM, respectively. Procurcumenol (7), isoprocurcumenol (5), zerumbone 
epoxide (8), zerumin A (4) and germacrone (1) showed moderate activity (80-90% protection). In the oxygen 
radical antioxidant capacity (ORAC) assay, all the test compounds showed strong antioxidant activity except 
curcumenol (3) which showed moderate antioxidant activity, as compared to the reference standard quercetin. 
 
Keywords: Curcumenol; dehydrocurdion; zerumbone epoxide; ORAC assay; NG108-15 cells. © 2015 ACG 
Publications. All rights reserved. 
 
1. Introduction 
Increased prevalence of neurodegenerative disorders in the aged population is affecting both 
economically and the quality of life of the patient and carer. The most prevalent neurodegenerative 
disorders include Alzheimer‟s disease (AD) and Parkinson‟s disease (PD). Scientists have predicted 
that by the year 2050, 1 in 85 people will be affected by AD, which is characterised by neurofibrillary 
tangles and senile plaques [1]. Parkinson‟s disease (PD) is another common neurological disease, in 
which the dopaminergic neurons in the substantia nigra of midbrain and their terminals in the striatum 
undergo cell death [2]. It leads to movement-related problems in the early stages, and thinking and 
behavioural symptoms in the later stages. Both AD and PD are multi-factorial which involve different 
etiopathogenic mechanisms implicating various genetic and environmental factors [3, 4]. Oxidative 
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stress, which is the result of mitochondrial dysfunction, has long been considered to be one of the 
major causes of neurodegeneration. Being the most energy intensive organ (20% of whole body‟s 
need), the brain is highly dependent on mitochondrial aerobic oxidative phosphorylation (OXPHOS) 
to produce ATP. During OXPHOS, electrons leak from the electron transport chain (ETC) as 
superoxide (O2
•−
) and give rise to various reactive oxygen species (ROS) including diatomic oxygen, 
hydrogen peroxide and hydroxyl radical [5]. In normal physiological condition, 1-2% of our consumed 
oxygen is converted into ROS, which is neutralised by the body‟s redox systems. As a second 
messenger system, the highly diffusible gaseous nitric oxide (NO) plays a vital role in the 
physiological functions in the CNS. The half-life of NO is very short and can convert into various 
reactive nitrogen species (RNS), including nitric oxide (NO
•
) by neuronal nitric oxide synthase 
(nNOS) and nitric oxide (NO
•





and nitrogen dioxide (NO2
•
). Large amount of various ROS and RNS are produced in pathological 
conditions where the redox homeostasis is insufficient for the neutralisation of excess oxidative 
radicals [6]. This will then lead to catastrophic events, which include modifications of biomolecules, 
e.g., lipid peroxidation, DNA mutations, and structural, functional alteration or fragmentation of 
proteins, leading to protein denaturation and neurodegeneration [7]. 
Plant extracts, including those rich in antioxidants are of great interest for their therapeutic and 
preventive role in neurodegenerative disorders. Numerous studies have been done on plant extracts 
and plant derived natural products for their neuroprotective activity. Some of the most highly studied 
plants include curcuma, ginger, ginko biloba, cinnamon, saffron, coffee, green tea and berries [8]. 
Phytochemical constituents including monoterpenes, sesquiterpenes, triterpenes, alkaloids, flavonoids 
and lignans were found to be the active component for the observed biological activity [9].  
Curcuma zedoaria (Christm.) Rosc. (Zingiberaceae), locally known as “temu putih” in 
Malaysia, is a perennial herb largely found in tropical countries including Malaysia, Indonesia, India, 
Japan and Thailand. It is one of the medicinally important species from the genus Curcuma. Also 
known as „Ezhu‟ in Chinese and „Krachura‟ in Sanskrit, C. zedoaria is used alone or in combination in 
the herbal remedies of Malaysia, Indian Ayurveda and Chinese medicine [10]. In traditional medicine, 
the rhizomes of C. zedoaria is used for the treatment of menstrual disorders, dyspepsia, stomachic, 
vomiting and cancer [11]. The plant is reported to have antimicrobial [12], antiulcer [13], analgesic 
[14], anti-inflammatory [15], hepatoprotective [16], and cytotoxic [17] activity. The isolated bioactive 
compounds from C. zedoaria include curcumenol, dihydrocurdione, curcumin, dihydrocurcumin, 
tetrahydromethoxycurcumin, tetrahydrobismethoxycurcumin as the analgesic principles [14], 
curcumin, demethoxycurcumin, bisdemethoxycurcumin, curcumenol (3) as  cytotoxic against various 
cancer cell lines [18, 19], furanodiene, germacrone (1), curdione, neocurdione, curcumenol (3), 
isocurcumenol, aerugidiol, zedoarondiol, curcumenone (6), curcumin as hepatoprotective [16], 
curzenone and dehydrocurdione (2) as anti-inflammatory agents [20]. 
Despite numerous studies on C. zedoaria, it has never been investigated for neuroprotective 
activity. In our continuous effort to study the bioactive compounds in medicinal plants used in 
Malaysia and South East Asian region [21-23], we have attempted the isolation of natural compounds 
from C. zedoaria and evaluated them for neuroprotective activity against H2O2-induced oxidative 
stress in NG108-15 cells. Antioxidant activity of the compounds under investigation was further 
carried out to correlate their antioxidant ability towards the neuroprotective activity. 
2. Materials and Methods 
2.1. Plant material 
 
The rhizomes of Curcuma zedoaria (Christm.) Rosc. were collected from Tawamangu, 
Indonesia and a voucher specimen (KL 5764) was deposited at the Herbarium, Department of 
Chemistry, University of Malaya. 
 
2.2. Extraction and isolation 
 
The air dried, powdered rhizomes (1.0 kg) of C. zedoaria was successively extracted by 
maceration with n-hexane (Hex) and dichloromethane (DCM). The n-hexane extract (20.2 g, yield 
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2.4%) was chromatographed on a silica gel column (0.063-0.200 mm) with a gradient elution system 
using n-hexane and ethyl acetate (EtOAc) (100:0-0:100). Based on the TLC pattern, fractions were 
pooled together to get a total of 21 fractions. Fraction 6 was chromatographed on a silica gel column 
(0.043-0.063 mm) using a gradient elution system (Hex:EtOAc 100:0-0:100), followed by purification 
through PTLC (Hex:EtOAc 90:10, 3 times run) to get germacrone (1, 21.6 mg). Fraction 7 was 
subjected to size exclusion chromatography using methanol (MeOH) and DCM in a 1:1 ratio, followed 
by PTLC (Hex:EtOAc 90:10) and HPTLC (Hex:EtOAc:MeOH 96:3:1) to afford dehydrocurdione (2, 
34.5 mg). Fraction 8 was separated by PTLC using petroleum ether (40-60°C) (PE) and EtOAc in a 
ratio of 85:15 for the first run and 82:18 for the second run to get curcumenol (3, 15.5 mg), and 
zerumin A (4, 9.8 mg). Isoprocurcumenol (5, 10.2 mg) was isolated from fraction 9 by successive 
development on PTLC using PE:EtOAc in the ratio of 90:10 and 85:15, respectively. Curcumenone (6, 
16.4 mg) was purified from fraction 12 by PTLC using three times run with PE:EtOAc:MeOH in a 
ratio of 85:14:1. Procurcumenol (7, 8.9 mg) was isolated from fraction 15 as a colourless oil by PTLC 
(PE:EtOAc:formic acid 85:14.5:0.5). Zerumbone epoxide (8, 11.9 mg) was isolated from silica gel 
(0.043-0.063 mm) column of fraction 16 using a gradient elution system of Hex and EtOAc (100:0-
0:100), followed by three times run on HPTLC (Hex:EtOAc:1,4-dioxane (85:14:1). The DCM extract 
(10 g) was fractionated on a silica gel column (Hex:EtOAc 95:5-0:100) to give 23 fractions.  Fraction 
2 was subjected to silica gel column (0.043-0.063 mm) with a gradient elution system of Hex and 
EtOAc (100:0-0:100) followed by RP-HPLC (H2O:MeOH 40:60, run time 80 min, flow rate 2.5 
mL/min) which afforded zederone (9, 24.4 mg) and gweicurculactone ( 10, 3.6 mg) at the retention 
time of 15.26 and 20.16 min, respectively. The spectral data of the isolated compounds (Fig. 1) were 
in agreement with the literature [24-27]. 
 
2.3. Cell culture 
 
NG108-15 was obtained from the American Type Culture Collection (ATCC) and cultured in 
DMEM (Sigma Aldrich) composed of 10% (v/v) heat inactivated FBS, 2% penicillin/streptomycin, 
1% amphotericin B (all from PAA, Austria) and HAT (Sigma Aldrich). NG108-15 cells were cultured 
and conditioned at 5% CO2 moist atmosphere at 37°C and checked routinely under inverted 
microscope (Motic) for any contamination. Cells with confluency of 70-80% were selected for the 
neuroprotective experiment. Cells exposed to vehicle alone (10% FBS DMEM, DMSO ≤ 0.5% v/v) 
was used as the control group. 
 
2.4. Assessment of neuroprotective activity 
 
The neuroprotective effect of the isolated compounds against H2O2-induced apoptosis in 
NG108-15 cells was evaluated by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] assay [28]. Cells were plated at a total density of 5 × 103 cells/well in a 96-well plate. The 
cells were left to adhere for 48 h and treated with test compounds (2 h) prior to H2O2 (400 µM) 
exposure for 24 h. Aliquots of MTT solution (20 µL) was added into each well and incubated at 37°C 
for another 4 h. The absorbance was measured on a microplate reader (ASYS UVM340) at 570 nm 




2.5. ORAC assay 
Oxygen radical antioxidant capacity (ORAC) assay was done as described by Cao et al. with 
slight modification [29]. The assay was performed on a 96-well black microtitre plate, with 25 µL of 
the samples, standard (Trolox), blank (solvent/PBS) or positive control (quercetin) in each well. 
Subsequently, 150 µL of working fluorescein solution was added to each well of the assay plate. The 
plate was incubated at 37°C for 5 min. Aliquot of (25 µL) AAPH working solution was added to each 
well, making up a total volume of 200 µL. Fluorescence was recorded at an excitation wavelength of 
485 nm and emission wavelength of 538 nm. Data were collected every 2 min during an observation 
period of 2 h, and were analysed by calculating the differences of area under fluorescence decay curve 
% Cell viability = 
Absorbance of treated cells 
Absorbance of control cells 
× 100% 




(AUC) of samples, standard or positive control against blank. The antioxidant capacity was expressed 
as Trolox equivalent (TE)/100 µg sample. 
 
 
Figure 1. Structures of the isolated compounds from C. zedoaria rhizomes. 
3.  Results and Discussion 
 
As summarized in Table 1, all the ten compounds tested, protected the NG108-15 cells from 
H2O2 induced oxidative stress at various degrees. Exposure to H2O2 (400 μM) reduced the viability of 
NG108-15 cells to 67.6% after a period of 24 h. Pretreatment of the cells with curcumenol (3) showed 
the maximum protection (100%) of the cells at the concentration of 4 µM but the effect reduced to 
97.7% as the concentration increased to 30 µM. Dehydrocurdione (2) also showed strong activity 
(100% protection) at the concentration of 10 µM, and the activity reduced by either an increase of 
decrease in the concentration. Germacrone (1), zerumin A (4), isoprocurcumenol (5), procurcumenol 
(7), and zerumbone epoxide (8) showed moderate activity (80-90% viability) as compared to the 
control. 
In the ORAC assay, zerumbone epoxide (8) showed the highest antioxidant activity with a TE 
of 35.41 µM/100 µg of sample. Isoprocurcumenol (5), zederone (9), dehydrocurdione (2), germacrone 
(1) showed higher antioxidant capacity than quercetin, used as standard in this assay. While the 
antioxidant activity of zerumin A (4), gweicurculactone (10), curcumenone (6), procurcumenol (7) 
were close to that of quercetin, curcumenol (3) showed a lesser extent of activity (Table 2). 
 
Table 1. Neuroprotective evaluation of compounds against H2O2-induced cell death in NG108-15 
cells. 
Compound Cell viability (%) 
 1 µM 4 µM 8 µM 10 µM 15 µM 30 µM 
Control 100 
H2O2 67.63±0.86 
Germacrone (1) 79.29±1.05* 77.80±1.15* 81.25±1.72* 79.61±2.38* 89.99±2.01* 78.68±1.39* 
Dehydrocurdione (2) 82.90±1.77* 90.76±1.45* 98.05±2.33* 100.60±1.72* 99.98±2.60* 88.59±1.75* 
Curcumenol (3) 78.03±1.23* 103.04±2.17* 100.73±2.63* 100.60±1.72* 99.98±2.60* 97.79±2.41* 
Zerumin A (4) 77.89±1.95* 77.98±1.09* 82.69±1.12* 86.84±1.76* 91.14±1.42* 74.41±1.45 
Isoprocurcumenol (5) 76.72±0.88* 79.51±0.91* 76.42±1.61* 77.08±1.07* 80.96±0.91* 75.94±1.01* 
Curcumenone (6) 66.25±1.50 59.74±1.86 66.93±1.66 73.86±1.18 70.58±1.13 79.18±1.43* 
Procurcumenol (7) 77.75±0.95* 79.08±1.289* 77.00±1.25* 75.73±2.22* 80.00±0.71* 72.87±0.71 
Zerumbone epoxide 
(8) 
75.66±0.68* 71.29±1.24 78.15±0.98* 73.66±1.70 74.63±1.27 84.32±1.09* 
Zederone (9) 62.50±1.41 61.47±1.53 72.41±0.97 76.33±1.19* 70.79±2.88 74.51±0.85 
Gweicurculactone 
(10) 
59.84±2.19 64.24±1.32 59.44±0.78 67.54±0.89 75.45±1.04 75.21±1.47 
All experiments were done in triplicate and results expressed as mean ± S.E. 
*P<0.05 vs H2O2 treated cells, One way ANOVA followed by Dunnett’s test 
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Table 2. Antioxidant capacity of the compounds in ORAC assay. 
Compound TE* Compound TE* 
Germacrone (1) 24.86 ± 2.33 Procurcumenol (7) 20.46 ± 1.88 
Dehydrocurdione (2) 26.18 ± 2.59 Zerumbone epoxide (8) 35.41 ± 2.25 
Curcumenol (3) 12.62 ± 2.67 Zederone (9) 27.78 ± 2.53 
Zerumin A (4) 19.86 ± 3.92 Gweicurculactone (10) 18.26 ± 1.66 
Isoprocurcumenol (5) 26.43 ± 1.88 Quercetin 21.73 ± 2.87 
Curcumenone (6) 21.16 ± 2.12   
*TE: Troloxequivalent in µM per 100 µg of sample; Results expressed as mean±SE 
 
In normal physiologic condition, small amount of H2O2 is produced during aerobic metabolism 
in the cell and is neutralised by redox systems of our body. This does not pose significant threat at 
young age due to the presence of strong antioxidant defence system. However, in aged person, an 
increased production of ROS and functional decline of neutralising systems creates an imbalance, 
leading to detectable level of oxidative damages. As a result of cumulative deposition of the 
pathogenesis, the effects get more noticeable which includes lack of coordination, imbalance, 
cognitive dysfunction and reduced muscle tone [30]. 
 Use of external H2O2 to create oxidative stress in NG108-15 cell is a popular method of 
studying neuroprotective effect of natural products [31]. Due to the neuronal glial properties, NG108-
15, a mouse neuroblastoma-rat glioma hybridoma cell line is used extensively as a neuronal model in 
electrophysiological and pharmacological research [32]. An excess application of H2O2 to NG108-15 
cells mimic a similar condition as it takes place during the oxidative stress in the body. Superoxide 
dismutase (SD), an important enzyme of antioxidant system of the body converts superoxide into H2O2 
which is further scavenged by catalase or glutathione redox pathway [33]. When there is an increased 
level of H2O2, the neutralisation by catalase or tissue thiols fail, giving rise to various reactive oxygen 
species. Application of excess exogenous H2O2 creates oxidative stress that is beyond the manageable 
level of the endogenous antioxidant system [32]. Cell death may happen through two major 
mechanisms, necrosis and apoptosis. Apoptosis is the most noticeable programmed cell death 
mechanism and is associated with distinct morphological changes, such as membrane blebbing, cell 
shrinkage and DNA fragmentation. On the other hand, necrosis is the premature death of cells 
associated with the loss in cell membrane integrity followed by uncontrolled release of cell death 
products into the intracellular space [34]. 
In the present investigation, nine sesquiterpenes and one labdane diterpene isolated from the 
rhizomes of C. zedoaria were tested for their possible neuroprotective role in H2O2-induced oxidative 
stress in NG108-15 cells. Among these, the guaiane type sesquiterpene, curcumenol (3) showed 100% 
protection of the cells at 4 µM concentration. The compound showed very little change in its activity 
even at the concentration of 30 µM, indicating that the compound might not be toxic to the cell within 
a wide concentration range. Dehydrocurdione (2), a germacrane type sesquiterpene also showed 
maximum protection of the cells at the concentrations of 10 and 15 µM, which reduced by 10% at 30 
µM concentration. Curcumenol (3) and dehydrocurdione (2) are the two major phytoconstituents of C. 
zedoaria and their content in the rhizomes is more than that of any other part of the plant. However, 
seasonal variation can change the ratio of these two constituents in the plant [14]. Biogenetically, these 
two compounds are also closely related which is evident from a biomimetic transformation study 
where dehydrocurdione (2) was converted into curcumenol (3) in a highly selective manner [35]. 
In a previous study, curcumenol (3) protected hepatic cells from D-GalN-induced cytotoxicity 
and inhibited LPS (lipopolysaccharide)-induced nitric oxide (NO) production in mouse macrophage 
[16]. Although inducible NO synthase (iNOS) is not expressed in normal brain, presence of cytokines 
and LPS can result in its expression in microglia and astocytes. Neuroinflammations trigger 
immunoresponses resulting in the infiltration of T cells and macrophage at the inflammatory site. 
These cells release immunomodulatory molecules including NO which leads to a more widespread 
CNS-injury [36, 37]. A low level of NO is present in brain for cellular signalling, but a high level of 
NO can be observed in neurodegenerative disorders causing neuronal cell death by inhibiting 
mitochondrial cytochrome oxidase [38]. Thus, the inhibition of NO production by curcumenol (3) can 
also contribute towards the neuroprotective activity of this compound. 




In another study, curcumenol (3) was isolated as the major anti-inflammatory agent from 
Curcuma phaeocaulis using COX-2 inhibitory assay [39]. There is strong evidence that COX-2 level 
increases significantly in neurodegenerative disease conditions. In AD, a direct correlation has been 
found with the COX-2 level with that of amyloid plaque and neuronal atrophy [36]. While in PD, 
injection of LPS in brain resulted in the increased level of inflammatory factors including COX-2 and 
iNOS prior to the death of dopaminergic neurons [40]. Therefore, the neuroprotective effect of the 
curcumenol (3) may be partly due to its anti-inflammatory action stemming through the inhibition of 
COX-2 enzyme [41]. 
To correlate the antioxidant activity of the compounds under investigation toward their 
neuroprotective activity, ORAC assay was performed. ORAC assay is considered as a complementary 
antioxidant test for neuroprotective assay [30]. It is a reliable method of testing antioxidant activity of 
biological samples including natural products due to its sensitivity towards broader class of 
compounds [42]. Moreover, it is the only assay which involves the use of peroxyl radical and 
quantifies the antioxidant capacity via area under curve (AUC) technique [43]. The result obtained 
from this assay is from the direct quenching of free radicals, which is related to the antioxidant 
capacity of the molecule itself [43]. All the compounds (1-10) tested, showed strong to moderate 
antioxidant activity in the order of zerumbone epoxide (8)> zederone (9)> isoprocurcumenol (5)> 
dehydrocurdione (2)> germacrone (1)> curcumenone (6)> procurcumenol (7)> zerumin A (4)> 
gweicurculactone (10)>curcumenol (3). While zerumbone epoxide (8), a humulane type sesquiterpene, 
showed the highest antioxidant capacity (35.41 TE/100 µg sample), and the activity was stronger than 
that of quercetin (21.16 TE/100 µg sample); in the neuroprotective assay, this compound showed a 
maximum of 84.32% protection of the cells at the highest concentration tested (30 µM). Interestingly, 
curcumenol (3), which showed the strongest neuroprotective activity (100%) among all the 
compounds tested, exhibited a moderate antioxidant activity (12.62 TE/100 µg sample). This suggests 
that the neuroprotective activity of this compound is not the sole contributor from its antioxidant 
activity, rather a combined effect of its anti-inflammatory, antioxidant and NO-production inhibitory 
activity. In case of zerumbone epoxide (8), the effect might be chiefly due to its antioxidant property. 
Dehydrocurdione (2), the other compound with strong neuroprotective activity, showed an antioxidant 
capacity of 26.18 TE/100 µg sample, higher than the standard, quercetin. 
This is the first report of neuroprotective activity of the constituents from C. zedoaria 
rhizomes. Curcumenol (3) and dehydrocurdione (2), two major constituent of ‘Zedoary turmeric oil’ 
were the most active compounds providing protection of NG108-15 cells. These two compounds have 
been the attention of researchers for their various pharmacological actions [14]. Present investigation 
dictates further investigation of curcumenol (3), dehydrocurdione (2) and other active constituents of 
C. zedoaria rhizomes for in vitro and in vivo studies to explore their usefulness in the development of 
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Abstract: A series of 21 compounds isolated from Curcuma zedoaria was subjected to 
cytotoxicity test against MCF7; Ca Ski; PC3 and HT-29 cancer cell lines; and a normal 
HUVEC cell line. To rationalize the structure–activity relationships of the isolated 
compounds; a set of electronic; steric and hydrophobic descriptors were calculated using 
density functional theory (DFT) method. Statistical analyses were carried out using  
simple and multiple linear regressions (SLR; MLR); principal component analysis (PCA);  
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and hierarchical cluster analysis (HCA). SLR analyses showed that the cytotoxicity of  
the isolated compounds against a given cell line depend on certain descriptors; and the 
corresponding correlation coefficients (R2) vary from 0%–55%. MLR results revealed that 
the best models can be achieved with a limited number of specific descriptors applicable 
for compounds having a similar basic skeleton. Based on PCA; HCA and MLR analyses; 
active compounds were classified into subgroups; which was in agreement with the cell 
based cytotoxicity assay. 
Keywords: Curcuma zedoaria; diterpenes; sesquiterpenes; cytotoxicity; DFT; QSAR 
 
1. Introduction 
Curcuma zedoaria (Christm.) Rosc. (Zingiberaceae) is a medicinal herb largely found in tropical 
Asian countries, including Malaysia, Indonesia, India, Japan and Thailand [1]. Also known as temu putih 
in Malaysia and Indonesia, C. zedoaria is widely consumed as spice, a flavouring agent in native 
dishes and is frequently used in food preparations for women during post-partum confinement [2,3].  
It has long been used as a folk medicine in different Asian countries for the treatment of menstrual 
disorders, dyspepsia, vomiting, cancer, stomachic, blood stagnation, hepato-protection and for promoting 
menstruation [1,4,5]. The rhizomes of C. zedoaria is considered as a rich source of terpenoids [6]. 
Quantaum chemical methods can be successfully applied to express molecular interactions between 
substrate and receptor in terms of molecular electronic properties of the substrates. Various qualitative 
and quantitative analyses and relationship studies can be found in the literature that used quantum 
chemical and statistical methods to achieve correlations between calculated variables and biological 
activities of natural and synthetic substrates [7–13]. Ishihara et al. employed semi-empirical PM5 
method to delineate the relationship between the cytotoxic activity and 11 chemical descriptors of  
a series of tropolone compounds and were able to show that the observed cytotoxic activity correlated 
well with compounds of structural similarities and was governed mainly by dipole moment (µ), 
hydrophobicity (logP), hardness (η), electrophilicity (ω) and electronegativity (χ) [14]. In another 
study, Stanchev et al. showed that the cytotoxic activity of a series of 4-hydroxycoumarins was well 
correlated with logP, µ, volume (V) and molecular orbital energies (EHOMO and ELUMO) [15]. Yang et al. 
used a semi-empirical method AM1 to determine the molecular descriptors of a series of ganoderic 
acids with cytotoxicity against tumour cells; they showed that EHOMO, electronegativity, electronic 
energy, logP and molecular area (A) are the variables that best discriminate between highly and less 
active ganoderic acids [16]. 
The present study aimed at elucidating the structure–cytotoxic activity relationships of a series of  
21 compounds isolated from C. zedoaria (Figure 1) against four human cancer cells and a normal cell, 
namely as hormone-dependent breast carcinoma cells (MCF-7), cervical carcinoma cells (Ca Ski), 
human prostate cancer cells (PC-3), human colon adenocarcinoma cells (HT-29), and human umbilical 
vein endothelial cells (HUVEC). Density functional theory was adopted at the level of B3LYP/6-31+G 
(d, p) in order to calculate electronic and steric molecular descriptors of the isolated compounds, 
 
Int. J. Mol. Sci. 2015, 16 9452 
 
followed by the application of statistical methods (SLR, MLR, PCA and HCA) to determine the main 






































































































































































































































































































































































Figure 1. Structure of compounds isolated from C. zedoaria. 
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2. Results and Discussion 
2.1. Simple Linear Regression (SLR) Analysis 
The values of the electronic, steric and hydrophobic descriptors of compounds 1–21, as well as their 
cytotoxic activities (IC50 in µM) against MCF-7, Ca Ski, PC-3, HT-29 and HUVEC cells are presented 
in Table 1. As observed, the cytotoxic activity of compounds (1–21) varied with the cell type. Thus,  
a simple linear regression analyses was done to determine the effect of each of the descriptors 
separately on the cytotoxicity of the isolated compounds. Figure 2 displays simple linear regression 
curves obtained with each descriptor for the cytotoxicity of the test compounds against MCF-7 cells, 
while the statistical parameters (correlation coefficient (R2), adjusted correlation coefficient (R2 adj) 
and standard deviation (SD)) for SLR curves between each descriptor and each tested cell line is 
presented in Table 2. 
2.1.1. Cytotoxicity against MCF-7 Cells and SLR Analysis 
Based on the IC50 values (Table 2), the compounds were sorted into an inactive group (IC50 > 400 µM) 
and an active group (IC50 < 400 µM). To avoid the large discrepancies in the IC50 values, the active 
group was further subdivided into group A (200 < IC50 < 300 µM); group B (100 < IC50 < 200 µM) 
and group C (IC50 < 100 µM). The SLR analysis shows that the influence of a given descriptor on 
cytotoxic activity is dependent on the nature of the descriptor itself. For instance, the electronic 
descriptors IP, AE, χ, η, S, ω and μ have no significant influence (R2 ≈ 0%–7%), while modest 
correlations were observed for descriptors α, A, V, LogP and M (R2 ≈ 40%–55%) (Figure 2). These 
results are consistent with those obtained by Ishihara et al., who showed that cytotoxic activity of  
20 synthesized tropolones was poorly correlated with each of 11 chosen descriptors [14,17]. 
2.1.2. Cytotoxicity against Ca Ski Cells and SLR Analysis 
Following the same pattern as that of Section 2.1.1, the compounds were divided into inactive and 
active groups, while the active group was further subdivided into group A, group B, and group C based 
on their IC50 values against Ca Ski cells. Table 2 represents the SLR parameters between each 
descriptor and log(IC50). As it can be seen, the effects of electronic descriptors IP, AE, χ, η, S and ω 
are negligible (R2 ≤ 10%), while α, A, V and M descriptors showed a moderate effect (R2 ≈ 28%–43%). 
Surprisingly, hydrophobicity played no role on the cytotoxicity of the compounds (R2 ≈ 0) (Table 2). 
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Table 1. Cytotoxicity IC50 (µM) and molecular descriptors obtained at B3P86/6-311+G (d, p) level for the isolated compounds. 
NO. IP EA χ η ω α μ Α V Log P M 
IC50 (µM) a 
MCF-7 Ca Ski PC-3 HT-29 HUVEC 
1 6.87 2.15 4.51 4.71 2.16 324 6.13 400 470 3.45 302.46 53.9 ± 0.7 47.9 ± 0.3 87.0 ± 7.9 71.1 ± 10.2 149.8 ± 6.3 
2 6.86 2.09 4.48 4.77 2.10 328 5.62 408 481 3.86 318.46 70.0 ± 3.3 NA b 68.8 ± 5.0 54.6 ± 6.3 81.0 ± 6.0 
3 6.85 2.00 4.43 4.85 2.02 363 5.63 457 541 4.20 348.53 14.3 ± 0.6 NA b 119.6 ± 9.8 138.6 ± 14.6 135.7 ± 12.1 
4 6.56 1.69 4.12 4.87 1.74 244 2.99 323 368 3.63 234.34 140.8 ± 4.7 92.6 ± 4.7 81.5 ± 11.9 96.9 ± 10.2 102.4 ± 9.0 
5 6.52 1.26 3.89 5.26 1.44 238 1.40 331 377 4.01 236.35 NA b – – – – 
6 6.40 1.39 3.89 5.01 1.51 248 4.06 321 355 3.81 218.34 NA b 180.0 ± 5.5 252.8 ± 22.4 196.5 ± 18.8 337.5 ± 1.4 
7 5.96 0.29 3.12 5.67 0.86 238 1.88 304 341 1.84 216.32 271.9 ± 12.0 NA b 182.6 ± 20.8 218.2 ± 20.3 189.1 ± 12.0 
8 6.58 1.80 4.19 4.78 1.84 241 6.35 313 353 0.84 246.31 NA b NA b 109.6 ± 7.7 77.5 ± 10.1 170.9 ± 11.0 
9 6.54 1.39 3.96 5.14 1.53 241 5.59 318 364 2.71 234.34 218.8 ± 17.1 NA b 187.3 ± 30.7 169.0 ± 19.6 206.5 ± 20.1 
10 6.49 1.66 4.08 4.83 1.72 243 3.67 320 364 2.85 243.34 251.7 ± 23.9 NA b 218.6 ± 20.1 299.2 ± 34.1 228.1 ± 6.6 
11 6.07 1.46 3.76 4.61 1.54 240 4.37 320 356 2.60 232.32 137.7 ± 6.5 – – – – 
12 6.50 0.37 3.43 6.13 0.96 254 2.61 342 389 3.80 236.4 154.5 ± 17.8 NA b 158.2 ± 19.0 218.3 ± 16.5 190.8 ± 12.7 
13 6.54 1.77 4.16 4.78 1.81 252 7.48 327 362 2.71 234.34 127.2 ±9.4 266.3 ± 1.3 56.8 ± 7.3 66.1 ± 9.8 69.6 ± 4.3 
14 6.21 0.57 3.39 5.64 1.02 260 3.86 333 376 3.58 248.37 37.4 ± 37.4 74.5 ± 4.0 69.7 ± 4.8 99.9 ± 10.9 104.3 ± 5.6 
15 5.71 2.26 3.99 3.45 2.30 290 11.67 305 330 3.46 228.29 136.8 ± 14.1 NA b 167.8 ± 9.6 156.4 ± 25.4 314.1 ± 26.7 
16 6.47 1.55 4.01 4.92 1.63 245 3.76 350 371 2.23 232.32 243.2 ± 13.8 – – – – 
17 7.09 2.12 4.61 4.97 2.14 227 4.90 298 339 3.43 220.31 109.4 ± 0.5 156.6 ± 2.7 49.0 ± 8.6 62.2 ± 12.3 64.5 ± 5.0 
18 6.51 1.80 4.15 4.71 1.83 247 6.66 310 340 3.51 216.32 NA b 351.3 ± 5.5 NA b NA b NA b 
19 6.77 1.64 4.21 5.13 1.72 256 0.71 362 394 3.5 248.37 32.2 ± 4.0 NA b 160.2 ± 16.9 174.3 ± 25.0 201.3 ± 34.6 
20 6.94 1.48 4.21 5.47 1.62 243 6.39 330 365 2.98 234.34 212.4 ± 13.2 80.2 ± 10.2 90.9 ± 13.7 92.6 ± 29.9 – 
21 7.24 2.03 4.63 5.21 2.06 259 4.88 332 386 3.86 262.35 238.0 ± 13.8 236.7 ± 30.9 221.8 ± 13.3 172.7 ± 29.7 – 
a The cytotoxicity results as reported by [18]; b NA = Not active. 
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Figure 2. Simple linear regression correlation (SLR) curves between the cytotoxic activity 
on MCF-7 cells and each descriptor of isolated compounds from C. zedoaria. 
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Table 2. Correlation coefficients (R2), adjusted correlation coefficients (R2adj) and standard deviations (SD) of simple linear regression curves 
(SLR) between each descriptor and the tested cell lines. 
Descriptor/s/ 





PC-3  HT-29  HUVEC 
%R2 %R2adj SD 
 
%R2 %R2adj SD 
 
%R2 %R2adj SD  %R2 %R2adj SD  %R2 %R2adj SD 
IP 4 −4 0.40 
 
0 −14 0.31 
 
8 2 0.22  14 8 0.22  30 24 0.19 
EA 6 −2 0.39 
 
6 −8 0.30 
 
5 −2 0.23  19 14 0.21  3 −4 0.23 
χ 5 −2 0.39 
 
2 −11 0.31 
 
8 2 0.22  23 18 0.20  13 7 0.21 
η 3 −4 0.40 
 
11 −2 0.30 
 
0 −6 0.23  5 −2 0.23  2 −6 0.23 
S 4 −4 0.40 
 
10 −3 0.30 
 
0 −7 0.23  2 −5 0.23  5 −3 0.23 
ω 7 0 0.39 
 
4 −10 0.31 
 
5 −1 0.23  14 19 0.21  3 −4 0.23 
α 52 48 0.28 
 
28 18 0.27 
 
2 −5 0.23  5 −1 0.23  1 −7 0.23 
DM 0 −7 0.40 
 
9 −4 0.30 
 
4 −3 0.23  13 7 0.22  0 −8 0.23 
A 55 51 0.27 
 
42 33 0.24 
 
2 −4 0.23  4 −2 0.23  3 −4 0.23 
V 53 49 0.28 
 
43 34 0.24 
 
3 −4 0.23  5 −1 0.23  5 −2 0.22 
Log P 40 36 0.31 
 
0 −14 0.31 
 
−7 0 0.23  0 −6 0.23  1 −7 0.23 
M 49 45 0.29 
 
36 26 0.25 
 
4 −3 0.23  8 2 0.22  −1 6 0.22 
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2.1.3. Cytotoxicity against PC-3 Cells and SLR Analysis 
The compounds were classified into groups on the basis of their activity against PC-3 cells in the 
same fashion as discussed earlier. All chosen descriptors showed negligible effect on cytotoxic activity 
(R2 ≈ 0%–8%) (Table 2). 
2.1.4. Cytotoxicity against HT-29 Cells and SLR Analysis 
In case of cytotoxicity of the isolated compounds against HT-29 cells, moderate effects were 
obtained with the electronic descriptors namely IP, EA, χ, ω and μ with 14%, 19%, 23%, 14% and 
13% correlation coefficients, respectively. In contrast to the results obtained for MCF-7 and Ca Ski 
cells, the steric descriptors did not show significant effects (R2 ≤ 8%) (Table 2). 
2.1.5. Cytotoxicity against HUVEC Cells and SLR Analysis 
For HUVEC cells, all descriptors showed no significant effect on the cytotoxic activity (R2 ≤ 5%), 
except IP and χ, which showed moderate effects (30% and 13% correlation coefficients, respectively) 
(Table 2). 
2.2. Multiple Linear Regression (MLR) Analysis 
In an attempt to further investigate the correlations between the calculated descriptors and the 
cytotoxic activity of the isolated compounds against each cell line, MLR analysis was performed. 
MLR analysis was conducted only for the compounds of the active group. 
2.2.1. Cytotoxicity against MCF-7 Cells and MLR Analysis 
Among the 17 compounds for which the IC50 values were observed against MCF-7 cells, compound 
15 (gweicurculactone) was used as the model compound, and therefore excluded from MLR analysis. 
The MLR model as given in Equation (1) was obtained from the correlation observed between 
log(IC50) and the descriptors. The corresponding curve is presented in Figure 3a. 
log(IC50)Pred. = −(60.85 ± 73.65) + (2.91 ± 3.91)IP − (0.70 ± 2.22)EA + (1.10 ± 2.62)χ + 
(3.62 ± 3.60)η + (314.17 ± 359.28)S − (3.38 ± 9.43)ω − (0.01 ± 0.06)α − (0.05 ± 0.16)μ 
− (0.02 ± 0.03)A + (0.01 ± 0.04)V − (0.63 ± 0.38)LogP + (0.01 ± 0.03)M 
(1) 
The predicted log(IC50)Pred. and residuals to experimental log(IC50)Obs. for the active compounds are 
given in Table 3. The correlation between all descriptors and cytotoxicity is relatively weak, with  
a standard deviation of SD = 0.41 and R2 = 84%. The predicted log(IC50)Pred. for the model compound 
tested (compound 15) is relatively high (4.48) with a residual value of 2.34. While the predicted IC50 
value suggested compound 15 is categorised in the inactive group, the observed IC50 dictates it to be an 
active compound. Consequently, this model (Equation (1)) was considered not suitable for cytotoxicity 
prediction. To obtain a better model, the first 11 compounds (1–11) with similar skeletons were chosen 
for MLR analysis. For better consistency in the analysis, they were further subdivided into labdane 
diterpenes (compounds 1–3) and germacrane sesquiterpenes (compounds 4–11). Only the active 
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compounds were subjected to MLR as shown in Equation (2) while compound 11 was selected as a 
test model in this study. 
log(IC50)Pred. = (7.77 ± 4.74) − (0.18 ± 0.52)IP − (0.06 ± 0.05)A + (0.03 ± 0.04)V −  









Figure 3. Multiple linear regression (MLR) correlations between most important 
descriptors and the cytotoxic activity of the active compounds isolated from C. zedoaria. 
(a) MLR analysis for cytotoxicity against MCF-7; (b) Modified MLR analysis of 
compounds 1–11 for cytotoxicity against MCF-7; (c) MLR analysis for cytotoxicity against 
Ca Ski; (d) MLR analysis for cytotoxicity against PC-3; (e) MLR analysis for cytotoxicity 
against HUVEC. 
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The model of Equation (2) was found to be superior to the previous model (Equation (1))  
with a correlation coefficient of 99.37% and a SD of 0.09. For purpose of validation, this model  
(Equation (2)), was applied for compound 11. The predicted log(IC50)Pred. was found to be 2.10, with  
a difference of only 0.04 from the experimental value. The difference between the predicted and 
observed cytotoxicity is 13 µM. The MLR model of Equation (2) demonstrated the importance of IP, 
steric parameters (area and volume), hydrophobicity (logP) and molecular weight (M) on the cytotoxic 
activity of the test compounds. These results are in good agreement with previous studies where steric 
parameters and hydrophobicity were found to be the most important descriptors to classify compounds 
into high and low activities [14,16]. Thus, the MLR of Equation (2) subdivided the test compounds into 
high and low cytotoxicity (Figure 3b). 
2.2.2. Cytotoxicity against Ca Ski Cells and MLR Analysis 
Nine compounds showing cytotoxic activity against Ca Ski cells were selected for this study. 
Compound 4 (dehydrocurdione) was chosen as model compound and thus excluded from MLR 
analysis. The MLR model obtained between log(IC50) and six best descriptors is given in Equation (3) 
and the corresponding regression curve is shown in Figure 3c. 
log(IC50)Pred. = (122.80 ± 7.42) − (11.88 ± 0.73)η − (608.30 ± 38.85)S + 0.03α + 0.02A 
− 0.06V + 0.03M 
(3) 
The predicted log(IC50) and residuals with respect to experimental values of active isolated 
compounds are presented in Table 3. The model was found to correlate the descriptors to the observed 
log(IC50) with good accuracy (R2 99.94% and SD 0.02). For the model compound (4), the predicted 
log(IC50)pred. is 1.93, with a difference of 0.04 from the experimental value. The difference between the 
predicted and observed cytotoxicity is 8 µM. Equation (3) shows the function of steric parameters 
(area and volume), molecular weight (M), hardness, softness and the polarizability of the isolated 
compounds towards the cytotoxicity against Ca Ski cells. 
2.2.3. Cytotoxicity against PC-3 Cells and MLR Analysis 
Seventeen compounds showing cytotoxicity against PC-3 cells were included in MLR analysis 
while compound 4 (dehydrocurdione) was excluded as the model compound. The MLR model 
(Equation (4)) obtained between log(IC50) and all descriptors gives a correlation of 88% (SD 0.17). 
log(IC50)Pred. = −(42.62 ± 12.74) + (3.48 ± 0.94)IP + (217.76 ± 58.86)EA −  
(11.07 ± 2.96)χ − (0.20 ± 0.05)η + (2.98 ± 0.82)S − (0.23 ± 0.11)ω − (0.04 ± 0.01)α + 
(0.04 ± 0.02)µ + (0.02 ± 0.01)A − (0.01 ± 0.01)V + (0.98 ± 0.48)LogP + (2.49 ± 0.75)M 
(4) 
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Table 3. Predicted log(IC50)Pred. and residuals of the active compounds obtained using MLR Equations (1)–(6). 
NO. 
Equation (1) Equation (2) Equation (3) Equation (5) Equation (6) 
log(IC50)Pred. Resid. log(IC50)Pred. Resid. log(IC50)Pred. Resid. log(IC50)Pred. Resid. log(IC50)Pred. Resid. 
1 1.79 0.06 1.73 1.69 1.68 0.00 1.86 −0.08 2.02 2.18 
2 1.69 −0.17 1.86 1.82 – – 1.96 0.12 2.06 1.91 
3 1.26 0.11 1.15 1.20 – – 2.03 −0.05 2.13 2.13 
4 1.85 −0.30 2.15 2.13 – – 2.39 −0.02 – – 
5 – – – – – – 2.26 0.00 – – 
6 – – – – 2.26 0.00 2.06 0.02 2.48 2.53 
7 2.43 0.00 2.43 2.41 – – 2.28 0.00 2.28 2.28 
8 – – – – – – 2.34 0.00 2.27 2.23 
9 2.37 0.03 2.34 2.39 – – – – 2.30 2.32 
10 2.44 0.04 2.40 2.43 – – – – 2.38 2.36 
11 2.31 0.17 – – – – – – – – 
12 2.14 −0.05 – – – – – – – – 
13 – – – – 2.43 -0.01 – – – – 
14 1.62 0.05 – – 1.87 -0.01 – – – – 
15 – – – – – – – – – – 
16 2.13 −0.26 – – – – – – – – 
17 2.22 0.18 – – 2.19 0.00 – – – – 
18 – – – – 2.55 0.01 – – – – 
19 1.74 0.22 – – – – – – – – 
20 2.38 0.05 – – 1.90 0.01 – – – – 
21 2.25 −0.13 – – 2.37 0.00 – – – – 
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The predicted IC50 (>400 µM) of compound (4) suggested it is an inactive compound, which is 
contradictory to the observed IC50 (81.5 µM) against PC-3 cells. In an attempt to derive a better model, 
the number of descriptors was reduced and the analysis was confined to compounds (1–11) with  
a similar basic skeleton. Compound 4 was excluded from MLR analysis. The best correlation was 
obtained with the electronic descriptors of IP, EA, ω and µ (Equation (5) and Figure 3d). The predicted 
log(IC50) and residuals to experimental results are presented in Table 3. 
Log(IC50)Pred. = (2.52 ± 3.16) + (0.36 ± 0.61)IP + (2.09 ± 0.54)EA − (3.30 ± 0.92)ω − 
(0.08 ± 0.05)µ 
(5) 
The predicted log(IC50)Pred. for the test compound 4 is 1.91, with a difference of 0.48 from the 
experimental value. Although the difference between the predicted (244 µM) and experimental IC50 
value (82 µM) is relatively high (162 µM), MLR analysis categorised it in the active group which is 
consistent with the observed results against PC-3 cells. 
2.2.4. Cytotoxicity against HT-29 Cells and MLR Analysis  
Seventeen compounds showing cytotoxicity against HT-29 cells (Table 1) were chosen for this 
study while compound 4 (dehydrocurdione) was excluded from MLR analysis. The MLR model 
obtained between log(IC50) and all descriptors derived a correlation of 81% (SD 0.22). The predicted 
value for the test compound 4 (IC50 = 283 µM) suggested it as an active compound (experimental  
IC50 = 97 µM). In terms of activity, compound 4 falls in group A as per predicted IC50, which is quite 
different from its group (C) determined from the experimental IC50. In an attempt to obtain a better 
model, the number of descriptors was reduced and the analysis was performed for the first 11 
compounds (1–11) with similar basic skeleton and compound 4 was excluded from MLR analysis. 
However, in every case, the difference between experimental and predicted IC50 was more than 100 µM, 
and therefore not presented herein. 
2.2.5. Cytotoxicity against HUVEC Cells and MLR Analysis 
Fifteen compounds that showed activity against HUVEC cells were included in this study and 
compound 4 (dehydrocurdione) was excluded from MLR analysis. The correlation between log(IC50) 
and all descriptors gave an R2 of 96% (SD 0.16). The predicted IC50 for compound 4 from this model 
was 142 µM higher than the experimental IC50. The best correlation was obtained when three 
descriptors, namely IP, χ, S and V were taken into consideration (R2 77%, SD 0.13) (Equation (6)). 
Predicted IC50 of compound 4 classified it as an active compound with a difference of 48 µM from the 
experimental IC50 value. 
Log(IC50)Pred. = (72.92 ± 37.80) − (14.02 ± 7.48)IP + (13.07 ± 7.14)χ + (13.07 ± 7.14)S 
− (0.0004 ± 0.0016)V 
(6) 
2.3. Principal Component Analysis (PCA) 
Principal component analysis (PCA) allows the reduction of the number of variables used in  
a statistical analysis to create a new set of variables (PCs) expressed in a linear combination of the 
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original data set [19]. The first new variable (PC1) contains the largest variance; while the second 
contains the second largest variance, and so on. Before applying the PCA method, each variable was 
standardized for ease of comparison between each other on the same scale. PCA analysis was 
performed only on MCF-7 cells. After several attempts to obtain a good classification of the isolated 
compounds, the best result was achieved with five variables, namely IP, A, V, logP and M. The first 
three components of PCA (PC1 = 90.50%, PC2 = 7.12%, and PC3 = 2.27%) conceded 99.89% of the 
overall variance of the data set (Table 4), while the sole combination of PC1 and PC2 described 
97.62% of variance (Table 4). The loading vectors for PC1, PC2, and PC3 are given in Table 5 and the 
plot of the score vectors of the two principal components (PC1 × PC2) is shown in Figure 4. 
Table 4. Variances (eigenvalues) obtained for the first three principal components. 
Component Eigenvalue Variance (%) Cumulated Variance (%) 
PC1 4.525 90.50 90.50 
PC2 0.3560 7.12 97.62 
PC3 0.1134 2.27 99.89 
Table 5. Loading vectors for the first three principal components. 
Variable PC1 PC2 PC3 
IP 0.43 0.61 0.66 
A 0.46 −0.38 −0.04 
V 0.46 −0.34 0.04 
logP 0.43 0.51 −0.74 
M 0.46 −0.32 0.08 
 
 
Figure 4. Plot of the score vectors of first principal components for cytotoxicity of 
compounds from C. zedoaria against MCF-7 cells. 
As can be seen in Figure 4, the compounds under investigation are divided into two groups based on 
PCA analysis: compounds with high activity (1–3) and low activity (4–10). The principal component 
PC1 presented in Table 5 can be expressed through the following equation: 
PC1 = 0.34IP + 0.46EA + 0.46V + 0.43logP + 0.46M (7) 
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Thus, a compound can be considered active if its IP, A, V, log P, and M values are similar to  
those described in the above Equation (7). When compared with published literature, the results of  
our present investigation followed the same trend with some agreement and disagreement in the 
involvement of descriptors for the activity of a series of compounds. For example, Yang et al. showed 
that cytotoxic ganoderic acids can be attained when higher values for the variables EHOMO, V, Eel, and 
logP are coupled with a smaller value for M [16]. Sauza et al. found that for a given flavone to be 
active against HIV, it must have smaller values for log P and V while EA must have a larger value [7]. 
In the present study, the results obtained from MLR or PCA are in coordination to show that the 
cytotoxicity of the compounds under investigation is dependent on the same descriptors (IP, A, V, logP 
and M) and afforded the same classification of the compounds (Figures 3b and 4). 
2.4. Hierarchical Cluster Analysis (HCA) 
In case of preliminary data analysis, HCA is a powerful tool for examining data sets for expected or 
unexpected clusters, including the presence of outliers. It examines the distances between the samples 
in a data set and represents them in a dendrogram which provides similar information as that of PCA 
results [20]. In HCA, each point forms only one cluster, and then the similarity matrix is analysed. The 
most similar points are assembled forming one cluster and the process is repeated until all the points 
belong to only one group [20]. The results obtained from MCF-7 cells are presented in the dendrogram 
(Figure 5). Vertical lines in the dendrogram represent the compounds while the horizontal lines 
represent the distances between compounds within the same group or from compounds of other 
groups. According to the distances, the compounds are subdivided into highly and weakly active 
groups and this classification is similar to those obtained from PCA and MLR analysis. 
  
Figure 5. Dendrogram obtained from HCA of cytotoxicity of compounds from C. zedoaria. 
3. Experimental Section 
3.1. Extraction and Isolation of Compounds from C. zedoaria 
Characterization of the isolated compounds (Figure 1) from C. zedoaria was performed by 
extensive spectroscopic studies including 1D, 2D NMR spectroscopy, GC, GC-MS analysis, and 
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compared with those reported in literature [21–24]. 1H and 13C NMR spectra of the isolated 
compounds (Figure 1) can be found in the supplementary data file. These compounds can be classified 
as labdane type diterpenes (1–3), germacrane type sesquiterpenes (4–11), guaiane type sesquiterpenes 
(12–15), elemane type sesquiterpenes (16), humulane type sesquiterpenes (17), cadinane type 
sesquiterpenes (18), carabrane type sesquiterpenes (19), spirolactone type sesquiterpenes (20), and  
a seco-guaiane type sesquiterpene (21). 
3.2. Theoretical Calculations 
Energy minimization and 3D structure optimization of the compounds were done by popular  
Becke three parameter Lee-Yang-Parr (B3LYP) exchange-correlation hybrid functional combined with  
a double-ζ Pople-type basis set 6-31+G (d,p), in which polarized and diffuse functions are taken into 
consideration [25]. B3LYP hybrid functional includes a mixture of Hartree-Fock exchange (20% of HF) 
with DFT exchange-correlation functional. The frequency analyses were carried out at the same level 
of theory. The absence of imaginary frequencies confirmed that the structures are true minima on  
the potential energy surface. The choice of the hybrid functional B3LYP is based on previous QSAR 
studies [26,27]. Recently, we successfully applied the hybrid functional B3P86 to calculate the 
electronic and structural descriptors for a series of phenolic Schiff bases [28]. 
The chemical descriptors selected to correlate with cytotoxic activity are: (i) electronic descriptors: 
frontier molecular orbital energies (EHOMO, ELUMO, which are well accepted as molecular descriptors  
in medicinal chemistry, since they are linked to the capacity of a molecule to form charge transfer complex 
with its biological receptor), ionization potential (IP), electronic affinity (EA), electronegativity (χ), 
hardness (η), softness (S), electrophilicity index (ω), dipole moment (μ), molecular polarizability (α); 
(ii) steric descriptors: surface area of a molecule (A), volume (V) and its molecular weight (M);  
and (iii) hydrophobicity descriptor: logP, where P stands for the octanol-water partition coefficient. 
The calculations of logP were carried out using Hyperchem Molecular package [29] by means of  
the atomic parameters derived by Ghose, Pritchett and Crippen and later extended by Ghose and  
co-workers [30,31]. The other descriptors were calculated using the DFT method and obtained in two 
different ways: (i) Orbital consideration, which is based on Koopman’s theorem where IP = −EHOMO 
and EA = −ELUMO [32]; and (ii) energy consideration, which is based on the use of the classical finite 
difference approximation, where the change of one electron is usually involved ΔN = ±1 [33]. In this 
method, IP = E+1 − E0 and EA = E0 − E−1 where E0, E−1 and E+1 are the electronic energies of neutral 
molecule, when adding and removing an electron to the neutral molecule, respectively. In addition to 
methods (i) and (ii), the electronic descriptors (e.g., hardness) can be calculated using internally 
resolved hardness tensor (IRHT) approach [34–36], which deals with the fractional occupation 
numbers based on Janak’s extension of DFT [37]. This approach is also based on orbital energies and 
takes into account the fractional occupation numbers based on Janak’s extension of DFT [37].  
De Luca et al. used the above approaches to investigate the solvent effects on the hardness values of  
a series of neutral and charged molecules, and found that these three methods can give similar results 
in the presence of solvent [38]. 
The solvent effects were taken into account implicitly by using the polarizable continuum model 
(PCM) as implemented in the Gaussian 09 package [39]. In PCM, the solute is embedded into a cavity 
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surrounded by solvent described by its dielectric constant ε (e.g., for methanol ε = 32.6) [40]. The use 
of an explicit solvent has been investigated notably by Guerra et al., who obtained a better description 
of the electronic properties using PCM compared to the explicit solvent [41]. A hybrid model was 
tested by Trouillas et al. [42]. The authors showed that only slight differences can be observed as 
compared to PCM. All theoretical calculations including ground state geometry optimization and 
frequency analysis calculations were performed with Gaussian 09 package [39]. 
Simple and multiple linear regression (SLR and MLR, respectively) analyses were used to 
determine regression equations, correlation coefficients R2, adjusted R2 and standard deviations (SD). 
PCA and HCA were employed to reduce dimensionality and investigate the subset of descriptors  
that could be more effective for classifying the isolated compounds according to their degree of 
cytotoxicity against tumour cells. 
The regression models and statistical analyses of obtained results were carried out by using DataLab 
package [43]. 
4. Conclusions 
In the present study, a set of electronic, steric and hydrophobicity descriptors were analysed using 
DFT quantum chemical calculations for a series of 21 compounds from C. zedoaria to determine the 
effect of the descriptors towards their cytotoxic activity against four different types of cancer cells 
(MCF-7, Ca Ski, PC-3 and HT-29), as well as a normal cell line (HUVEC). The statistical analyses 
showed that the influence of individual descriptor on the cytotoxicity of these compounds is not 
significant with an R2 less than 50% and a standard deviation higher than 0.20. The results also showed 
that the cytotoxicity of the compounds towards a given cell line rather depends on a set of certain 
descriptors. MLR, PCA and HCA allowed us to define the cytotoxicity of the compounds as high, 
moderate, and low based on their cytotoxicity. 
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Abstract: Curcumenol and curcumenone are two major constituents of the plants of 
medicinally important genus of Curcuma, and often govern the pharmacological effect  
of these plant extracts. These two compounds, isolated from C. zedoaria rhizomes were 
studied for their binding to human serum albumin (HSA) using the fluorescence quench 
titration method. Molecular docking was also performed to get a more detailed insight into 
their interaction with HSA at the binding site. Additions of these sesquiterpenes to HSA 
produced significant fluorescence quenching and blue shifts in the emission spectra of 
HSA. Analysis of the fluorescence data pointed toward moderate binding affinity between 
the ligands and HSA, with curcumenone showing a relatively higher binding constant  
(2.46 × 105 M−1) in comparison to curcumenol (1.97 × 104 M−1). Cluster analyses revealed 
that site I is the preferred binding site for both molecules with a minimum binding energy 
of −6.77 kcal·mol−1. However, binding of these two molecules to site II cannot be ruled out 
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as the binding energies were found to be −5.72 and −5.74 kcal·mol−1 for curcumenol  
and curcumenone, respectively. The interactions of both ligands with HSA involved 
hydrophobic interactions as well as hydrogen bonding. 
Keywords: Curcuma zedoaria; sesquiterpene; human serum albumin; protein-ligand 
interaction; molecular docking; fluorescence spectroscopy 
 
1. Introduction 
Curcuma zedoaria (Christm.) Rosc. (Zingiberaceae), also known as “white turmeric” is a perennial 
herb, largely found in tropical countries including Malaysia, Indonesia, India and Thailand [1].  
In Malaysia, it is known as “temu putih” and is widely consumed as spice, flavoring agent for native 
dishes and an additive in food preparations for women in confinement after child birth [2,3].  
It is extensively used in folk medicine for the treatment of menstrual disorders, dyspepsia, vomiting, 
and blood stagnation [1,4,5]. The plant is also used in the practice of traditional Chinese medicine for 
the treatment of cervical cancer [6]. 
The rhizomes of C. zedoaria are considered as a rich source of bioactive sesquiterpenes [7]. 
Curcumenol (A) and curcumenone (B) (Figure 1) are two of the most important sesquiterpenes 
possessing a number of beneficial biological activities. Curcumenol, a guaiane type sesquiterpene is 
known to exhibit analgesic [8], cytotoxic [9,10], hepatoprotective [11] and antimicrobial [12] properties, 
while curcumenone, a caraborane type sesquiterpene has been reported to be a vasorelaxant [13], 
hepatoprotective [11] and an effective inhibitor of intoxication [14]. 
 
Figure 1. Chemical structures of curcumenol (A) and curcumenone (B). 
Human serum albumin (HSA) serves as the primary transport protein in the human circulation 
capable of binding reversibly both endogenous and exogenous ligands such as fatty acids, hormones 
and drugs. It consists of 585 amino acids in a single polypeptide chain [15]. Crystallographic data has 
shown the presence of three homologous domains (I, II, and III), each comprised of subdomains A and 
B. The two high affinity ligand binding sites on HSA, known as Sudlow’s site I and II, are located  
in subdomains IIA and IIIA, respectively [16]. 
The interaction of a compound with serum albumin is known to influence its bioavailability, 
distribution, metabolism and elimination from the body. In particular, the affinity between a protein 
Int. J. Mol. Sci. 2015, 16 5182 
 
 
and a ligand affects the concentrations of the free and bound forms of the ligand as well as the duration 
of its half-life, which consequently determine its efficacy [15]. Therefore, investigations on the 
interaction of serum albumin with bioactive ligands may provide valuable information concerning their 
therapeutic efficacies [17]. 
Being the major and active constituents of C. zedoaria, curcumenol and curcumenone play 
important roles in exerting pharmacological activities after consumption of the herb. As the key 
components of a widely used natural product, curcumenol and curcumenone require the determination 
of pharmacokinetic parameters to establish their safety and efficacy. Furthermore, binding studies to 
HSA provide valuable parameters toward the establishment of the pharmacokinetic profile of such 
agents. In light of the above, the present report describes the binding properties of curcumenol and 
curcumenone to HSA based on fluorescence spectroscopic and molecular docking results. 
2. Results and Discussion 
2.1. Quenching Mechanism 
Interactions between small ligands and macromolecules such as proteins have been widely 
investigated using fluorescence spectroscopy. Quenching of the protein fluorescence as well as shift  
in the emission maximum in the presence of a ligand can indicate a number of phenomena including 
complex formation, random collisions, energy transfer and excited state reactions [18–20]. Figure 2 
shows intrinsic fluorescence spectra of HSA in the wavelength range, 300–400 nm upon excitation  
at 280 nm, obtained in the absence and the presence of increasing curcumenol and curcumenone 
concentrations. Addition of increasing concentrations of these ligands to HSA produced progressive 
decrease in the fluorescence intensity and significant blue shift in the emission maximum, suggesting 
interactions between these compounds and HSA. About 40% decrease in the fluorescence intensity  
at 338 and 2 nm blue shift were observed at the highest curcumenol concentration (60 μM), used  
in this study. On the other hand, curcumenone produced ~50% quenching in HSA fluorescence 
intensity, which was accompanied by a 6 nm blue shift in the emission maximum at the same ligand 
concentration. The shift in the emission maximum of HSA towards shorter wavelength suggested 
increased hydrophobicity in the microenvironment of the protein fluorophores upon interaction with 
these compounds [21]. It seems probable that ligand binding triggered the movement of hydrophobic 
residues in the vicinity of the fluorophores (Tyr and Trp), particularly around lone Trp-214, which  
is located in the vicinity of Sudlow’s site I [15]. It is important to note that Trp fluorescence makes 
major contribution in the protein fluorescence due to the presence of the emission maximum around 
338 nm [21]. This has been supported by our docking results in which about half of the residues lining 
the binding pocket are purely hydrophobic in nature. Furthermore, other lining residues such as Lys  
(4 CH2 groups), Arg (3 CH2 groups), Tyr (benzene ring), Gln (2 CH2 groups) also contribute towards 
hydrophobicity of the binding pocket. Presence of hydrophobic milieu in the binding pocket makes 
favorable contribution in the ligand binding phenomenon as hydrogen bonds formed in the nonpolar 
environment seem to be much stronger.  




Figure 2. Emission spectra of human serum albumin (HSA) in the absence and the 
presence of increasing curcumenol (A) and curcumenone (B) concentrations, obtained  
in 20 mM sodium phosphate buffer, pH 7.4 upon excitation at 280 nm. [HSA] = 3 μM, 
[Ligand] = (1–13): 0, 3, 6, 9, 12, 15, 18, 24, 30, 37.5, 45, 52.5 and 60 μM. T = 25 °C. 
Although quenching of protein fluorescence can be regarded as an indication of binding between  
a compound and the protein, it is equally probable that the quenching phenomenon was due to 
collisions between the quencher molecule and the protein [21]. These two mechanisms of fluorescence 
quenching are known as static and collisional quenching, respectively, and can be differentiated by the 
bimolecular quenching constant, kq value, associated with the quenching process [21]. As a general 
rule, the kq value for a diffusion-controlled phenomenon typically falls in the region of 1010 M−1·s−1, 
while higher kq value indicates a binding reaction [21]. Figure 3 displays Stern-Volmer plots of the 
ligand–HSA systems, obtained after analyzing the quenching data using Equation (1). The resulting 
KSV and kq values for the interaction of both curcumenol and curcumenone with has are listed in  
Table 1. As can be seen, the kq values obtained were two orders of magnitude higher than the value 
expected for a process following the collisional quenching mechanism. This suggested that the 
quenching of HSA by curcumenol and curcumenone was governed by the static quenching mechanism, 
which involved the formation of a ground state complex between the ligands and HSA. 
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Table 1. Quenching and binding parameters for curcumenol-/curcumenone-HSA interactions, 
as obtained in 20 mM sodium phosphate buffer, pH 7.4 at 25 °C. 
Parameter Curcumenol Curcumenone 
KSV, M−1 1.07 × 104 1.85 × 104 
kq, M−1·s−1 1.67 × 1012 2.90 × 1012 
Kb, M−1 1.97 × 104 2.46 × 105 
n 1.07 1.26 
2.2. Binding Parameters 
The binding constant (Kb) for the ligand–HSA interaction and the number of binding sites (n) on the 
protein for these ligands were determined from the double logarithmic plots of log (F0 − F)/F versus 
log [Q] (Figure 4). The values of n and Kb were obtained from the slope and the y-intercept of  
these plots, respectively, and are listed in Table 1. The values of Kb, obtained for the interaction of 
curcumenol and curcumenone with HSA revealed intermediate affinity between these ligands and the 
protein. This was comparable to other ligand binding studies involving HSA [11,20,22,23]. It is worth 
noting that higher extent of quenching of HSA fluorescence by curcumenone was also reflected by  
its higher Kb (2.46 × 105 M−1) value in comparison to that obtained for the curcumenol–HSA system 
(1.97 × 104 M−1). Interestingly, the value of n for the interaction of curcumenone with HSA was 
noticeably higher (1.26) compared to that (1.07) of curcumenol. There seems to be a higher likelihood 
of curcumenone to bind to other site(s) on the protein molecule in addition to its primary binding site. 
However, a slight difference in the value of “n” cannot be taken to clearly differentiate cooperative 
phenomenon with respect to curcumenone binding as double log Stern-Volmer equation suffers from 
several pitfalls. 
 
Figure 4. Double logarithmic plots for the interaction of HSA with curcumenol  
and curcumenone. 
2.3. Molecular Docking 
In order to predict the binding modes of curcumenol and curcumenone to the two main ligand 
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and HSA were carried out. For each binding site, 100 docking simulations and clustering analysis  
at a root-mean-square deviation tolerance of 2.0 Å were performed. The docking analysis of  
1BM0-curcumenol complex at the binding site I revealed a total of eight (8) multimember 
conformation clusters (Figure 5A) with the mean binding energy of −6.40 kcal·mol−1. The highest 
populated cluster had 29 out of 100 conformations. However, the configuration with the lowest 
binding energy (−6.77 kcal·mol−1) was not a member of the highest populated cluster. At the binding 
site II (Figure 5B), six (6) multimember conformation clusters, possessing mean binding energy of 
−5.53 kcal·mol−1 were identified, with the highest populated cluster having 72 members out of  
100 conformations. Although the lowest binding energy configuration (−5.72 kcal·mol−1) was  
a member of the highest populated cluster, its binding energy was higher compared to the lowest 
binding energy configuration at site I (−6.77 kcal·mol−1). Thus, we predict that site I of HSA would be 
the preferable binding site of curcumenol to HSA (1BM0). 
 
Figure 5. Cluster analyses of the AutoDock docking runs of curcumenol in the drug 
binding site I (A) and site II (B) of HSA (1BM0). 
Clustering analysis of the 1BM0-curcumenone complex (Figure 6) revealed similar clustering 
pattern for both binding sites, as observed with the 1BM0-curcumenol system. The lowest binding 
energy conformation for site I of 1BM0-curcumenone was −6.77 kcal·mol−1, while that for site II was 
−5.74 kcal·mol−1. These observations also suggested the preference of site I for curcumenone binding 
to HSA. 




Figure 6. Cluster analyses of the AutoDock docking runs of curcumenone in the drug 
binding site I (A) and site II (B) of HSA (1BM0). 
The predicted binding models of curcumenol and curcumenone with the lowest docking energy 
(−6.77 kcal·mol−1) at site I of HSA were used for binding orientation analysis (Figure 7). Since the 
cluster analysis also supported the binding of curcumenol and curcumenone at site II of HSA, the lowest 
docking energy complex for curcumenol (−5.72 kcal·mol−1) and curcumenone (−5.74 kcal·mol−1) at site 
II of HSA were also analyzed (Figure 8). The ligand binding sites were defined as amino acid residues 
within 5 Å distance of the ligand. In the 1BM0-curcumenol complex at site I, the binding site was 
found to be located deep within the protein structure in a hydrophobic cleft walled by 18 amino acids: 
Tyr-150, Lys-195, Gln-196, Lys-199, Leu-219, Arg-222, Asp-237, Leu-238, Val-241, His-242,  
Arg-257, Leu-260, Ala-261, Lys-286, Ser-287, His-288, Ile-290 and Ala-291. However, in the  
1BM0-curcumenone complex at the same site, the binding site was surrounded by 16 amino acids: 
Tyr-150, Lys-195, Gln-196, Lys-199, Leu-219, Arg-222, Phe-223, Leu-234, Leu-238, His-242, 
Arg-257, Leu-260 Ile-264, Ser-287, Ile-290 and Ala-291. The 1BM0-curcumenol complex formation 
at site II involved 14 amino acid residues, namely Leu-394, Leu-398, Lys-402, Phe-403, Asn-405,  
Ala-406, Val-409, Arg-410, Lys-413, Thr-540, Lys-541, Glu-542, Leu-544 and Lys-545. On the other 
hand, 1BM0-curcumenone complex at site II was associated with 13 amino acid residues: Leu-398, 
Lys-402, Phe-403, Asn-405, Ala-406, Leu-407, Val-409, Arg-410, Lys-413, Thr-540, Lys-541,  
Glu-542, and Lys-545. 





Figure 7. Predicted orientations of the lowest docking energy conformations of  
1BM0-ligand complexes. The binding sites were enlarged to show hydrogen bonding 
(green lines) between amino acid residues and the ligands. Amino acid residues that form 
hydrogen bonds with the ligands are rendered in ball and stick and colored yellow.  
(A) Curcumenol in the binding site I of HSA (1BM0); (B) Curcumenone in the binding site 
I of HSA (1BM0). 
 
Figure 8. Predicted orientations of the lowest docking energy conformations of  
1BM0-ligand complexes. The binding sites were enlarged to show hydrogen bonding 
(green lines) between amino acid residues and the ligands. Amino acid residues that form 
hydrogen bonds with the ligands are rendered in ball and stick and colored yellow.  
(A) Curcumenol in the binding site II of HSA (1BM0); (B) Curcumenone in the binding 
site II of HSA (1BM0). 
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Presence of hydrophobic amino acid residues at the binding sites of HSA might have contributed 
towards the stability of the ligand-HSA complex through hydrophobic interactions. However, the 
presence of several polar amino acid residues within the proximity of the bound ligands indicated that 
the interactions between these ligands and HSA at both site I and site II cannot be presumed to be 
exclusively hydrophobic. Furthermore, in the 1BM0-curcumenol complex docking conformation,  
one hydrogen bond was predicted involving the hydrogen atom of Arg-257 and the ethereal oxygen 
atom of curcumenol (Table 2). For the 1BM0-curcumenone complex docking conformation,  
4 hydrogen bonds were predicted involving hydrogen atoms from three different amino acid residues 
of HSA (Tyr-150, Arg-222 and Arg-257) and the oxygen atoms of the acetyl and ketone groups of 
curcumenone. In contrast, there was only one hydrogen bond in the 1BM0-curcumenone complex at 
site II, formed by the oxygen atom of curcumenone and the hydrogen atom of Lys-413 (Table 2). Both 
ligands showed one hydrogen bonding at the binding site. For 1BM0-curcumenol complex at site II, 
the hydrogen bond formed between the hydrogen atom of Lys-545 and the oxygen atom of hydroxyl 
group while for 1BM0-curcumenone complex, the hydrogen bond was associated with the hydrogen 
atom of Lys-413 and oxygen of the ketone group (Table 2). 
Table 2. Predicted hydrogen bonds between interacting atoms of the amino acid residues 
of HSA (1BM0) and the ligands at site I and site II. 
Compound HSA Binding Site Protein Atom Ligand Atom Distance (Å) 
Curcumenol 
Site I Arg257:HH22 O (ethereal) 1.907 
Site II Lys545:HZ3 O (hydroxyl) 1.684 
Curcumenone 
Site I 
Tyr150:HH O (ketone) 1.907 
Arg222:HH11 O (acetyl) 1.930 
Arg257:HE O (ketone) 1.969 
Arg257:HH22 O (ketone) 2.236 
Site II Lys413:HZ3 O (ketone) 2.025 
These results suggested that although curcumenol and curcumenone can bind to both sites I and II 
of HSA, the binding is more preferable at site I. Although, the lowest binding energies for both ligands 
at site I were the same (−6.77 kcal·mol−1) in molecular docking study, the 1BM0-curcumenone 
complex involved a greater number of hydrogen bonding (four) than that of 1BM0-curcumenol 
complex (one). This is reflected in the fluorescence quenching assay where curcumenone showed a 
higher extent of fluorescence quenching compared to curcumenol. Thus, it can be inferred that both 
curcumenol and curcumenone showed similar HSA binding properties, with curcumenone having a 
slightly higher affinity towards HSA. 
3. Experimental Section  
3.1. Materials 
Human serum albumin (HSA), essentially fatty acid free was obtained from Sigma-Aldrich Inc. (St. 
Louis, MO, USA). All other chemicals were of analytical grade purity. 
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3.2. Isolation and Purification of Curcumenol and Curcumenone 
The rhizomes of C. zedoaria (1.0 kg) were finely powdered and macerated with n-hexane for three 
days at room temperature, followed by successive extractions with dichloromethane and ethyl acetate, 
and finally with Soxhlet extraction using methanol. The n-hexane extract yielded 24.2 g (2.4%), out  
of which 20.0 g were subjected to silica gel column chromatography. The elution was performed 
initially using n-hexane followed by n-hexane/ethyl acetate gradient. Fractions were then combined 
according to similarity of the TLC spots to give 21 fractions. Fraction 8 was further purified using 
preparative thin layer chromatography to give curcumenol (15.5 mg), whereas curcumenone (16.4 mg) 
was purified from fractions 12 and 13. The structures were established through extensive spectroscopic 
studies and were found consistent with previous reports [24,25]. 
3.3. Preparation of Protein and Ligand Solutions 
The stock solution of HSA was prepared in 20 mM sodium phosphate buffer, pH 7.4 and its 
concentration was determined spectrophotometrically using a specific extinction coefficient value  
of 5.3 at 280 nm [26]. Stock solutions of curcumenol and curcumenone were prepared by dissolving 
desired quantities of their crystals in ethanol and diluting to the desired concentrations with 20 mM 
sodium phosphate buffer, pH 7.4. 
3.4. Ligand Binding Studies 
The interactions of curcumenol and curcumenone with HSA were studied using fluorescence 
quench titration method [23,27]. The concentration of HSA was maintained at 3 μM, while the ligand 
concentrations ranged from 0–60 μM. The final volume of the reaction mixture was made up to 3 mL 
with 20 mM sodium phosphate buffer, pH 7.4. The samples were allowed to equilibrate for 30 min 
prior to fluorescence measurements. The fluorescence spectra of these samples were recorded at 25 °C 
on a Jasco FP-6500 spectrofluorometer with a 1 cm path length quartz cuvette. Both excitation and 
emission slits were set at 10 nm, while the scan speed was maintained at 500 nm·min−1. The samples 
were excited at 280 nm, and the emission spectra were recorded in the wavelength range, 300–400 nm. 
3.5. Analysis of the Binding Data 
In order to reveal the quenching mechanism of HSA fluorescence, the binding data were analyzed 
according to the Stern-Volmer equation [21]: 
ܨ଴ ܨ⁄ = ܭௌ௏ሾܳሿ + 1 = ݇௤߬଴ሾܳሿ + 1 (1)
where F0 and F are the fluorescence intensities of HSA in the absence and the presence of the 
quencher, respectively, KSV is the Stern-Volmer constant, [Q] is the quencher concentration, kq is the 
bimolecular quenching constant and τ0 is the fluorescence lifetime of free HSA. A value of 6.38 × 10−9 s 
was used for τ0 [28].  
The binding constant, Kb and the number of binding sites, n for ligand–HSA interactions were 
determined by treating the fluorescence data according to the following equation (Equation (2)) [18]: 
log ሺܨ଴ − ܨሻ ܨ⁄ = ݊ logሾܳሿ + logܭ௕ (2)
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3.6. Molecular Modelling 
The structures of curcumenol and curcumenone were drawn using ACD/ChemSketch Freeware 
(Advanced Chemistry Development Inc., Toronto, ON, Canada), 3-D optimized and exported as a mol 
file. The geometry optimization of these structures was refined with the VegaZZ 2.08 [29] batch 
processing MOPAC script (mopac.r; keywords: MMOK, PRECISE, GEO-OK) using AM1 
semiempirical theory [30] and converted and stored as a mol2 file. Molecular docking, visualization 
and rendering simulation were performed using AutoDock 4.2 [31] and AutoDockTools 1.5.4 [32] at 
the Academic Grid Malaysia Infrastructure. For the docking study, the curcumenol and curcumenone 
non-polar hydrogens were merged and the rotatable bonds were defined. The crystal structure of HSA 
(PDB code 1BM0, res. 2.5 Å) was downloaded from the Protein Data Bank (PDB) [33]. Its water 
molecules were removed and the atomic coordinates of chain A were stored in a separate file and used 
as input for AutoDockTools, where polar hydrogens, Kollman charges and solvation parameters were 
added. The two binding sites (site I and site II) were defined using two grids of 70 × 70 × 70 points 
each with a grid space of 0.375 Å centered at coordinates x = 35.26 y = 32.41 z = 36.46 for site I and  
x = 14.42 y = 23.55 z = 23.31 for site II. Lamarckian genetic algorithm with local search (GA-LS) was 
used as the search engine, with a total of 100 runs for each binding site. In each run, a population of 
150 individuals with 27,000 generations and 250,000 energy evaluations were employed. Operator 
weights for crossover, mutation and elitism were set to 0.8, 0.02 and 1, respectively. For local search 
default parameters were used. Cluster analysis was performed on docked results using RMS tolerance 
of 2.0 Å. The protein-ligand complexes were visualized and analyzed using AutoDockTools (The 
Scripps Research Institute, La Jolla, CA, USA). 
4. Conclusions 
Curcumenol and curcumenone are well known as plant-derived natural products finding their use in 
therapeutic applications in recent years. The present investigation provides an insight into the HSA 
binding properties of these pharmacologically important molecules. Curcumenol and curcumenone 
showed similar binding characteristics, with the latter having a stronger affinity to HSA. Both 
compounds bind to site I and site II on HSA, facilitated by hydrophobic forces and hydrogen bonds. 
The data presented can be useful in the establishment of their pharmacokinetic profiles in the process 
of future drug development.  
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The title compound, systematic name 9-isopropylidene-2,6-
dimethyl-11-oxatricyclo[6.2.1.01,5]undec-6-en-8-ol, C15H22O2,
which crystallizes with two molecules of similar conformation
in the asymmetric unit, features three fused rings, two of which
are five-membered and the third six-membered. Of the two
five-membered rings, the one with an O atom has a distinct
envelope shape (with the O atom representing the flap). The
six-membered ring is also envelope-shaped as it shares a
common O atom with the five-membered ring. In the crystal,
the two independent molecules are linked by a pair of O—
H  O hydrogen bonds, generating a dimer.
Related literature
For the C2 modification isolated from Globba malaccensis






a = 9.3495 (7) A˚
b = 12.535 (1) A˚
c = 11.7727 (9) A˚
 = 96.532 (1)
V = 1370.76 (18) A˚3
Z = 4
Mo K radiation
 = 0.07 mm1
T = 100 K






2882 reflections with I > 2(I)
Rint = 0.046
Refinement
R[F 2 > 2(F 2)] = 0.037





H atoms treated by a mixture of
independent and constrained
refinement
max = 0.21 e A˚
3
min = 0.18 e A˚3
Table 1
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
O1—H1  O4 0.89 (3) 1.92 (3) 2.799 (2) 168 (3)
O3—H3  O2 0.86 (3) 1.92 (3) 2.771 (2) 171 (3)
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT
(Bruker, 2009); data reduction: SAINT; program(s) used to solve
structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine
structure: SHELXL97 (Sheldrick, 2008); molecular graphics: X-
SEED (Barbour, 2001); software used to prepare material for
publication: publCIF (Westrip, 2010).
We thank the University of Malaya for supporting this
study.
Supplementary data and figures for this paper are available from the
IUCr electronic archives (Reference: HB5676).
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Comment
Zingerberaceae is a herbaceous plant found in tropical forests that comprises of 52 genera with 1500 species. Most species
are found in the South East Asian region. Curcuma zedoaria, also known as white turmeric, is a species that is a rich source
of terpenoids.
Curcumenol, isolated from Globba malaccensis Ridl, belongs to the monoclinic, space group C2, with a 16.8467 (4),
b 7.6799 (2), c 11.8613 (10) Å and β 115.997 (1) °. This modification is less dense, as noted from its calculated density
of 1.28 (Muangsin et al., 2004). The present modification (I), (Fig. 1) shows nearly identical bond dimensions in the two
independent molecules. The two molecules form a dimer in the crystal, being linked by two O—H···O hydrogen bonds.
Experimental
The rhizome of Curcuma zedoaria was collected from Tawangmangu, Indonesia.
Dried rhizomes (1 kg) were powdered and extracted three times with n-hexane and after this, with dichloromethane,
ethylacetate, and methanol. The extracts were concentrated under reduced pressure given several fractions.
The n-hexane crude extract (20 g) was subjected to column chromatography over silica gel 60(0.063–0.200 mm, 70–230
mesh ASTM) eluted with a mixture of n-hexane: ethyl acetate with increasing polarity. Separation by TLC gave 21 fractions.
Fraction 10 (1.41 g) was chromatographed over silica gel (0.040–0.063 mm, mesh 230–400 ASTM) eluted with a gradient
solvent system of n-hexane: ethyl aceate to give 5 fractions. The second fraction was further purified by high performance
thin layerchromatography and using petroleum ether: ethyl acetate: acidified methanol in a 85:14:1 ratio as the developing
solvent. Slow evaporation of the solvent gave (I) as colorless prisms.
Refinement
Carbon-bound H-atoms were placed in calculated positions (C—H 0.95 to 0.98 Å) and were included in the refinement in
the riding model approximation, with U(H) set to 1.2 to 1.5U(C).
In the absence of heavy atoms, 2923 Friedel pairs were merged.
The hydroxy H-atoms were located in a difference Fourier map, and were refined without restraints; their Uiso values
were freely refined.




Fig. 1. View of the first molecule of (I) at the 70% probability level; hydrogen atoms are
drawn as spheres of arbitrary radius.
Fig. 2. View of the second molecule of (I) at the 70% probability level; hydrogen atoms are
drawn as spheres of arbitrary radius.
9-isopropylidene-2,6-dimethyl-11-oxatricyclo[6.2.1.01,5]undec-6-en-8-ol
Crystal data
C15H22O2 F(000) = 512
Mr = 234.33 Dx = 1.135 Mg m−3
Monoclinic, P21 Mo Kα radiation, λ = 0.71073 Å
Hall symbol: P 2yb Cell parameters from 3511 reflections
a = 9.3495 (7) Å θ = 2.4–27.4°
b = 12.535 (1) Å µ = 0.07 mm−1
c = 11.7727 (9) Å T = 100 K
β = 96.532 (1)° Prism, colorless




diffractometer 2882 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tube Rint = 0.046
graphite θmax = 27.5°, θmin = 2.2°
ω scans h = −12→12
13257 measured reflections k = −16→15
3298 independent reflections l = −15→15
Refinement
Refinement on F2
Primary atom site location: structure-invariant direct
methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
supplementary materials
sup-3
R[F2 > 2σ(F2)] = 0.037
Hydrogen site location: inferred from neighbouring
sites
wR(F2) = 0.090
H atoms treated by a mixture of independent and
constrained refinement
S = 1.03
w = 1/[σ2(Fo2) + (0.0535P)2 + 0.0302P]
where P = (Fo2 + 2Fc2)/3
3298 reflections (Δ/σ)max = 0.001
323 parameters Δρmax = 0.21 e Å−3
1 restraint Δρmin = −0.18 e Å−3
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
O1 0.24626 (15) 0.50024 (12) 0.49296 (13) 0.0165 (3)
H1 0.268 (3) 0.497 (2) 0.569 (3) 0.033 (7)*
O2 0.06839 (14) 0.62132 (11) 0.52267 (11) 0.0136 (3)
O3 0.03989 (15) 0.49267 (12) 0.71017 (12) 0.0160 (3)
H3 0.045 (3) 0.538 (3) 0.656 (3) 0.043 (9)*
O4 0.28533 (14) 0.46600 (12) 0.72943 (11) 0.0137 (3)
C1 0.2006 (2) 0.60463 (17) 0.47181 (17) 0.0141 (4)
C2 0.1560 (2) 0.62872 (17) 0.34601 (17) 0.0153 (4)
C3 0.2186 (2) 0.59756 (17) 0.25570 (17) 0.0178 (4)
C4 0.1634 (3) 0.6348 (2) 0.13744 (18) 0.0266 (5)
H4A 0.0671 0.6656 0.1381 0.040*
H4B 0.1584 0.5741 0.0846 0.040*
H4C 0.2287 0.6890 0.1125 0.040*
C5 0.3508 (2) 0.52777 (19) 0.2618 (2) 0.0231 (5)
H5A 0.3878 0.5157 0.3421 0.035*
H5B 0.4248 0.5631 0.2226 0.035*
H5C 0.3257 0.4592 0.2248 0.035*
C6 0.0287 (2) 0.70366 (17) 0.34497 (17) 0.0171 (4)
H6A −0.0595 0.6710 0.3051 0.020*
H6B 0.0476 0.7719 0.3070 0.020*
C7 0.0140 (2) 0.72101 (17) 0.47172 (17) 0.0144 (4)
C8 −0.1354 (2) 0.74213 (18) 0.50599 (18) 0.0188 (4)
H8 −0.1786 0.8026 0.4584 0.023*
C9 −0.2388 (2) 0.6479 (2) 0.4898 (2) 0.0252 (5)
H9A −0.2524 0.6276 0.4089 0.038*
H9B −0.3317 0.6681 0.5145 0.038*
H9C −0.1987 0.5874 0.5356 0.038*
C10 −0.1057 (2) 0.7814 (2) 0.62979 (19) 0.0231 (5)
H10A −0.0960 0.7204 0.6834 0.028*
H10B −0.1851 0.8277 0.6495 0.028*
C11 0.0359 (2) 0.84454 (19) 0.63593 (19) 0.0232 (5)
H11A 0.1000 0.8254 0.7057 0.028*
H11B 0.0168 0.9222 0.6371 0.028*
C12 0.1062 (2) 0.81353 (17) 0.52712 (17) 0.0169 (4)
H12 0.0964 0.8756 0.4734 0.020*
supplementary materials
sup-4
C13 0.2640 (2) 0.78423 (17) 0.54836 (17) 0.0165 (4)
C14 0.3074 (2) 0.68708 (17) 0.52234 (17) 0.0153 (4)
H14 0.4067 0.6693 0.5357 0.018*
C15 0.3668 (2) 0.86938 (19) 0.5957 (2) 0.0242 (5)
H15A 0.4647 0.8402 0.6069 0.036*
H15B 0.3395 0.8942 0.6692 0.036*
H15C 0.3634 0.9293 0.5420 0.036*
C16 0.1638 (2) 0.50276 (17) 0.78584 (16) 0.0139 (4)
C17 0.1685 (2) 0.42847 (17) 0.88859 (17) 0.0151 (4)
C18 0.0631 (2) 0.40510 (18) 0.95131 (17) 0.0185 (4)
C19 0.0876 (2) 0.3318 (2) 1.0536 (2) 0.0269 (5)
H19A 0.1859 0.3035 1.0596 0.040*
H19B 0.0187 0.2726 1.0443 0.040*
H19C 0.0740 0.3717 1.1232 0.040*
C20 −0.0861 (2) 0.4506 (2) 0.9308 (2) 0.0283 (6)
H20A −0.0908 0.5024 0.8681 0.042*
H20B −0.1099 0.4861 1.0004 0.042*
H20C −0.1552 0.3930 0.9105 0.042*
C21 0.3243 (2) 0.39168 (18) 0.91067 (17) 0.0173 (4)
H21A 0.3322 0.3138 0.8986 0.021*
H21B 0.3659 0.4092 0.9895 0.021*
C22 0.3990 (2) 0.45412 (18) 0.82278 (17) 0.0154 (4)
C23 0.5286 (2) 0.40276 (19) 0.77721 (18) 0.0199 (5)
H23 0.5990 0.3832 0.8444 0.024*
C24 0.4981 (3) 0.3034 (2) 0.7059 (2) 0.0280 (5)
H24A 0.4503 0.2504 0.7499 0.042*
H24B 0.5888 0.2738 0.6855 0.042*
H24C 0.4354 0.3213 0.6361 0.042*
C25 0.5938 (2) 0.4943 (2) 0.71440 (19) 0.0229 (5)
H25A 0.5450 0.5011 0.6356 0.027*
H25B 0.6977 0.4818 0.7105 0.027*
C26 0.5709 (2) 0.5955 (2) 0.7840 (2) 0.0247 (5)
H26A 0.5388 0.6555 0.7327 0.030*
H26B 0.6613 0.6162 0.8310 0.030*
C27 0.4527 (2) 0.56609 (18) 0.86173 (17) 0.0172 (4)
H27 0.4996 0.5604 0.9422 0.021*
C28 0.3310 (2) 0.64559 (18) 0.85997 (17) 0.0176 (4)
C29 0.1969 (2) 0.61599 (17) 0.82481 (17) 0.0160 (4)
H29 0.1210 0.6664 0.8241 0.019*
C30 0.3704 (3) 0.75649 (19) 0.9014 (2) 0.0253 (5)
H30A 0.2833 0.8004 0.8977 0.038*
H30B 0.4378 0.7880 0.8529 0.038*
H30C 0.4158 0.7532 0.9806 0.038*
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
O1 0.0223 (7) 0.0128 (7) 0.0142 (8) 0.0047 (6) 0.0011 (6) 0.0017 (6)
supplementary materials
sup-5
O2 0.0151 (6) 0.0123 (7) 0.0137 (7) 0.0011 (5) 0.0026 (5) 0.0029 (6)
O3 0.0140 (7) 0.0201 (8) 0.0134 (7) −0.0019 (6) −0.0002 (5) 0.0034 (6)
O4 0.0115 (6) 0.0172 (8) 0.0123 (7) 0.0015 (6) 0.0014 (5) 0.0005 (6)
C1 0.0155 (9) 0.0134 (10) 0.0136 (9) 0.0016 (8) 0.0027 (7) 0.0000 (8)
C2 0.0168 (9) 0.0130 (10) 0.0158 (10) −0.0015 (8) 0.0002 (7) 0.0001 (8)
C3 0.0241 (10) 0.0146 (10) 0.0150 (10) −0.0019 (9) 0.0029 (8) 0.0000 (8)
C4 0.0398 (13) 0.0256 (12) 0.0142 (10) 0.0004 (11) 0.0028 (9) −0.0020 (9)
C5 0.0294 (12) 0.0206 (12) 0.0209 (11) 0.0032 (9) 0.0097 (9) 0.0001 (9)
C6 0.0192 (10) 0.0173 (11) 0.0144 (10) −0.0004 (8) 0.0003 (8) 0.0017 (8)
C7 0.0150 (9) 0.0121 (10) 0.0157 (10) 0.0020 (8) 0.0006 (7) 0.0032 (8)
C8 0.0176 (10) 0.0192 (12) 0.0200 (10) 0.0042 (8) 0.0045 (8) 0.0044 (9)
C9 0.0153 (10) 0.0272 (13) 0.0333 (13) 0.0004 (9) 0.0043 (9) 0.0051 (10)
C10 0.0243 (11) 0.0230 (12) 0.0231 (11) 0.0077 (9) 0.0080 (9) 0.0025 (9)
C11 0.0266 (11) 0.0226 (13) 0.0201 (11) 0.0070 (10) 0.0012 (9) −0.0038 (9)
C12 0.0229 (10) 0.0127 (10) 0.0147 (10) 0.0015 (8) 0.0012 (8) 0.0020 (8)
C13 0.0203 (10) 0.0153 (11) 0.0138 (10) −0.0030 (8) 0.0011 (8) 0.0028 (8)
C14 0.0139 (9) 0.0190 (11) 0.0128 (10) −0.0013 (8) 0.0011 (7) 0.0036 (8)
C15 0.0260 (11) 0.0192 (12) 0.0263 (12) −0.0064 (9) −0.0014 (9) 0.0006 (10)
C16 0.0130 (9) 0.0163 (10) 0.0122 (9) 0.0007 (8) 0.0016 (7) 0.0002 (8)
C17 0.0159 (9) 0.0152 (10) 0.0134 (9) −0.0011 (8) −0.0015 (8) 0.0002 (8)
C18 0.0192 (10) 0.0214 (12) 0.0144 (10) −0.0023 (9) −0.0003 (8) 0.0024 (9)
C19 0.0257 (12) 0.0342 (14) 0.0205 (11) −0.0088 (10) 0.0016 (9) 0.0083 (10)
C20 0.0165 (11) 0.0448 (16) 0.0241 (12) −0.0011 (11) 0.0049 (9) 0.0047 (11)
C21 0.0172 (10) 0.0199 (11) 0.0144 (10) 0.0026 (9) 0.0010 (8) 0.0033 (8)
C22 0.0123 (9) 0.0213 (11) 0.0119 (10) 0.0018 (8) −0.0023 (7) 0.0017 (8)
C23 0.0155 (10) 0.0271 (13) 0.0173 (10) 0.0053 (9) 0.0021 (8) 0.0033 (9)
C24 0.0269 (11) 0.0262 (14) 0.0322 (13) 0.0075 (10) 0.0096 (10) −0.0035 (10)
C25 0.0163 (10) 0.0322 (13) 0.0206 (11) 0.0011 (9) 0.0040 (8) 0.0044 (10)
C26 0.0169 (10) 0.0300 (13) 0.0272 (12) −0.0034 (9) 0.0034 (9) 0.0039 (10)
C27 0.0158 (10) 0.0238 (12) 0.0114 (10) −0.0031 (8) −0.0008 (8) −0.0002 (8)
C28 0.0228 (10) 0.0179 (11) 0.0128 (10) −0.0004 (9) 0.0041 (8) −0.0005 (8)
C29 0.0183 (9) 0.0151 (11) 0.0150 (10) 0.0018 (8) 0.0044 (8) 0.0014 (8)
C30 0.0295 (12) 0.0221 (12) 0.0240 (12) −0.0065 (10) 0.0023 (9) −0.0060 (10)
Geometric parameters (Å, °)
O1—C1 1.390 (3) C14—H14 0.9500
O1—H1 0.89 (3) C15—H15A 0.9800
O2—C1 1.449 (2) C15—H15B 0.9800
O2—C7 1.453 (2) C15—H15C 0.9800
O3—C16 1.385 (2) C16—C29 1.513 (3)
O3—H3 0.86 (3) C16—C17 1.523 (3)
O4—C22 1.447 (2) C17—C18 1.329 (3)
O4—C16 1.455 (2) C17—C21 1.522 (3)
C1—C14 1.511 (3) C18—C20 1.501 (3)
C1—C2 1.523 (3) C18—C19 1.512 (3)
C2—C3 1.329 (3) C19—H19A 0.9800
C2—C6 1.515 (3) C19—H19B 0.9800
C3—C4 1.503 (3) C19—H19C 0.9800
supplementary materials
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C3—C5 1.510 (3) C20—H20A 0.9800
C4—H4A 0.9800 C20—H20B 0.9800
C4—H4B 0.9800 C20—H20C 0.9800
C4—H4C 0.9800 C21—C22 1.529 (3)
C5—H5A 0.9800 C21—H21A 0.9900
C5—H5B 0.9800 C21—H21B 0.9900
C5—H5C 0.9800 C22—C23 1.522 (3)
C6—C7 1.530 (3) C22—C27 1.542 (3)
C6—H6A 0.9900 C23—C24 1.511 (3)
C6—H6B 0.9900 C23—C25 1.529 (3)
C7—C8 1.521 (3) C23—H23 1.0000
C7—C12 1.545 (3) C24—H24A 0.9800
C8—C9 1.524 (3) C24—H24B 0.9800
C8—C10 1.534 (3) C24—H24C 0.9800
C8—H8 1.0000 C25—C26 1.539 (3)
C9—H9A 0.9800 C25—H25A 0.9900
C9—H9B 0.9800 C25—H25B 0.9900
C9—H9C 0.9800 C26—C27 1.557 (3)
C10—C11 1.537 (3) C26—H26A 0.9900
C10—H10A 0.9900 C26—H26B 0.9900
C10—H10B 0.9900 C27—C28 1.511 (3)
C11—C12 1.554 (3) C27—H27 1.0000
C11—H11A 0.9900 C28—C29 1.328 (3)
C11—H11B 0.9900 C28—C30 1.505 (3)
C12—C13 1.514 (3) C29—H29 0.9500
C12—H12 1.0000 C30—H30A 0.9800
C13—C14 1.330 (3) C30—H30B 0.9800
C13—C15 1.500 (3) C30—H30C 0.9800
C1—O1—H1 105 (2) H15A—C15—H15C 109.5
C1—O2—C7 103.23 (13) H15B—C15—H15C 109.5
C16—O3—H3 108 (2) O3—C16—O4 108.49 (15)
C22—O4—C16 103.31 (13) O3—C16—C29 114.09 (17)
O1—C1—O2 108.73 (15) O4—C16—C29 106.99 (15)
O1—C1—C14 113.42 (17) O3—C16—C17 113.64 (17)
O2—C1—C14 107.18 (16) O4—C16—C17 102.46 (15)
O1—C1—C2 113.92 (17) C29—C16—C17 110.27 (16)
O2—C1—C2 102.77 (15) C18—C17—C21 126.42 (19)
C14—C1—C2 110.05 (16) C18—C17—C16 128.31 (19)
C3—C2—C6 126.34 (18) C21—C17—C16 105.13 (16)
C3—C2—C1 128.53 (19) C17—C18—C20 124.1 (2)
C6—C2—C1 105.00 (16) C17—C18—C19 121.5 (2)
C2—C3—C4 120.92 (19) C20—C18—C19 114.39 (18)
C2—C3—C5 124.38 (19) C18—C19—H19A 109.5
C4—C3—C5 114.66 (17) C18—C19—H19B 109.5
C3—C4—H4A 109.5 H19A—C19—H19B 109.5
C3—C4—H4B 109.5 C18—C19—H19C 109.5
H4A—C4—H4B 109.5 H19A—C19—H19C 109.5
C3—C4—H4C 109.5 H19B—C19—H19C 109.5
H4A—C4—H4C 109.5 C18—C20—H20A 109.5
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H4B—C4—H4C 109.5 C18—C20—H20B 109.5
C3—C5—H5A 109.5 H20A—C20—H20B 109.5
C3—C5—H5B 109.5 C18—C20—H20C 109.5
H5A—C5—H5B 109.5 H20A—C20—H20C 109.5
C3—C5—H5C 109.5 H20B—C20—H20C 109.5
H5A—C5—H5C 109.5 C17—C21—C22 103.41 (16)
H5B—C5—H5C 109.5 C17—C21—H21A 111.1
C2—C6—C7 103.77 (16) C22—C21—H21A 111.1
C2—C6—H6A 111.0 C17—C21—H21B 111.1
C7—C6—H6A 111.0 C22—C21—H21B 111.1
C2—C6—H6B 111.0 H21A—C21—H21B 109.0
C7—C6—H6B 111.0 O4—C22—C23 108.73 (16)
H6A—C6—H6B 109.0 O4—C22—C21 102.34 (15)
O2—C7—C8 109.23 (15) C23—C22—C21 117.75 (18)
O2—C7—C6 102.38 (16) O4—C22—C27 108.54 (16)
C8—C7—C6 118.09 (17) C23—C22—C27 104.17 (16)
O2—C7—C12 108.61 (15) C21—C22—C27 115.02 (16)
C8—C7—C12 104.05 (16) C24—C23—C22 115.91 (18)
C6—C7—C12 114.25 (16) C24—C23—C25 114.24 (18)
C7—C8—C9 114.86 (18) C22—C23—C25 103.31 (18)
C7—C8—C10 103.63 (17) C24—C23—H23 107.7
C9—C8—C10 114.29 (18) C22—C23—H23 107.7
C7—C8—H8 107.9 C25—C23—H23 107.7
C9—C8—H8 107.9 C23—C24—H24A 109.5
C10—C8—H8 107.9 C23—C24—H24B 109.5
C8—C9—H9A 109.5 H24A—C24—H24B 109.5
C8—C9—H9B 109.5 C23—C24—H24C 109.5
H9A—C9—H9B 109.5 H24A—C24—H24C 109.5
C8—C9—H9C 109.5 H24B—C24—H24C 109.5
H9A—C9—H9C 109.5 C23—C25—C26 105.89 (17)
H9B—C9—H9C 109.5 C23—C25—H25A 110.6
C8—C10—C11 105.77 (17) C26—C25—H25A 110.6
C8—C10—H10A 110.6 C23—C25—H25B 110.6
C11—C10—H10A 110.6 C26—C25—H25B 110.6
C8—C10—H10B 110.6 H25A—C25—H25B 108.7
C11—C10—H10B 110.6 C25—C26—C27 105.59 (19)
H10A—C10—H10B 108.7 C25—C26—H26A 110.6
C10—C11—C12 105.99 (18) C27—C26—H26A 110.6
C10—C11—H11A 110.5 C25—C26—H26B 110.6
C12—C11—H11A 110.5 C27—C26—H26B 110.6
C10—C11—H11B 110.5 H26A—C26—H26B 108.8
C12—C11—H11B 110.5 C28—C27—C22 112.18 (17)
H11A—C11—H11B 108.7 C28—C27—C26 114.80 (18)
C13—C12—C7 111.99 (17) C22—C27—C26 105.62 (17)
C13—C12—C11 114.85 (17) C28—C27—H27 108.0
C7—C12—C11 105.52 (17) C22—C27—H27 108.0
C13—C12—H12 108.1 C26—C27—H27 108.0
C7—C12—H12 108.1 C29—C28—C30 123.2 (2)
C11—C12—H12 108.1 C29—C28—C27 120.2 (2)
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C14—C13—C15 122.5 (2) C30—C28—C27 116.66 (18)
C14—C13—C12 120.07 (19) C28—C29—C16 120.68 (18)
C15—C13—C12 117.38 (19) C28—C29—H29 119.7
C13—C14—C1 120.76 (19) C16—C29—H29 119.7
C13—C14—H14 119.6 C28—C30—H30A 109.5
C1—C14—H14 119.6 C28—C30—H30B 109.5
C13—C15—H15A 109.5 H30A—C30—H30B 109.5
C13—C15—H15B 109.5 C28—C30—H30C 109.5
H15A—C15—H15B 109.5 H30A—C30—H30C 109.5
C13—C15—H15C 109.5 H30B—C30—H30C 109.5
C7—O2—C1—O1 −166.41 (15) C22—O4—C16—O3 −165.83 (16)
C7—O2—C1—C14 70.62 (18) C22—O4—C16—C29 70.65 (18)
C7—O2—C1—C2 −45.36 (18) C22—O4—C16—C17 −45.36 (18)
O1—C1—C2—C3 −41.0 (3) O3—C16—C17—C18 −42.5 (3)
O2—C1—C2—C3 −158.4 (2) O4—C16—C17—C18 −159.3 (2)
C14—C1—C2—C3 87.7 (3) C29—C16—C17—C18 87.1 (3)
O1—C1—C2—C6 142.99 (17) O3—C16—C17—C21 141.52 (17)
O2—C1—C2—C6 25.6 (2) O4—C16—C17—C21 24.7 (2)
C14—C1—C2—C6 −88.34 (19) C29—C16—C17—C21 −88.93 (19)
C6—C2—C3—C4 −1.1 (3) C21—C17—C18—C20 175.0 (2)
C1—C2—C3—C4 −176.4 (2) C16—C17—C18—C20 −0.2 (4)
C6—C2—C3—C5 176.2 (2) C21—C17—C18—C19 −2.8 (4)
C1—C2—C3—C5 1.0 (4) C16—C17—C18—C19 −178.0 (2)
C3—C2—C6—C7 −173.7 (2) C18—C17—C21—C22 −172.6 (2)
C1—C2—C6—C7 2.5 (2) C16—C17—C21—C22 3.6 (2)
C1—O2—C7—C8 172.96 (16) C16—O4—C22—C23 173.18 (17)
C1—O2—C7—C6 47.00 (17) C16—O4—C22—C21 47.91 (18)
C1—O2—C7—C12 −74.17 (17) C16—O4—C22—C27 −74.09 (17)
C2—C6—C7—O2 −29.52 (19) C17—C21—C22—O4 −30.8 (2)
C2—C6—C7—C8 −149.48 (18) C17—C21—C22—C23 −149.86 (18)
C2—C6—C7—C12 87.7 (2) C17—C21—C22—C27 86.7 (2)
O2—C7—C8—C9 −48.6 (2) O4—C22—C23—C24 −49.5 (2)
C6—C7—C8—C9 67.7 (2) C21—C22—C23—C24 66.2 (3)
C12—C7—C8—C9 −164.47 (18) C27—C22—C23—C24 −165.10 (18)
O2—C7—C8—C10 76.7 (2) O4—C22—C23—C25 76.2 (2)
C6—C7—C8—C10 −166.94 (19) C21—C22—C23—C25 −168.10 (18)
C12—C7—C8—C10 −39.1 (2) C27—C22—C23—C25 −39.4 (2)
C7—C8—C10—C11 34.1 (2) C24—C23—C25—C26 162.08 (18)
C9—C8—C10—C11 159.84 (18) C22—C23—C25—C26 35.3 (2)
C8—C10—C11—C12 −15.7 (2) C23—C25—C26—C27 −17.4 (2)
O2—C7—C12—C13 38.7 (2) O4—C22—C27—C28 38.7 (2)
C8—C7—C12—C13 155.00 (16) C23—C22—C27—C28 154.41 (17)
C6—C7—C12—C13 −74.8 (2) C21—C22—C27—C28 −75.2 (2)
O2—C7—C12—C11 −86.90 (18) O4—C22—C27—C26 −87.07 (18)
C8—C7—C12—C11 29.4 (2) C23—C22—C27—C26 28.7 (2)
C6—C7—C12—C11 159.54 (17) C21—C22—C27—C26 159.03 (17)
C10—C11—C12—C13 −132.17 (19) C25—C26—C27—C28 −131.0 (2)
C10—C11—C12—C7 −8.3 (2) C25—C26—C27—C22 −6.9 (2)
C7—C12—C13—C14 −1.7 (3) C22—C27—C28—C29 −1.6 (3)
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C11—C12—C13—C14 118.7 (2) C26—C27—C28—C29 119.0 (2)
C7—C12—C13—C15 176.55 (17) C22—C27—C28—C30 177.41 (17)
C11—C12—C13—C15 −63.1 (2) C26—C27—C28—C30 −62.0 (2)
C15—C13—C14—C1 −178.33 (18) C30—C28—C29—C16 −179.05 (19)
C12—C13—C14—C1 −0.2 (3) C27—C28—C29—C16 −0.1 (3)
O1—C1—C14—C13 −154.67 (18) O3—C16—C29—C28 −154.60 (18)
O2—C1—C14—C13 −34.7 (2) O4—C16—C29—C28 −34.6 (2)
C2—C1—C14—C13 76.4 (2) C17—C16—C29—C28 76.1 (2)
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
O1—H1···O4 0.89 (3) 1.92 (3) 2.799 (2) 168 (3)
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Curcuma zedoaria also known as Temu putih is traditionally used in food preparations and treatment of various ailments including
cancer. The cytotoxic activity of hexane, dichloromethane, ethyl acetate, methanol, and the methanol-soxhlet extracts of Curcuma
zedoaria rhizomes was tested on two human cancer cell lines (Ca Ski and MCF-7) and a noncancer cell line (HUVEC) using
MTT assay. Investigation on the chemical components in the hexane and dichloromethane fractions gave 19 compounds, namely,
labda-8(17),12 diene-15,16 dial (1), dehydrocurdione (2), curcumenone (3), comosone II (4), curcumenol (5), procurcumenol (6),
germacrone (7), zerumbone epoxide (8), zederone (9), 9-isopropylidene-2,6-dimethyl-11-oxatricyclo[6.2.1.01,5]undec-6-en-8-ol
(10), furanodiene (11), germacrone-4,5-epoxide (12), calcaratarin A (13), isoprocurcumenol (14), germacrone-1,10-epoxide (15),
zerumin A (16), curcumanolide A (17), curcuzedoalide (18), and gweicurculactone (19). Compounds (1–19) were evaluated for
their antiproliferative effect using MTT assay against four cancer cell lines (Ca Ski, MCF-7, PC-3, and HT-29). Curcumenone (3)
and curcumenol (5) displayed strong antiproliferative activity (IC
50
= 8.3 ± 1.0 and 9.3 ± 0.3 𝜇g/mL, resp.) and were found to
induce apoptotic cell death on MCF-7 cells using phase contrast and Hoechst 33342/PI double-staining assay. Thus, the present
study provides basis for the ethnomedical application of Curcuma zedoaria in the treatment of breast cancer.
1. Introduction
It is widely reported that more than 35,000 plant species
are used for medicinal purposes worldwide. Of these, 1,200
and 2,000 plant species from Peninsular Malaysia and East
Malaysia respectively, are used in folklore medicine [1]. One
such plant is Curcuma zedoaria (Berg.) Rosc. belonging to
the Zingiberaceae family and known by the locals as Temu
putih or Kunyit putih.The leaf blades are 80 cm long, usually
with a purple-brown flush running along the midrib on both
surfaces of the leaf. In the young plants, the rhizomes of
Curcuma zedoaria are easily confused with those of Curcuma
aeruginosa and Curcuma mangga because both have almost
similar yellow color.However, a cross-section of the rhizomes
of the mature plants of Curcuma aeruginosa is slightly dark
purplish whilst Curcuma mangga have brighter yellow color
[2]. Temu putih is used by the Malays in the preparation
of traditional medicine—consumed either on their own or
in mixtures with other plant species. They are also widely
consumed as spices, as flavors in native dishes, and as food
preparations in postpartum confinement [2–4]. Curcuma
zedoaria also called Er-chu in Chinese is clinically used
for the treatment of cervical cancer [5]. In Japan, it has
also been used as an aromatic stomachic [6]. Whilst in the
Ayurvedic medicine, it is used for the treatment of fevers
(cooling), antiseptic, mild expectorant, and deodorizer [7].
In Indonesia, Curcuma zedoaria is widely consumed in the
form of “jamu” for the treatment of breast and cervical
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cancers [8]. Medicinal plants are used widely especially in
Asia as an alternative medicine for cancer-related diseases
because it is believed for having active natural occurring
compounds in killing cancer [9, 10]. However, there are only
limited studies on the efficacy on the use of medicinal plants
[11]. It is therefore important to identify the components
which are responsible for the chemotherapeutic effects and
the molecular pathway by which these compounds affect
cancer cell death. Up to date, there are numerous reported
articles on the cytotoxic components of Curcuma zedoaria
and the mechanism of cell death exerted by some of these
compounds [5–8, 12–20]. In our continuous effort to study
the bioactive and theirmode of actions frommedicinal plants
of Curcuma species, this communication reports the isolation
of 19 compounds and among these, two bioactive compounds
(curcumenone and curcumenol) were identified as cytotoxic
components and were able to induce apoptosis.
2. Materials and Methods
2.1. Plant Samples. Curcuma zedoaria rhizomes were col-
lected from Tawamangu, Indonesia, and a voucher specimen
(KL 5764) was deposited at the herbarium of the Department
of Chemistry, Faculty of Science, University of Malaya, Kuala
Lumpur, Malaysia.
2.2. Extraction of Plant Sample. Briefly, the washed and dried
rhizomes of Curcuma zedoaria were finely ground. The fine
powders of Curcuma zedoaria (1.0 kg) were soaked in n-
hexane for 3 days. Then, the solvent containing extract was
decanted and filtered (were repeated twice each time with
five liters of n-hexane). All the filtrates were combined and
evaporated using a rotary evaporator (Buchi, Switzerland) to
give the n-hexane extract. The n-hexane-insoluble residue


















insoluble residue was further extracted with EtOAc to give
the EtOAc-soluble and EtOAc-insoluble extract. The EtOAc-
insoluble extract was then extracted with MeOH to give the
MeOH extract. The insoluble residue obtained after MeOH
extraction was further subjected to soxhlet extraction using
methanol to give the MeOH SE extract after evaporation of
excess solvent. All the extracts were weighed after solvent
evaporation.
2.3. Cell Culture. The human cell lines MCF-7 (breast can-
cer), Ca Ski (cervical cancer), and HT-29 (colon cancer)
were cultured as monolayer in RPMI 1640 growth media.
HUVEC (human umbilical vein endothelial cells) and PC-
3 (prostate cancer) cells were cultured in DMEM. All cells
were purchased from theAmericanTissueCultureCollection
(ATCC, USA) except for human umbilical vein endothelial
cells (HUVEC)whichwere obtained fromScienCell Research
Laboratories (Carlsbad, CA). All the media were supple-
mented with 10% v/v foetal bovine serum (FBS), 100 𝜇g/mL
penicillin/streptomycin, and 50 𝜇g/mL amphotericin B. The
cells were cultured in a 5% CO
2
incubator at 37∘C.
2.4. MTT Cytotoxicity Assay. Cell viability was investigated
using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT) assay. Cells were detached from the 25 cm3
tissue culture flask when it achieved 80% confluency. The
detached cells were pellet by centrifugation (1,000 rpm; 5
minutes). Cells (3.0×104 cells/mL)were seeded onto a 96-well
microtiter plate (Nunc).The cells were incubated at 37∘CCO
2
incubator for 24 h to give adherent cells. The test compounds
(1–100 𝜇g/mL) were added onto the 96-well microtiter plate
containing adherent cells. The untreated cells were incubated
in 10% media containing 0.5% DMSO (without addition of
any test compounds/extracts). This mixture was regarded
as the negative control whereas doxorubicin as the positive
control. The plates were incubated for 72 h at 37∘C in a
5% CO
2
incubator. After 72 h, the media were removed
and 100 𝜇L of fresh medium and 20𝜇L of MTT (Sigma,
filter sterile, 5mg/mL) were added to each well and further
incubated for 4 hours (37∘C) after which the media were
substituted with 150 𝜇L DMSO.The 96-well microtiter plates
were then agitated at room temperature onto an incubator
shaker to dissolve the formazan crystals. The absorbance (𝐴)
of the content of the plates was measured at 540 nm using a
microplate reader. The percentage of inhibition of each test
sample was calculated according to the following formula:
Percentage of inhibition (%) = (𝐴control − 𝐴 sample)/𝐴control ×
100%.The average of three replicates was then obtained. The
IC
50
for each extract was extrapolated from the graphs of
the percentage inhibition versus concentration of test agents.





value is the concentration of test agents that cause 50%
inhibition or cell death, averaged from the three experiments
[21–23]. The selectivity index (SI) was also calculated as
described by [24, 25] using the ratio between IC
50
of the
extract or compounds on normal cell lines (HUVEC) and
IC
50
of the tested extract or compounds on cancerous cell
lines. Selectivity index (SI) values equal or greater than three
were considered to have a high selectivity towards cancerous
cells. An SI value denotes the selectivity of the sample to the
tested cell lines [24, 25].
2.5. General Methods on Characterization of the Active Prin-
ciples. TLC techniques were used to monitor the purity of
isolated compounds. Analytical TLC was performed on the
precoated plates with silica gel 60 F
254
(Merck of 20.25mm)
(normal phase). HPTLC and PTLC were carried out on the
precoated plates with silica gel 60 GF
254
(Merck, 20.25mm).










heating. CCwas carried out onKieselgel 60 (0.043–0.063mm
and 0.063–0.200mm) (Merck) and Sephadex LH 20 (25–
100m) (Merck). HPLC was used to isolate and purify the
compounds. HPLC was performed using Waters System
equipped with Binary Gradient Module (Waters 2545), Sys-
tem Fluidics Organizer and PhotodiodeArrayDetector (190–
400 nm; Waters 2998), and Sample Manager (Waters 2767).
The column used was Waters XBridge Prep C18 5 𝜇M (10 ×
250mm) column with Waters XBridge Prep C18 5𝜇M (10 ×
10mm) column guard cartridge. The data were collected
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and analyzed by MassLynx software. 1D NMR (1H, 13C,
Dept 135) and 2D NMR (HSQC, HMBC, COSY, NOESY)
spectra were recorded from a JEOL 400MHz FT NMR
spectrometer at 400MHz for 1H-NMR and at 100MHz for
13C-NMR. Chemical shifts in ppm were referenced to the
internal standard TMS (𝛿 = 0 ppm) for use in 1H-NMR
andCDCl
3
(𝛿: 77.0 ppm), 13C-NMR spectra, respectively.The
GC-MS analyses were performed using Shimadzu QP2010
Series gas chromatography and operated in the split lessmode
at 275∘C. The column used was DM 5MS (5% diphenyl/95%
dimethyl polysiloxane) capillary column (30.0m × 0.25mm
× 0.25 𝜇m) with helium as carrier gas at a flow rate of
1mLmin−1. The column temperature was programmed as
follows: initially at 60∘C, then increased to 250∘C at 5∘C
per minute, and then held for 1 minute. The total ion
chromatogram was obtained by autointegration using Chem
Station and the components were identified by comparing
their mass spectral data with the accompanying Spectral
Database (NIST 05, Mass Spectral Library, USA) whenever
possible. IR spectra were obtained on a Perkin Elmer 1600
Series FT-IR infrared spectrophotometer with chloroform as
solvent. The wavelength is indicated in cm−1. Mass spectra
of LC-MS were recorded using Agilent Technologies 6530
Accurate-Mass Q-TOF LC-MS.
2.6. Extraction and Isolation of Pure Compounds. The pow-
dered rhizomes (1.0 kg) were initially extracted with hexane
to give the hexane extract (24.2 g, 2.4%). The hexane extract
(20.0 g) was then subjected to silica gel column chromatog-
raphy (CC) eluting initially with hexane followed by hex-
ane enriched with increasing percentages of ethyl acetate
(EtOAc). Fractions were then combined according to similar-
ity of thin layer chromatography (TLC) spots to give 21 frac-
tions (fractions 1–21). Germacrone-4, 5 epoxide (12, 12.4mg)
and germacrone-1, 10 epoxide (15, 8.0mg) were isolated from
fraction 5 throughmicro CC and preparative thin layer chro-
matography (PTLC). Fraction 6 afforded germacrone (7, 21.6
mg) and furanodiene (11, 8.8mg) upon purification with CC
and PTLC. Fraction 7 was further chromatographed using
various isolation techniques such as Sephadex-LH20, PTLC,
and high performance thin layer chromatography (HPTLC)
to afford dehydrocurdione (2, 34.5mg), curcumanolideA (17,
4.9mg), and two labdanes, namely, labda-8 (17), 12 diene-
15, 16 dial (1, 16.2 mg) and labda-8(17), 12 diene-15, 15-
dimethoxy-16-al or calcaratarin A (13, 22.6mg). Fraction
8 was further purified using PTLC to give curcumenol (5,
15.5mg) and zerumin A (16, 9.8mg). Isoprocurcumenol (14,
10.2mg) was isolated from fraction 9 using two successive
PTLC. Fraction 10was chromatographed and further purified
by HPTLC to afford a second monoclinic modification of
curcumenol as a crystallized dimer elucidated by single crys-
tal X-ray diffraction analysis.This dimer is 9-isopropylidene-
2, 6-dimethyl-11-oxatricyclo [6.2.1.01,5] undec-6-en-8-ol (10,
5.4mg) as previously described [20], whilst curcuzedoalide
(18, 13.4mg) was isolated from fraction 10 using HPLC.
Curcumenone (3, 16.4mg) was purified from fractions 12 and
13. Procurcumenol (6, 8.9 mg) and zerumbone epoxide (8,
11.9mg) were isolated from fractions 15 and 16, respectively,




extract (10 g) was
then subjected to silica gel CC with initial elution of 5%
EtOAc-hexane and gradually increasing the polarity to 100%
EtOAc andfinallywithMeOH. Fractionswere then combined
according to similarity of TLC spots to give 23 fractions
(fractions 1–23). Fraction 2 was subjected to micro CC to
afford comosone II (4, 6.6mg), zederone (9, 24.4mg), and
gweicurculactone (19, 3.6mg) upon purification with HPLC.
All the isolated compounds were identified using NMR
spectroscopy and other supportive data (MS, IR, and UV)
and results obtained were consistent with reported data [14–
18, 20, 23, 26–32]. The structures of isolated compounds are
shown in Figure 1. The method of isolation is summarized in
Figure 2.
2.7. Phase Contrast Microscopy. Briefly, MCF-7 cells (5 ×
10
5
) were grown in a tissue culture dishes (60mm) for
overnight.Then, the cells were treated with curcumenone (3)
and curcumenol (5) at a concentration of 12.5 and 25 𝜇g/mL,
respectively. After 48 hours, cells were gently rinsedwith PBS.
Theobservation ofmorphological changes of apoptoticMCF-
7 cells after treatment with the two bioactive compounds was
viewed using an inverted phase contrast microscope (Leica
DMI 3000B, Germany) at 400x magnification according to
the method [33].
2.8. Fluorescence Microscopy. The morphological features of
MCF-7 cells upon treatment by the test compounds also
observed by double staining of Hoechst 33342/PI assay
[33–37] using the inverted fluorescence microscope (Leica,
DM16000B). Briefly, 5 × 105 cells were grown overnight
and treated with 12.5 and 25 𝜇g/mL of curcumenone (3)
and curcumenol (5). After treatment of cells with the test
compounds for 48 hours, both floating and adherent cells
were collected by centrifugation and washed once with cold
PBS. Then, Hoechst 33342 solutions (10𝜇g/mL) were added
and incubated at 37∘C for 7 minutes. The cells were then
stained with PI (2.5𝜇g/mL) and further incubated in the
dark for 15 minutes. Cell suspension (100 𝜇L) was mounted
onto glassmicroscope slides andobservedunder fluorescence
microscope using UV/488 dual excitation (460 nm emission
of Hoechst 33342, 575 nm emission of PI). Approximately a
total of 200 target cells were calculated and themorphological
characteristics of the nuclei were analyzed for quantification
of apoptosis and necrosis [37]. The percentage of apoptotic,
necrotic, and dead cells was determined according to the
formula described by [37].
2.9. Statistical Analysis. All data were presented as mean ±
standard deviation. All experiments were conducted in tripli-
cates.The data were subjected to one-way analysis of variance
(ANOVA) with the significant differences between groups
determined by Duncan’s multiple range tests (DMRT) at 95%
significant difference (𝑃 < 0.05) using STATGRAPHICS Plus
software (version 3.0, Statistical Graphics Corp., Princeton,
NJ, USA).






























































Figure 1: The structures of isolated compounds.
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Hexane extracts (20 g)
CC: silica gel
CC: silica gel
n-hexane/EtOAc (100 : 0-0 : 100) → MeOH
Hex : EtOAc (95 : 5) → 100% EtOAc → MeOH
Dichloromethane extract (10 g)
Figure 2: Schematic represents the isolation method of the bioactive compounds from Curcuma zedoaria.
Table 1: Antiproliferative activity [IC50 values (𝜇g/mL)] and selectivity index of crude and fractionated extracts of Curcuma zedoaria against
human cancer and noncancer (HUVEC) cell lines.
Extracts IC50 (𝜇g/mL)
a
MCF-7 SIb Ca Ski SIb HUVEC
Hexane 18.4 ± 1.6 5.4 19.0 ± 1.5 5.3 >100.0
Dichloromethane 40.6 ± 2.3 2.5 83.5 ± 2.7 1.2 >100.0
Ethyl acetate >100.0 1.0 >100.0 1.0 >100.0
Methanol >100.0 1.0 >100.0 1.0 >100.0
Methanol (soxhlet extraction) >100.0 1.0 >100.0 1.0 >100.0
aData are presented as mean ± standard deviation (SD) of three replicates.
bSI is the selectivity index. SI values ≥3.0 denote high selectivity towards cancerous cells.
3. Results and Discussion
3.1. Detection of Cell Viability by MTT Assay. The antipro-
liferative activity of crude and extracts of Curcuma zedoaria
was analysed using MTT assay. The IC
50
values (𝜇g/mL)
were evaluated for these crude extracts averaged from three
experiments against two human cancer cell lines (Ca Ski and
MCF-7) and a noncancer cell (HUVEC) and the result is
summarized inTable 1. A plant extractwith IC
50
≤ 20𝜇g/mL
is considered active [21–23]. The hexane extract showed
high inhibitory activity against Ca Ski and MCF-7 cells,





cytotoxicity against MCF-7 and exhibited weak cytotoxicity
against Ca Ski. The extracts of Curcuma zedoaria altogether
showed to be essentially ineffective on the normal cells.
Selectivity indexes (SI) of the antiproliferative activity of
Curcuma zedoaria extracts were evaluated by the ratio of the
cytotoxic activity (IC
50
) of each extracts against the cancer
cells with the normal cells (HUVEC).
The SI with greater or equal value of three was considered
to be highly selective towards cancer cells [24, 25, 38, 39].
As shown in Table 1, the hexane extract showed selective
activity towards Ca Ski and MCF-7 cells with SI values
of 5.3 and 5.4, respectively. Thus, the data have revealed
that the hexane extracts exhibited antiproliferative effect and
possessed selective activity towards Ca Ski and MCF-7 cells,
in reference to normal cells (HUVEC).
3.2. Isolation of Active Principles. The isolation of the active
principles (compounds 1–19) has been described extensively
in section methodology. These chemical components were
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Table 2: Antiproliferative activity [IC50 values (𝜇g/mL)]
a and selectivity index of isolated compounds against selected human cancer cell lines




MCF-7 Ca Ski PC-3 HT-29 HUVEC
labda-8(17), 12 diene-15, 16 dial (1) 16.3 ± 0.2 (2.8) 14.5 ± 0.1 (3.1) 26.3 ± 2.4 (1.7) 21.5 ± 3.1 (2.1) 45.3 ± 1.9
dehydrocurdione (2) 33.0 ± 1.1 (0.7) 21.7 ± 1.1 (1.1) 19.1 ± 2.8 (1.3) 22.7 ± 2.4 (1.1) 24.0 ± 2.1
curcumenone (3) 8.3 ± 1.0 (6.0) >100.0 (0.5) 39.8 ± 4.2 (1.3) 43.3 ± 6.2 (1.2) 50.0 ± 8.6
comosone II (4) >100.0 76.0 ± 1.2 na na na
curcumenol (5) 9.3 ± 0.3 (2.8) 18.5 ± 1.0 (1.4) 17.3 ± 1.2 (1.5) 24.8 ± 2.7 (1.0) 25.9 ± 1.4
procurcumenol (6) 16.1 ± 2.2 (1.0) 62.4 ± 0.3 (0.3) 13.3 ± 1.7 (1.2) 15.5 ± 2.3 (1.1) 16.3 ± 1.0
germacrone (7) 59.1 ± 2.9 (1.2) 39.3 ± 1.2 (1.9) 55.2 ± 4.9 (1.3) 42.9 ± 4.1 (1.7) 73.7 ± 0.3
zerumbone epoxide (8) 24.1 ± 0.1 (0.6) 34.5 ± 0.6 (0.4) 10.8 ± 1.9 (1.3) 13.7 ± 2.7 (1.0) 14.2 ± 1.1
zederone (9) >100.0 (0.4) >100.0 (0.4) 27.0 ± 1.9 (1.6) 19.1 ± 2.5 (2.2) 42.1 ± 2.7
second monoclinic curcumenol (10) >100.0 (0.7) >100.0 (0.7) na na 71.7 ± 6.1
furanodiene (11) 36.5 ± 2.6 (1.1) na 39.5 ± 4.5 (1.0) 47.2 ± 4.4 (0.9) 40.9 ± 2.6
germacrone-4, 5-epoxide (12) 37.2 ± 4.0 (1.3) na 43.9 ± 7.2 (1.1) 39.6 ± 4.6 (1.2) 48.4 ± 4.7
calcaratarin A (13) 62.5 ± 4.8 (0.8) na 41.7 ± 3.4 (1.1) 48.3 ± 5.1 (1.0) 47.3 ± 4.2
isoprocurcumenol (14) 58.8 ± 4.2 (0.8) na 37.4 ± 4.5 (1.2) 51.6 ± 3.9 (0.9) 45.1 ± 3.0
germacrone-1, 10-epoxide (15) 61.2 ± 5.8 (0.9) na 53.2 ± 4.9 (1.0) 72.8 ± 8.3 (0.8) 55.5 ± 1.6
zerumin A (16) 22.3 ± 1.1 (1.2) na 21.9 ± 1.6 (1.2) 17.4 ± 2.0 (1.5) 25.8 ± 1.9
curcumanolide A (17) 29.8 ± 3.1 (0.7) na 18.8 ± 2.4 (1.2) 21.3 ± 3.2 (1.0) 21.7 ± 7.0
curcuzedoalide (18) 49.8 ± 3.6 (0.9) na 62.1 ± 8.1 (0.7) 58.2 ± 3.5 (0.8) 45.3 ± 7.8
gweicurculactone (19) 31.2 ± 3.2 (2.3) na 38.3 ± 2.2 (1.9) 35.7 ± 5.8 71.7 ± 6.1 (2.0)
doxorubicin∗ 0.1 ± 0.0 (4.0) 0.2 ± 1.0 (2.0) na na 1.4 ± 0.0
aData are presented as mean ± standard deviation (SD) of three replicates.
bSI is the selectivity index. SI ≥3.0 denotes high selectivity towards cancerous cells.
∗na-not available.
identified using spectroscopic (NMR, IR, and UV) and
spectrometric studies (GS-MS, LC-MS, and MS) and were
found to be in agreement with reported data [14–18, 20, 23,
26–32].
3.3. Antiproliferative Activity of Compounds (1–19). The com-
pounds (1–19) isolated from the hexane and dichloromethane
extracts were further evaluated on four selected cancer cell
lines (MCF-7, Ca Ski, HT-29, and PC-3) and a normal human
umbilical vein endothelial cell (HUVEC). Many researchers
have utilizedHUVEC cell lines in determining cytotoxicity of
test samples against normal cells [40–44]. Similar approach
has also widely employed in high-throughput screening in
drug discovery [45]. Test samples showingmild or no toxicity
towards normal cell lines (HUVEC) would be a potentially
good candidate for drug development. The antiproliferative
activity of the compounds (1–19) is presented in Table 2.
The isolated terpenoids from Curcuma zedoaria were found
to possess moderate antiproliferative effect against the four
selected human carcinoma. In the present study, only cur-
cumenone (3) and curcumenol (5) demonstrated strong
antiproliferative activity against MCF-7. Curcumenone (3)
was selectively toxic to MCF-7 cells whilst curcumenol (5)
displayed appreciable selectivity towards MCF-7 in reference
to HUVECs with SI values of 6.0 and 2.8, respectively.
It appeared therefore that compounds (3) and (5) have
selective activity towards MCF-7 cell line. To the best of
our knowledge, there is no report on the cytotoxicity of
compounds (3), (5), and (10) against human MCF-7, Ca
Ski, and PC-3 cell lines. In a study by [14], curcumenone
isolated from the rhizomes of Curcuma zedoaria has been
reported to have protective effect on alcohol-treated mice
and acceleration of liver alcohol dehydrogenase activity. It
is also been found as an effective protective effect on D-
galactosamine/lipopolysaccharide-induced acute liver injury
[5]. In a previous reported publication, [46] claimed that
curcumenol is widely used to treat cancer and inflammation
and also known as an antibiotic or anticancer drug. In their
study, [46] found that curcumenol is not a mechanism-based
inhibitor through time- and NADPH-dependent inhibitions
and also suggested that curcumenol may be safely used with-
out inducing metabolic drug-drug interaction through P450
inhibition. Labda-8(17), 12 diene-15, 16 dial (1) displayed high
selective activity towards Ca Ski and appreciable selectivity
to MCF-7 but only exhibited moderate cytotoxicity against
the cancer cells. Procurcumenol (6) and zerumbone epoxide
(8) exhibited good cytotoxic effect against PC-3 and HT-
29 cell lines but were not selective on these tumor cells.
Previously, [26] described that zerumbone epoxide isolated
from the rhizomes of Curcuma zedoaria possessed cytotoxic
effects. Thus, this is in a good agreement with our current





Figure 3: Morphological analysis of MCF-7 cells treated with curcumenone and curcumenol as observed under inverted phase contrast
microscope (400x).
study. Compounds (1–10) displayed appreciable to weak
cytotoxic activity against Ca Ski (IC
50
values ranging from
14.5 ± 0.1 to 100.0 𝜇g/mL, respectively). Only curcumenone
(3) did not show any antiproliferative activity against Ca
Ski. Other compounds (1, 2, 5, 9, 16, and 17) also exhibited
moderate inhibitory activity against the tested carcinoma
PC-3 and HT-29 cell lines. All tested compounds showed
mild cytotoxicity towards the normal cell lines (HUVEC).
Curcumenone (3) and zerumbone epoxide (8) were found
to have slight toxicity towards the normal cell. Although
the pure compounds are not as effective as doxorubicin in
inhibiting the proliferation of the cancer cells, they inflict
less damage to the noncancerous cells. To the best of our
knowledge, it is important to note that compounds (1, 8, 12-
13, and 19) are reported here for the first time from Curcuma
zedoaria. In this study, zerumin A (16) was isolated from
the hexane fraction and displayed moderate cytotoxic effect
on MCF-7, Ca Ski, and PC-3 cell lines. This is in agreement
with that reported by [23] whereby zerumin A isolated from
Curcuma mangga exhibited antiproliferative effect on Ca Ski
andMCF-7 displaying IC
50
of 8.7±0.29 and 14.2±0.06 𝜇g/mL,
respectively. In our previous study [19], curzerenone and
alismol were also reported present in Curcuma zedoaria
which were not found in the present study. The reason for
this difference is possibly due to the source of the plant
samples. The plant sample in the present study was obtained
from Tawamangu, Java, Indonesia, whilst those in the earlier
report were collected from Jogjakarta, Indonesia. In addition,
it is also important to note that diterpenoids (compounds
1, 13, and 16) were not detected in the sample obtained
from Jogjakarta, and the isolation of curzerenone and alismol
were based on bioassay-guided procedure. The cytotoxicity
assay used in the present study could only provide important
preliminary data to help select isolated compounds with
potential anticancer properties. Further studies on the effect
of curcumenone (3) and curcumenol (5) on the mode of
MCF-7 cell death were thus pursued.
3.4. Induction of Apoptosis. The result from the cytotoxicity
assay provides important preliminary data that may help
select compounds with promising anticancer effects for





Figure 4: Apoptosis-inducing effect of curcumenone and curcumenol on MCF-7 cells by double staining using Hoechst 33342/PI and
visualized under fluorescence microscope (630x).
further work. A detailed investigation on the underlying
mechanism involved in cell death would provide a more
convincing evidence of anticancer effect. Thus, apoptosis
induction of the active compounds in the cancer cells was
investigated. Apoptosis is described as programmed cell
death. It is an essential process that enables the removal
of cells from tissues thus maintaining the proper function
of multicellular organisms. In the average human adult,
about 50–70 billion cells die by apoptosis each day. However,
diseases such as cancer resulted when cells fail to die. A
series of events is involved in the process of apoptosis. The
events start with cell dehydration which leads to cytoplasm
condensation and alteration in cell shape and size. The next
event is chromatin condensation which starts at the nuclear
periphery and results in the concave shape of the nucleus,
followed by nuclear membrane integration and nuclear frag-
mentation. Nuclear fragmentation and other organelles of
the apoptotic cells are enveloped by fragments of cytoplasm
and form apoptotic bodies which are phagocytosized by
neighboring cells, thus preventing inflammatory reaction.
These events can be observed in an inverted phase contrast
and fluorescence microscope. Thus, apoptosis was first and
is still best described morphologically [37]. Induction of
apoptosis based on biochemical changes or flow cytometric
analyses should always be backed up with morphological
studies [37].
3.5. Morphology of MCF-7 Cells Treated with Curcumenone
and Curcumenol as Observed under Inverted Phase Contrast
Microscope. In this study, the apoptosis inducing capacity
of the two bioactive compounds, namely, curcumenone (3)
and curcumenol (5), on MCF-7 cells was thus investigated
using inverted phase contrast microscope. MCF-7 cells were
incubated for 48 h with 12.5 and 25𝜇g/mL of curcumenone
(3) and curcumenol (5), respectively. Exposure of MCF-7
cells to the compounds led to cell shrinkage, loss of contact
with adjacent cells, and decrease in cell numbers (Figure 3).
In comparison, the untreated (control) cells were observed as
intact and were cuboids or polygonal in shape. Floating cells
detached from the surface of the tissue culture dishes (not
shown) were also observed.
3.6. Hoechst 33342/PI Staining of MCF-7 Cells upon Treat-
ment with Curcumenone and Curcumenol. Dual staining by
Hoechst 33342/propidium iodide (PI) of MCF-7 and Ca Ski
cells revealed that induction of apoptotic death occurred after
48 h incubation with curcumenone (3) and curcumenol (5).























































Figure 5: Apoptotic index and percentage of necrotic cells. Values expressed aremeans ± standard deviation (s.d.) of triplicatemeasurements.
The asterisks (∗) denote significant differences between groups (𝑃 < 0.05).
The untreated cells displayed intact regular form and were
homogenously stained with a dimmer blue color. After
the cells were treated (48 h) with 12.5 and 25 𝜇g/mL of
curcumenone (3) and curcumenol (5), respectively, apoptotic
nuclei emitted much brighter blue fluorescence due to the
highly condensed chromatin. As in Figure 4, crescents were
observed around the periphery of the nucleus due to chro-
matin condensation. Cells that were in late apoptosis emitted
pink fluorescence.The organized structure of pink chromatin
denoted dead cells with normal nuclei. Dead cells with
apoptotic nuclei showed highly condensed and fragmented
bright pink chromatin. Necrotic cells were swollen with
irregularmembranes and fluorescence bright pink chromatin
(due to PI).There was a significant increase in the percentage
of apoptotic cells due to increasing dose of tested compounds.
Curcumenol (5) revealed better inducing apoptosis capacity
in comparison to curcumenone (3) as observed in Figure 5.
4. Conclusions
In this study, Curcuma zedoariawas shown to possess several
compounds that have antiproliferative effect on four cancer
cell lines (MCF-7, Ca Ski, PC-3, and HT-29). Amongst these,
two compounds, namely, curcumenone (3) and curcumenol
(5), present in the hexane extract were able to induce
apoptosis in MCF-7 cells by inhibiting the proliferation of
the cancer cells. However, further investigations are necessary
to determine their mode of action. It is noteworthy to
mention that the hexane extract and the two compounds
curcumenone and curcumenol showed low toxicity towards
the normal cell line (HUVEC). If this also occurs in vivo
then this plant has the potential to be developed as anticancer
agent.
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Curcuma purpurascens Bl., belonging to the Zingiberaceae family, is known as temu tis in Yogyakarta, Indonesia. In this study,
the hydrodistilled dried ground rhizome oil was investigated for its chemical content and antiproliferative activity against selected
human carcinoma cell lines (MCF7, Ca Ski, A549, HT29, and HCT116) and a normal human lung fibroblast cell line (MRC5).
Results from GC-MS and GC-FID analysis of the rhizome oil of temu tis showed turmerone as the major component, followed by
germacrone, ar-turmerone, germacrene-B, and curlone.The rhizome oil of temu tis exhibited strong cytotoxicity against HT29 cells
(IC
50
value of 4.9 ± 0.4 𝜇g/mL), weak cytotoxicity against A549, Ca Ski, and HCT116 cells (with IC
50
values of 46.3 ± 0.7, 32.5± 1.1,
and 35.0 ± 0.3 𝜇g/mL, resp.), and no inhibitory effect against MCF7 cells. It exhibited mild cytotoxicity against a noncancerous
human lung fibroblast cell line (MRC5), with an IC
50
value of 25.2 ± 2.7 𝜇g/mL.This is the first report on the chemical composition
of this rhizome’s oil and its selective antiproliferative effect on HT29. The obtained data provided a basis for further investigation
of the mode of cell death.
1. Introduction
Curcuma is a renowned genus in the family of Zingiberaceae
due to the popularity of turmeric, Curcuma longa L. [1].
Curcuma species are native to several countries of Southeast
Asia and extensively cultivated in Bangladesh, India, China,
Taiwan, Sri Lanka, Indonesia, Peru, Australia, and the West
Indies [2]. The name Curcuma was established by Linnaeus
(1753), and its generic epithet is derived from the Arabic word
“kurkum,” meaning yellow colour, which refers to the colour
of the rhizomes [3, 4]. Curcuma has been circumscribed
by its cone-like inflorescence of few-flowered, congested
bracts and versatile, usually spurred anthers [5]. Curcuma
is mostly grown for its foliage or rhizomes, which are
widely used as a starch source, food seasoning or flavours
in native dishes, coloured pigments (orange, yellow, citron,
amber, blue, greenish-blue, and violet-blue), and ingredients
in traditional medicines to treat various ailments, including
aches, pains, wounds, liver disorders, and cancers [4, 6, 7].
Curcuma purpurascens Bl. is one of the less known
Curcuma species and is considered of minor importance [4].
C. purpurascens, locally known as temu tis in Yogyakarta,
Indonesia, is also known as Solo’s (east of Yogyakarta) temu
glenyeh or temu blenyeh, whose scientific name is Curcuma
soloensis Val. [8]. Villagers from the Kediri district of East
Java plant C. purpurascens or temu tis at the base of Mount
Wilis. The rhizomes are dried and ground before being
sold to wholesalers as alternative medicine. The powdered
rhizomes are usually taken together with other herbs to treat
ailments, such as cough and skin infections [8, 9]. Temu tis
can grow up to 1.75m in height and usually flowers from
October to February [9]. Morphologically, the rhizomes of
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temu tis are similar to those of common turmeric (Curcuma
longa).However, cross-sections of the rhizomes of temu tis are
slightly bigger and paler in colour in comparison to common
turmeric [8]. Hence, the dried ground rhizomes of temu
tis are often used to adulterate dried ground rhizomes of
common turmeric andCurcuma xanthorrhiza (locally known
as temulawak) for higher profit margins [8].
Until now, the phytochemical and biological investiga-
tions reported on this plant have been very limited. The
plantlet of temu tis was reported to be successfully trans-
planted to soil via propagation using in vitro tissue culture
methods [9]. The essential oil content of the dried ground
rhizomes of temu tis showed the presence of only four
compounds, namely, turmerone and ar-turmerone (as the
major components), as well as xanthorrhizol and isofurano-
germacrene (also known as curzerene) [8]. Hexane and
chloroform extracts of the rhizomes of C. purpurascens
were reported to exhibit the strongest inhibition against
Candida albicans [10]. Fractions C and G obtained from the
hexane extract and fraction 𝑎 obtained from the chloroform
extract were found to have good antifungal activity,
comparable to that of the reference standard, miconazole
[10]. 1-𝛼-Terpineol, 𝛽-eudesmol, farnesol, 1,6-dimethyl-9-(1-
methylethylidene)-5,12-dioxatricyclo[9.1.0.0(4,6)]dodecan-
8-one, and caryophyllene oxide were identified in these
fractions via gas chromatography-mass spectrometry
(GC-MS) [10].
Although temu tis is considered one of the less important
Curcuma species, there is still a need to investigate the
chemical constituents of its rhizome oil and its biological
activity. Results from chemical investigation of the rhizome
oil of temu tis can be utilised to authenticate temu tis and to
determine the presence of adulteration in ground turmeric.
Results from biological investigations on the rhizome oil
or extracts of temu tis would provide more insight into
the potential use of this plant for therapeutic purposes.
Thus, in the present study, the essential oil obtained from
hydrodistilled dried ground rhizome oil of temu tis was anal-
ysed for its chemical composition, and its antiproliferative
activity against selected human carcinoma cell lines was also
investigated. This is the first report on the chemical content
of the hydrodistilled dried ground rhizome oil of temu tis
and its antiproliferative activity against selected human cell
lines.
2. Materials and Methods
2.1. Collection of Plant Materials and Extraction of Rhi-
zome Oil. The dried rhizomes of temu tis were collected
from Yogyakarta, Indonesia, in September 2012. A voucher
specimen, KL 5793, was deposited at the herbarium of the
Chemistry Department, Faculty of Science, University of
Malaya, Kuala Lumpur, Malaysia. The rhizomes (300.00 g)
were cut into small pieces, ground, and immediately soaked
in distilled water (1.00 L) in a round-bottomed flask. The
soaked sample was distilled in a Clevenger-type apparatus
for 5 hours. The yield of the oil (2.16 g, 0.72%) was calculated
based on the weight of the dried plant material.
2.2. GC-MS and GC-FID Analysis. The oil was analysed on
an Agilent Technologies 7890A GC system equipped with
an FID detector using a fused HP-5 silica capillary column
(5% diphenyl- and 95% dimethyl-polysiloxane, 30.00m ×
0.32mm ID, 0.25 𝜇m film thickness) with helium as the car-
rier gas at a flow rate of 1.0mL per minute. The column tem-
perature was initially programmed to and kept at 60.0∘C for
10.0 minutes, then increased at 3.0∘C per minute to 230.0∘C,
and held for 1.0 minute.The temperatures of the injector port
and detector were set to 230.0∘C and 250.0∘C, respectively,
with a split ratio of 1 : 20. GC-MS analysis was performed on
an Agilent Technologies 6890N GC System equipped with
a 5975 inert mass selective detector (70 eV direct inlet) on
an HP-5ms capillary column (30.0m × 0.25mm ID, 0.25 𝜇m
film thickness). The column temperature was programmed
to 60.0∘C for 10.0 minutes, then increased to 230.0∘C at 3.0∘C
per minute, and held for 1.0 minute at 230.0∘C. Helium was
used as the carrier gas at a flow rate of 1.0mL per minute
with a split ratio of 1 : 20. The injector port temperature was
set to 230.0∘C and detector to 250.0∘C.The obtained total ion
chromatogram was autointegrated by ChemStation, and the
components were identified by comparison with an accom-
panying mass spectral database [11]. The arithmetic index
(AI) was experimentally measured from the programmed
temperature GC-FID by arithmetic interpolation between
bracketing alkanes, using a homologous series of n-alkanes
as standards [12, 13].
2.3. Cell Propagation. Human breast carcinoma cells
(MCF7), human cervical carcinoma cells (Ca Ski), human
lung carcinoma cells (A549), human colon carcinoma
cells (HCT116 and HT29), and noncancerous human lung
fibroblast cells (MRC5) were purchased from the American
Tissue Culture Collection (ATCC, USA). All the cells were
cultured using protocols described earlier [14]. MCF7, Ca
Ski, A549, and HT29 cells were cultured in supplemented
RPMI 1640 medium, HCT116 cells in supplemented
McCoy’s 5A medium, and MRC5 in supplemented Eagle’s
minimum essential medium (EMEM). The RPMI 1640,
McCoy’s 5A, and EMEM media (Sigma-Aldrich, USA) were
supplemented with 10.0% v/v foetal bovine serum (PAA
Laboratories, Austria), 100.0 𝜇g/mL penicillin/streptomycin
(PAA Laboratories, Austria), and 50.0 𝜇g/mL amphotericin
B (PAA Laboratories, Austria). The EMEM medium was
also supplemented with 11.0mg/mL sodium pyruvate
(Sigma-Aldrich, USA). Briefly, the cells were cultured in
25.0 cm3 tissue culture flasks (Nunc, Denmark) in 5.0% CO
2
in an air-jacketed incubator (ESCO, USA) kept at 37.0∘C
in a humidified atmosphere and routinely observed under
inverted microscope (Carl Zeiss Axio Vert.A1, Germany) for
any contamination. The medium was replaced every 2 or 3
days until cell confluence was achieved, and the cells were
detached using Accutase (PAA Laboratories, Austria). The
rhizome oil of temu tis was dissolved in molecular-biology-
grade dimethyl sulfoxide (DMSO) from Sigma-Aldrich,
USA.
2.4. Antiproliferative Assay. The antiproliferative assay was
performed using an MTT assay according to the method of
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Table 1: Chemical composition of the essential oil of temu tis’ rhizomes.
Number Compounds Arithmetic indices (AI) Percentage of Methods of
Calculated Literature [13] peak area identification
1 1,8-Cineole 1031 1026 3.3 MS, AI
2 Camphor 1144 1141 4.0 MS, AI
3 Borneol 1166 1165 0.3 MS, AI
4 Terpinen-4-ol 1178 1174 0.3 MS, AI
5 p-Cymen-8-ol 1184 1179 0.2 MS, AI
6 𝛼-Terpineol 1191 1186 0.8 MS, AI
7 Thymol 1293 1289 0.1 MS, AI
8 𝛿-Elemene 1339 1335 0.2 MS, AI
9 Piperitenone 1342 1340 0.7 MS, AI
10 𝛽-Elemene 1393 1389 1.2 MS, AI
11 cis-𝛼-Bergamotene 1416 1411 0.1 MS, AI
12 trans-Caryophyllene 1421 1417 1.8 MS, AI
13 𝛾-Elemene 1435 1434 1.6 MS, AI
14 Aromadendrene 1441 1439 0.1 MS, AI
15 𝛼-Humulene 1455 1452 0.1 MS, AI
16 trans-𝛽-Farnesene 1458 1454 0.2 MS, AI
17 𝛾-Muurolene 1478 1478 0.5 MS, AI
18 ar-Curcumene 1484 1479 2.6 MS, AI
19 𝛼-Selinene 1488 — 1.3 MS
20 Curzerene 1500 1499 5.8 MS, AI
21 𝛽-Bisabolene 1510 1505 0.4 MS, AI
22 𝛽-Sesquiphellandrene 1526 1521 2.7 MS, AI
23 Selina-3,7(11)-diene 1544 1545 0.6 MS, AI
24 Germacrene-B 1561 1559 8.8 MS, AI
25 ar-Turmerol 1580 1580 3.3 MS, AI
26 Guaiol 1595 1600 0.3 MS, AI
27 trans-𝛽-Elemenone 1607 1602 2.5 MS, AI
28 𝛾-Eudesmol 1633 1630 0.7 MS, AI
29 𝛽-Eudesmol 1637 — 0.7 MS
30 Atractylone 1654 1657 0.6 MS, AI
31 ar-Turmerone 1671 1668 9.4 MS, AI
32 Turmerone 1675 — 13.5 MS
33 Germacrone 1702 — 13.2 MS
34 Curlone 1705 — 6.2 MS
Total rhizome oil = 88.1%
Remarks: MS: mass spectroscopy [11]; AI: arithmetic indices [13].
[15] with some modifications. Cells were plated into sterile
96-well culture plates at a density of 3.0 × 104 cells/mL. The
96-well plates were incubated in 5.0% CO
2
in an air-jacketed
incubator at 37.0∘C for 24 hours for the cells to adhere.
The medium was removed after 24 hours of incubation, and
150.0 𝜇L of fresh medium containing various concentrations
of the rhizome oil of temu tis was added. The plates were
further incubated for 72 hours. Then, 20.0 𝜇L of MTT solu-
tion (Sigma-Aldrich, USA) was added to each well, and the
plates were again incubated for 4 hours. Medium containing
MTT was discarded, and 150.0𝜇L of DMSO was added into
each well to dissolve the formazan crystals.The absorbance of
each well was measured at 570 nm using a microplate reader
(Synergy H1 Hybrid Multi-Mode Microplate Reader, USA).
The IC
50
values were determined by the interpolation of the
dose-response curve for each cell line.
3. Results and Discussion
3.1. Yield of Rhizome Oil Extraction. Hydrodistillation
of the dried rhizomes of temu tis (300.0 g) yielded 2.2 g
(0.7%) of oil. The identified constituents of the rhizome
oil are listed in Table 1. The constituents were identified by
matching their mass spectra and arithmetic indices with
reference libraries [11–13]. Thirty-four (34) compounds
consisting of eight (8) monoterpenoids (9.7%), fifteen (15)
sesquiterpenes (22.2%), and eleven (11) sesquiterpenoids
(56.2%) were identified from the rhizome oil of temu tis.
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Figure 1: The GC-FID profile of the essential oil of rhizomes of Curcuma purpurascens Bl. (temu tis).
The monoterpenoids are 1,8-cineole, camphor, borneol,
terpinen-4-ol, p-cymen-8-ol, 𝛼-terpineol, thymol, and
piperitone, while the sesquiterpenes are 𝛿-elemene,
𝛽-elemene, cis-𝛼-bergamotene, trans-caryophyllene, 𝛾-
elemene, aromadendrene, 𝛼-humulene, trans-𝛽-farnesene,
𝛾-muurolene, ar-curcumene, 𝛼-selinene, 𝛽-bisabolene, 𝛽-
sesquiphellandrene, selina-3,7(11)-diene, and germacrene-B.
The identified sesquiterpenoids are curzerene, ar-turmerol,
guaiol, trans-𝛽-elemenone, 𝛾-eudesmol, atractylone, ar-
turmerone, turmerone, germacrone, and curlone. These
components made up 88.1% of the total components
detected in the GC chromatogram of the oil (Figure 1).
The major components identified were turmerone (13.5%),
germacrone (13.2%), ar-turmerone (9.4%), germacrene-B
(8.8%), and curlone (6.2%), which together amount to 51.1%
of the total oil.
3.2. GC-MS and GC-FID Analysis. The findings of this study
differ from a previous study on the rhizome oil of temu
tis, which reported turmerol and ar-turmerone as the major
components [8]. The current study also did not find xanth-
orrhizol in the rhizome oil of temu tis. This study identified
thirty-four (34) compounds in the rhizome oil of temu tis, but
the previous study identified only turmerone, ar-turmerone,
xanthorrhizol, and curzerene [8]. Ground rhizomes of temu
tis have been used as adulterants in ground common turmeric
and C. xanthorrhiza (temulawak) for higher profit margins
[8]; thus, it is necessary to compare the chemical content of its
rhizome oil with those of common turmeric and temulawak.
Previous studies on the essential oil content of dried rhizomes
of common turmeric reported ar-turmerone as the major
component, ranging from 21.4% to 49.0% [16–18], while the
essential oil content of fresh rhizomes showed ar-turmerone
content ranging from 24.4% to 49.1% [16, 19, 20]. Others
reported 𝛼-turmerone as the major component ranging from
21.4% to 44.1% [21, 22]. Ar-curcumene (40.0% to 65.0%)
was reported to be the major compound identified from the
rhizome oil of temulawak [23, 24], followed by xanthorrhizol
(21.5%) [24]. A recent report identified xanthorrhizol as
the major component (31.9% to 64.4%) in the rhizome
oil of temulawak [25, 26]. Hence, the results of chemical
investigations on the rhizome oil of temu tis in this study
differ from those reported in the literature for both common
turmeric and temulawak. The presence of ar-turmerone and
xanthorrhizol found in the essential oil of temu tis by the
Indonesian researchers in the previous study could possibly
be due to adulteration by common turmeric and temulawak
in the sample used [8].
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Table 2: Cytotoxicity activity of the rhizome oil of temu tis.
Cell lines
MCF7 Ca Ski A549 HCT116 HT29 MRC5
IC50 values (𝜇g/mL) >100.0 32.5 ± 1.1 46.3 ± 0.7 35.0 ± 0.3 4.9 ± 0.4 25.2 ± 2.7
Tabulated values are mean standard error (SE, SE < 5.00) of three replicates.
The yield of the rhizome oil of temu tis reported in the
previous study was 4.6% [8], while that of the rhizome oil of
temu tis obtained in this study is only approximately 0.7%. A
previous study on the rhizome oil of temulawak showed that
the yield of the rhizome oil from temulawak is approximately
4.5% [25], while the yield of essential oil from both fresh and
dried rhizomes of common turmeric ranged from 0.7% to
1.1% [17, 19, 21, 22]. The similarity of the yield of the rhizome
oil of temu tis obtained by the Indonesian researchers (4.6%)
with that obtained by Jantan et al. [25] again indicated that
the ground temu tis used in their study could have been
adulterated with temulawak.
3.3. Antiproliferative Effect. The antiproliferative effects of
the rhizome oil of temu tis against human breast carcinoma
cells (MCF7), human cervical carcinoma cells (Ca Ski),
human lung carcinoma cells (A549), human colon carcinoma
cells (HCT116 and HT29), and noncancerous human lung
fibroblast cells (MRC5) were investigated via an MTT assay,
and the results are shown in Table 2. According to the US
NCI’s plant screening program, crude extracts with IC
50
values (concentration that inhibited 50% of cell proliferation)
of less than 20.0𝜇g/mL following incubation between 48
and 72 hours are considered to have in vitro cytotoxic
activity [27]. The rhizome oil of temu tis exhibited very good
cytotoxic effects against HT29 cells with an IC
50
value of 4.9±
0.4 𝜇g/mL. However, it exhibited no inhibitory effect against
MCF7 cells and very mild cytotoxicity against A549, Ca Ski,
and HCT116 cells with IC
50
values of 46.3 ± 0.7, 32.5 ± 1.1,
and 35.0 ± 0.3 𝜇g/mL, respectively. The rhizome oil of temu
tis also exhibited mild cytotoxicity against the noncancerous
human lung fibroblast cell line, MRC5 (IC
50
value of 25.2 ±
2.7 𝜇g/mL).
There are few reports found in the scientific literature
on the antiproliferative effect of the rhizome oil of Curcuma
species. Two studies reported that the rhizome oil ofCurcuma
zedoaria exhibited an inhibitory effect on the growth of
a human promyelocytic leukaemia cell line (HL-60) and
nonsmall cell lung carcinoma cell lines (H1299, A549, and
H23) with IC
50
values of 500.0, 80.0, 80.0, and 185.0 𝜇g/mL,
respectively [28, 29]. The rhizome oil of Curcuma wenyujin
had an antiproliferative effect on the human hepatoma cell
line, HepG2, with an IC
50
value of 70.0 𝜇g/mL [30]. However,
the reported antiproliferative effects for the rhizome oil
of both Curcuma zedoaria and Curcuma wenyujin did not
meet the definition of in vitro cytotoxic activity defined by
the US NCI’s plant screening program [27] because their
IC
50
values are greater than 20.0 𝜇g/mL following 72 hours
of incubation. Thus, the rhizome oil of temu tis exhibited
better antiproliferative effects against the investigated human
carcinoma cell lines in comparison to those reported in the
literature [28–30], and the obtained IC
50
value against HT29
cells is less than 20.0𝜇g/mL following 72 hours of incubation.
The good cytotoxic effect exerted by the rhizome oil of
temu tis against HT29 cells may be due to the presence of an
appreciable amount of ar-turmerone (9.4%) and germacrene-
B (8.8%) in the rhizome oil. Germacrene-B was reported to
exhibit good cytotoxicity against a human ovarian cell line,
A2780, with an IC
50
value of 6.4 𝜇g/mL; however, presently,
there is no report on the molecular pathway of cancer
cell death induced by germacrene-B [31]. Ar-turmerone was
reported to have an inhibitory effect against several cell lines,
namely, a humanmyelogenous leukaemia carcinoma cell line
(K562), a human histiocytic lymphoma carcinoma cell line
(U937), a mouse lymphocytic leukaemia carcinoma cell line
(L1210), and a rat basophilic leukaemia carcinoma cell line
(RBL-2H3), with IC
50
values between 20.0 and 50.0 𝜇g/mL
[32]. Ar-turmerone was also reported to induce apoptosis
in HepG2 cells (a human hepatocellular carcinoma cell line)
via reactive oxygen species- (ROS-) mediated activation
of extracellular signal-related (ERK) and c-Jun N-terminal
(JNK) kinases, which then trigger both extrinsic and intrinsic
caspase cascades, leading to apoptosis [33].
In this study, the rhizome oil of temu tis was found
to exhibit a strong inhibitory effect against HT29 cells but
very mild cytotoxicity against HCT116 cells, even though
both cells are human colon carcinoma cell lines. HT29
cells express cyclooxygenase-2 (COX-2), while HCT116 cells
do not [34]. The expression of COX-2 protein is elevated
during colon carcinogenesis [35]. A recent study reported
that ar-turmerone blocked theNF-𝜅B, PI3K/Akt, and ERK1/2
signalling pathways in human breast cancer cells, which
led to suppression of 12-O-tetradecanoylphorbol-13-acetate-
(TPA-) induced upregulation of matrix metalloproteinase-
(MMP-) 9 and COX-2 expression [36]. Ar-turmerone (9.4%)
in the rhizome oil of temu tis may have suppressed COX-2
expression by blocking theNF-𝜅B, PI3K/Akt, andERK1/2 sig-
nalling pathways, and synergistic effects of other constituents,
such as turmerone, germacrone, germacrene-B, and curlone,
may have inhibited the proliferation of HT29 cells. However,
the amount of ar-turmerone was insufficient to exert any
inhibition against the proliferation of MCF7 cells. Further
in vivo toxicity studies on animal models will be attempted
to determine the toxicity of the rhizome oil of temu tis, as
it showed a mild inhibitory effect against MRC5 cells, the
noncancerous human lung fibroblast cell line (IC
50
value of
25.2 ± 2.7 𝜇g/mL).
4. Conclusion
In conclusion, GC-MS analysis of the rhizome oil of temu
tis could be developed into a standard method to identify
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and differentiate the rhizome of temu tis from the rhizomes
of common turmeric and temulawak. The rhizome oil of
temu tis exhibited selective cytotoxic effect towards HT29
cell lines. Its inhibitory effect against HT29 cells may be
due to the augmentation of COX-2 expression levels by
ar-turmerone and synergistic effects of other constituents,
such as turmerone, germacrone, germacrene-B, and curlone.
In addition, the data obtained from this study provide a
scientific basis for the use of this rhizome oil in the treatment
of cancer-related diseases.
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